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Abstract  
 Giardia is a major cause of diarrheal disease worldwide. It is a flagellated 
cyst-forming enteric pathogen that inhabits the lumen of the small intestine. Two 
genetically distinct lineages (assemblages A and B) are of public health relevance 
and are often associated with water-borne outbreaks. Yet, the mechanism of 
pathogenesis and virulence in Giardia is poorly understood. A soluble component 
derived from healthy, viable and human infective Giardia trophozoites was shown 
to be able to mediate profound changes in the physiology of human derived enteric 
cells, consistent with the production of secreted virulence factors by the parasite. 
Quantitative proteomic analysis was successfully applied to the whole parasite and 
supernatants derived from the parasite in order to ascertain which parasite 
proteins are secreted. The genome of Giardia is believed to contain open reading 
frames which could encode as many as 6,000 proteins although hitherto there was 
only direct evidence for expression of a few hundred of these. Approximately 1,600 
proteins were identified from each assemblage, the vast majority of which being 
common to both lineages. To look for actual enrichment in the supernatant, the 
ratio of proteins in the supernatant was compared with the pellet. This defined a 
far smaller group of putatively secreted proteins enriched comprising a high 
proportion encoded by genes annotated to have signal peptides, known virulence 
factors such as the Cathepsin B cysteine proteases and Variable Surface Proteins, 
scavenging proteins such as an extracellular nuclease and a high proportion of 
hitherto hypothetical proteins and proteins of unknown function. Further analysis 
of the genes encoding these proteins indicated that they were highly variable and 
likely to be under positive selection pressure, confirming their probable role in host-
pathogen interactions and their potential as markers for discriminating virulent 
strains. Based on the proteomic analysis, a new model of pathogenic mechanism 
for Giardia-induced damage to enteric epithelium in which extracellular nuclease, 
Cathepsin B and Tenascin may have a concerted action was proposed and may have 
important implications in the understanding of Giardia pathogenesis.  
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1.1/ Giardia Historical Background 
In 1681, Antony van Leeuwenhoek described Giardia for the first time while 
he was observing his own diarrhoeal stools under a microscope(Steuart et al., 2008) 
(Ford, 2005, Dobell, 1920). The next description was not until 1859 when the 
organism was described in greater detail by Vilém Dušan Lambl who thought this 
parasite belonged to the genus Cercomonas. Thus, he named it Cercomonas 
intestinalis. Thereafter, some investigators named the genus after Lambl while 
others named the species infecting humans after him (Giardia lamblia) (Adam, 
2001). In 1879, Battista Grassi discovered a rodent parasite, now known to be a 
Giardia species, and named it Dimorphus muris apparently unaware of Lambl’s 
earlier description. In 1882 and 1883, Johann Künstler described an organism in 
tadpoles (possibly G.agilis) that he named Giardia. It was the first time that Giardia 
was used as a genus name. This genus name was chosen to honor Professor Alfred 
Giard, an eminent french zoologist. Raphaël Blanchard, in 1888, suggested Lamblia 
intestinalis after Lambl. Charles W. Stiles changed it to Giardia duodenalis in 1902 
and to Giardia lamblia in 1915 to commemorate Professor Giard and Dr. Lambl 
(Ford, 2005, Adam, 2001). The same year (1915), Charles A. Kofoid and Elizabeth B. 
Christiansen proposed Giardia lamblia instead of Blanchard’s suggestion of Lamblia 
intestinalis (Kofoid and Christiansen, 1915) and, in 1920, Kofoid and Christiansen 
used Giardia enterica (Adam, 2001). 
 For many years, the naming of species caused controversy. Some 
researchers suggested naming species on the basis of the host of origin, which 
could have led to name over 40 species. On the other hand, others were focusing 
on morphology like Charles E. Simon, in 1922, who used morphologic criteria to 
distinguish between G. lamblia and G. muris and accepted the name G. lamblia for 
the forms infecting humans (Simon, 1922). 
In 1952, Francis Filice published a detailed morphologic description of 
Giardia and proposed that three species names be used on the basis of the median 
body’s morphology: G. duodenalis, G. muris and G. agilis (Adam, 2001). The names 
for the human parasite Giardia duodenalis, Giardia lamblia and Giardia intestinalis 
are all currently used despite the potential for confusion that this has created. 
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Indeed, through the 1970s, the species name Giardia lamblia became widely 
accepted; and, since the 1980s, some scientists have encouraged the use of the 
name Giardia duodenalis. Moreover, in the 1990s, the use of Giardia intestinalis has 
been encouraged. Since the beginning of the XXI century, the use of one of the 
three names rather than another seems to have lessened. In fact, G. duodenalis, G. 
intestinalis and G. lamblia appear to be used equally in publications. According to 
PubMed, for a total of 12,256 publications on Giardia, 31 % (3,777) used the term 
G. lamblia, 34 % (4,209) used G. intestinalis and 35 % (4,270) used G. duodenalis. In 
2009, Monis and collaborator proposed a revised taxonomy based on genetics and 
suggesting that each assemblage is a lineage evolving independently. G. duodenalis 
was suggested for assemblage A, G. enterica for assemblage B, G. canis for 
assembalges C and D, G. bovis for assemblage E, G. cati for assemblage F and G. 
simondi for assemblage G (Table 1.1). However, these names have been hardly used 
in publications. In 2013, however, 259 studies on Giardia were published, 145 (56%) 
referred to Giardia as G. lamblia, the 114 publications left used equally G. 
intestinalis (22 %) and G. duodenalis (22 %). For the purposes of this dissertation, I 
will use Giardia to identify the species complex and I will identify the different 
assemblages as it is currently common practice. 
1.2/ Classification of Giardia 
1.2.1/ Phylogeny 
As described above, for many years, the classification of Giardia was only 
based on morphology, which had led to the description of a large number of species 
and a history of taxonomic confusion and controversy for the Giardia genus (Caccio 
et al., 2005, Thompson, 2002). Today, with the development of molecular 
techniques, genotypic classifications are based on sequence analysis of genetic 
markers integrated with structural, biochemical correlations and with pathology; 
which allows a more robust classification of Giardia and other protists (Plutzer et 
al., 2010, Cavalier-Smith, 2003). 
Traditionally, Giardia has been considered as belonging to Phylum 
Sarcomastigophora, Subphylum Mastigophora (=Flagellata), Class 
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Zoomastigophorea, Order Diplomonadida and Family Hexamitidae (Morrison et al., 
2007).  
A decade ago, a new systematic classification was developed and based on 
genetic, structural and biochemical data (Keeling et al., 2005). According to this, 
Giardia would belong to Domain Eukaryota, Kingdom Excavata (unicellular 
Eukaryotes which contain free-living and symbiotic forms and also some important 
parasites of humans), Phylum Metamonada (large group of flagellate protozoa), 
Subphylum Trichozoa, Superclass Eopharyngia, Class Trepomonadea, Subclass 
Diplozoa, Order Giardiida, Family Giardiidae and Genus Giardia (Keeling et al., 2005) 
The members of the Excavata kingdom, which is a divergent and controversial 
“super-group”, are loosely united by a combination of morphological and molecular 
evidence. The phylogenetic robustness of the Excavata kingdom as a whole has yet 
to be determined; however, three subgroups are considered as clades: (i) 
Preaxostyla (including Trimastix and Oxymonads), (ii) Fornicata (Diplomonads, 
Retortamonads and Carpediemonas), (iii) an unnamed clade consisting of 
euglenozoa, Heterolobosea and Jakobida (Hampl et al., 2009).  In 2005, however, 
Keeling et al showed that there were morphological similarities in cytoskeletal 
ultrastructure uniting this kingdom (Keeling et al., 2005). In 2006, multigene 
phylogenetic analyses of six nuclear-encoded protein-coding genes showed that 
excavates were further associated (Simpson et al., 2006). In 2009, Hampl et al also 
showed the monophyly of Excavata by progressively removing long-branch gene 
sequences and taxa to decrease the long-branch attraction (LBA) artefact. However, 
the robust monophyletic group obtained was still not fully recovered as globally 
optimal (Hampl et al., 2009) (Fig 1.1). Although many studies suggest that Giardia 
belongs to the eukaryotic super-group Excavata, the small nucleolar ribonucleic 
acids (snoRNAs) latterly identified from Giardia might be considered to imply G. 
lamblia emerged somewhat later or more adjacent to the higher eukaryotes (Luo et 
al., 2009). 
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1.2.2/ Taxonomy 
The first original species descriptions were based on presumed host 
specificity because all species possess cysts with the same morphology except for G. 
microti which can be identified by the fact that its cysts contain two differentiated 
trophozoites whereas cysts from other species contain a single trophozoite. 
However, this was abandoned in favour of trophozoite morphology based on 
comparisons initiated by Filice in 1952 (Monis and Thompson, 2003, Filice, 1952). In 
the Genus Giardia, six species have been identified on the basis of light microscopic 
(shape of trophozoite and median body) and electro microscopic (form of 
ventrolateral flange, ventral disc and flagellum) characteristics (Fig1.2) (Plutzer et 
al., 2010, Monis and Thompson, 2003, Adam, 2001). G. agilis which infects 
Amphibians; G. ardeae and G. psittaci are found in Birds; G. muris and G. microti are 
found in rodents (Caccio et al., 2005, Adam, 2001). The sixth species, G. lamblia (G. 
duodenalis or G. intestinalis), includes Giardia strains isolated from a large range of 
mammalian hosts (Fig1.3). 
Considering its wide host range and the small amount of morphological 
variation displayed, Giardia lamblia can be considered as a species complex. Seven 
distinct groups, named assemblages, are assigned to Giardia (assemblage A to G) 
based on the genetic analysis of different Giardia genes such as triosephosphate 
isomerase (tpi), glutamate dehydrogenase (gdh), and β-giardin (bg) genes. The 
closely related genotypes are grouped into assemblages and sub-assemblages (Feng 
and Xiao, 2011, Plutzer et al., 2010, Sprong et al., 2009, Adam, 2001). 
Assemblage A and B are responsible for human infections and are also found 
in a wide range of mammals. Assemblage A can also be found in livestock; and 
assemblage B has been found in wildlife and dogs but to a much lesser extent than 
in humans. The remaining assemblages show more restricted host ranges, 
assemblages C and D are found in Canids, E in livestock, F in cats, and G in rodents 
(Sprong et al., 2009, Caccio et al., 2005) (Table 1.1). Isoenzyme analysis of 
laboratory-adapted strains and deoxyribonucleic acid (DNA) sequence analyses at 
different loci showed the presence of subgroups, called sub-assemblages, in  
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Fig 1. 2: Morphological features of a Giardia trophozoite and examples of trophozoite 
morphology of three species of Giardia (modified from Monis and Thompson, 2003, with 
permission). 
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Fig 1. 3: Dendogram depicting the genetic relationships of isolates of G iardia. (modified 
from Monis et al, 2003, with permission). Genetic relationships of Giardia, G. muris and G. 
ardeae were inferred by Neighbour-Joining analysis of allozymes of 21 enzymes detected in 
different isolates (and, rarely, within single isolate), via isoenzyme profiles, using Roger’s 
Distance. Roger’s distance was obtained from the mean Euclidean  distance between allele 
frequencies at each locus identified by allozyme analysis. The mean Euclidean distance is 
considered as the shortest straight-line distance between the focal point (here Giardia) and 
its nearest neighbour (G. muris, G. ardeae and Giardia different assemblages), the Euclidian 
distance is based on the Pythagorean formula. 
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assemblages A and B (Sprong et al., 2009, Monis et al., 1999). Some studies have 
shown that assemblages A and B encompassed genetic groups I to IV, with sub-
assemblages AI, AII, BIII, and BIV (Monis et al., 2009, Robertson et al., 2007, van der 
Giessen et al., 2006, Monis et al., 2003, Mayrhofer et al., 1995). The Giardia sub-
assemblages AI and AII were shown to cycle predominantly within defined hosts, AI 
in livestock, AII in humans; and these cycles don’t interact significantly (Monis et al., 
2009, Sprong et al., 2009). Some genotyping studies have, however, reported AII in 
dogs and cats in some Indian and Mexican communities (Ballweber et al., 2010, 
Eligio-Garcia et al., 2008, Traub et al., 2004). A new sub-assemblage, AIII, was 
identified in wild hoofed animals; (Sprong et al., 2009) (Table 1.1). In assemblage B, 
two sub-assemblages were identified: BIII and BIV. In human isolates, these two 
sub-assemblages were found with a very similar frequency (Sprong et al., 2009). 
They were also found in other mammals (beavers, monkeys, marine animals) with a 
similar frequency too but in a lesser prevalence than in humans (Sprong et al., 
2009) (Table 1.1). Several genes, such as tpi, bg and the small subunit rRNA gene 
(SSU-rRNA) are used to discriminate Giardia DNA at an assemblage level; however, 
only bg, tpi and gdh are sufficiently discriminatory to characterise amongst sub-
assemblages (Scorza et al., 2012, Sprong et al., 2009). Most sub-assemblage studies 
only used single locus approaches to characterise and subtype strains from both 
assemblage A and B which can lead to some discrepancy in the taxonomy. In order 
to increase accuracy of Giardia assemblage and sub-assemblage investigations, a 
multi-locus genotyping strategy is now used to study Giardia genetic diversity (Huey 
et al., 2013, Scorza et al., 2012, Covacin et al., 2011, Lebbad et al., 2010, Caccio et 
al., 2008). Beside assemblages A-G, a new Giardia assemblage was identified and 
characterised in marine vertebrates (seals and gulls): Assemblage H (Lasek-
Nesselquist et al., 2010). This new assemblage was only isolated in a single 
geographic area suggesting a local source; and it was also only genetically 
characterised by gdh amplification. The amplification of tpi was also used to 
characterise Giardia species but did not provide evidence of this new assemblage. 
Moreover, tpi amplified sequences showed a bias towards assemblage B. Plus, none 
of the other gene usually used to characterise Giardia species were used during this 
study. Therefore, this assemblage H, isolated in marine vertebrates, cannot be 
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completely accepted as a new Giardia assemblage yet and requires further 
investigation. 
In 2009, Monis et al proposed a revised taxonomy of Giardia species 
including the host specificity (Monis et al., 2009) (Table 1.2). They showed that the 
genetic distance separating assemblages A and B is at the same level as the genetic 
distance separating the other suggested species. They stated that a revised 
taxonomy of Giardia was necessary for two reasons. First, taxonomy should 
recognise and reflect the biological and evolutionary differences within G. lamblia, 
specifically the host specificity. Second, recognising the different assemblages as 
distinct species could affect ways of thinking in terms of zoonotic potential and 
human health threats. To Monis et al, the fact that the genetic characteristics of the 
assemblages are preserved in sympatric, local areas where the cycles of 
transmission possibly interact reinforces the argument that Giardia assemblages 
represent independently evolving metapopulations. In their study, Monis et al 
showed some limitations in the current taxonomy of Giardia. However, too many 
studies have only used a single locus genotyping sequence to identify Giardia 
assemblages and their subtypes. It has been shown that a gene history may be 
different from a species phylogeny (Heled and Drummond, 2010). Indeed, 
discrepancies such as horizontal transfer, lineage sorting and gene 
duplication/extinction, between a single locus tree and a species tree may be 
problematic for closely related species and sub-species. Therefore, more genetic 
information on the different assemblages and sub-assemblages are needed to 
determine whether or not assemblages are distinct Giardia species. Using the multi-
locus genotyping approach instead of a single marker may determine if a new 
taxonomy is required for Giardia. 
1.2.3/ Sex: an important factor to consider when classifying 
all forms of life such as Giardia 
The origin of sex has always been a central evolutionary question in 
phylogeny and taxonomy. Indeed, one of the major innovations in eukaryotes was  
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Table 1.1: Giardia species and their relationship with their hosts.  
 
 
 
 
 Table 1.2: Revised taxonomy of Giardia and other species (Monis et al., 2009, with 
permission). 
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the origin of sexual reproduction by meiosis with its consequences for effecting 
genome-wide recombination (Cavalier-Smith, 2002). Genetic exchanges have been 
extensively studied in protists such as kinetoplastids and apicomplexans (Heitman, 
2006, Gaunt et al., 2003, Bingle et al., 2001). And yet, little is known about sex in 
other protists such as Giardia and other metanomads. Several studies have though 
suggested that Giardia might undergo sexual reproduction (Lasek-Nesselquist et al., 
2009, Logdson, 2008, Cooper et al., 2007, Heitman, 2006, Ramesh et al., 2005, 
Tibayrenc et al., 1991). 
In eukaryotes, sexual reproduction is accomplished by meiosis. It is a 
specialised process of cell division that results in haploid cells (Villeneuve and 
Hillers, 2001, Heywood and Magee, 1976). In 2001, Villeneuve and Hillers identified 
stereotypical reductive division in meiosis as a major evolutionary innovation in 
eukaryotic cells; stipulating that the delineation of its history might be key to 
understanding the evolution of sex. In 2005, Ramesh et al identified a set of genes 
encoding homologues of known components of the “core meiotic recombination 
machinery”. By conducting a phylogenic study of the genes found in Giardia and 
their putative homologues in other eukaryotes, Ramesh et al showed that the 
Giardia genes are orthologs of their counterparts in organisms known to undergo 
sexual reproduction. From the 17 meiotic genes identified, all but four were found 
in Giardia. According to Ramesh et al, when compared to the same genes in the 
databases of animals, plants and fungi known to have meiotic sex, each to the four 
genes not found in Giardia is also missing from one or more sexual organisms 
(Birky, 2005, Ramesh et al., 2005). None of these genes contain mutations that 
would interrupt their open reading frames (ORFs) (Birky, 2005). Such mutations 
would accumulate in non-functional genes and not in functional genes; which 
shows that Giardia might be capable of sexual reproduction. 
Population genetics studies have analysed the diversity of genes at 
molecular levels, focusing on allelic sequences. Alleles are alternate forms of a gene 
that vary from each other in sequence, yet code for the same polypeptide or RNA 
(Birky, 1996). Alleles usually occupy the same locus on a particular chromosome. In 
diploid or polyploid organisms, the copies (two or more) of a gene can be the same 
or different alleles; this is referred as allelic homozygosity and allelic heterozygosity 
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respectively (Birky, 1996). A population genetics theory suggests that high levels of 
divergence in a lineage are evidence that the lineage has been asexual for a very 
long time. Indeed, organisms that asexually reproduce do not share alleles among 
lineages; and the allelic copies begin to acquire different mutations from the 
moment that sexual reproduction is lost (Birky, 1996). In 2008, Poxleitner et al 
suggested that a fusion of the two Giardia nuclei might occur during the 
encystation of Giardia trophozoites; this phenomenon of nuclear fusion is called 
karyogamy and is found in many polyploid and haploid organisms (Poxleitner et al., 
2008, Birky, 1996, Tibayrenc et al., 1991). According to Poxleitner et al, this 
potential karyogamy of Giardia nuclei could result to Giardia genome’s low levels of 
allelic heterozygosity. In their study, Poxleitner et al also showed that karyogamy 
and material genetic exchanges take place during encystation using fluorescence in 
situ hybridization (FISH) and transmission electron microscopy (TEM). Moreover, 
two other studies showed that recombination and genetic exchanges within and 
between assemblages were possible in Giardia; using population genetics study, 
polymerase chain reaction (PCR) and sequencing, genealogies and tests for 
recombination (Lasek-Nesselquist et al., 2009, Cooper et al., 2007). However, 
despite the fact that genetic exchange was shown to be possible in Giardia via tests 
for recombination, this phenomenon hasn’t been directly observed in Giardia yet. 
The only conclusions we can draw from Lasek-Nesselquist et al., Poxleitner et al., 
Cooper et al., and Ramesh et al. studies are: (i) Giardia might be capable of meiosis 
and, thus, sexual reproduction; (ii) the evolution of meiosis might have happened 
early in the eukaryotic evolution; and (iii) the “conserved meiotic machinery” is 
composed of a set of genes that encode a variety of component proteins (Lasek-
Nesselquist et al., 2009, Poxleitner et al., 2008, Cooper et al., 2007, Birky, 2005, 
Ramesh et al., 2005).  
The studies by Cooper et al (2007) and Lasek-Nesselquist et al (2009) 
provide convincing evidence that Giardia exhibits genetic exchange. However, 
direct evidence of meiotic recombination is still lacking. Furthermore, if meiotic 
reproduction does take place in Giardia, its frequency should be determined as well 
as the mechanism of meiotic reproduction involved. Ascertaining whether meiotic 
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reproduction occurs in Giardia will yield a better understanding of Giardia’s 
phylogeny and taxonomy (Morrison et al., 2007, Birky, 1996).  
1.3/ Giardiasis, transmission and health importance  
1.3.1/ Transmission 
Transmission of Giardia occurs via direct contact with infected humans or 
animals, or via ingestion of contaminated water or contaminated food. 
Transmission of protozoan pathogens by contaminated food can occur via 3 main 
routes: (i) through contamination of food ingredients on the farm by polluted 
irrigation water, (ii) through contaminated materials involved in the final step for 
product processing or washing, or (iii) through transfer or spread via infected food 
handlers or food preparers (Dawson, 2005). Food transmission of Giardia mainly 
happens by cross-contamination via people with children in nappies and/or pets. 
The first food transmission by food handler was reported in 1981 by Osterholm et 
al. In this outbreak, 29 people developed giardiasis; investigations showed that this 
outbreak was caused by eating contaminated home-canned salmon. A child in 
nappies was present in the home where contaminated food was prepared; it was 
therefore suggested that the child was infected with Giardia and that the food 
preparer failed washing her hands after changing the child nappies before handling 
food (Smith et al., 2007, Porter et al., 1990, Osterholm et al., 1981). In 1990, Porter 
et al reported another giardiasis outbreak caused by eating contaminated fruit 
salad. A child in nappies was also present in the food handler’s home in this case. 
The first hypothesis of contamination for this case was the same as for the first 
outbreak due to home-canned salmon, the food preparer failed to wash her hands 
after changing the nappy and before handling the food. However, a pet rabbit was 
also present in the case reported in 1990 by Porter and collaborator. This rabbit 
may have been positive for Giardia when it entered the home and therefore was 
excreting cysts. Cysts may have been transferred to the food preparer’s hands who 
failed to wash her hands prior to handle the fruit salad. In both cases, 
contamination came from food handlers failing to wash their hands before cooking 
which shows the importance of a good hygiene prior to handle any raw food.  
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During the outbreak reported by Porter and collaborator, the question of whether 
domestic animals could have also played a part in this transmission had been 
raised. In 2005, Hunter and Thompson discussed the possibility of zoonotic 
transmission of Giardia by comparing different case control studies. They came to 
the conclusion that zoonotic transmission is not strongly supported for giardiasis. 
Indeed, most types of Giardia are adapted to single host species which reduces the 
probability of zoonotic transmission as a major contamination route for Giardia 
(Hunter and Thompson, 2005) (Table 1.1). 
The cyst, which is the infective form responsible for the infection 
dissemination, is excreted in the environment by infected hosts. It can remain 
viable and infectious for long periods in a moist, cool environment (WHO, 2008). In 
2006, Roberston and Gjerde studied the resistance of Giardia cysts and their 
viability in a Norwegian river environment over winter time. After 39 days, viable 
cysts were still detected in the control samples (constant temperature: +4°C in cold 
chambers) but not after 54 days. For the cysts in the river environment, viable cysts 
were detected up to 29 days (water temperature varied between 7.3 and 1.1°C 
over the 162 days of winter) (Robertson and Gjerde, 2006). In 1954, Rendtorff 
determined that Giardia had a low infective dose, between 10 and 100 cysts had to 
be ingested by the host to develop the symptoms of giardiasis. According to the 
World Health Organisation (WHO), fewer than 10 cysts represent a meaningful risk 
of infection for one host (WHO, 2008, Rendtorff, 1954). Although Giardia cysts have 
been shown to be resistant to cold water for long period of time, it has been 
suggested that their infectivity may not be as high as for freshly excreted cysts 
(Alum et al., 2012). A new method combining RT-PCR with electrophysiology 
analysis of cell culture post-trophozoite attachment (ECC-RT-PCR) was developed to 
test the viability and infectivity of Giardia cysts (Alum et al., 2012). However, this 
technique was only tested on G. muris and only for its development. For how long 
Giardia cysts remain infective has yet to be investigated.  
One of the most efficient ways to remove microorganisms from drinking 
water is through a filtration process. Filtration consists in the physical removal of 
turbidity and microorganisms (Betancourt and Rose, 2004). During filtration, water 
passes through a pore structure composed of diverse bed materials such as a bed of 
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sand (sand filtration), a layer of diatomaceous earth which are siliceous 
sedimentary rocks (diatomaceous earth filtration), and a combination of coarse 
anthracite coal overlying finer sand (dual- and tri-media filtration) (Betancourt and 
Rose, 2004). However, a study showed that conventional water treatment systems 
did not always ensure the complete removal of waterborne parasites as some 
Giardia cysts were found (LeChevallier et al., 1991). This study also suggested that 
high disinfection levels or more efficient disinfection procedures were required to 
protect against passage of Giardia cysts. Chlorination is the disinfection step the 
most used in most countries to obtain water for human consumption; but Giardia 
cysts are highly resistant to chlorination (Betancourt and Rose, 2004). Most of the 
giardiasis outbreaks are due to contaminated recreational/drinking water (Nichols 
et al., 2009, Karanis et al., 2007, Hunter and Thompson, 2005, Wallis et al., 1996). 
Swimming in contaminated waters and swimming pools has also been recognised 
as an important route of transmission. Contamination of recreational waters and 
swimming pools are due to human/animal wastes, accidental faecal contamination 
and rainfall/storm waters (Nichols et al., 2009, Shields et al., 2008, Karanis et al., 
2007). Besides the transmission via contaminated treated water, several studies 
have highlighted the major role of untreated water, such as lakes and rivers (Hunter 
and Thompson, 2005, Welch, 2000). Untreated water is mainly used by populations 
from developing countries in which main urban areas have water treatment 
systems; but these systems are not extended to agricultural areas. Populations use 
water from rivers and lakes on a daily basis for purposes such as cooking, drinking, 
bathing, swimming and washing food. The lack of latrines can also contribute to a 
high transmission rate; inhabitants are defecating directly into the water (Noor 
Azian et al., 2007, Balcioglu et al., 2007, Prado et al., 2003, Cifuentes et al., 2000) 
Infected hosts act as a reservoir potentially contaminating new 
environments when releasing cysts in their faeces. In 1954, Rendtorff showed that 
the duration of cysts shedding may vary from 5 to 41 days after the end of the 
symptoms for most patients after feeding prisoners with different doses of Giardia 
cysts from asymptomatic human donors.  However, for two patients, the release of 
cysts persisted for 129 and 132 days. According to Rendtorff, symptoms usually last 
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for 6 to 15 days, with an average of 9.1 days, in immunocompetant people 
(Rendtorff, 1954).  
1.3.2/ Pathology and epidemiology 
1.3.2.1/ Giardiasis 
 Giardiasis clinical manifestations are highly variable between infected hosts 
and can range from acute to chronic infections; while some individuals may remain 
asymptomatic. The incubation period usually varies from 9 to 15 days with an acute 
stage generally beginning with a feeling of intestinal disturbance, nausea and 
anorexia (Wolfe, 1992). The main symptom of giardiasis is diarrhoea which 
generally leads to the disease diagnosis. Characteristically, the diarrhoea is watery 
and can be explosive and foul-smelling; it is often associated with fatigue and loss 
of weight. The other typical symptoms developed by infected hosts are bloating, 
abdominal pain, vomiting, and mild-fever (Cotton et al., 2011, Wolfe, 1992, 
Flanagan, 1992). Diarrhoea can occur with or without malabsorption syndrome. 
Malabsorption may be responsible for the loss of weight; even in the absence of 
diarrhoea, nutrients may be malabsorbed (Beaumont and James, 1986). 
Occasionally, some non-specific symptoms, such as lassitude, headache and 
myalgia, occur during a chronic phase (Wolfe, 1992). Moreover, some extra-
intestinal symptoms may occur including polyarthritis, apthous ulceration, or 
urticaria (Flanagan, 1992). These symptoms can also be associated with failure to 
thrive. Children, especially infants, are more infected than adults (Botero-Garces et 
al., 2009, Bartlett et al., 1991); those malnourished and from developing countries 
in particular (Botero-Garces et al., 2009). Several studies have shown the relation 
between Giardia infections and stunting in infected children. Children with chronic 
giardiasis often fail to thrive and may develop growth defects  (Kotloff et al., 2013, 
Botero-Garces et al., 2009, Berkman et al., 2002, Sullivan et al., 1991). Early 
childhood diarrhoeal illness has been associated with stunted growth which may 
lead to low cognitive function, metabolic syndromes and pre-diabetes, altered 
intestinal mucosal architecture associated with changes in small bowel functions, 
reduced enterocyte mass, and evidence of immune activation and inflammation of 
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the mucosa (Scharf et al., 2014, Kotloff et al., 2013, Johnston et al., 2013, Barakat 
and Halawa, 2013, Richard et al., 2013).  
The acute phase of giardiasis may last for days to weeks. The host factors, 
such as immune status, diet, age or concomitant intestinal microbiota, play a part in 
the severity of symptoms and the duration (Cotton et al., 2011, Robertson et al., 
2010, Grazioli et al., 2006); Giardia parasite factors, such as genotype, resistance to 
treatment and ability to evade the host immune system have key roles in the 
severity and duration of the disease (Robertson et al., 2010). The acute stage can 
often be followed by a chronic phase; chronic symptoms may be sporadic, 
continuous, intermittent or recurrent with episodes of diarrhoea. This chronic stage 
may last for years. Immunocompromised individuals seem more at risk to undergo 
chronic giardiasis. Indeed, patients with hypogammaglobulinemia have been 
associated with a predisposition to develop chronic giardiasis; although HIV 
patients don’t seem to show increased sensitivity to Giardia infection (Nkenfou et 
al., 2013, Oksenhendler et al., 2008, Escobedo and Nunez, 1999). This suggests that 
CD4+ T lymphocytes may not be the T cells involved in the clearance of Giardia 
during infection. Chronic giardiasis seems to have an increased frequency in 
patients with immunodeficiency diseases such as Immunoglobulin (Ig) deficiency, X-
linked agammaglobulemia (XLA), and common variable immunodeficiency (CVID) 
(Agarwal and Mayer, 2009, Herbst et al., 1994, Hermaszewski and Webster, 1993). 
XLA, Ig deficiency and CVID are either responsible for defective mature B cells  or for 
failure to normally develop and differentiate B cells into plasma cells (Agarwal and 
Mayer, 2009, Herbst et al., 1994). The most common immunodeficiency is an Ig A 
deficiency. Luminal Ig A might play a role in the clearance of parasite; therefore, the 
lack of secretory Ig A in patients may allow attachment and proliferation of 
intestinal parasites such as Giardia (Agarwal and Mayer, 2009). CVID has also been 
suggested to cause a T cell dysfunction due to the fact that gastrointestinal 
diseases, and giardiasis in particular, are more common in patients with CVID 
(Herbst et al., 1994). However, why some patients with CVID develop 
gastrointestinal diseases while others do not still remains unclear (Agarwal and 
Mayer, 2009) 
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A few studies also showed similarities of symptoms between Giardia 
infections, especially chronic infections, and irritable bowel syndromes (IBS). 
D’Anchino et al, in 2002, demonstrated the association of persistent low grade 
inflammation with faecal persistence of Giardia; while Grazioli et al, in 2006, 
investigated the prevalence of Giardia in 137 patients with IBS (Grazioli et al., 2006, 
D'Anchino et al., 2002). To prevent information and observational bias, Grazioli et al 
excluded from their study patients with previous gastrointestinal consultations, 
patients with symptoms lasting for more than one year, patients who had recently 
been taking anti-inflammatory drugs and antibiotics. Patients with alarming 
symptoms, such as weight loss, vomiting and bleeding were also excluded of the 
study. They evaluated the presence of Giardia infection in patients with IBS via (i) 
direct search of parasites in duodenal biopsies, (ii) histological examination of 
duodenal biopsies and (iii) parasitological evaluation of stool samples. They showed 
that 6.5 % of these patients with IBS also had giardiasis. A significant association 
between giardiasis and H. pylori infection was also found in the 137 patients 
selected for this study. Indeed, 14 % of patients diagnosed with H. pylori had 
giardiasis while 1% of patients without H. pylori had giardiasis. This suggests that 
the two infections might share some risk factors such as a common route of 
transmission (Grazioli et al., 2006, Moreira et al., 2005). These results showed that 
Giardia may be a common cause of IBS-like symptoms.  
1.3.2.2/ Epidemiology 
Giardia is one of the most widespread protozoa causing diarrhoea in the 
world with approximately 200 million symptomatic individuals, and 500,000 new 
cases reported each year (WHO, 1996). Giardia is especially common in areas 
where poor sanitary conditions and defective water treatment prevail. In the 
United Kingdom (UK), the United States (US) and Mexico, giardiasis seasonality has 
been shown to have a peak incidence during late summer. However, no seasonal 
pattern has been observed during day care outbreaks (Ortega and Adam, 1997). 
This waterborne pathogen has a prevalence of 2 to 5 % and 20 to 30 % in 
industrialised and developing countries respectively. Several studies have shown 
that children were more frequently infected than adults, particularly those 
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malnourished. The prevalence of Giardia infection in infants, and children under 10 
years old, vary between 15 to 20 % in developing countries (Noor Azian et al., 2007, 
Ortega and Adam, 1997).  
Recent studies using PCR suggest that the proportion of reported giardiasis 
represents 5% of common waterborne diseases; and that campylobacteriosis and 
salmonellosis are the most common waterborne diseases in Europe with  
proportions of 55% and 35% respectively (Fig 1.4 A) (ECDC, 2013, ECDC, 2012). 
These studies also show that reported cases of Giardia infection accounted for 8% 
of all reported cases of gastro-intestinal infections in the UK (Fig 1.4 B.) (PHE, 2013, 
ECDC, 2013, ECDC, 2012). In the US, similar studies show that approximately 20 % 
of all the reported cases of common gastro-intestinal diseases between 2004 and 
2013 were giardiasis (Fig 1.4 C) (CDC, 2013). Giardiasis appears to have a very low 
incidence rate in European countries where Giardia infection were reported and 
monitored (Fig 1.5). The highest and lowest incidence rates were observed in 
Bulgaria, with an incidence rate of 234.1 reported cases per million per year, and in 
Lithuania, with an incidence rate of 0.843 reported cases per million per year, 
respectively (Fig 1.5) (ECDC, 2013, ECDC, 2012, ECDC, 2010a). When compared to 
the other European countries with an incidence rate for giardiasis, the UK has one 
of the highest incidence rates observed, with 58.9 reported cases per million per 
year (Fig 1.5) (ECDC, 2013, ECDC, 2012, ECDC, 2010a). 
 Assemblage A and B are associated with human infections; their distribution 
varies considerably among studies and within the same country. Feng and Xiao 
reviewed the analysis of over 4,000 human isolates, from different geographical 
areas, by PCR amplification of DNA extracted from faeces. According to them, 
assemblage B appears to be slightly more common in both industrialised and 
developing countries than assemblage A, in the case of endemic giardiasis. Indeed, 
708 cases in developed countries and 1,589 cases in developing countries have 
been reported as assemblage B infections; for assemblage A, 482 and 1,096 cases 
have been reported in developed and developing countries respectively (Feng and 
Xiao, 2011). Even with the data summarised in this chapter, there is only a small 
amount of data available to epidemiologically link Giardia genotypes/subtypes – in 
source and/or drinking water- and human endemic giardiasis. Data on human  
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Fig 1. 5: Giardiasis incidence rate per country in Europe between 2006 and 2011  (ECDC, 
2013, ECDC, 2012, ECDC, 2010a). Incidence rates for giardiasis were calculated via the 
following formula:  
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒄𝒂𝒔𝒆𝒔 𝒂𝒓𝒊𝒔𝒊𝒏𝒈 𝒊𝒏 𝒕𝒉𝒆 𝒄𝒐𝒖𝒏𝒕𝒓𝒚 𝒐𝒗𝒆𝒓 𝟔 𝒚𝒆𝒂𝒓𝒔
𝑨𝒗𝒆𝒓𝒂𝒈𝒆 𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒉𝒆 𝒄𝒐𝒖𝒏𝒕𝒓𝒚 𝒃𝒆𝒕𝒘𝒆𝒆𝒏 𝟐𝟎𝟎𝟔−𝟐𝟎𝟏𝟏
, for each 
European country with available data on number of Giardia infection between 2006 and 
2011. Incidence rates were expressed in Number of reported cases per million per year. 
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giardiasis epidemiology in outbreaks are very limited. However, a systematic review 
analysed 14 publications on Giardia sporadic infections, outbreaks and case-control 
study from 22 countries and suggested that assemblage B was more present, during 
outbreaks, than assemblage A or assemblages A/B co-infection, with 60, 35 and 5% 
respectively (Caccio and Ryan, 2008). Even if assemblage B seems overall more 
present that assemblage A, no strong conclusions can be yet drawn from current 
data available. The fact that genetic exchange was shown to be possible in vitro 
suggests that Giardia may be capable of genetic recombination among member of 
the species complex (Caccio and Ryan, 2008, Poxleitner et al., 2008, Cooper et al., 
2007, Ramesh et al., 2005); as a consequence, its virulence may vary according to 
the genetic exchange occurring during infection. Many questions still remain 
unanswered and more investigations are needed to understand Giardia infection 
epidemiology. 
Giardiasis is associated with wide symptomatology, ranging from the 
absence of symptoms to acute or chronic diarrhoea, malabsorptive and allergic 
manifestations, weight loss, vomiting and childhood failure to thrive; but whether 
the severity of the disease is influenced by host, parasite, or host-parasite factors 
remains still largely unknown (Feng and Xiao, 2011, Caccio et al., 2005). The study 
of the association between Giardia assemblages and virulence has produced some 
inconsistent and contradictory results so far. Some studies have linked assemblage 
A to mild intermittent diarrhoea and assemblage B to severe, acute or persistent 
diarrhoea (Feng and Xiao, 2011, Caccio and Ryan, 2008, Caccio et al., 2005, Homan 
and Mank, 2001). Other studies have linked assemblage A to severe giardiasis and 
assemblage B to asymptomatic to mild giardiasis (Feng and Xiao, 2011, Read et al., 
2002). Another study, realised in south-west London between 1999 and 2005, has 
shown similar epidemiological and clinical features. But differences between both 
assemblages, in term of fever intensity, have been observed; assemblage A being 
more frequently associated with fever than assemblage B, and yet, assemblage B is 
predominant in the urban UK setting (Breathnach et al., 2010). At present, data 
available for assemblage virulence are inconclusive (Nash, 2013, Feng and Xiao, 
2011, Breathnach et al., 2010, Caccio and Ryan, 2008, Caccio et al., 2005, Homan 
and Mank, 2001). The exact contribution of Giardia genetic variability to 
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symptomatology and virulence is still under debate and requires further 
investigation.  
 Mixed infections have also been reported in several studies and countries, 
the percentage of mixed infections ranges from 2 % to 21 % (Gelanew et al., 2007). 
Most of these infections are assemblage A/B; some studies have identified 
assemblages A or B with C or D (canine-specific) infections (Traub et al., 2009). 
Mixed infections of assemblages A and F (cat-specific) have been identified in 
humans in Ethiopia (Gelanew et al., 2007). However, none of these results could be 
confirmed by analysis of either tpi or ssu rRNA genes (Feng and Xiao, 2011, Traub et 
al., 2009, Caccio and Ryan, 2008, Gelanew et al., 2007). These mixed infections are 
endemic and have only been observed in small local communities.  
1.3.3/ Control and prevention 
 Nine national and international institutions: the Centre for Disease Control 
and Prevention (CDC), the World Health Organization (WHO), the New Zealand 
Ministry of Health (NZMH), the National Health Service (NHS), the National Travel 
Health Network and Centre (NaTHNaC), the “Institut de Veille Sanitaire” ( the 
French Centre for disease control, InVS), the Canadian Public Health Agency (PHAC), 
the Manitoba Public Health Branch (MPHB), and the European Centre for Disease 
control (ECDC), were consulted to establish the main recommendations  for the 
control and prevention of giardiasis. In this survey, 9 out of 9 showed the same 
recommendations for the prevention and control of giardiasis (WHO, 2013, 
NaTHNaC, 2013, MPHB, 2013, NZMH, 2013, InVS, 2012, ECDC, 2010b, CDC, NHS, 
PHAC). The most important recommendation is to maintain general good hygiene 
by washing hands before and after handling food, after changing nappies and using 
the toilet. Raw food such as fruits and vegetables should be washed with 
uncontaminated water; it is also suggested to avoid faecal exposure during sexual 
activity. Potentially contaminated water such as recreational bodies of water 
(swimming pool) and untreated drinking water (shallow wells, lakes, rivers, ponds, 
streams) should not be swallowed (Lebwohl et al., 2003). 
 Potentially contaminated water can be treated by boiling it for longer than 
one minute or by filtering it through a pore size of one μm (or smaller). Public water 
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supplies are regulated and treated according to standard protocols; which vary 
from one country to another according to their own laws and regulations. 
1.3.4/ Clinical diagnosis and typing 
 The identification of Giardia can be achieved either by using classical 
diagnostic methods such as serological and microscopic techniques or by using 
molecular techniques for diagnosis and genetic analysis. 
1.3.4.1/ Classical diagnostic methods 
 Microscopy 
 The conventional detection method of Giardia cysts is microscopy; and the 
microscopic examination of stool is the most established diagnostic technique 
(Koehler et al., 2013, Lebwohl et al., 2003). Other biological samples such as 
duodenal, tissue, environmental and or/water samples are also examined via 
microscopy in order to detect and identify Giardia (Schuurman et al., 2007, Behr et 
al., 1997, Sauch, 1985). Some morphological features of the trophozoite such as 
median body shape and location, shape, ventro-lateral disc length, length of caudal 
flagella, and number and shape of nuclei, can be used for the identification of 
Giardia. It is however impossible to identify trophozoite or cysts to species level via 
light microscopy; staining techniques can however be used to help detect these 
Giardia stages and differentiate them from other micro-organisms and 
environmental debris present within samples (Koehler et al., 2013, Adam, 2001). 
 Simple staining protocols can be performed, such as Lubol’s iodine staining, 
iron-haematoxylin, Giemsa and trichrome (Zhang et al., 2012, Arbo et al., 2006, 
Kellogg and Elder, 1999, Shetty and Prabhu, 1988); or cysts can be concentrated 
using, for example, formalin-ether (Koehler et al., 2013, Wegayehu et al., 2013). 
Motile trophozoites can also be detected by direct microscopy of fresh samples, 
smears being immediately prepared with warm (37°C, saline solution. Dead 
trophozoites can be detected by air-dried faecal smears stained with Giemsa. Due 
to the fact that Giardia infection is localised in the upper part of the gastrointestinal 
tract, cyst excretion is intermittent and  multiple successive faecal samples analysis 
is required for a period of 1 to 2 weeks (Koehler et al., 2013). 
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 Immunological tools 
In the detection of Giardia cysts and trophozoites, the use of immunological 
techniques can be advantageous over microscopy. Fluorescence microscopy can 
also be used to detect Giardia cyst and trophozoites. Indeed, fluorescence 
microscopy and direct fluorescence antibody (DFA) such as a fluorescein 
isothiocyanate-conjugated anti-Giardia antibody recognising surface epitopes, such 
as 65 kDa Giardia antigen, on cysts have been shown to be very efficient, with a 
sensitivity and specificity average ranges between 85% to 100% and 99 to 100 % 
respectively for the detection of cysts in faecal smears and environmental samples 
(Table 1.3) (Koehler et al., 2013, Rimhanen-Finne et al., 2007, Aldeen et al., 1998). 
 The detection of Giardia antigens in faecal samples, coproantigens, is 
another way of detecting Giardia infections. Enzyme-linked immunoassays such as 
enzyme-linked immunosorbent assays (ELISAs) have been used, and have shown 
high specificity and sensitivity with a range between 63 and 100 % (Aldeen et al., 
1998, Behr et al., 1997). Immuno-chromatographic (IC) tests have also been 
achieved and have given variable specificity and sensitivity depending on study, 
between 79 to 100 % and 26 to 100 % respectively (Elsafi et al., 2013, Goni et al., 
2012, Costache et al., 2009, Garcia and Garcia, 2006, Pillai and Kain, 1999). 
However, a study determined that the sensitivity of coproantigen assays could be 
lower than microscopic approaches (Johnston et al., 2003). Most IC tests are easy to 
implement and are usually a combined set of several antibodies  to test for different 
parasites. This could affect the specificity of the test as cross -reactions may occur 
when testing for several pathogens (Koehler et al., 2013). Variation in the different 
assays diagnostic performance may also be due to intermittent shedding of cysts 
and Giardia antigens. A decreased sensitivity might be correlated to a low numbers 
of cysts in faeces or trophozoites in the host intestine (Strand et al., 2008). In their 
study, Strand et al suggested that coproantigen methods are useful in an outbreak 
setting but not for diagnosis of patients with refractory or persistent giardiasis 
following treatment. Yet, coproantigen detection methods have the capacity to 
detect infections prior to the cysts excretion in the host faeces; which makes them 
one the best choice for a cost-effective and rapid screening of large numbers of  
 Chapter I 
Chapter I 
46 | P a g e  
Ta
b
le
 1
. 3
: 
Li
st
 o
f 
an
ti
b
o
d
ie
s 
av
ai
la
bl
e
 f
o
r 
th
e
 id
e
n
ti
fi
ca
ti
on
 o
f 
G
ia
rd
ia
 v
ia
 im
m
un
o
lo
gi
ca
l t
e
ch
n
iq
u
e
s 
fr
o
m
 t
he
 m
ai
n
 a
n
ti
b
o
d
ie
s 
su
p
p
ly
in
g 
co
m
p
an
ie
s 
in
 t
h
e
 U
K
 
 Chapter I 
Chapter I 
47 | P a g e  
faecal samples (Koehler et al., 2013, Johnston et al., 2003); but, like widely used 
diagnostic techniques, they do not currently allow for the identification and 
characterisation of Giardia species or genotypes.  
1.3.4.2/ Molecular techniques 
 Since classical diagnostic methods cannot be used to distinguish between 
different species and assemblages of Giardia, various nucleic acid-covalent 
techniques have been developed to identify and characterise Giardia and the 
genetic variations within and amongst Giardia species and assemblages. Some 
molecular methods rely on specific in situ hybridisation of probes to particular 
genetic loci within Giardia genome, but most rely on the specific amplification of 
one or more loci from small quantities of genomic DNA by PCR. Such studies have 
contributed to a better understanding of Giardia biology, epidemiology and 
population genetics (Feng and Xiao, 2011, Ankarklev et al., 2010, Adam, 2001). 
Comparative studies between microscopic, enzyme immunoassays and PCR have 
shown that molecular techniques were highly sensitive and specific with a range 
between 80 % and 100 % (Elsafi et al., 2013, Goni et al., 2012).  
 DNA fingerprinting 
 PCR-fingerprinting coupled methods depend on the screening of a genome 
in search for neutrally evolving repetitive DNA, and also for variation in organisation 
and sequence length. These techniques do not necessarily require prior knowledge 
of the genome or genes to characterise a parasite, which can be advantageous. 
However, the genetic fingerprint of Giardia cyst or trophozoite isolates represents a 
population of organisms rather than an individual. The random amplification of 
polymorphic DNA analysis (RAPD) has been applied to Giardia because of its ability 
to detect variation within and among populations of a particular species (Pelayo et 
al., 2003, Welsh and McClelland, 1990, Williams et al., 1990). In RAPD analysis, only 
a single arbitrary primer is used instead of two sequence-specific primers (Deng and 
Cliver, 1999). At first, RAPD was considered useful due to its ability to amplify from 
small amounts of genomic DNA and its capacity to rapidly screen genomes for 
variation (Hadrys et al., 1992). But, some significant issues with the specificity and 
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reproducibility of RAPD were found because of the low stringency often used in PCR 
(Perez et al., 1998). Also the fact that a single arbitrary primer is used may give false 
positive results due to the techniques susceptibility to contaminant-organism or 
foreign DNA; and is therefore recommended for Giardia only with axenic isolates 
grown in vitro (Deng and Cliver, 1999).  
 Minisatellites display allelic hypervariability due to differences in repeat 
copy number within alleles, hence variation in size (Jeffreys et al., 1985). They have 
been shown to be a very useful tool in the discrimination between Giardia 
individual strains and in epidemiological analysis (Carnaby et al., 1995, Carnaby et 
al., 1994, Upcroft et al., 1990). The use of the human polycore minisatellite probes 
33.6 and 33.15 and the M13 phage DNA probe were shown to allow the 
identification of a range of putative hypervariable minisatellites in Giardia (Carnaby 
et al., 1995, Upcroft et al., 1990). Even with such promising results, the study of 
Giardia minisatellites to identify between strains has surprisingly been neglected 
over the last 20 years. The development and use of minisatellites probes for Giardia 
may give more insights on Giardia taxonomy as its taxonomy is still under debate. 
Indeed, fingerprinting minisatellites may allow identifying whether Giardia 
assemblages are different species or not; and therefore, it may also allow a better 
discrimination on a sub-assemblage/species level. 
 Restriction fragment length polymorphism-, specific-, real time-, 
multiplex PCR and sequencing 
 Discrimination of Giardia species and assemblages are based on single-
nucleotide polymorphisms (SNPs). PCR techniques using specific primer pairs for a 
selective amplification of different genetic loci, followed by enzymatic cleavage or 
sequencing, are employed. The Giardia specific key markers used for this are: 
 Genes coding for β-giardin (bg), elongation factor 1-α (ef1-α), triose-
phosphate isomerase (tpi), glutamate dehydrogenase (gdh), and 
variable surface proteins (vsp) 
  The Giardia lamblia open reading frame-C4 (GLORF-C4) 
 Nuclear ribosomal RNA genes such as 18S rRNA and internal 
transcribed spacer 1 and 2 (ITS-1, -2) 
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SSU sequence can also provide useful genetic markers for specific identification of 
Giardia as it has relatively low intraspecific and relatively high interspecific 
sequence variations (Koehler et al., 2013, Feng and Xiao, 2011). 
 Additional markers, used to achieve assemblage or sub-assemblage 
identification based on specific PCR, RFLP or sequencing are present in the tpi, bg, 
and gdh genes (Monis et al., 1999). These genes have been used in systematic 
investigation of Giardia to provide the basis of the current classification of 
members within the Giardia genus (Feng and Xiao, 2011, Caccio and Sprong, 2010, 
Sprong et al., 2009). In addition, ITS of ribosomal DNA (rDNA) are also useful for 
assessing genetic variability within Giardia species due to their higher intraspecific 
variation compared to the rRNA gene regions examined thus far (Caccio and 
Sprong, 2010). 
 PCR-based restriction fragment length polymorphism (PCR-RFLP) approach 
is sometimes also used for the genetic analysis and classification of Giardia 
(Robertson et al., 2007). Although this approach has been proven useful, it does not 
detect all sequence and length variations within and between amplicons. This is due 
to the fact that the restriction enzymes used only recognise a small number of 
potentially variable sites. The problems of this approach can also include an 
incomplete enzymatic digestion of amplicons and/or sequence variations within 
individual amplicons leading to a misinterpretation of the RFLP profiles obtained 
(Koehler et al., 2013). The “gold-standard” for detecting genetic variation and 
polymorphism remains DNA sequencing and comparative analysis; which can be 
applied to single-copy as well as multi-copy genes; with the condition that there is 
sequence homogeneity between copies of target genes (Sprong et al., 2009). 
Moreover, DNA sequence data analysis is suitable for direct, comparative genetic 
and phylogenetic studies at any time. However, some data have shown some 
incongruity in genotyping results when different genetic loci are targeted. Indeed, 
the difficulty in assigning some isolates, predominantly for specimen from humans 
and dogs, has been raised (Feng and Xiao, 2011, Sprong et al., 2009). The high 
prevalence of mixed infections may be one factor contributing to the incongruity 
observed. To overcome this issue, the multi-locus genotyping (MLG) approach has 
been increasingly used to characterise Giardia. Yet, the grouping of the parasites 
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into individual MLGs has been further complicated by the fact that many isolates 
may exhibit double peaks at specific positions in electropherograms. In 2010, 
Lebbad et al observed double peaks in electropherograms in assemblages B, C, D 
and E isolates but never in assemblages A, F and G isolates. This suggests that MLG 
approach may be more useful for the typing of assemblage A isolates (Lebbad et al., 
2010, Caccio et al., 2008). 
 Real time quantitative PCR (q-PCR) enables the monitoring of DNA 
amplification as it occurs in vitro (Koehler et al., 2013). This PCR can be combined 
with the high resolution melt (HRM) approach which allows the detection of 
mutations, polymorphisms and epigenetic differences in double-stranded DNA 
(dsDNA) (Koehler et al., 2013). This approach has been used for the specific 
detection of Giardia species or assemblages (Zhang et al., 2012, Almeida et al., 
2010, Haque et al., 2007, Bertrand et al., 2004). However, HRM analyses may not 
always be able to delineate multiple, distinct types of sequence, such as paralogues, 
within samples; particularly if the melting temperature or melting profiles of such 
sequences are similar, which can induce merging of peaks resulting in an 
uninterpretable profile (Koehler et al., 2013). Yet, the high-throughput potential 
and relatively low cost of HRM analysis as well as its ability to differentiate between 
Giardia isolates, make the HRM combined q-PCR approach a suitable tool for the 
identification and differentiation of Giardia species and population variants if 
suitable genetic markers are used. 
 Multiplexed tandem-PCR (MT-PCR), which combines a primary phase of 
target loci enrichment with an analytical phase using primary amplification as 
template, and Luminex, which used fluorescently dyed micro-beads for large scale 
genotyping, approaches have also been shown to have a great potential for 
medium to large scale epidemiological studies of Giardia and other waterborne 
pathogens (Jex et al., 2012, Taniuchi et al., 2011, Stark et al., 2011). Multiplex PCR 
consists in the amplification of multiple genetic loci, representing either the same 
organisms or multiple organisms, in a single reaction. Although useful, multiplex 
PCRs can raise significant problems due to potential cross -hybridisation or 
competition between multiple primer sets which could result in poor PCR 
amplification and/or the generation of non-specific products (Koehler et al., 2013, 
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Elnifro et al., 2000). The development of MT-PCR addresses some of the limitations 
of multiplex PCR. MT-PCR consists of two amplification phases: (i) a primary phase 
to enrich target loci using multiplexed primers in a few PCR cycles (10-15 cycles), 
each primer pair targets a distinct genetic locus which is coupled to (i i) an analytical 
phase where a highly diluted product from the primary amplification is used as a 
template (Jex et al., 2012). During this analytical phase, the targeted amplification is 
performed in tandem for each genetic locus using a specific nested-PCR rather than 
by multiplex (Jex et al., 2012). A comparative study showed that MT-PCR exhibited 
100 % sensitivity and specificity compared to the “gold-standard” that is microscopy 
(Stark et al., 2011). The micro-beads used in the Luminex approcah are internally 
dyed with fluorescent dyes to produce specific spectral address (Koehler et al., 
2013, Taniuchi et al., 2011). The beads high-density digital coding allows the 
tracking of the target organisms but also of other important identifiers such as 
sample code and type, geographical origin, collection date, and reagent kits, which 
could provide a robust detection approach for multiplex assays (Koehler et al., 
2013). This should enable the development and implementation of effective water 
and environment surveillance programmes. Moreover, a recent study combining 
Luminex assays with TaqMan array card (TAC) system allowed the detection of 19 
enteropathogens, including Giardia, with a specificity and sensibility of 96 % and 98 
% respectively suggesting that combining molecular and bioinformatics techniques 
may be the answer to a better and faster diagnostic of Giardia infection and 
giardiasis (Liu et al., 2013). 
 Genomic comparison 
Most of the Giardia genotyping studies have relied on the sequence 
characterisation of human and animal-derived cysts and trophozoites using only 
SNPs (Caccio and Ryan, 2008, Caccio et al., 2005). However, some data showed 
inconsistent genotyping results when different loci were targeted (Caccio et al., 
2008). The development of genomics tools for Giardia has provided new insights on 
assemblages A and B whole genomes and genes function (Adam et al., 2013, Perry 
et al., 2011, Franzen et al., 2009, Morrison et al., 2007). These studies have also 
highlighted assemblage-specific genes which could potentially be good targets for a 
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faster characterisation of Giardia during an infection. In addition, genomics 
approach is a fast and low cost technique as it doesn’t require the amplification of 
DNA sequences to compare different samples and data are processed through 
database via bioinformatics tools.  
 Fluorescent in situ hybridisation (FISH) 
 Fluorescently labelled oligonucleotide probes are used to specifically detect 
target sequences within RNA or DNA. Most FISH assays used for cyst detection have 
relied on the hybridisation of the RNA rather than the DNA of a cell; targeting a 
variable region of the small subunit (SSU) of rRNA. This is due to the fact that rRNAs 
are transcribed to high abundance within the cell. (Bednarska et al., 2007, Lemos et 
al., 2005). It has been suggested that only viable cysts would be detected due to 
RNA degradation after cell death; thus, rRNA would not be detectable in dead cysts. 
This makes FISH probes of use to study the cyst viability in faecal or environmental 
samples (Dorsch and Veal, 2001). However, the use of FISH probes for cyst viability 
assays is dependent on the rate of target decay. It has been assumed that this 
decay is fast upon cell death, but this remains to be quantitatively assessed for 
rRNA. It is likely that the rate of degradation will vary depending on different 
environmental conditions such as temperature, pH or potential RNase 
contamination due to cellular damage. 
 Several studies have demonstrated the utility of FISH probes as a 
dependable method to detect cysts, but most of the probes used to date have not 
yet allowed for reliable discrimination between species or assemblages (Koehler et 
al., 2013). Nonetheless, in one study probes to the rRNA SSU were able to 
discriminate between Giardia muris, Giardia ardeae and Giardia lamblia 
(=duodenalis/intestinalis) (Erlandsen et al., 2005).  
1.3.5/ Treatment 
 Giardia infections can remain asymptomatic or induce severe and/or 
chronic giardiasis, in which case treatment is generally indicated (Gardner and Hill, 
2001). Recent studies have shown strain-specific pathogenicity of different 
genotypes and possibly some sub-genotypes in rodent models (Solaymani-
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Mohammadi and Singer, 2011, Benere et al., 2011). Yet, in humans, association 
between strain-specific genotypes and clinical symptoms have been inconclusive so 
far (Hahn et al., 2013, Robertson et al., 2010). Six main classes of agents are 
currently used to treat giardiasis (i) Nitroimidazoles, (ii) Quinacrine, (iii) 
Furazolidone, (iv) Benzimidazoles, (v) Paromomycin, and (vi) Bacitracin zinc 
(Gardner and Hill, 2001).  
1.3.5.1/ Nitroimidazoles 
The nitroimidazoles, in particular metronidazole (MTZ), were discovered in 
1955 and were found to be highly effective against several protozoan such as 
Trichomonas vaginalis or Entamoeba histolytica (Durel et al., 1960) (Fig 1.6 A.). MTZ 
[1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole; Flagyl] was reported to be effective 
against giardiasis in 1962 (Darbon et al., 1962, Durel et al., 1960). MTZ current 
model of action suggests its intracellular reduction to a toxic radical form via 
Giardia anaerobic metabolic pathway and by several parasites reductases, including 
pyruvate: ferredoxin oxidoreductase (PFOR), nitroreductase and thioredoxin 
reductase (Nillius et al., 2011, Leitsch et al., 2011). Indeed, pyruvate: ferredoxin 
proteins from the parasite donate electrons to the drug’s nitro group; after 
reduction of this nitro group, MTZ becomes “activated”, and a gradient allowing 
MTZ intracellular transport is established (Hahn et al., 2013, Gardner and Hill, 
2001). Once activated, the reduced MTZ binds to the parasite DNA macromolecules 
which results in DNA damage in the form of loss of helical structure, impaired 
template function and strand breakage. This DNA damage results in the death of 
the trophozoite (Gardner and Hill, 2001). In addition, MTZ also inhibits trophozoite 
respiration (Upcroft and Upcroft, 1998, Paget et al., 1989). Since its discovery, MTZ 
and other nitroimidazoles (such as tinidazole and ornidazole) have been the first 
choice for the treatment of giardiasis.  
MTZ is readily and completely absorbed after oral administration, it 
penetrates body tissues and secretions such as saliva, breast milk or semen and 
vaginal secretion. MTZ is mainly metabolised in liver and excreted in the urine 
(Gardner and Hill, 2001, Lau et al., 1992). Since their discovery, MTZ and other 
nitroimidazoles (tinidazole, secnidazole, benzoyl MTZ, nimorazole and ornidazole) 
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have been the first choice for the treatment of giardiasis. However, patients treated 
with nitroimidazoles can show a wide range of mild to severe side effects (Table 
1.4). The most common side effects of MTZ treatment include headache, metallic 
taste, vertigo, nausea. In addition, pancreatitis, central nervous system toxicity, at 
high doses, and transient reversible neutropenia (abnormally low number of 
neutrophils) have all been attributed to MTZ (Gardner and Hill, 2001, Harris et al., 
2001, Thompson et al., 1993). The other nitroimidazoles used in the treatment of 
giardiasis have been shown to provoke mild side effects such as nausea, anorexia, 
and abdominal pain (Harris et al., 2001). 
1.3.5.2/ Quinacrine 
Quinacrine (Mepacrine/Atabrine) was first introduced as antimalarial drug in 
1930; it became an important agent against Giardia after World War II (Gardner 
and Hill, 2001) (Fig 1.6 D.). Quinacrine has been proven to be very effective by 
different studies, and to have one advantage over nitroimidazole drugs as it also 
kills cysts as a decrease excystation was observed in both in vitro- and patient-
derived cysts (Harris et al., 2001, Gillin and Diamond, 1981). The antiprotozoal 
mechanism of action of quinacrine has yet to be fully elucidated; however several 
alternative hypotheses have already been suggested. Firstly, this drug is thought to 
interfere with flavin compounds of enzymes such as NADH oxidase, which could 
decrease the oxygen consumption by the parasite (Paget et al., 1989). Secondly, 
quinacrine is a known cholinesterase inhibitor and therefore could be involved in 
the inhibition of Giardia acetylcholine pathway. Finally, quinacrine is thought to 
intercalate with the parasite DNA, thereby inhibiting the nucleic acid synthesis 
(Gardner and Hill, 2001, Thompson et al., 1993). 
Quinacrine is rapidly absorbed from the intestinal tract and widely 
distributed in body tissues. Quinacrine is clinically very effective against Giardia; 
some studies have indeed shown an average 95 % efficacy over 5 to 10 days (Wolfe, 
1992, Kavousi, 1979). Yet, this drug has been reported to have a very wide range of 
adverse effects from a bitter taste, vomiting and nausea to more severe symptoms 
such as blood dyscrasias (pathologic conditions or disorders in which the blood’s 
constituents are either abnormal or present in abnormal quantity), toxic psychosis, 
 Chapter I 
Chapter I 
55 | P a g e  
insomnia, myalgia, or haemolysis on glucose-6-phosphate dehydrogenase deficient 
patients (Harris et al., 2001, Gardner and Hill, 2001) (Table 1.4). 
1.3.5.3/ Furazolidone 
Furazolidone is a member of the nitrofuran family which was discovered in 
the 1940s (Fig 1.6 B.). Furazolidone is effective against many bacterial infections, 
including Klebsellia spp., Clostridium spp., Campylobacter spp., Staphylococcus 
aureus and E. coli (Harris et al., 2001, Gardner and Hill, 2001); and in 1960, 
furazolidone was reported to be an effective antigiardial agent (Webster, 1960). As 
for Quinacrine, forazolidone mechanism of action is not completely explained and 
requires further investigation. It is thought to undergo reductive activation in 
Giardia trophozoite, like metronidazole (MTZ). However, instead of being reduced 
by ferredoxin I, furazolidone may be reduced by NAD(P)H oxidases as well as PFOR. 
This is mainly due to the fact that nitrofurans have a more positive redox potential 
than nitroimidazoles (Brown et al., 1998, Upcroft and Upcroft, 1998). Once 
reduced, forazolidone is thought to damage important cellular components 
including DNA. In one study, furazolidone was shown to act on two specific stages 
of Giardia cell cycle, S and G2+M; which indicates an inhibition of DNA synthesis 
and of the cell cycle completion (Hoyne et al., 1989). 
Furazolidone is promptly absorbed via the gastrointestinal tract and 
metabolised by body tissues; which leads to low concentrations in serum and urine. 
According to a few studies, about 10 % of patients treated with furazolidone 
reported gastrointestinal symptoms such as nausea, vomiting, diarrhoea, malaise. 
Other side effects can also include a brown discoloration of urine, haemolysis in 
glucose-6-phosphate dehydrogenase-deficient patients, urticaria, hypersensitivity, 
pruritus (itching sensation) (Gardner and Hill, 2001, Wolfe, 1992) (Table 1.4). The 
drug has also a monoamine oxidase (MAO) inhibitory effect and should not be given 
to individuals taking MAO inhibitors. Plus, some rare cases of disulfiram-like 
reaction were reported when furazolidone was taken with alcohol (Gardner and 
Hill, 2001). 
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Fig 1. 6: The four most used antigiardial drugs (modified from Harris et al, 2001 and 
Upcroft and Upcroft, 1998 with permission). A. Metroinidazole, member of the 
Nitroimidazole family drugs and main way of treatment of giardiasis. B. Furazolidone, a 
nitrofuran compound used in treatment of many bacterial infections and giardiasis.  C. 
Albendazole,member of the Benzimidazole family drug, used in treatment of many 
parasitic worm infections and giardiasis. D. Quinacrine, a substituted acridine and 
antimalarial drug also effective against Giardia. E. Paromomycin (or humatin) member of 
the aminoglycoside family, indicated for the treatment of E. hystolitica, T. vaginalis and 
Giardia. 
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1.3.5.4/ Benzimidazoles 
Benzimidazoles are bicyclic aromatic compound formed by the fusion of 
benzene and imidazole. Their chemotherapeutic property against helminths and 
parasites was established in the 1950s. Thousands of benzimidazole molecules 
were synthetized but only a few had an effect on parasites. Amongst these agents, 
two were shown to have an effect on Giardia infections and used to treat giardiasis: 
albendazole (Fig 1.6 C) and mebendazole (Aguayo-Ortiz et al., 2013, Gardner and 
Hill, 2001). Benzimidazole agents exert their toxic effect on parasites by binding to 
the β-tubulin cytoskeleton, resulting in the disruption/inhibition of cytoskeleton 
polymerisation and impaired glucose intake (Gardner and Hill, 2001, Venkatesan, 
1998). It has been postulated that the colchicine site in the microtubules may play a 
role in the benzimidazole binding to the giardial β-tubulin (Clark and Holberton, 
1988, Lacey, 1988). In 1994, Katiyar et al suggested that the glutamic acid 198 (Glu 
198) on the β-tubulin amino acid chain may be involved without being able to prove 
it. However, a recent study has demonstrated that this amino acid (AA) was 
involved in the benzimidazole-β-tubulin binding (Aguayo-Ortiz et al., 2013, Katiyar 
et al., 1994). 
Benzimidazoles are poorly absorbed by the gastrointestinal tract, although 
their absorption can be improved by co-ingestion of a fatty meal. Compare to the 
other types of drugs used in the treatment of giardiasis, benzimidazoles have less 
side effects on patients (Table 1.4). During a short-term use, it may cause anorexia 
and constipation; and during a long-term use, a high dose of albendazole can cause 
reversible neutropenia and elevated hepatic enzyme levels (Gardner and Hill, 2001, 
Liu and Weller, 1996). Due to a possible teratogenicity, albendazole is contra-
indicated in pregnancy. 
1.3.5.5/ Paromomycin and bacitracin zinc 
 Paromomycin 
Paromomycin, also called humatin, is a member of the aminoglycoside 
family and is a broad-spectrum antibiotic (Fig 1.6 E.). Paromomycin was first 
isolated in 1956 and shown to be effective against T. vaginalis and E. histolytica 
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infections. It was also proposed as a treatment for Giardia in resistant infections 
and during pregnancy (Gardner and Hill, 2001, Kreutner et al., 1981). Paromomycin 
inhibits Giardia protein synthesis by interfering with the parasite’s 50S and 30S 
ribosomal subunits; which causes the misreading of messenger RNA (mRNA) codons 
(Edlind, 1989).  
Paromomycin is poorly absorbed from the intestinal lumen; indeed, it has 
been shown that even large-dose of oral administration achieve only minimal 
concentrations in the patients’ blood and urine (Kreutner et al., 1981). However, 
due to this minimal absorption, Paromomycin is selectively toxic as its action 
depends on the unique giardial ribosomal RNA (rRNA) structure (Edlind, 1989). Via 
in vitro susceptibility testing, its activity against Giardia has been demonstrated to 
be lower than the activity of nitroimidazoles, quinacrines or forazolidones  
(Boreham et al., 1985, Gordts et al., 1985). Paromomycin can cause side effects 
such as ototoxicity and nephrotoxicity if absorbed systemically (Table 1.4). 
However, with limited systemic absorption, toxicity should not be a problem for 
patients with normal kidney function (Gardner and Hill, 2001, Harris et al., 2001). 
 Bacitracin zinc 
 Bacitracin was first isolated in 1945 from a strain of Bacillus; it used 
systemically against severe staphylococcal infections until 1960 when its toxicity 
and the development of other antibiotics restricted its use. To promote stability 
into the bacitracin complex, zinc was added, giving it the name of bacitracin zinc 
(Gardner and Hill, 2001, Kucers et al., 1997). Following the in vitro demonstration of 
its action against E. histolytica and Trichomonas, bacitracin zinc was found to be 
active against Giardia (Andrews et al., 1995, Andrews and Bjorvatn, 1994, Andrews 
et al., 1994). Bacitracin acts on pathogens by interfering with their 
dephosphorylation step in cell membrane synthesis. Undecaprenyl pyrophosphate 
is an important molecule involved in the peptidoglycan synthesis. The tight binding 
of bacitracin to undecaprenyl pyrophosphate was shown to prevent undecaprenyl 
pyrophosphate hydrolysis. As a result, undecaprenyl monophosphate, the product 
of undecraprenyl pyrophosphate hydrolysis, is less available for binding with the 
UDP-peptidyl N-acetylmuramic acid (UDP-MurNAc) – pentapeptide complex to 
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initiate the second stage of the peptidoglycan synthesis suggesting that cell wall 
biosynthesis was inhibited (Ming and Epperson, 2002). 
 Some adverse effects such as diarrhoea, abdominal discomfort and nausea 
were observed in some patients. The use of bacitracin zinc can also lead to 
nephrotoxicity and gastrointestinal disturbance with prolonged oral administration 
(Gardner and Hill, 2001) (Table 1.4). 
1.3.5.6/ Drug resistance and new chemotherapeutic agents 
 Drug resistance and relapse 
 Besides the fact that all the antigiardial drugs can provoke adverse effects in 
patients (Table 1.4), treatment failures have also been reported for all of them. 
However, it is important to differentiate between drug resistance, cure followed by 
reinfection and post-Giardia lactose intolerance. If it is a reinfection (positive stool 
sample examination for Giardia antigen), re-infected patients should respond to 
original therapeutic agent used; reinfections are common in Giardia endemic 
regions around the world and in situation of poor faecal-oral hygiene. Therefore, 
risk factors should be assessed and guidance on hygiene and prevention should be 
given to re-infected patients. Disaccharidases are enzymes present in the intestinal 
lumen which cleave complex sugars such as lactose into simple sugars such as 
glucose (Bayless and Christopher, 1969). Deficiency in disaccharidase activity leads 
to an increase of complex sugars concentration within the intestinal lumen; this 
excess of complex sugar acts as osmotic loads resulting in an outpouring of fluid 
into the small intestine which increases the gastrointestinal motility (Bayless and 
Christopher, 1969). Post-Giardia lactose intolerance is the most common 
disaccharidase deficiency associated with giardiasis; it can occur in 20 to 40 % of 
patients with Giardia infection (Gardner and Hill, 2001). Thus, if the stool sample 
examination is negative for Giardia, patient will be advised to avoid lactose-
containing food, and this syndrome may last for several weeks but will normally 
resolve eventually. 
 True treatment failure could mean that patients are infected with a drug-
resistant Giardia isolate. Resistance to most antigiardial drugs has been 
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documented or studied in vitro; and different drug class susceptibilities for several 
genotypically different clones of Giardia found in the human duodenum were 
observed (Upcroft and Upcroft, 2001, Upcroft et al., 1999, Carnaby et al., 1994, 
Farthing, 1992). A consistent correlation between in vitro resistance and clinical 
failure or success has yet to be determined; which still leaves unanswered the 
question of true parasite resistance for Giardia. When clinically resistant strains 
have been identified, treatments with longer repeat courses or higher doses of the 
original drug are given to the patients (Gardner and Hill, 2001). Yet, the most 
successful way of eradicating Giardia seems to be the use of a drug from a different 
class to avoid potential cross-resistance. However, this may not be always effective 
e.g. Brasseur and Favennec reported that two of their patients failed albendazole 
treatment following two courses of MTZ but did respond positively to quinacrine 
(Brasseur and Favennec, 1995). In case of failure, the last option is to combine 
drugs together to increase the response from patients. For example, MTZ-
albendzole, MTZ-quinacrine, or a nitroimidazole plus quinacrine; for courses of at 
least two weeks (Gardner and Hill, 2001).  
 New chemotherapeutic agents 
 Most of the drugs used in the treatment of giardiasis have considerable side 
effects and are, most of the time, contraindicated (Gardner and Hill, 2001, Harris et 
al., 2001) (Table 1.4). Therefore, the study of new chemotherapeutic agents plays a 
fundamental role in the rationale for the treatment if Giardia infections.  
 In 2009, Muller et al reported Giardia protein disulfide isomerases (PDI), 
more specifically PDI2 and PDI4 and Giardia lamblia Nitroreductase-1 (GlNR-1), as 
promising targets for new drugs (Rossignol, 2010, Muller et al., 2007). A study has 
shown that GlNR-1 increases Giardia susceptibility to nitro drugs such as MTZ and 
albendazole; this study also suggests that GlNR-1 may play a role in the reduction of 
the nitro drugs used in the treatment of giardiasis (Nillius et al., 2011). In another 
recent study, Giardia has been shown to be highly sensitive in vitro to 
tetrahydrolipsatin, an anti-obesity drug also called Orlistat (Hahn et al., 2013). 
Orlistat is a derivative of the naturally occurring lipase inhibitor lipstatin from 
Streptomyces toxytricini (Hahn et al., 2013, Weibel et al., 1987). Orlistat was shown 
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to inhibit pancreatic lipases making it a good anti-obesity drug (Hahn et al., 2013, 
Borgstrom, 1988). Although lipid metabolism is crucial for rapid proliferation and 
survival of organisms, Giardia was shown to have restricted resources to synthesis 
and metabolise lipid suggesting that Giardia depends strongly on the exploitation of 
lipids supplied by the host environment (Das et al., 2002). According to Hahn et al, 
Orlistat may inhibit Giardia’s growth; it may also alter the parasite trophozoite’s 
morphology and detachment, in vitro. Even with promising targets and drugs, in 
vivo model experimentations are required as Giardia’s susceptibility may vary 
according to the infective strain. There is also an important need of standardisation 
for the evaluation of antigiardial drugs. 
1.4/ Biology of Giardia  
During its life cycle, Giardia alternates between two different stages  (Fig 1.7) 
(i) the infectious cyst stage, found in external environment (Fig.1.8 A.) and (ii) the 
trophozoite stage, found in host small intestine (Fig. 1.8 B.). Giardia infections are 
initiated by ingestions of cysts from contaminated water or food, or through direct 
faecal-oral contact (Carranza and Lujan, 2010, Adam, 2001, Adam, 1991).  
1.4.1/ Cyst structure 
The cyst is the infective form of Giardia and is resistant to the external 
environment conditions as well as to the gastric acid in the stomach of the infected 
host. The Giardia cyst contains four nuclei and is approximately 5 by 7 to 10 µm in 
diameter, and is covered by a wall of 0.3 to 0.5 µm thickness composed of an outer 
filamentous layer and an inner membranous layer with two membranes (Fig.1.8A). 
The outer portion of the wall is surrounded by a web of 7- to 20-nm filaments 
whereas the inner portion contains an outer and inner cyst wall membrane 
separated by a thin layer of cytoplasm (Adam, 2001, Adam, 1991, Erlandsen et al., 
1990). Four major proteins (29, 75, 88 and 122 kilodaltons (kDa) in size) have been 
identified in the outer wall by the hybridization of cyst wall-specific antibodies to 
specific bands on Western immunoblots (Adam, 1991, Reiner et al., 1989). 
Immunogold electron microscopy has been used to localise these proteins to the 
filamentous structures of the outer portion of the cyst wall (Adam, 1991, Erlandsen 
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et al., 1990). Flagellar axonemes, vacuoles, ribosomes and fragments of the ventral 
disk are found inside the cyst wall  
1.4.2/ Trophozoite structure 
Trophozoites are non-invasive, and proliferate while attached to the 
epithelial cells of the gut. They are the primary cause of the clinical manifestation of 
the disease (Adam, 1991). Trophozoites replicate by vegetative growth in the 
intestine (Elmendorf et al., 2003). The trophozoite is between 12 to 15 µm long, 5 
to 9 µm wide, and 1 to 2 µm thick (Carranza and Lujan, 2010, Adam, 2001) (Fig. 1.8 
B.). Giardia trophozoite possesses two nuclei surrounded by nuclear envelopes that 
remain intact throughout the cell cycle; and has a complex cytoskeleton that 
maintains the shape of the parasite and anchors the four pairs of flagella (Fig. 1.8B), 
the median body, and the ventral disc (VD) (Carranza and Lujan, 2010, Elmendorf et 
al., 2003). The four pairs of flagella emerge ventrally, anteriolaterally, 
posteriolaterally, and caudally from the cell body. The flagella, median body, and 
VD have been proposed to be important for the attachment of trophozoites to 
enterocytes in the intestine (Carranza and Lujan, 2010, Palm et al., 2005, Elmendorf 
et al., 2003, Lujan et al., 1997). 
From a structural perspective, Giardia trophozoites are simple. They possess 
some basic characteristics of eukaryotic cells such as the presence of nuclei with 
nuclear envelopes linked to the endoplasmic reticulum (ER), and lysosome-like 
peripheral vacuoles that are located underneath the plasma membrane (Carranza 
and Lujan, 2010, Elmendorf et al., 2003, Adam, 2001). However, they lack some 
typical eukaryotic organelles like peroxisomes, a morphologically evident Golgi 
apparatus, and classical mitochondria; although a mitochondrial remnant has been 
described and characterised (Tovar et al., 2003). Giardia has a well-developed ER 
and can form secretory vesicles (Gottig et al., 2006, Lujan and Touz, 2003, Lujan et 
al., 1997). In the cell cytoplasm and adjacent to the plasma membrane (except in 
the region of the ventral disc), there are numerous vesicles and tubules (peripheral 
vacuoles or PVs) which have been proposed to have an endosome and lysosome 
function (Carranza and Lujan, 2010, Gottig et al., 2006). 
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A.           
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
Fig 1. 8: Giardia’s different stages (modified from Ankarklev et al, 2010, with permission). 
A. Thick and resistant cyst found in external environment like water, the cyst wall and inner 
layer consist of two membranes and protect the parasite. Cysts are oval -shaped and non-
motile; they measure 8-12 μm long by 7-10 μm wide. A cyst has four tetraploid nuclei; its 
outer wall is 0.3-0.5 μm thick and is composed of a network of filaments ranging from 7 to 
20 nm diameter; the main proteins composing this wall are N-acetylgalactosamine and 
three cyst wall proteins (CWP1, CWP2 and CWP3). The adhesive disk and flagella are 
disassembled and stored in the parasite. 
 Photo: http://techalive.mtu.edu/meec/module02/images/giardia_cysts.jpg. 
B. Flagellated trophozoites are found in host small intestine, and measure 12-15 μm long 
by 5-9 μm wide. There are 8 flagella organised in four pairs: the anterior flagella (AF), 
ventral flagella (VF), posterior/lateral flagella (PLF) and caudal flagella (CF); dashed lines 
indicate internal structures. The median body is microtubular structure of unknown 
function; the adhesive disk is a large, rigid attachment structure composed of 
microtubules. There are several central and peripheral mitosomes in the trophozoite. 
Peripheral vesicles are lysosome-like vesicles that lie beneath the plasma membrane 
throughout the cell. 
Photo: http://hermes.mbl.edu/news/press_releases/2007/2007_09_27.html, credit: Joel 
Mancuso, University of California, Berkeley, USA. 
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1.4.3/ Excystation 
Once in the host digestive system, cysts release trophozoites in the upper 
small intestine; this mechanism is called excystation and is initiated by the acids 
present in the host stomach. (Alvarado and Wasserman, 2010, Bernal et al., 1998). 
Excystation occurs rapidly (between 10 and 15 min) and involves a reorganisation of 
the parasite’s cytoskeleton enabling an excyzoite to emerge through the cyst wall 
(Ankarklev et al., 2010). Several studies suggested that signalling proteins such as 
protein kinase A (PKA), protein phosphatase 2A (PP2A) and calmodulin may have an 
important role during excystation (Alvarado and Wasserman, 2010, Lauwaet et al., 
2007, Reiner et al., 2003, Abel et al., 2001, Bernal et al., 1998). It was suggested 
that PKA and PP2A may be key modulators during the first stage of acid induction; 
and calmodulin has been shown to be involved in the liberation of the excyzoite 
(Lauwaet et al., 2007, Abel et al., 2001, Bernal et al., 1998). A cysteine protease 
(CP2) was also shown to be involved in the excystation mechanism; CP2, released 
from lysosome-like peripheral vesicles, may degrade the cyst wall from the inside, 
facilitating the liberation of the excyzoite (Adam, 2001). Once liberated, excyzoites 
undergo cytokinesis twice, without intervening S phases  to produce four 
trophozoites which are able to attach to the intestinal epithelia (Ankarklev et al., 
2010, Bernander et al., 2001). 
1.4.4/ Encystation  
 To permit the parasite to survive in hostile external environmental 
conditions and to guarantee the transmission of the infection to susceptible hosts, 
Giardia undergoes a mechanism, called encystation, to form a resistant cyst (Adam, 
2001, Lujan et al., 1997). New formed cysts are released in the environment by 
evacuation in faeces.  Encystation is an adaptive process to cope with the decrease 
of nutrients, cholesterol in particular, in the presence of high bile concentration in 
the lower small intestine (Lujan et al., 1996). Encystation is accomplished in three 
crucial steps: (i) the induction of encystation-specific gene expression, specifically 
those necessary for the synthesis and processing of cyst wall proteins (CWPs) (Lujan 
et al., 1998, Lujan et al., 1995b, Mowatt et al., 1995); (ii) the synthesis and 
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intracellular transport of CWPs through newly developed organelles such as the 
Golgi apparatus and encystation-specific secretory vesicles (ESVs) (Lujan et al., 
1995a); and (iii) the assembly of the extracellular wall (Hehl et al., 2000). 
During the early phase of encystation, CWPs are synthesized and 
transported to cell surface for assembly into the extracellular cyst wall (Gottig et al., 
2006, Lujan and Touz, 2003, Lujan et al., 1997). This major protein transport is a 
regulated secretion process depending on intracellular signals, and consists in the 
export of at least three CWPs and glycans. CWPs are synthesised as luminal proteins 
without membrane anchors and are likely to be dependent on transmembrane 
cargo receptor or escorter proteins, at least for their export from the ER (Hehl and 
Marti, 2004). Before secretion, the cyst wall material is accumulated and 
concentrated in specific intermediate compartments: ESVs . A study suggested that 
the soluble CWPs were not exported from the ER by a default pathway but by a 
signal-dependent mechanism (Hehl et al., 2000). Another study confirmed that 
most regions of CWP3 were important for correct transport of the cyst wall 
component to ESVs and to the extracellular matrix while investigating targeting of a 
chimeric CWP3 reporter (Sun et al., 2003). Marti et al (2003) showed that CWP1 
export signals were recognised by cargo receptors or escorter molecules which 
have yet to be determined. This study also showed that endogenous CWP1 or 
reporters containing CWP targeting signals were only able to exit the ER and 
accumulate in ESVs after trophozoites had received an encystation stimulus (Marti  
et al., 2003). This suggests that the transport of CWPs is a tightly regulated 
secretory process and not just an automatic consequence of increas ed synthesis of 
soluble cargo into the ER lumen. Later during encystation, sites for initiation of the 
cyst wall filament assembly appear on the trophozoite plasmalemma; followed by 
the assembly of the filamentous portion of the cyst wall (Adam, 2001, Reiner et al., 
1989). Upon completion of encystation, motility is lost, and the outer portion 
becomes rounded and filamentous. Moreover, Giardia cysts are no longer attached 
to a surface. ESVs disappear and the internal cyst part included two trophozoites 
with four nuclei that have not yet completed cytokinesis (Adam, 2001). 
It is crucial for Giardia survival that trophozoites encyst not only when faced 
with harsh environmental conditions, such as low cholesterol or alkaline pH and 
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high bile concentration, but also without the presence of any external inducer in 
order to guarantee its dissemination. A recent study showed that Giardia 
trophozoites can undergo encystation under both vegetative growth and encysting 
conditions (Sulemana et al., 2014). Indeed, after three to six hours in inducing 
conditions, encysting trophozoites continued to encyst regardless of whether the 
initial stimulus remained. This suggests that there is a point of commitment during 
encystation, after which encysting trophozoites cannot revert to growing or dividing 
trophozoites; therefore maximising Giardia’s chance of survival. However, the 
mechanisms regulating these decision-making processes have yet to be 
determined. 
 The full sequencing of Giardia genome has identified an extensive number 
of putative protein kinases, which suggests a complex requirement of signal 
transduction to coordinate cell proliferation but also the encystation-excystation 
processes (Morrison et al., 2007). Even though the proteins and pathways involved 
in signal transduction have only begun to be understood, few studies have 
described a possible mechanism involving several enzymes (Carranza and Lujan, 
2010, Li et al., 2009, Touz et al., 2008, Bazan-Tejeda et al., 2007, Lauwaet et al., 
2007, Kim et al., 2005): 
 Extracellular regulated kinases 1 and 2 (ERK1 and ERK2) possess 
homology to the Mitogen-activated protein kinase (MAPK) family which 
members are involved in signalling in higher eukaryotes (Ellis et al., 2003). 
In Giardia, ERK1 and ERK2 were shown to be activated by phosphorylation, 
to translocate to the nuclei and to phosphorylate other proteins, including 
putative transcription factors (Ellis et al., 2003). In their study, Ellis et al 
demonstrated that these two enzymes localised to different structures; 
ERK1 to the median body, VD and basal bodies whereas ERK2 localised to 
the nuclei and caudal flagella. ERK2 was also shown to change its 
localisation pattern during encystation, being mostly cytoplasmic. 
 PP2A is a highly conserved serine/threonine protein phosphatase 
which has been associated with encystation-excystation process in Giardia 
(Lauwaet et al., 2007). Lauwaet and collaborator have shown PP2A to 
localise to cytoskeleton structures and occasionally to cyst wall. Western 
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blot analyses showed that PP2A protein level in Giardia resembled the 
mRNA expression; and was up-regulated in cysts and also in the beginning 
of excystation (Carranza and Lujan, 2010, Lauwaet et al., 2007). 
 Protein kinase B (PKB) is part of a serine/threonine kinases subgroup; 
Giardia PKB has a transmembrane domain in the cytoplasmic region and a 
potential nuclear localisation signal in the regulatory domain. PKB was 
shown to be constitutively expressed and up-regulated during encystation 
(Kim et al., 2005). 
 Protein kinase C (PKC) is also a member of the serine/threonine 
kinases family. PKC plays key regulatory roles in signal transduction 
pathways controlling cellular responses including differentiation (Bazan-
Tejeda et al., 2007). Several isoforms of PKC have been identified in Giardia 
which all show changes in expression during encystation. Bazan-Tejeda et 
al demonstrated that selective PKC inhibitors blocked the encystation in a 
dose-dependent manner. 
 Arginine deiminase (ADI) is a cytoplasmic enzyme that belongs to the 
guanidine modifying super family; it catalyses the irreversible catabolism of 
arginine to citrulline in the arginine dehydrolase (ADH) pathway. ADI 
serves also as an important source of energy (Li et al., 2009). In 2008, Touz 
et al reported that ADI played multiple roles in signal transduction 
pathways leading to the control of encystation and antigenic variation. It 
was suggested that this was due to the potential of ADI to citrullinate 
arginines present in Giardia proteins (Touz et al., 2008). However, this 
additional function of Giardia ADI is still discussed since another study 
reported that recombinant dimeric enzymes were unable to perform this 
process (Li et al., 2009). 
 Heat shock protein 90 (Hsp90) is a versatile chaperone protein 
involved in the modulation of diverse cellular processes such as cell cycle, 
signal transduction, differentiation. The majority of proteins chaperoned by 
Hsp90 have been shown to be transcription factors and protein kinases (Roy 
et al., 2012, Taipale et al., 2010). A recent study has shown Hsp90 
implication in Giardia encystation by inhibiting Giardia Hsp90 in 
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trophozoites in pre-encystation stage and during encystation (Nageshan et 
al., 2014). This inhibition resulted in a robust induction of encystation during 
the pre-encystation stage; but not during encystation. This suggests that 
Hsp90 may be involved in the modulation of encystation in Giardia. 
However, the downstream events upon Hsp90 inhibition leading to 
induction of encystation remain unclear and have yet to be investigated. 
These different studies have shown the implications of these enzymes in 
Giardia signal transduction pathway; however a link between these elements is still 
necessary and requires further investigation.  
1.4.5/ Giardia secretory pathway 
 Two pathways have so far been characterised for the transport of proteins 
in Giardia: (i) the endomembrane protein transport system, (ii) lysosome-like 
peripheral vesicles, (Lujan and Touz, 2003, Adam, 2001). 
1.4.5.1/ The endomembrane protein transport system 
 ER and Golgi complex are key components of the eukaryote endomembrane 
system which is involved in the protein folding and translocation. In higher 
eukaryotes, proteins destined for secretion possess a signal sequence directing 
them to the ER as they are translated in the ribosomes. The protein signal sequence 
binds to the signal recognition particle (SRP); this complex then binds to the SRP 
receptor (SR) present on the cytoplasmic side of the ER. The ER is composed of 
chaperonins such as Ig heavy chain-binding protein (BiP) and protein disulfide 
isomerases (PDIs). 
Giardia ER was first observed after the cloning and characterization of SRα 
and the identification of an extensive membrane system labeled with anti-BiP 
antibody (Soltys et al., 1996). BiP functions as a chaperone protein aiding in the 
folding and transport of newly synthesized proteins  (Craig et al., 1993). BiP 
chaperones were essentially found in reticular membranous net in vegetative and 
encysting trophozoites, but BiP proteins were also observed inside encystation-
specific secretory vesicles (ESVs) during encystation; which was probably due to 
them still being associated with CWPs during transit of CWPs to the plasma 
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membrane (Lujan and Touz, 2003). PDIs were shown to be involved in the disulfide 
bond formation of newly synthetized secretory proteins; this event occurs in the ER 
lumen (Gilbert, 1997). Three PDIs have been identified in Giardia; two of them – 
PDI-1 and PDI-2 - were described as atypical due to the presence of KRKK ER-
retention signal on their short cytoplasmic tails (Knodler et al., 1999). PDI-3, on the 
contrary, was shown to possess a C-terminal KQRL ER-retention signal. All three 
PDIs localise in the ER in vegetative trophozoites; however, PDIs were also observed 
within ESVs and on the surface of encysting parasites (Reiner et al., 2001). BiP and 
PDI-2 expression was shown to increase during trophozoite differentiation into cyst, 
which suggests that the rapid synthesis of cyst wall proteins during encystation 
requires more ER chaperones (Lujan et al., 1997). The presence of ER chaperones 
outside the ER during encystation also suggests that, due to the presence of an 
elementary endomembranous system in Giardia, the proper quality control for ER-
protein retention may either be absent, fail, or not be sufficient to deal with an 
increase in expression of cyst wall components (Lujan and Touz, 2003, Knodler et 
al., 1999). 
In eukaryotes, Golgi complex serves as a major sorting point in the secretory 
pathways. It selectively targets proteins and lipids to different organelles. The Golgi 
apparatus consists of a series of flattened cisternal membranes forming a stack with 
a defined cis to trans orientation (Marti and Hehl, 2003, Lujan and Touz, 2003). 
Cargo modifications during transport through this cisternae stack include: (i) 
processing N- and O-linked oligosaccharides; (ii) addition of mannose-6-phosphate 
residues to lysosomal proteins; (iii) sulfation; (iv) phosphorylation; and (vi) acylation 
(Marti and Hehl, 2003). At the most trans side of the Golgi apparatus, the trans-
Golgi network (TGN), proteins, glycans and lipids are packed into different classes of 
vesicles bound for the plasma membrane or other organelles in the cell (Marti and 
Hehl, 2003). The Golgi apparatus has a unique architecture which is remarkably 
conserved throughout eukaryotic evolution (Mellman and Simons, 1992). However, 
the typical eukaryotic Golgi complex appears to be missing in vegetative Giardia 
trophozoites. It has been suggested that Giardia trophozoites may possess one or 
more organelles where typical Golgi functions take place, even though they do not 
have a Golgi-like appearance (Lujan and Touz, 2003). Interestingly, the rise of an 
 Chapter I 
Chapter I 
72 | P a g e  
elaborate Golgi complex, consisting in 3 – 20 parallel cisternae and dramatic 
changes in the nuclear envelope, including the appearance of numerous nuclear 
pores, were observed close to the nuclear membrane only in encysting trophozoites 
via the use of electron microscopic techniques (Lujan and Touz, 2003). Whether this 
perinuclear region contains Golgi markers has yet to be determined. Interestingly, a 
set of membrane-bound structures other than peripheral vesicles were identified 
and localised near the ER and/or nuclear envelope compartment; but their 
implication as part of a putative trophozoite secretory system remains to be 
elucidated (Benchimol, 2002). All this suggests that Giardia trophozoite nuclear 
envelope may play an important role in protein sorting and transport. The 
sequences of two Giardia syntaxins were reported (Dacks and Doolittle, 2002). 
Syntaxins are associated with transport through the Golgi apparatus; they belong to 
the SNAREs family. SNAREs are soluble NSF (N-ethylmaleimide-sensitive factor) 
attachment proteins receptors (SNAP receptors). They play crucial roles in vesicular 
transport and membrane fusion in higher eukaryotes  (Parlati et al., 2002). The 
identification of Golgi-related syntaxins in Giardia trophozoites provides further 
evidence for the presence of a cryptic Golgi complex in the parasite.  
The formation of transport vesicles and their delivery to the target 
membranes were shown to be controlled by small GTPases of the ADP-ribosylation 
factor (ARF) and Rab families respectively (Pfeffer, 2001, Sogaard et al., 1994). ARFs 
are required for maintaining intracellular transport and the organelle structure 
integrity. In Giardia, an ARF homologue was identified and immunolocalised to a 
region surrounding both nuclei, in an area described as likely to be the rough ER 
(RER) (Lujan and Touz, 2003). A Giardia-Rab 1 GTPase was also described and 
shown to localise to the ER and PVs (Langford et al., 2002). Rab 1 was also 
associated with ESVs during encystation. Rab proteins were described as organelle-
specific GTPases that facilitate the delivery of transport vesicles by regulating the 
protein-protein interaction (Parlati et al., 2002, Pfeffer, 2001). The investigation of 
the transport and protein-protein interaction of Golgi resident markers like-Rab 1 
may help localising and identifying the minimal Golgi-like structure still missing in 
Giardia trophozoite. 
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1.4.5.2/ Protein transport to the lysosome-like peripheral 
vesicles 
Most eukaryotes possess a system of endosomes and lysosomes that 
degrade and recycle endogenous proteins or proteins acquired by endocytosis and 
phagocytosis from the extracellular space. Early endosomes internalise 
endocytosed proteins to allow for their return to the cell membrane or transport to 
late endosomes. Once in the late endosomes, proteins are transported to and 
degraded by the lysosomes (Scott et al., 2014). Both endosomes and lysosomes are 
acidic with a pH < of 6 and of 5 respectively. Giardia lacks compartments 
resembling early/late endosomes and lysosomes. Instead, it possesses peripheral 
vacuoles (PVs) that are located underneath the plasma membrane and seem to 
function as endosomes and lysosomes (Lanfredi-Rangel et al., 1998). The lysosomal 
targeting pathway has been well studied and defined in yeast and mammalian cells. 
In this pathway, soluble hydrolases were shown to be sorted away from the 
secretory pathway by reaching the lysosomes through a receptor-mediated 
process, via oligosaccharide signals attached to the proteins in the Golgi apparatus 
(Lujan and Touz, 2003). In Giardia trophozoites, soluble enzymes such as acid 
phosphatase and cathepsin B were shown to localise to the PVs by their immune-
localisation (Lanfredi-Rangel et al., 1998, Ward et al., 1997). Supposing that Giardia 
possesses a mechanism similar to the one described above, soluble proteins would 
need to interact with a receptor to be transported to the PVs; so far, no receptor 
were described to be involved in protein delivery to PVs. Moreover, protein 
glycosylation was shown to be controversial in Giardia due to the lack of evidence 
for either N- or O-glycosylation in any trophozoite protein (Lujan et al., 1995a).  
Transmembrane proteins are sorted from the Golgi to endosome/lysosomes 
via motifs present in their AA sequence. Tyrosine-based signals have been shown to 
be the motifs usually present in the cytoplasmic tail of integral proteins involved in 
lysosomal protein transport (Le Borgne and Hoflack, 1998). Touz et al. showed that 
tyrosine-based motifs were playing an important role in Giardia lysosomal 
trafficking. They also found an encystation-specific cysteine protease (ESCP) in the 
lysosome-like PVs (Touz et al., 2003, Touz et al., 2002). ESCP was described as a 
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transmembrane protein carrying an YRPI motif within its cytoplasmic tail. This motif 
was demonstrated to be crucial for ESCP delivery as deletion and point mutations of 
the motif missorted ESCP to the plasma membrane (Touz et al., 2003). All these 
findings indicate that Giardia possesses an endosomal/lysosomal system 
concentrated in one single organelle, the PV. This suggests that the subdivision of 
this organelle into endosome/lysosome specific compartments occurred later than 
the development of a basic machinery for lysosomal-protein delivery. Additionally, 
a study showed that in certain periods of Giardia life cycle, PVs could function as 
secretory organelles (Slavin et al., 2002). 
1.5/ Host-parasite interactions 
The human intestine acts as an anaerobic “bioreactor” programmed with a 
colossal population of bacteria. This population of bacteria, up to 1 x 1014, far 
surpasses all the other microbial communities associated with the body’s surfaces 
in size (Backhed et al., 2005, Savage, 1977). All three domains of life - Archaea, 
Eukarya and Bacteria- are found in the gastrointestinal tract and formed a 
microbiota approximately 10 times greater than the total number of human 
somatic and germ cells in a body (Backhed et al., 2005). 
1.5.1/ The human intestinal epithelium 
The intestinal epithelium is a critical interface between the environment and 
the organism. It is composed of the mucous coat, the closely packed microvilli and 
the glycocalix which prevent direct contact of most macromolecules on the apical 
side; and the tight junctions which restrict paracellular transport to small molecules 
(Fig 1.9) (Snoeck et al., 2005). 
 The mucosal surface of the intestine forms a major mechanical barrier that 
separates the host’s internal milieu from the external environment. However, it is 
not a passive barrier. Indeed, the tight junctions are dynamic s tructures regulated 
by events taking place in the intestine; and the enterocytes have a function in the 
presentation of antigens to T cells and then, in their digestion (Cobrin and Abreu, 
2005).  
 Chapter I 
Chapter I 
75 | P a g e  
1.5.1.1/ The intestinal epithelial cells: Enterocytes 
Enterocytes are the intestinal absorptive cells found in the small intestine 
and colon. These cells are hyperpolarized, joined together by tight junctions (TJs), 
and efficient protein sorting and addressing are essential to the establishment and 
maintenance of cell polarity, on which the integrity of the epithelial barrier depends 
(Snoeck et al., 2005, Jung et al., 1995) (Fig 1.9). 
Enterocytes have a distinctive structural asymmetry. Indeed, sorting 
compartments of the secretory apparatus, subsets of membrane and cytoskeletal 
proteins and microtubules are asymmetrically distributed throughout the 
cytoplasm. These subsets of proteins localise to functionally and structurally distinct 
membrane domains, termed apical and basolateral (Drubin and Nelson, 1996). They 
are composed of a TGN, nucleus, ER, TJs which join cells together; and a lot of 
vesicles: apical early endosome, apical recycling endosome, late endosome, 
common lysosome, basolateral early endosome, lysosomes and mitochondria. 
These vesicles are involved in the transport of macromolecules and nutrients from 
the apical surface to the basal-lateral surface and inversely (Fig 1.9) (Snoeck et al., 
2005). 
Since the intestinal cells are hyperpolarized, a short-circuit current (Isc) 
allows a current to travel along a path where essentially no (or a very low) electrical 
impedance is encountered; and reflects net ions transport in the form of cation 
absorption or anion secretion on the apical side (Fig 1.10). In epithelial cell, the Isc 
represents the highest electric current between the apical (negatively charged) and 
the basolateral (positively charged) surfaces. The electric resistance of this Isc is 
called trans-epithelial electrical resistance (TEER) and seems to be at the origin of 
the cell permeability to molecules (Narai et al., 1997). 
Some of the major functions of enterocytes are (i) ion uptake, including 
sodium, calcium for example; this uptake typically occurs through active transport 
with hydrolysis of one molecule of ATP; (ii) Water uptake which follows the osmotic 
gradient established by the Na+-K+-ATPase channel on the basolateral surface; it can 
be a transcellular or a paracellular transport; (iii) Sugar uptake, sugar molecules are 
absorbed and cross the apical membrane of the enterocytes using the Na+- 
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Fig 1. 9: Model for endocytic traffic in polarized enterocytes (Based on Snoeck et al, 2005, 
with permission). The apical and basolateral surfaces are separated by tight junctions (TJs). 
Upon internalization (     ), fluid and membrane components are delivered (          ) to 
distinct early endosomes, the apical (AEE) or the basal (BEE). Then, from the AEE, 
internalized components can be recycled ( ) or transcytosed (        ), be delivered to 
the late endosome (LE) and ultimately to lysosomes; or they can be delivered to the apical 
recycling endosome (ARE) or to the common endosome (CE) for recycling through the ARE 
or to transcytose. From the BEE, internalized components can recycle, be delivered to the 
CE for recycling to the basolateral membrane (           ) or transcytose through the AEE or the 
ARE, or they can be delivered to the LE and lysosomes. Membrane proteins newly 
synthesized (   ) can be directly delivered to the apical or basolateral surface after sorting in 
the TGN (trans-Golgi Network). 
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dependent glucose transporter (iv) peptides and amino acid uptake, proteins are 
cleaved to amino acids or small peptides and are then absorbed on the apical 
membrane. 
1.5.1.2/ The intestinal molecular pathways 
There are three way possible for the transport of molecules throug 
enterocytes. 
 Transcellular transport 
Because of the enterocyte physical structure, it is very unlikely that 
macromolecules can cross the lipid bilayer into the cytosol. Indeed, its plasma 
membrane being composed of a lipid bilayer in which membrane-bound proteins 
and glycoproteins are situated, the molecules can only be transported by receptors 
present at the enterocyte membrane surface. The major pathway for molecules is a 
transcellular transport called endocytosis which is a receptor-mediated mechanism 
(Fig 1.10). Besides transport of molecules, endocytosis is also involved in regulation 
of cell-surface receptor expression, maintenance of cell polarity, and antigen 
presentation (Conner and Schmid, 2003, Drubin and Nelson, 1996). In enterocytes, 
three other pinocytosis mechanisms have been proposed: (i) clathrin-mediated 
endocytosis, which is the major pinocytic pathway; (ii) caveolin-mediated 
endocytosis, which is a slow process consequently unlikely contributing significantly 
to bulk fluid-phase uptake; (iii) and clathrin-caveolin-independent endocytosis, 
which remains poorly understood (Snoeck et al., 2005, Conner and Schmid, 2003) 
(Fig 1.11). 
Another way to absorb nutrients, ions or water is via epithelial transporters 
which are integral membrane protein pumps or channels (Snoeck et al., 2005). 
Nutrients, such as sugars, ions, and amino acids, enter the enterocyte cytoplasm at 
the apical membrane by these transporters and exit the basolateral membrane. 
Some are adenosine triphosphate (ATP)-dependent and others rely on the osmotic 
gradient between the lumen of the intestine and the mucosa (Fig 1.10). 
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 Paracellular transport 
For some molecules, another way to go through the intestinal epithelial barrier 
is paracellular transport. Instead of crossing through enterocytes, molecules go 
through the tights junctions, which are dynamic structures, between adjacent 
epithelial cells (Fig 1.10). However, the passage of large molecules through tight 
junctions is not possible; they have to be cleaved into peptides or amino acids for 
proteins, or saccharose, glucose, for example, for polysaccharides. Chantret et al 
compared 20 different human colonic carcinoma cell lines in order to determine 
which line spontaneously developed normal human intestinal cell characteristics, 
such: (i) the organization of the cells into a polarized monolayer; (ii) the presence of 
an apical brush border; and (iii) the presence of brush border-associated hydrolases 
such as sucrase-isomaltase, lactase, or alkaline phosphatase (Chantret et al., 1988). 
The only human colonic carcinoma cell line able to do all three was the human 
colonic adenocarcinoma derived epithelial cell line-2 (CaCo-2) concluding that only 
the CaCo-2 cell line showed the differentiation characteristics of mature 
enterocytes. Moreover, in another study, Grasset et al showed that the CaCo-2 cells 
exhibited a similar electrical properties as enterocytes, by displaying a measurable 
TEER and a positive Isc reflecting ion and molecules transport through cells similarly 
to human enterocytes (Grasset et al., 1984). 
 Water uptake in the intestine 
 Water transport across the cell membranes takes place via several routes: (i) 
by osmosis, via the lipid bilayer and the water channels called aquaporins (AQP) (Fig 
1.12 A.); (ii) by co-transport, via co-transporters or uniporters such as the 
Potassium-Chloride co-transporter (KCC) (Fig 1.12 B.); (iii) or by co-transport and 
osmosis at the same time, via specific co-transporter such as the Sodium-glucose 
co-transporter 1 (SGLT-1) (Fig 1.12 C.) (Zeuthen, 2010) 
AQP are integral membrane proteins expressed in various organs and 
tissues. They serve as channels in the transfer of water and, sometimes, small 
molecules across the membrane (Takata et al., 2004, Agre et al., 2002) (Fig 1.13). 
The water is transferred through the cell membranes via the osmotic pressure  
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Fig 1. 10: Model of ions transport in polarized enterocytes. On the apical surface, there 
are four major ions transporters. The H+-ATPase (1) and H+-K+-ATPase (2) are ATP-
dependent, they need energy for the ions absorption and/or secretion. Via the hydrolysis 
of one molecule of ATP into ADP and inorganic phosphate (Pi), ions are absorbed or 
secreted or both. Currently, two of these channels have been identified through which Cl - 
can be secreted into the intestinal lumen, thus creating the driving osmotic gradient for 
fluid secretion, namely: (i) CFRT which is embedded as dimers into the membrane, it is 
regulated by the phosphorylation of protein kinase A (PKA) and it is a cyclic adenosine 
monophosphate (cAMP)- dependent mechanism; (ii) CaCC which is an Ca2+-dependent 
pathway for Cl- secretion, when the cytosolic concentration of Ca2+ increases, the secretion 
of ions Cl- into the lumen is increasing too.  
On the basolateral surface, there are four major transporters too. Three of them have a 
role in the chloride secretion: (i) the Na+-K+-ATPase channel (5) is ATP-dependent and 
provides the energetic requirements for active Cl - secretion by transporting three Na+ ions 
out of the cell and two K+ ions into the cell; (ii) the Na+-K+-2 Cl- co-transporter (NKCC) which 
mediates Cl- uptake at the basolateral pole and thereby provides the substrate for the 
apical Cl- secretion; (iii) potassium channels (4) maintain cellular electroneutrality by 
compensating for Cl - efflux and keeping the cell in a state of hyperpolarization. The last 
main basolateral receptor is kidney anion exchanger 1 (kAE1) (3) which has a role in the 
absorption of Cl- ions from the basolateral side; it exchanges HCO3- anion from the cytosol 
with Cl- extracellular. 
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Fig 1. 11: The different types of pinocytosis in mammalian cells (reproduced and modified 
from Conner et al, 2003, with permission).  These pathways differ with regard to the size of 
the endocytic vesicle, the nature of endocytosed molecules, receptors and lipids, and the 
mechanism of vesicle formation  
The macropynocitosis is unlikely to occur by enterocytes since this mechanism involves 
extensive membrane ruffling and sampling of large volumes of the extracellular milieu. The 
clathrin-mediated endocytosis involves the concentration of high-affinity transmembrane 
receptors and their ligands into “clathrin-coated pits” for the formation of a coated vesicle 
bringing the molecules into the cytosol to be recycle by endosomes. Caveolae, which are 
flask-shaped invaginations of the plasma membrane, are involved in the caveolin-mediated 
endocytosis. These invaginations demarcate cholesterol and sphingolipid-rich 
microdomains in which many different signalling molecules and membrane transporters 
are concentrated. 
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regulation and driven by a hydrostatic gradient within the hemipore. 10 AQP 
channels have been identified so far, AQP0 to AQP10 (Agre et al., 2002). Some are 
aquaglyceroporins; they are water and glycerol permeable. AQP1 is the main AQP 
channel, it is found in any type of organs or tissues. In the intestine, AQP5 is mainly 
found in the small intestine; and AQP3, which is an aquaglyceroporin, is mainly 
found in the colon (Matsuzaki et al., 2004, Takata et al., 2004, Agre et al., 2002). 
Co-transporters and uniporters are membrane transport proteins. They can 
transport one or several molecules through the cell plasma membrane. The tight 
coupling between water and molecules in co-transport allows co-transporters to 
function as molecular water pumps (Fig 1.12 B.). The free energy contained in the 
transported molecules gradient can be transferred to the water flux. In some co-
transporters, like the sodium-glucose co-transporter 1 (SGLT-1), both modes of 
transport can occur (Fig 1.12 C.). They co-transport water through the plasma 
membrane but also possess water channel properties (osmosis). The transport of 
water via these transporters is bimodal; osmosis and co-transport can be done in 
parallel (Zeuthen, 2010). 
1.5.2/ Pathophysiology 
 Giardia trophozoites adhere to the epithelial surface of the small intestine 
via the ventral disc (VD). This attachment triggers a series of events: (i) the increas e 
of intestinal cell apoptosis; (ii): the disruption of the intestinal barrier function; (iii) 
a diffuse shortening of the brush border microvilli and malabsorption; (iv) 
hypersecretion of anion (such as chloride) and increase of the intestinal transit 
(diarrhoea) (Cotton et al., 2011). 
1.5.2.1/ Increase of the intestinal cell apoptosis 
 Programmed cell death (PCD) helps to maintain homeostasis of 
intestinal cells either via senescence in which case cells stop dividing or via 
apoptosis in which cellular mechanism trigger the cell’s own death. Apoptosis 
assists in preserving the homeostatic turnover of gastrointestinal epithelial cells ; it 
is also involved in maintaining a correct cell number in organisms by balancing cell 
growth and death. The main regulatory component of apoptotic death is the  
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Fig 1. 12: The different water transport routes (Based on Zeuthen, 2010, with permission). 
A. Via osmosis which is driven by the water chemical potential difference. B. Via co-
transport of substrates, such as potassium-chloride co-transporter (KCC), co-transporters 
function as molecular water pumps; the free energy contained in the substrate gradient is 
transferred to the transport of water. C. Via co-transport and osmosis, some co-
transporters can employ both co-transport and osmosis to transport water and substrates 
through cell membranes. 
 
   
Fig 1. 13: Schematic representation of the AQP3 structure. AQP3 is mainly expressed in 
the epithelia of the upper digestive tract and the lower digestive tract (from the colon to 
the anus). Each AQP isoforms is composed of a single polypeptide chain of  approximately 
270 AAs and spans the membrane 6 times. Both the amino- and carboxyl-terminal ends are 
in the cytoplasm; and highly conserved regions (hemipores) contain the consensus motif: 
asparagine-proline-alanine (NPA). 
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sequential activation of proteolytic cysteinyl aspirate-specific proteases called 
caspases (Hall et al., 1994). The induction of apoptosis by Giardia in enterocytes 
was established by Roxstrom-Lindquist et al (2005). In this study, PCD-associated 
genes such as CC and CXC chemokine ligand and other chemo-attractant receptor 
genes, transcription regulators genes, and cell cycle regulator genes were up-
regulated in cells exposed to Giardia components (Roxstrom-Lindquist et al., 2005). 
Furthermore, it has been established that high rates of epithelial apoptosis occur 
shortly after exposure to Giardia, both in patients with chronic giardiasis and in 
vitro (Troeger et al., 2007, Roxstrom-Lindquist et al., 2005, Chin et al., 2002). Some 
studies suggested that Giardia infections initiate apoptosis via the activation of pro-
apoptotic caspase-8, known to be triggered following the activation of caspase-6, a 
caspase-3 downstream target (Cotton et al., 2011). Caspases are a family of 
proteases that cleave their substrates after aspartic acid residues (Slee et al., 1999). 
They are present in cytosol as inactive zymogens, called pro-caspases, which 
require proteolytic processing to achieve their active configuration. Several distinct 
routes lead to caspase activation depending upon the stimulus that initiates the 
death program. Their activation was shown to be stepwise with a downstream 
effect as caspases are able to process other caspases (Slee et al., 1999). The main 
extrinsic pathway was shown to be initiated at the cell membrane by ligands of 
tumour necrosis factor (TNF) receptors; this ligand-binding leads to assembly of the 
death-inducing signalling complex which recruits and activates capsase-8 and -10 
(Connolly et al., 2014). The intrinsic pathway is initiated by mitochondria whose 
outer membrane becomes permeable to cytochrome c upon certain cellular 
stresses such as DNA damage or ER stress (Connolly et al., 2014, Tait and Green, 
2010). Both intrinsic and extrinsic pathways converge on activating the executioner 
caspase-3 and -7 throughout the downstream induction of other caspases (Tait and 
Green, 2010, Slee et al., 1999). Whether or not the caspase activation by Giardia is 
direct or occurs due to the activation of caspases-6 and -3 has to be determined (Fig 
1.14). The possible roles of apoptosis inducing factors (AIFs) in Giardia-induced 
enterocyte apoptosis are unknown; AIFs may activate apoptotic DNA breakdown in 
a caspases-independent design when released after a loss of mitochondrial integrity 
(Cotton et al., 2011). Although both parasite and host factors can induce intestinal 
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epithelial cell apoptosis, the components responsible for its activation during 
giardiasis have yet to be identified.  
1.5.2.2/ Disruption of the intestinal barrier function 
 In the intestine, adjacent enterocytes are connected by TJs. These TJs 
establish a selective barrier that separates the external environment from 
underlying host tissues; they also are the first line of defence against the influx of 
harmful luminal contents, such as pathogens and cytotoxic products (Kotler et al., 
2013, Anderson and Van Itallie, 1995). They are composed of a branching network 
of sealing strands. Each strand acts independently from the others and are formed 
from various transmembrane proteins (claudin proteins embedded in both plasma 
membranes), cytosolic plaque proteins (Zonula occudens, ZO-1) and cytosolic 
regulatory proteins (myosin light chain kinase, MLCK; and Rho kinase, ROCK) 
(Anderson and Van Itallie, 1995). Giardia-mediated increases of the intestinal 
permeability result from modifications of the apical TJs, including disruption of ZO -
1, cytoskeletal filamentous (F)-actin, claudin-1, and α-actinin which is a component 
of the actomyosin ring that regulates paracellular flow (Cotton et al., 2011, Troeger 
et al., 2007, Scott et al., 2002). In vivo studies of Giardia show that high intestinal 
permeability and macromolecular uptake occur contemporaneously with the peak 
of trophozoite colonisation. A return to normal baseline is observed following host 
parasite clearance (Cotton et al., 2011, Scott et al., 2002). In 2002, Chin et al 
demonstrated that inhibition of caspases-3 prevents relocalisation of F-actin and 
ZO-1, suggesting a direct cause-effect relationship between Giardia-induced 
apoptosis and small intestinal barrier function. However, which of the tight junction 
regulatory protein (MLCK and/or ROCK) is activated by the caspase-3 mediated F-
actin and ZO-1 disruption has to be determined (Fig 1.14). Furthermore, by which 
mechanisms Giardia is disrupting the intestinal epithelial barrier function, during 
giardiasis, is still unknown and needs further investigations. 
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1.5.2.3/ Diffuse shortening of brush border microvilli, 
malabsorption and anion hypersecretion 
 Giardiasis can also reduce the whole intestinal absorptive surface area, 
either in the presence or absence of villous atrophy. However, some studies have 
clearly demonstrated that the total duodenal surface area is decreased in patients 
with chronic giardiasis; this is supported by previous studies showing that Giardia 
infections induce the diffuse shortening of epithelial brush border (Troeger et al., 
2007, Scott et al., 2004, Scott et al., 2000). This process is triggered by activated 
CD8+ lymphocytes; consistent with the hypothesis that Giardia-mediated 
immunopathophysiology occurs secondary to the disruption of the intestinal barrier 
(Scott et al., 2004). However, CD8+ lymphocytes are known to contribute to the 
parasite clearance as well as to contribute to the pathophysiology. Some studies 
have shown that maldigestion happens during giardiasis due to a deficiency in 
numerous brush border enzymes; they have also demonstrated that diffuse 
shortening of brush border microvilli causes small intestinal malabsorption due to 
reduced absorption of water, glucose and electrolytes (Buret, 2007, Scott et al., 
2004, Scott et al., 2000, Faubert, 2000, Cevallos et al., 1995). Malabsorption of 
nutrients and electrolytes creates an osmotic gradient that draws water into small 
intestinal lumen causing a small intestine distension and rapid peristalsis (Fig 1.14). 
It has been reported that Giardia-infected individuals can also have elevated levels 
of faecal fatty acids (Morken et al., 2009). It is possible that high levels of 
undigested carbohydrates contribute to diarrhoea, in Giardia infections, following 
their transformation into short chain fatty acids by colonic microbiota (Cotton et al., 
2011). An increased chloride secretion has also been shown to contribute further to 
diarrhoea in giardiasis (Baldi et al., 2009, Troeger et al., 2007, Cevallos et al., 1995). 
In summary, diarrhoea in Giardia-infected individuals is induced by several 
mechanisms including diffuse shortening of brush border microvilli, malabsorption, 
and anion hypersecretion. These phenomenons appear to be initiated via caspase-
dependent apoptosis and tight junctional disruptions (Fig 1.14). The parasitic 
and/or host factors involved in these events have still to be identified. 
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Fig 1. 14: Giardia infection Pathophysiology. Giardia infection triggers a cascade of 
physiological reactions within the intestinal epithelial cells: First, caspase 8 protein is 
activated either directly or via other caspases (caspase 3 and 6); and induces apoptosis. The 
intestinal barrier function is disrupted via the inhibition of caspase 3 which modifies the 
tight junctions’ permeability; this leads to the activation of T cells inducing a parasites 
clearance but also a diffuse shortening of brush border microvilli. The shortening of 
microvilli causes malabsorption and a chloride (Cl -) secretion increase. Giardia-induced 
diarrhoea may result from the combination of all these intestinal enterocyte physiological 
reactions. 
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1.5.3/ Giardia pathogenic factors 
The intestinal epithelium is continuously exposed to a multitude of food and 
other antigens that may either be beneficial or harmful for the host. Consequently 
the intestinal immune system has to balance between either tolerance against 
commensal bacteria and food antigens or protective immune responses induced by 
intestinal pathogens and toxins (Cobrin and Abreu, 2005, Medzhitov and Janeway, 
2000).  
To survive and colonise such a hostile environment, Giardia has to adapt 
constantly to the host environment changes via modification in proteins expressed 
by the trophozoites. Giardia genome is distributed between five chromosomes, its 
size slightly varies between assemblage A and B (Table 1.5) (Adam et al., 2013, 
Morrison et al., 2007). Assemblage A (WB isolate) is approximately 11.7 mega base 
pair (Mb) in size, divided among 306 contigs and with a very low level of 
heterozygosity (< 0.01 %) (Perry et al., 2011, Morrison et al., 2007). Assemblage B 
genome is 12.01 Mb in size, divided among 544 contigs and with a level of 
heterozygosity higher than assemblage A (0.425 %) (Adam et al., 2013, Franzen et 
al., 2009). Sub-assemblage A2 (DH isolate) genome is 10.7 Mb in size which makes it 
the smallest assembled Giardia genome to date; its genome is divided among 239 
contigs and its level of heterozygosity is also very low (0.037 %) (Adam et al., 2013). 
Whole genomes were compared showing that there is a substantial synteny 
between isolates A1 and A2 and an overall preservation of genome synteny 
between A1 isolate and assemblage B (Adam et al., 2013, Franzen et al., 2009). For 
all five chromosomes, central regions showed greater levels of similarity than the 
more distal regions. Only a few assemblage-specific genes are found in assemblage 
B, except for vsp gene family where the repertoires of assemblage A and B are 
completely different (Adam et al., 2013, Franzen et al., 2009). Interestingly, all 
meiosis-related genes identified in assemblage A are found in assemblage B. Several 
are well conserved, but some are not as conserved and some even show deletion or 
insertion in important regions (Franzen et al., 2009). It has been shown that 
exposure to epithelial cells resulted in significant changes in Giardia gene 
expression and the release of several Giardia-produced metabolic enzymes: (i) 
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surface lectins, (ii) giardin proteins, (iii) variant surface proteins (VSPs), and (iv) 
cysteine proteases (CPs) (Ringqvist et al., 2011, Ringqvist et al., 2008, Roxstrom-
Lindquist et al., 2006). Most of these Giardia-expressed parasitic factors are 
involved in the trophozoite attachment via its ventral disc (Cotton et al., 2011). 
1.5.3.1/ Lectins 
 Lectins are surface sugar-binding proteins that are highly specific for their 
sugar moieties. They play a role in many different biological functions: from 
regulation of cell adhesion to glycoprotein synthesis; they also have a role in the 
recognition phenomena involving cells and proteins. They are also found during the 
colonisation of a new host by pathogens. Indeed, some viruses use them to attach 
to host cells. In 1986, two studies have demonstrated the presence of Giardia-
secreted lectin proteins during Giardia infection (Lev et al., 1986, Farthing et al., 
1986). Farthing et al showed that Giardia possesses a surface membrane-associated  
lectin with specificities for glucosyl and mannosyl residues from the experimental 
cell line they used, rabbit erythrocyte. Lev et al confirmed this discovery by showing 
the presence of Giardia-secreted lectin during parasite attachment to enterocytes. 
Mannosyl residues are present on the surface of mammalian intestinal epithelial 
cells and appear to be receptors for bacterial mannose-binding lectins, which led to 
the conclusion that lectins may participate in the trophozoite attachment to the 
host enterocytes (Farthing et al., 1986). Lev et al also suggested that lectins may be 
responsible for the microvillus shortening. Even if the presence of Giardia-secreted 
lectins have been demonstrated decades ago, how these lectins and to what extend 
they participate in the parasite attachment remain unclear and need further 
investigation. 
The best characterised Giardia lectin was observed in haemagglutination 
assay after trypsin treatment of sonicated trophozoites; it was therefore called 
trypsin activated Giardia lectin (taglin) (Lev et al., 1986). Taglin was shown to be a 
possible agent contributing to the microvillus shortening observed during Giardia 
infection (Farthing et al., 1986). A 30 kDa antigen has been identified as a common 
immunoreactive protein displaying the lectin activity; however this protein was not 
characterised until 2003. Weiland and collaborators identified the proteins  
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Table 1. 5: Comparison of genomic features of Giardia genomes sequenced  
(modified from Adam et al., 2013 with permission) 
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recognised by taglin as alpha-1 (α1-) and alpha-2 (α2-) giardins, two proteins 
present in Giardia cytoskeleton and involved in the attachment of trophozoites to 
intestinal cells (Weiland et al., 2003) 
1.5.3.2/ Giardins 
Giardins are Giardia-specific proteins; they are components of Giardia 
cytoskeleton within the ventral disc. Four major classes have been identified so far: 
alpha (α)-giardin, beta (β)-giardin, gamma (γ)-giardin and delta (δ)-giardin (Feliziani 
et al., 2011, Wei et al., 2010, Palm et al., 2003, Peattie, 1990, Peattie et al., 
1989).The α-giardin form a large class of annexin-like proteins, encoded by 21 
different genes (named α1-α19), having significant sequence similarities. They are 
located at the outer edges of the ventral disc microribbons and are found in both 
assemblages A and B with a genome synteny (Feliziani et al., 2011, Wei et al., 2010). 
Although Steuart et al determined that α2-giardin was an assemblage A-specific 
protein, a recent study showed the presence of a α2-giardin gene-like in 
assemblage B, with 92 % AA identified and encoded from gene in a syntenic 
position (Franzen et al., 2009, Steuart et al., 2008). α1-giardin was further 
characterised than any other α-giardins, and was shown to be an immunodominant 
glycosaminoglycan (GAG)-binding protein associated with the plasma membrane 
(Weiland et al., 2003). GAGs are proteoglycans involved in various processes 
including adhesion of microbes to eukaryotic cells. The most widely expressed GAG 
on the intestinal epithelial cells is GAG heparan sulphate (Ianelli et al., 1998); α1-
giardin was shown to bind to highly sulphated sugars such as heparin and heparan 
sulphate in a calcium-dependent manner (Weiland et al., 2003). Alpha-1 giardin was 
also shown to be partly localised on the surface of excyzoites. All of this suggests 
that α1-giardin may play a role in the early stage of the host-parasite interaction. 
Not all the functions of α-giardins have yet been identified; but all the α-giardins 
were shown to be expressed throughout the parasite life cycle (Palm et al., 2005). 
Beta (β)-giardins are striated fibre-assemblin-like proteins and are closely 
associated with microtubules and δ-giardin which are component of microribbons 
(Feliziani et al., 2011). There are three β-giardin isoforms identified (Palm et al., 
2005). They are adhesive-specific proteins which assemble in 2.5 nm filaments 
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which are then further assembled into the superstructure of the dorsal ribbons of 
the ventral disc. This suggests a primarily structural role for this protein (Crossley 
and Holberton, 1985, Holberton, 1981). Feliziani et al have recently showed that 
there was neither structural difference between assemblage A and B β-giardin, nor 
genetic difference. However, by Immunofluorescence assay (IFA), they have 
observed differences into the organisation of the protein within the ventral disc 
between both assemblages. Gamma (γ)-giardins have been identified as 
microribbon proteins and three different isoforms have been isolated. However, 
their localisation and functions within the ventral disc microribbon are still 
uncertain (Feliziani et al., 2011, Palm et al., 2005). Delta (δ)-giardins are different 
from α-giardin and γ-giardin; but share conserved AA motifs with β-giardin 
suggesting that they belong to the same protein family (Jenkins et al., 2009, Palm et 
al., 2005). A recent study showed that, in absence of δ-giardin, the ventral disc 
ability to bind/remain attached to inanimate surface was affected; this led to the 
conclusion that δ-giardins might be important for the trophozoite attachment to 
host cells; although the mechanism inducing this failure to attach is still unknown 
(Jenkins et al., 2009). Although most giardins so far characterised have localised to 
the ventral disc, how the four classes of giardins interact to provide structure to the 
ventral disc requires further investigations. 
1.5.3.3/ Variant-specific surface proteins  
 In order to control giardial infections, cellular and humoral immunity is 
required; the production of CD8+ T lymphocytes correlates in particular with the 
parasite clearance (Faubert, 2000). To escape the host humoral immune response, 
several protozoan pathogens can undergo antigenic variation. In Giardia, this 
evasion is achieved by the on-off switching of the expression genes encoding VSPs. 
VSPs are cysteine-rich proteins covering the entire surface of the parasite, including 
flagella; the VSP family comprises a repertoire of approximately 200 genes in both 
human-infecting assemblages, A and B (Ankarklev et al., 2010, Adam et al., 2010, 
Nash, 2002, Adam, 2001). No identical VSPs have been found in the two 
assemblages (Franzen et al., 2009). The vsp coding regions comprise about 3 % of 
Giardia total genome; it can be raised to 4 % with the inclusion of the upstream 
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intergenic areas (which may be tasked with control of the vsp genes expression) 
(Adam et al., 2010).  
 The VSPs size ranges from 20 to 200 kDa; VSPs have variable amino termini 
(CXXC) and semi-conserved carboxyl termini (containing GGCY motifs). They also 
have a conserved hydrophilic cytoplasmic tail (CRGKA). Immediately adjacent to this 
CRGKA domain is a hydrophobic domain that forms the protein membrane anchor 
(Fig 1.15) (Ankarklev et al., 2010, Adam et al., 2010). The entire surface of Giardia is 
covered with VSPs; the expression of VSPs at the surface is mutually exclusive, 
except during differentiation and switching when several VSPs are simultaneously 
expressed (Prucca et al., 2011). Switching has been reported to happen every 6 to 
13 generations; however, it depends on the growth conditions, Giardia isolate and 
the specific VSP expressed (Ankarklev et al., 2010). According to Singer et al, there 
is a selection for and against VSPs in immunodeficient hosts which demonstrates 
that VSPs may play a key role in the host-parasite interaction. In this study, it was 
also suggested that clear preferences existed for specific VSPs in different hosts. 
Antigenic variation may allow the parasite to express VSPs that enhance survival in 
many different hosts and environmental conditions explaining the large repertoire 
of VSPs present in Giardia genome(Singer et al., 2001). However, the differences 
between hosts that may affect VSP selection have yet to be determined. 
 In addition to being involved in the immune evasion and host-parasite 
interaction, VSPs are also components of cellular signalling. Indeed, some VSPs are 
specifically palmitoylated on the cysteine residue in the conserved CRGKA carboxyl -
terminal motif, located in the cytoplasmic tail (Fig 1.15). This palmitoylation helps 
to regulate the segregation of the proteins that are detergent resistant to domains 
on the plasma membrane (so-called lipid rafts) (Touz et al., 2005, Hiltpold et al., 
2000). It was also suggested that complement-independent antibody-mediated 
cytotoxicity was due to specific changes or signalling mediated by the palmitoylated 
CRGKA cytoplasmic tail (Touz et al., 2005). Other VSPs can be citrullinated on the 
CRGKA arginine residue by arginine deiminase (Fig 1.15). Citrullation has an 
important role in the VSP switching mechanism; a mutation of this residue affects 
the switching frequency (Touz et al., 2008). 
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Fig 1. 15: Variant Surface Proteins (VSPs) schematic representation (Based on Ankarklev et 
al., 2010 with permission). VSPs produce a dense coat by covering the whole surface of the 
trophozoite. Only one type of VSP is found on the parasite surface (except during 
differentiation and the switching which occurs every 6 to 13 generations). One VSP usually 
dominates in a population of parasites; however, a few express other VSPs. VSPs contain 
about 11-12 % of cysteine AA, most of which is found numerous CXXC (      ) that build up 
disulfide bonds. The amino terminus is the most variable portion and is called variable 
domain; this domain seems to be at the interface between the parasite and its 
environment. The extracellular domain close to the plasma membrane is a semi-conserved 
domain and contains one or two GGCY motifs (        ). All VSPs have a conserved hydrophilic 
cytoplasmic tail composed of the amino acids CRGKA. This motif can be modified by 
palmitoylation of the cysteine residue and by citrullination of the arginine residue.  
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Our knowledge of the molecular mechanisms involved in the regulation of 
Giardia antigenic variation is still limited. There is no evidence of (i) gene 
rearrangements, (ii) DNA modifications along with the presence of expression-
linked copies, (iii) sequence alterations of the DNA, (iv) telomere-linked 
transcription requirements. All of these regulation mechanisms have been linked to 
antigenic variation in others protozoan parasites (such as Trypanosoma brucei and 
Plasmodium falciparum) (Lopez-Rubio et al., 2007). However, Kulakova et al 
suggested that epigenetic mechanisms control VSP regulation. They demonstrated 
that the expression of vsp was not because of special DNA rearrangement. They 
also showed that antigenic variation occurred in the absence of vsp gene 
movement but was associated with in situ chromosome changes in the immediate 
upstream sequences of the expressed VSP (Kulakova et al., 2006). This suggests that 
some epigenetic mechanisms may be involved in vsp gene transcription activation 
(Ankarklev et al., 2010, Kulakova et al., 2006). Other studies proposed an 
alternative hypothesis: vsp genes post-transcriptional silencing occurs via a micro 
RNA (miRNA)-mediated mechanism (Saraiya and Wang, 2008, Prucca et al., 2008). 
During their investigation, Prucca et al showed that the silencing machinery in 
Giardia processes specifically vsp RNAs in vitro. Hence, it is possible that chromatin 
modification and post-transcriptional processes collaborate to regulate VSP 
expression. 
 Their transport to the surface represents a vital trafficking pathway in 
Giardia. An immunoelectron microscopy study showed the presence of VSPs in the 
ER, at the plasma membrane and in PVs, but not in ESVs of encysting cells 
(McCaffery et al., 1994). However, no intermediate compartments containing VSP 
cargo protein in the export pathway between the ER and the plasma membrane 
were identified. It was suggested that, because of a C-terminal transmembrane 
anchor and a short five AA cytoplasmic domain (CRGKA), these proteins were in 
direct contact with the cytoplasm and thus potentially able to mediate their own 
export from the ER. Marti et al showed that it was possible to generate an inducible 
chimeric reporter that trafficked to the plasma membrane by combining the 
exodomain of a Toxoplasma gondii surface antigen (SAG1) and the conserved C-
terminus of a VSP under the control of the CWP1 promoter. This indicates that the 
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C-terminus of VSPs may be sufficient to direct a foreign antigen to the plasma 
membrane (Marti and Hehl, 2003). On the other hand, by using the entire VSP 
exodomain in a reporter domain, another study showed that the transport of VSP 
to the plasma membrane despite the absence of the cytoplasmic domain (Touz et 
al., 2003). However, due to the fact that a control experiment using a heterologous 
exodomain was not included in this study, it remained unclear whether the reporter 
lacking a C-terminus targeting signal was exported to the plasma membrane simply 
by co-transport through interaction with endogenous VSPs. A number of reporter 
proteins with different heterologous components were unable to exit the ER and 
progress along the secretory pathway without a VSP C-terminus which indicates 
that the presence of a general default pathway seems unlikely (Hehl and Marti, 
2004, Marti and Hehl, 2003). It was suggested that coatomer proteins II (COPII) 
were recruited directly via the conserved cytoplasmic tail for the export of VSPs 
(Hehl and Marti, 2004). Once VSPs have left the ER, their transport to the plasma 
appears to follow a direct pathway with fast kinetics (Marti and Hehl, 2003). 
 VSPs are the most studied of Giardia-pathogenic factors; they are the main 
mechanism for Giardia evasion of the host humoral immune response. Therefore, 
how exactly antigenic variation occurs in Giardia in absence of any immune 
pressure has to be determined. How a VSP is replaced by another during antigenic 
switching requires also further investigations, as regulation mechanisms of VSPs 
expression. 
1.5.3.4/ Cysteine proteases 
 Cysteine proteases (CPs) are proteins degrading polypeptides; they catalyse 
the cleavage of amide linkages in macromolecular proteins and oligomeric peptides 
(Fig 1.16). They are commonly encountered in fruits but are also found in animals, 
viruses or protozoa. CPs are involved in many cellular processes such as growth, 
PCD (apoptosis and senescence), accumulation and mobilisation of storage proteins 
(such as in seeds). Moreover, they have roles in signalling pathways and in the 
response to biotic and abiotic stresses. In parasites, cysteine proteases have key 
roles in immunoevasion, enzyme activation, virulence, tissue and cell invasion, 
excystment, hatching and moulting (Sajid and McKerrow, 2002). CPs size ranges 
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Fig 1. 16: Schematic representation of peptide substrate interaction with an active 
cysteine protease (Based on Sajid and Mckerrow, 2002, with permission). AA residues from 
the peptide are denoted by “S” (for substrate) and the CP sub-sites that the peptide 
interacts with are given the letter “P” (for active site pocket). Sulfhydryl nucleophile, the 
active site of the CP, is represented as   ̶ SH; the peptide bond is attacked prior to hydrolysis 
(scissile bond). The carboxyl side and corresponding subsites are referred as the prime side 
and are respectively designated: S1’, S2’, Sn’ and P1’, P2’, Pn’. The amino side of the peptide 
and corresponding subsites are referred as the non-prime side and respectively termed: S1, 
S2, Sn and P1, P2, Pn. 
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from 10 kDa monomers to multimeric complexes of several hundred kDa. Catalysis 
can be induced either via endoprotease activity (within polypeptide) or via 
exopeptidase activity (from amino/carboxyl ends). CPs are classified into clans, the 
most abundant of these clans is CA which is divided into families. C1 is one of these 
families and is represented by cathepsins B, C, H and L. Cathepsins are synthesised 
as zygomens; they are activated by proteolytic removal of their N-terminal 
propeptide (DuBois et al., 2006, Turk et al., 2002). Orthologs of many of the genes 
encoding for these CPs are present in Giardia genome. 
 The first cathepsin-like protease genes identified in Giardia were CP1, CP2 
and CP3 which encode cathepsin B-like proteases (Ward et al., 1997). Twenty-seven 
cathepsin-like protease genes have now been identified in Giardia genome (DuBois 
et al., 2008); they encode three main CP classes: cathepsin B-like, cathepsin C-like 
and cathepsin K/L-like proteases. These genes, which are not found in groups or 
tandem arrays, are located throughout Giardia’s genome. According to sequence 
analysis, most of the Giardia cathepsins, like their homologues, possess a pro-
domain and are likely synthesised as inactive precursors (DuBois et al., 2008, 
DuBois et al., 2006). It has been demonstrated that the expression of most CPs 
increases upon excystation. The cathepsin B-like proteases encoding genes seem to 
be expressed at higher level than the cathepsin C-like or K/L-like protease genes 
(DuBois et al., 2006). As reported by Sajid and McKerrow, Giardia cathepsin B-like 
proteases lack the “occluding loop” present in cathepsins B of higher eukaryotes. 
This occluding loop gives cathepsin B proteases their peptidyldipeptidase and 
dipeptidyl carboxypeptidase activity; as it stabilises the carboxyl end of substrate 
peptides upon substrate-protease binding (DuBois et al., 2006, Sajid and McKerrow, 
2002). Therefore, Giardia cathepsin B-like proteases are still believed to exhibit only 
endopeptidase activity against peptides (DuBois et al., 2008). 
Several studies have investigated the possible biological roles for some of 
the Giardia cathepsin-like proteases. Ward et al have shown a decrease of the 
number of trophozoites during excystation of G.muris cysts when CPs inhibitors 
were added to the media suggesting that CPs were involved in the excystation 
process during colonisation of a new host by the parasite. They also demonstrated 
that CP2 may be the agent responsible for breaking down the cyst wall during 
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excystation. DuBois and collaborator also showed that CP2 gene is expressed at a 
high level compared to most other genes during vegetative growth and encystation; 
suggesting that CP2 may have more functions in Giardia intracellular processes. 
Another study also presented data suggesting that a cathepsin C-like protease 
(encystation-specific cystein protease: ESCP) was the intracellular CP involved in the 
encystation of trophozoites (Touz et al., 2002). Indeed, the cyst wall proteins, 
forming the Giardia cyst, require proteolytic processing of an alkaline tail before 
being released from encystation-specific vesicles and added into the cyst wall. In 
2006, a study showed for the first time that CPs are involved in the attachment of 
trophozoites to the host epithelial cells (Rodriguez-Fuentes et al., 2006). By using 
CPs inhibitors, they observed a decrease of the parasites adhesion. This discovery 
supports the hypothesis that protease secretion plays a role in the adhesion of 
Giardia to the epithelial cells. It has been proposed that, in vivo, CPs may play a role 
in the degradation of mucin, facilitating either the adhesion of the parasite to host 
cells or the parasite motility. 
 Members of CA clan, cathepsin B in particular, have been shown to be either 
targeted to intracellular vesicle compartments or secreted which suggests that, 
besides their implications in encystation, excystation and trophozoite attachment 
to host intestinal cells, Giardia cathepsin B-like proteases may be involved in other 
host-pathogen interaction pathways (Sajid and McKerrow, 2002). A recent study 
suggested that Giardia cathepsin B-like proteases degrade intestinal interleukin-8 
(IL8) and are responsible for the host low inflammation reaction to Giardia infection 
(Cotton et al., 2014).  
Although 27 genes encoding CPs have been located throughout Giardia 
genome and few of CPs major roles in trophozoite excystation, encystation and 
attachment were identified, their implication in the disease pathogenesis and host 
immunity still remains elusive. Analysis of assemblages A and B coding regions 
indicated an amino acid identity of only 78 % (Franzen et al., 2009). This suggests 
that CPs may play different roles, specific to one assemblage, in the modulation 
and/or attenuation of the host immune response (Cotton et al., 2014). Whether CPs 
have some assemblage-specific roles needs to be assessed and further investigate. 
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1.5.4/ Giardia-secreted factors 
 Since its discovery 300 hundred year ago, Giardia still remains an enigma. 
Even if at least five of Giardia pathogenic factors have been identified (Table 1.6), 
none has been directly associated with giardiasis so far. Earlier studies have raised 
the possibility of protein release into the growth medium during in vitro incubation 
of Giardia trophozoites (Katelaris and Farthing, 1992). Others, more recently, have 
tried to identify some possible Giardia-secreted proteins which could be the cause 
of the physiological changes within epithelial cells (Ringqvist et al., 2011, Ankarklev 
et al., 2010, Ringqvist et al., 2008, Rodriguez-Fuentes et al., 2006). 
 Cysteine proteases were shown to be secreted by Giardia trophozoites upon 
incubation with different intestinal epithelial cell lines suggesting that CPs may play 
a role in the attachment of trophozoites to the intestinal epithelia (Rodriguez-
Fuentes et al., 2006). It was also suggested that secreted CPs may play a role in the 
degradation of intestinal mucin as shown by an in vivo study (Paget and James, 
1994). Another study showed that Giardia released three metabolic enzymes: (i) 
Enolase; (ii) arginine deiminase (ADI); and (iii) ornithine carbamoyltransferase (OCT) 
in response to interaction with intestinal cells (Ringqvist et al., 2008). Enolase has 
been shown to be involved in pathogenesis of other pathogens colonising mucosal 
surfaces such as prokaryotic Streptococcus agalactiae and eukaryotic Candida 
albican in which either enolases are either secreted or present at the surface of the 
organism (Fluegge et al., 2004, Sundstrom and Aliaga, 1994). However, the specific 
activity of Giardia-secreted enolase was not determined during this study; 
therefore, the role of enolase, if any, during host-pathogen interaction remains to 
be determined (Table 1.6). ADI and OCT are used in Giardia to actively metabolise 
arginine for energy. Arginine depletion was shown to reduce the ability of intestinal 
cells to produce nitric oxide (NO), anti-microbial innate defence molecule. NO 
inhibits both encystation and excystation in Giardia (Eckmann et al., 2000). NO was 
previously shown to inhibit giardial growth but not viability, in vitro, and also both 
encystation and excystation (Eckmann et al., 2000). Therefore, luminal OCT and ADI 
might reduce the levels of intestinal arginine leading to a lower production of NO by 
intestinal epithelial cells. Arginine depletion is also known to induce apoptosis in  
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human cell lines (Philip et al., 2003); human giardiasis patients show an increase 
rate of intestinal epithelial cell apoptosis (Troeger et al., 2007). A recent study 
showed the implication of Giardia–secreted cathepsin B in the degradation of 
intestinal interleukin-8 (IL-8) leading to an attenuation of the IL-8-induced 
neutrophil chemotaxis (Cotton et al., 2014). This shows that Giardia is capable of 
attenuating aspects of the host’s pro-inflammatory response. However, whether 
both assemblage A and B trophozoites are able to do so remains unclear and has to 
be investigated. The mechanisms involved in the attenuation of IL-8 production by 
Giardia-secreted cathepsin B require also further investigations. All these studies 
suggest that Giardia secretes molecules having potential roles in host immune 
system evasion, parasite attachment and anti-inflammatory modulation. Yet, all 
these different analyses were done on Giardia lysates after incubation with 
different intestinal cell lines which could lead to transcriptional changes in the 
trophozoites during interaction with the host intestinal epithelia. Whether or not 
trophozoites secrete proteins prior to interacting with intestinal cells, or during 
colonisation of a new environment, has not been determined yet. Identifying the 
protein secreted by Giardia at early stage of infection could give some insights on 
how the infection begins and may help understand how the different giardiasis 
symptoms occur. 
During secretory diarrhoea, chloride secretion is increased by pathogen 
enterotoxins such as the cholera toxin secreted by Vibrio cholera. The electrogenic 
chloride ion secretion from enterocytes is thought to be responsible for the osmotic 
imbalance that draws fluid into the lumen. The normal physiological secretion can 
be altered by enterotoxins; thus, the secretion accelerates due to a fluid entry 
overwhelming the normal chloride absorption (Lucas, 2010). Even if Giardia 
infection causes non-secretory diarrhoea, it has been thought to increase the anion 
secretion, in a similar fashion to pathogens causing secretory diarrhoea (Hodges 
and Gill, 2010, Troeger et al., 2007). However, a recent study in our laboratory has 
shown that a Giardia-secreted factor inhibits the enterocyte chloride secretion (Al-
Naimi et al, unpublished data). In that study, an Ussing chamber system was used 
to determine whether or not Giardia cultures and supernatants of both human 
assemblages could influence the trans-Epithelial Electrical Resistance (TEER) and 
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short-circuit current (Isc) of the colonic cell line CaCo-2. After 24 hours incubation 
with Giardia, a significant decrease of the CaCo-2 TEER was observed (Fig 1.17). In 
order to study the effect of Giardia co-culture and supernatants on the CaCo-2 Isc, 
CaCo-2 cells were incubated with Giardia culture/supernatants and either chloride 
channel inhibitors or activators were added (Fig 1.18). After 24 hours, the cellular 
Isc for the chloride channel inhibitors, 4,4’-disothiocyanatostibene-2,2’-disulfonic 
acid (DIDS) and Glybenclamide (Gly 101), was suppressed. Moreover, there was a 
reduction in both the forskolin and the Uridine 5’-Triphosphate (UTP) on the Isc 
stimulating reaction (Fig 1.19). A reduced effect was also observed when CaCo-2 
cells were incubating with diluted Giardia supernatants (Fig 1.19 B.). This effect on 
chloride secretion by Giardia supernatants indicates that Giardia secretes a soluble 
factor which affects the intestinal epithelial cells. CaCo-2 cells were shown to be 
viable by performing a viability assay (data not shown). This strongly supports the 
possibility of Giardia-secreted factors acting on the intestinal cells chloride 
secretion. The fact that intestinal ion transport is abrogated by Giardia trophozoite-
secreted factor suggests that intestinal water transport may also be disrupted by 
the parasite secreted factor. Moreover, it was previously suggested that an 
inhibition of chloride secretion lead to a decrease in cell volume (Walters et al., 
1992), which suggests that Giardia-secreted factor may also have an effect on the 
intestinal cell volume and therefore morphology. However, what this soluble factor 
is, the mechanism involved and the effect on intestinal cell morphology require 
further investigation. 
1.6/ Aims of the study 
 Having a better understanding of how Giardia causes diarrhoea is crucial to 
developing interventions to fight this waterborne disease. To investigate Giardia 
virulence factors, many studies tried to answer an important question: Does Giardia 
secrete soluble mediators which disrupt the effective functions of the intestinal 
epithelium? (Ringqvist et al., 2011, Ringqvist et al., 2008, Al-Naimi et al., 
Unpublished data). Giardia possesses peripheral vesicles and ESVs suggesting that 
trophozoites may release soluble factors in the intestinal lumen. 
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Fig 1. 17: Effect of 24 hours Giardia co-culture on the CaCo-2 TEER. CaCo-2 cells were 
mounted in Ussing chamber. (n=6) Values are expressed relative to controls. The results 
were assessed by student’s t-test and expressed as mean values ±standard error mean 
(SEM). Significant difference **P<0.01 compared with controls  
 
 
Fig 1. 18: Schematic representation of Chloride secretion activators/inhibitors sites of 
action. The chloride secretion was inhibited by Glybenclamide (GlyH 101) on the calcium-
activated Cl- channel (CaCC) and by 4,4’-disothiocyanatostibene-2,2’-disulfonic acid (DIDS) 
on the cystic fibrosis conductance regulator (CFRT). The ion secretion was stimulated by 
Uridine 5’-triphosphate (UTP) on the Purinoreceptor 2 (P2Y2); and by Forskolin on the 
cAMP Receptor Protein (CRP). 
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What these soluble mediators are remains partly unknown and need to be 
further investigated. Few in vitro studies have shown that Giardia trophozoites are 
able to release several enzymes having an effect on intestinal cells during host-
pathogen interaction (Table 1.6) (Cotton et al., 2014, Ringqvist et al., 2011, 
Ringqvist et al., 2008, Rodriguez-Fuentes et al., 2006). However, which proteins are 
released by Giardia at the early stage of the infection, and in what quantity, prior to 
host-pathogen interaction have never previously been investigated. 
The aims of this thesis are: 
(i) To investigate the effects of both Giardia assemblage A and B 
supernatants, obtained from in vitro culture, on intestinal cells 
morphology and turgidity via immunofluorescence and microscopic 
analyses. 
(ii) To investigate the effects of both Giardia assemblage A and B 
supernatants, obtained from in vitro culture, on intestinal cell main 
water and ion transporters (AQP3, SGLT-1 and CFTR) via 
immunofluorescence microscopy and western blot analyses. 
(iii) To obtain high quality supernatant free from exogenous proteins for 
subsequent proteomics analysis. 
(iv) To determine quantitative secretion profile for both assemblage A and B 
via mass spectrometry and bioinformatics analyses. 
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2.1/ Materials 
All materials were supplied by either Sigma-Aldrich (UK); Sera Laboratories 
International (SLI, UK); Molecular Probes (UK); Invitrogen (UK), or Santa Cruz 
Biotechnology (USA) unless otherwise stated. 
2.1.1/ Antibiotics, TYI-S-33 and Dulbecco’s Modified Eagle 
Medium (DMEM)  
2.1.1.1/ Antibiotics and reagents 
Penicillin/Streptomycin (P/S) stock solution – 100 units/ml penicillin G; 100 µg/ml 
streptomycin. Stored at -20°C 
10* Phosphate buffered saline (PBS) – Dissolved 80 g NaCl, 2 g KCl, 26.8 g Na2HPO4 
– 7H2O and 2.4 g KH2PO4 in 800 ml H2O. pH was adjusted to 7.4 with HCl and 
volume to 1 l with H2O.  
The solution was sterilized by autoclaving (20 min, 121°C, liquid cycle) and stored at 
room temperature. 
PBS – 100 ml of 10x PBS in 900 ml of dH2O. The diluted solution was also sterilized 
by autoclaving and then was stored at room temperature. 
B12 Vitamin mix – dissolved 8.5 g B12 Vitamin mix (Sigma-Aldrich, UK) into 100 ml 
ultrapure water. Solution was sterilised, kept away from light and stored at -20°C. 
2.1.1.2/ TYI-S-33 medium (Keister’s modification) (Table 2.1) 
888 ml sterilised distilled water, 1 g dibasic potassium (K2HPO4), 0.6 g 
monobasic potassium (KH2PO4), 1 g NaCl, 5 g neutralized pancreatic digest, 25 g 
yeast extract, 0.5 g dehydrated bovine bile, 10 g D-glucose, 2 g L-cysteine, 0.2 
ascorbic acid (vitamin C), 22.8 mg ferric ammonium citrate, 100 ml albumin bovine 
serum-heat inactivated (ABS-HI), 20ml B12 vitamin mix, 5 ml P/S antibiotics. In 
order to reach a 7.0-7.1 pH, NaOH was added to the solution (Table 2.1). 
Medium was stored at -20°C, in 50ml falcon tubes. 
. 
 Chapter I  
Chapter II 
108 | P a g e  
 
 
 
 
Table 2.1: TYI-S-33 Medium formula for in vitro growth of Giardia (Keister, 1983) 
Component Quantity/litre Final concentration 
K₂PO₄ 1 g 4.4 mM 
KH₂PO₄ 600 mg 4.4 mM 
NaCl 1 g 
 Neutralized Pancreatic digest 5 g 
 Yeast extract 25 g 
 Dehydrated Bovine Bile 500 mg 
 D-glucose 10 g 56 mM 
L-cysteine HCL 2 g 16.5 mM 
Ascorbic acid 200 mg 1.1 mM 
Ferric NH₄-citrate 22.8 mg 
 NaOH Bring pH to 7.0-7.1 
  
(1.65 ml of 10 M solution) 
Heat-inactivated Serum a 100 ml 10% 
(Bovine or fetal Calf) 
  
B12 Vitamin mix a 20 ml 
 a The vitamin B12 mix and heat-inactivated serum were kept as solution at - 20°C. All  the 
components except the heat-inactivated serum and the vitamin B12 mix were dissolved in water, 
brought to 900 ml; heat-inactivated (56°C for 20 min) serum and vitamin B12 mix were then added. 
The solution was steril ized on a 0.45 µm-pore-size filter, aliquoted in 50 ml falcon tubes and stored 
at -20°C. During in vitro growth, the organisms were grown in sealed glass tubes nearly filled with 
medium. 
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2.1.1.3/ Dulbecco’s Modified Eagle Medium (DMEM)  
Supplemented DMEM – containing Non-Essential Amino Acid (NEAA) and 4.5 g/l 
glucose, 1% L-glutamine, 1% P/S, and 10% Foetal Calf Serum (FCS). Stored at +4°C. 
2.1.2/ Cell lines 
_ The human colonic adenocarcinoma derived epithelial cell line: Caco-2, which was 
kindly given by Dr Yongping Bao (BioMedical Research Centre, UEA, Norwich, UK) 
(Roxstrom-Lindquist et al., 2005, Grasset et al., 1984). 
_ Giardia: WB (assemblage A) and GS (assemblage B) strains and culture 
supernatants, which were kindly provided by Dr Jorge Tovar et al , from the School 
of Biological Sciences of The Royal Holloway, University of London (Smith et al., 
1982, Meyer, 1970) (Fig 2.1). 
 
 
Fig 2. 1: Giardia isolates: WB (assemblage A) and GS (assemblage B) (Al-Naimi et al, 
unpublished) 
2.1.3/ Giardia Supernatant preparation  
Non-supplemented DMEM – containing NEAA [+], 4.5 g/l Glucose [+], L-glutamine [-
], Sodium pyruvate [-].Stored at +4°C. 
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2.1.4/ Protein analysis 
2.1.4.1/ Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 SDS-PAGE buffers 
30 % acrylamide/Bis solution 37.5:1 (2.6%) Acrylamide – N,N’-methylene-bis-
acrylamide Electrophoresis Purity Reagent (Bio-Rad Laboratories, UK). 
1.5 M Tris-HCl pH 8.8 – 54.45 g Tris base, 150 ml distilled water (ddH2O), pH 
adjusted with HCl. 
0.5 M Tris-HCL pH 6.8 – 6 g Tris base, 60 ml distilled water, pH adjusted with HCl. 
10% Sodium Dodecyl Sulfate (SDS) – 50 g dissolved in 500 ml distilled water. 
10% ammonium persulfate (APS) – 100 mg dissolved in 1 ml distilled water. 
1 L of 10 x Gel running buffer pH 8.3 – 30.3 g Tris base, 144 g glycine, 10 g SDS. 
1L of 1 x Gel running buffer – 100 ml 10 x Running buffer, 900 ml distilled water. 
Loading buffer – 4 ml ddH2O, 1 ml 0.5 M Tris-HCl pH 6.8, 1.6 ml 10 % SDS, 0.8 ml 
glycerol, 0.2 ml bromophenol blue. Stored at -20°C. 
 SYPRO staining buffers and reagents 
SYPRO Fixing solution – 50 % methanol, 7 % acetic acid in a 200 ml solution. 
SYPRO Washing solution – 10 % methanol, 7 % acetic acid in a 100 ml solution. 
SYPRO® Ruby protein gel stain – 500 ml solution, Molecular probes, Invitrogen, UK. 
 Gels for SDS-PAGE electrophoresis 
Gels were prepared the day before running the electrophoresis, and kept at 
4°C. The percentage of acrylamide used varied according to protein size (Table 2.2). 
The soluble factor size being unknown, SDS-PAGE electrophoresis were run under 
standard conditions, 10 and 12 % acrylamide separation gels  and 5 % acrylamide 
stacking gels were prepared. 
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Table 2.2: Separation Polyacrylamide gel recipes (for two gels).  
 
Separation gels: 
Recipe for 10% Acrylamide gel (15 ml): 
1.5 M Tris pH 8.8     3.8 ml 
30% Acryl-bisacrylamide (BioRad, UK)  5.0 ml 
10% SDS (Melford, UK)    0.15 ml 
10% Ammonium Persulfate (APS)   0.15 ml 
TetraMethylEthylenDiamineTEMED (BioRad, UK) 0.006 ml 
Sterile H2O      4.9 ml 
 
Recipe for8 % Acrylamide gel (15 ml): 
1.5 M Tris pH 8.8     3.8 ml 
30% Acryl-bisacrylamide (BioRad, UK)  4.0 ml 
10% SDS (Melford, UK)    0.15 ml 
10% APS      0.15 ml 
TEMED (BioRad, UK)     0.009 ml 
Sterile H2O      6.9 ml 
500 µl of isopropanol were added on top of the gels during polymerization. 
Once gels polymerized, isopropanol was removed, top of the gels were washed 
once with ddH2O, and stacking gels were poured. 
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Stacking gel: 
Recipe for a 5% Acrylamide gel (3 ml): 
0.5 M Tris pH 6.8     0.38 ml 
30% Acryl-bisacrylamide    0.5 ml 
10% SDS      0.03 ml 
10% APS      0.03 ml 
TEMED      0.003 ml 
Sterile H2O      2.1 ml 
2.1.4.2/ Western blot 
 Western blot buffers and reagents 
10x Transfer Buffer/stock pH 9.2 –390 mM glycine, 480 mM Tris, 0.3 % SDS in a 1 
litre solution. 
1x Transfer buffer – 100 ml 10x Transfer buffer, 200 ml Methanol in a 1 litre 
solution. 
10x Tris-Buffered Saline and Tween20 solution (TBST) – 200mM Tris, 1.5 mM NaCl. 
1 % Tween in a 1 litre solution. pH was set to 7.6. 
1x TBST – 100 ml 10x TBST in a 1 l solution. 
20x NuPAGE® MES SDS Running buffer– 500 ml solution, Life technologies Ltd, 
Invitrogen (Paisley, UK). 
1x NuPAGE® MES SDS Running buffer – 100 ml 20x NuPAGE® MES SDS Running 
buffer in 1.9 L distilled water. 
Odyssey blocking buffer –. 500 ml solution, Li-Cor inc (UK). 
 Western blot gels 
As the sizes of the target proteins vary widely (from 40 to 150 kDa), precast 
gels with a concentration gradient were purchased from Life technologies Ltd, 
Invitrogen (Paisley, UK). 
NuPAGE® Novex® – 4-12 % Bis-Tris Gels 1.0 mm 10 wells. 
           4-12 % Bis-Tris Gels 1.0 mm 12 wells. 
           4-12 % Bis-Tris Gels 1.0 mm 15 wells. 
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2.1.4.3/ Immunofluorescence Assay Material 
4 % Paraformaldehyde (PFA)/PBS – 16 g of PFA was added to 200 ml of just boiled 
water. NaOH was added until the liquid lost turbidity. 100 ml was added to 80 ml of 
H2O and 20 ml of 10x PBS then adjusted to pH 7-8. The solution was aliquoted and 
frozen at -20°C. 
0.5% Bovine Serum Albumin (BSA) – 0.5 mg BSA in 100 ml 1x PBS. Stored at -20°C. 
4',6-diamidino-2-phenylindole (DAPI): – 1:500 dilution, 5 µl DAPI in 2.5 ml of 1x PBS. 
Wrapped in foil and stored at -20°C. 
2.1.4.4/ Antibodies and fluorescent dyes 
 Rabbit anti-AQP3 (Clone H-80), Rabbit anti-SGLT1 and one monoclonal 
Mouse anti-CFTR (Clone A-3) were purchased from Santa-Cruz Biotechnology 
(Dallas, USA). A monoclonal Mouse anti-CFTR was purchased from R&D systems 
(Minneapolis, USA); and another monoclonal Mouse anti-CFTR antibody was 
purchased from AbCam Plc (Cambridge, UK). Rabbit anti-ZO1 was purchased from 
Invitrogen (Paisley, UK). Mouse anti-β actin was purchased from Sigma (St Louis, 
USA). All the antibodies were used as directed below (table 2.3).  
Table 2.3: Working dilutions for Antibodies used for Immunofluorescence and Western 
blot 
  
Working dilution 
 
 Primary Antibody  Clone 
Western 
blot 
IFA Company 
Rabbit anti-AQP3 H-80 1:1,000 1:50 Santa-Cruz Biotechnology (sc-20811) 
Rabbit anti-SGLT1 - 1:1,000 1:300 Santa-Cruz Biotechnology (sc-98974) 
Rabbit anti-ZO1 - - 1:400 Invitrogen (40-2200) 
Mouse anti-CFTR 13-1 1:250 1:50 R&D systems (MAB-1660) 
Mouse anti-CFTR CF3 1:750 1:50 Abcam (ab2784) 
Mouse anti-CFTR A-3 1:500 1:50 
Santa-Cruz Biotechnology (sc-
376683) 
Mouse anti-β actin AC-15 1:25,000 - Sigma (A5441) 
 Alexafluor 488nm and Alexafluor 594nm were purchased from Molecular 
Probes (Invitrogen, Paisley, UK). Goat anti-mouse 680 nm and Goat anti-rabbit 800 
nm were purchased from Li-Cor (Lincoln, USA). DAPI was purchased from Sigma (St 
Louis, USA). All antibodies and fluorescent dyes were used as directed below (table 
2.4). 
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All the microscopy was performed using the Axioplan 2 imaging microscope 
and the Axiovision software version 4. 8.2 unless otherwise stated. 
Table 2.4: Working dilutions for Secondary Antibodies and Fluorescent dyes used for 
Immunofluorescence and Western blot 
 
Working dilution   
Secondary Antibody/Fluorescent 
Dyes 
Western 
blot 
IFA Company 
Goat anti-Rabbit Alexa fluor® 488 - 1:1,000 Molecular probes (A-11008) 
Donkey anti-Mouse Alexa fluor® 
594 
- 1:1,000  Molecular Probes (A-21203)  
IRDye 680LT Goat anti-Mouse 1:7000 - Li-Cor (926-68020) 
IRDye 800LT Goat anti-Rabbit 1:7000 - Li-Cor (926-32211) 
DAPI - 1:100 Sigma (D9542)  
2.1.4.5/ Protein extraction 
Phosphatase inhibitor cocktail set II – Calbiochem, Germany. 
M-PER® Mammalian Protein Extraction Reagent  – Thermo Scientific, Waltham, 
USA. 
2.1.5/ Flow cytometry viability assay 
10* PBS – Dissolve 80 g NaCl, 2 g KCl, 26.8 g Na2HPO4 – 7H2O and 2.4 g KH2PO4 in 
800 ml H2O. pH was adjusted to 7.4 with HCl and volume to 1 l with H2O.  
The solution was sterilized by autoclaving and stored at room temperature. 
PBS – 100 ml of 10x PBS in 900 ml of dH2O. The diluted solution was also sterilized 
by autoclaving and then was stored at room temperature. 
Non-supplemented DMEM – containing NEAA [+], 4.5 g/l Glucose [+], L-glutamine [-
], Sodium pyruvate [-].Stored at +4°C. 
Trigene – Desinfectant cleaner for laboratory applications, Tristel Solutions Ltd, 
Snailwell, Cambridgeshire, UK. Trigene was diluted in sterile water at a 1:5 dilution. 
Propidium Iodide (PI) – 1mg/ml. Invitrogen, UK. 
2.1.6/Proteomic assay 
2.1.6.1/ Samples preparation  
30 % Trichloroacetic acid (TCA) – 6 ml TCA in 20 ml H2O (Sigma-Aldrich, Dorset, UK). 
100 % Acetone– Sigma-Aldrich (Dorset, UK). 
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3,000 MWCO PES Membrane Vivaspin Columns – Vivaproducts (Littleton, USA). 
25mM Ammonium Bicarbonate (Ambic) – 19.77 g Ambic in 10 ml Ultrapure H2O. 
1% RapiGestTM  – Waters MS techonologies (Starstedt, Leicester, UK). 
3mM dithiothreitol – Sigma-Aldrich (Dorset, UK). 
9mM iodoacetimde – Sigma-Aldrich (Dorset, UK). 
Proteomic grade trypsin – Sigma-Aldrich (Dorset, UK). 
NuPAGE® Novex® – 4-12 % Bis-Tris Gels, from Life technologies Ltd, Invitrogen 
(Paisley, UK). 
Trypsion – Sigma-Aldrich (Dorset, UK). 
2.1.6.2/ Proteomic analysis 
 Mass Spectrometry (MS) 
nanoACQUITY-nLC system – Waters MS technologies (Manchester, UK). 
LTQ-Orbitrap Velos mass spectrometer – ThermoFisher Scientific (Bremen, 
Germany). 
 Data analysis 
Progenesis LC-MS software – version 4.1, Nonlinear Dynamics (UK). 
Mascot software – version 2.3.02, Matrix Science. 
2.1.7/ Statistical analysis software 
Student Package for Social Science software (SPSS) version 18 – SPSS Inc, Chicago, 
Illinois, USA. 
2.2/ Methods 
2.2.1/ Tissue culture 
All the aspects of tissue culture including media preparation were carried 
out under sterile conditions in a class II tissue culture cabinet. 
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2.2.1.1/ Giardia trophozoites 
 Routine culture of Giardia trophozoites 
Trophozoites were cultured in 15 ml glass tubes and maintained in TYI-S-33 
medium modified according to Keister (Keister, 1983), and supplemented with 0.5% 
penicillin / streptomycin. Cells were grown to confluence at 37°C in an atmosphere  
of 5% CO2 and 95% air, and were subcultured every 3 to 4 days. To subculture, 
tubes were put on ice for 15 up to 20 min and then slowly, manually shaken to 
remove cells from tube wall and 10 µl of cells were added in new glass tubes 
containing 13 ml of fresh TYI-S-33 medium.  
 Preparation of Giardia trophozoite supernatant 
 Parasites were grown until they reached confluence, and put on ice for 20 
min. Then, both WB and GS strains were transferred into 15 ml falcon tubes and 
separated by centrifugation for 10 min at 3,000 rotations per minute (rpm). 
Supernatants were collected and stored at -20°C until use for cellular assay on 
CaCo-2 cells. Pellets were either resupsended in 1:5 Trigene solution (diluted in 
PBS) for flow cytometry analysis or used for proteomic analysis (Fig 2.2 A and C.). 
In order to have Giardia WB and GS supernatants as free from 
contamination with the bovine serum proteins as possible, a “supernatant 
cleaning” protocol was created. After 20 min on ice, both WB and GS strains were 
transferred into 15 ml falcon tubes and separated by centrifugation for 10 min at 
3,000 rpm. Supernatants were removed and pellets were washed three times with 
pre-warmed PBS (4 ml, 2 ml and 1 ml respectively) to remove any bovine proteins 
from the milieu of culture. Pellets were centrifuged for 10 min at 3,000 rpm 
between each wash. After the third wash, pellets were resuspended in pre-warmed 
non-supplemented DMEM, to boost the cellular growth and secretion, and 
incubated for approximately 60 min at 37°C. After 60 min incubation, samples were 
chilled for 5 min; and supernatants were separated from pellets by centrifugation 
for 10 min at 3,000 rpm. Supernatants were collected and stored at -20°C until use 
for either proteomics analysis or cellular assay on Caco-2; Pellets were either 
resupsended in 500 µl PBS for flow cytometry analysis or used for proteomics  
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Fig 2.2: Preparation of Giardia samples for SDS-PAGE/Western blot assays, flow 
cytometry, proteomics and cellular assays on CaCo-2 cells. All samples were grown in 
normal milieu of culture (TYI-S-33), then chilled for 20 min and transferred in 15ml plastic 
tubes and centrifuged 10 min at 3,000 rpm (      ). A. Giardia samples prepared directly from 
culture tubes. Pellets were resuspsended (     ) in 500 μl PBS to perform flow cytometry 
assay; and supernatants were tested against CaCo-2 cells as described in section 2.2.2.3. B.  
Giardia cells were washed three times with PBS, incubated in FCS-free DMEM for up to 60 
min at 37°C, chilled for 5 min and centrifuged. Pellets were either used for flow cytometry 
after resuspension in 500μl PBS or stored at -20°C for proteomics analysis. Supernatants 
were stored at -20°C for either proteomics analysis or cellular assay on CaCo-2. C. Samples 
were killed with 1:5 Trigene (diluted in PBS); to be used as a “dead cell” control in flow 
cytometry.  
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analysis (Fig 2.2 B.). 
When used for cellular assay, Giardia supernatants were diluted in 
supplemented DMEM either at 1: 250 and 1:1,000 for immunofluorescence, or 
1:250, 1:500, 1:1,000 and 1:5,000 for western blot. 
2.2.1.2/ Caco-2 cells 
 Routine culture of CaCo-2cells 
Cells were grown in 75 cm² flasks and maintained in Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% foetal calf serum (FCS), 1% L-
glutamine, 1% penicillin/streptomycin (100 units/ml penicillin G / 100 µg/ml 
streptomycin). Cells were cultured at 37°C in a humidified atmosphere of 5 % CO2 in 
air. The medium was changed every 48 to 72 hours to remove debris from flasks. 
Once 80 % confluence was reached, Caco-2 cells were washed three times 
with 1x PBS; 1 ml of trypsin was added to the flask which was left at 37°C for 5 
minutes. Then 9 ml of media were added to inactivate Trypsin; 1 to 2.5 ml of cells 
were transferred to a new T75 flask with fresh media up to 15 ml. Medium was 
changed approximately 24 hours after the passage of the cells and then every 48 to 
72 hours.  
 Preparation of CaCo-2 cells for protein analysis 
Cells were cultured in DMEM, at 37°C and 5% CO2, on chambered glass 
coverslips or in multiwall-plates for immunofluorescence and protein extraction, 
respectively, in DMEM (Table 2.5). A Neubauer chamber was used to determine the 
number of cells needed per microliter (Fig 2.3). The following formula was then 
then employed to obtain the average number of cells per ml: 
        Average number of cells x dilution (if used) x 104 
The new cell suspension was prepared with a 1:3 relation; for 1ml of cells, 3 
ml of DMEM. 
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Table 2.5: Cell densities for different culture plates for protein extraction and 
immunofluorescence assay. 
Once CaCo-2 cells reached 80% confluence, cells were washed once with 
PBS and incubated with different dilutions of both Giardia human strains (as 
described in Chapter 2.1.1.2) for 1, 8 and 24 hours. 
At the end of the incubation period, cells were washed once with PBS and 
then either fixed on glass coverslips with 4% PFA for immunofluorescence, or their 
proteins were extracted in order to perform the western blot analysis (as described 
in sections 2.2.3.1 and 2.2.2.1 respectively). 
2.2.2/ Protein analysis 
2.2.2.1/ SDS-PAGE 
 Protein concentration assessment 
The level of protein was determined by Bicinchoninic Acid Assay (BCA 
protein assay kit, Thermo Scientific, UK) and read on DynamTech plate reader or 
OMEGA plate reader (BMG Labtech, Germany) (λ= 550 nm). The level of protein 
was between 120 and 220 μg/μl. The supernatants were used without any dilution. 
Only the control (TYI-S-33) was diluted to 1/100 and 1/500, its concentration being 
too high to be read on the plate reader. 
 SDS-PAGE 
Proteins were mixed with loading buffer and then loaded in a ratio of 3:1 
and boiled for 5 min (Laemmli et al., 1970). Gels were placed in a vertical gel tank 
system and 500 ml of running buffer 1x were placed between them until it 
overflowed into the surrounding tank. Gels were loaded with 20 µl of diluted and 
undiluted supernatants alongside a protein standard molecular weight marker 
(Precision Plus Dual Colour Protein Standard, BioRad, UK) and run at 100 Volts (V), 
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Fig 2. 3: Example of a Neubauer counting chamber. The counting grid is 3 mm x 3 mm in 
size, subdivided in 9 squares of 1 mm width. Boundary lines of the Neubauer chamber are 
the centre lines ( ). The four squares on each side of the Neubauer chamber 
represent the counting area (     ) where cells in suspension (  ) are counted. They are 
subdivided into 16 small squares. The ruled surface below the cover glass is 0.1 mm, giving 
a volume over each of the 16 small squares of 0.00025 mm3. 
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for approximately 2 hours, or until the protein standard indicated good separation 
at room temperature.  
 Gel fluorescent staining with SYPRO 
Gels were immersed twice in a fixing solution bath for 30 min and stained 
with 40 ml of a pre-diluted SYPRO solution, overnight, in a container protected from 
the light (Lopez et al., 2000). The next day, gels were washed once with a washing 
solution for 30 min and then twice with ultrapure water for 5 min. 
2.2.2.2/ Western blot 
 Protein extraction 
After being seeded in 12 well-plates and incubated with different 
concentrations of Giardia assemblage A and B supernatants (1:250, 1:500, 1:1,000, 
and 1:5,000). CaCo-2 cells were incubated with M-PER (Thermo fisher, US) for 5 
minutes at +4°C in order to extract proteins.  
To obtain the best protein concentration during the protein extraction, the 
optimum volume of M-PER needed was assessed according to Thermo Fisher 
suggested volume table (Table 2.6), starting at 250 µl decreasing down to 50 µl for a 
12 well-plate culture vessel. The optimum protein concentrations were obtained by 
incubating CaCo-2 cells with 50 µl of M-PER. Once incubated with M-PER, cells were 
scraped using cell scraper and transferred into 1.5 ml eppendorf tubes. Tubes were 
centrifuged at 13,000 rpm for 10 minutes. Supernatants were collected into 0.5 ml 
eppendorf tubes, protein concentrations were assessed by BCA, and tubes were 
stored at -20°C until use for western blot analysis. 
Table 2.6: Suggested volume of Thermo Scientific M-PER Reagent to use for different 
sizes of standard culture plates. 
Culture Vessel/ Plate Size M-PER Reagent volume 
100 mm* 500 – 1,000 µl 
60mm * 250 -500 µl 
6 well-plate 200 -400 µl 
24 well-plate 100 -200 µl 
     96 well-plate 50 - 100  µl 
* Cells grown in 100 mm plates typically contain 107 cells (50 mg) and yield ~3 mg total protein 
depending on cell  type. 
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 Protein concentration assessment 
The level of protein was assessed as described above in chapter 2.2.1.1. 
Samples were prepared accordingly to their protein concentration in order to load 
10 µg of proteins. 
 SDS-electrophoresis 
Proteins were mixed with loading buffer (3:1 ratio) and boiled for 5min at 
100°C (Laemmli et al., 1970). Precast gels were placed in a vertical gel tank system 
and 500 ml of 1x NuPAGE® MES SDS Running buffer were placed between them 
until it overflowed into the surrounding tank. Gels were loaded with 15 µl of 
samples alongside a protein standard molecular weight marker (Precision Plus Dual 
Colour Protein Standard, BioRad, UK) and run at 150 V for approximately 1 hour, or 
until the protein standard indicated good separation, at room temperature. 
 Protein blotting 
 After SDS-electrophoresis, PVDF membranes were activated in methanol 
and gels were semi-dry blotted for 30 minutes at 15 V for one gel or 25 V for two 
gels. Membranes were washed and blocked in Odyssey blocking buffer (Li-Cor, UK) 
for one hour. Primary antibodies were prepared in Odyssey blocking buffer and left 
overnight at +4°C on rotary shaker (Table 2.3). Membranes were washed four times 
in TBST, 5 minutes per wash. Secondary antibodies were also prepared in Odyssey 
blocking buffer and left at room temperature for 1.5 hours (Table 2.4). Membranes 
were washed in TBST four times 5 minutes and once in PBS for 5 minutes. 
 Imaging of infrared tagged antibodies (Li-Cor, UK) was performed on the 
Odyssey machine (Li-Cor, UK) and associated imaging software. 
2.2.2.3/ Microscopy and Immunofluorescence analysis 
 Incubation with Giardia supernatant 
 Once seeded on chambered glass coverslips, with an 80% confluence, CaCo-
2 cells were incubated at 37°C with either 1:250 or 1:1,000 dilution of Giardia 
assemblages A and B supernatants, DMEM was used as a negative control showing 
the standard condition of growth.  
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 Immunofluorescence assay 
At the end of the incubation period, cells were washed once in PBS and fixed 
on glass coverslips using 4% paraformaldehyde (PFA) for 20 min. Then, cells were 
permeabilised with 1% NP4O for three minutes; and incubated with 30 to 100 μl of 
primary antibody/BSA block for one hour. 0.5% BSA block for AQP3 antibody and 
3% BSA block for SGLT-1, ZO-1 and CFTR antibodies respectively. Coverslips were 
washed three times in PBS and incubated with 30 to 100 μl of Ig G secondary 
antibody for 30 min. To finish, cells were washed three times with PBS and 
incubated with 30 to 100 μl of DAPI for three min. After the nuclei staining of the 
cells by DAPI, cover slips were hydromounted (Hydromount, National Diagnostics 
inc, USA) on microscope slides and left to dry for 24 hours at +4°C. This protocol 
was modified from the procedure firstly described by Pinto et al (Pinto et al., 1983). 
 Microscopic images analysis 
All cell images were obtained on a Zeiss Axioplan 2 microscope at either 
x400 or x630 magnification, unless otherwise stated (Table 2.7). Images were 
deconvolved using the Axioplan software (version 4.8.2); and analysed using both 
Axiovision software (version 4.8.2) and ImageJ (version 1.45s). 
Table 2. 7: Excitation and emission wavelength ranges of filter sets 
Filter Set (Zeiss) Excitation Wavelength (nm) Emission Wavelength (nm) 
15 546 590 
25 400, 495, 570 460, 530, 625 
38 470 525 
43 545 605 
49 365 445 
2.2.3/ Flow cytometry viability analysis 
2.2.3.1/ Samples preparation 
Giardia samples were prepared as stated above in chapter 2.2.1.1 (Fig 2.2). 
2.2.3.2/ Flow cytometry  
A flow cytometry assay was performed to estimate the ratio of living/dead 
cells within Giardia colonies under different culture conditions (Fig 2.2). 
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Due to a high number of trophozoites, 250 μl of samples were diluted in 1 
ml of PBS (1:4 dilution); and, according to the manufacturer’s instruction, 10 μg/ml 
of propidium iodide (PI) were added in order to assess trophozoites viability via the 
BD Accuri™ C6 flow cytometer (BD Biosciences, Franklin Lakes, New Jersey, USA),  
using a blue laser (λ= 488 nm) and an optical filter 585/40. Data were analysed 
using BD Accuri C-flow software (version 1.0.227.4). 
2.2.4/ Proteomic assay 
2.2.4.1/ Sample preparation 
Giardia supernatant samples were prepared as stated above in chapter 
2.2.1.1, using either non-supplemented DMEM containing phenol red (Fig 2.4 A.) or 
non-supplemented phenol red- free DMEM (Fig 2.4 B.)  
Pellets were stored at - 20°C, and the level of protein within supernatant 
samples was assessed as described in chapter 2.2.1. Once determined the level of 
protein within supernatant samples, proteins were concentrated using Vivaspin 
columns with a 3000 Molecular Weight cut-off (MWCO). Samples were centrifuged 
at 12,000 rcf (Relative Centrifugal Force) for 30 minutes; pellets were then 
collected. Proteins were washed in 1 ml 25 mM Ammonium biocarbonate (Ambic) 
at 12,000 rcf for 30 minutes, this step was repeated either once for phenol red-free 
samples or twice for samples containing phenol red. Proteins were then incubated 
at room temperature in 50 μl of 25 mM Ambic for one hour, and centrifuged at 
3,000 rcf for 2 minutes (Fig 2.5). 
The level of protein in concentrated samples was assessed by BCA assay and 
SDS-PAGE electrophoresis were run to verify that proteins did not degrade during 
the concentration assay.  
Samples were then sent to the Institute of Infection and Global Health, at 
the University of Liverpool, for proteomic analysis. In order to run a mass 
spectrometry analysis, pellet samples were first dispensed into low protein-binding 
microcentrifuge tubes and made up to 160 µl by addition of 25 mM Ambic. Proteins 
from the pellet samples were denatured using 10 µl of 1% (w/v) RapiGest TM in 25 
mM Ambic; followed by three freeze-thaw cycles and two cycles of 10 min   
 Chapter I  
Chapter II 
125 | P a g e  
 
 
Figure 2.4: Preparation of Giardia supernatant and pellet samples for proteomic assay. 
Parasites were chilled for 20 minutes, transferred into 15 ml falcon tubes and centrifuged 
at 3,000 rpm for 10 minutes. Supernatants were discarded and pellets were washed three 
times in warmed 1xPBS (4 ml, 2 ml and 1 ml respectively). Pellets were then incubated for 
45 minutes at 37°C either in A. non-supplemented DMEM containing phenol red or B. non-
supplemented phenol red-free DMEM. After 45 minutes incubation, parasites were chilled 
for 5 minutes, transferred in 15 ml falcon tubes and centrifuged at 3,000 rpm for 10 
minutes. Pellets were stored at -20°C. Proteins present in supernatant samples were 
concentrated prior to perform Proteomic assay. 
 
 
Figure 2.5: Protocol to concentrate proteins contained in Giardia supernatant samples 
prior to Proteomic assay. Supernatants were transferred in Vivaspin columns with a 3,000 
MWCO and centrifuged at 12,000 rcf for 30 min. Proteins were washed up to 3 times with 
25 mM Ambic (depending on presence of phenol red within DMEM) and centrifuged at 
12,000 rcf for 30 min. Then, 50 μl of 25 mM Ambic were added and samples were left at 
room temperature for one hour; final spin at 3,000 rcf for 2 min to recover proteins. BCA.  
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sonication in a water bath. Samples were then incubated at 80°C for 10 min and 
reduced with 3 mM dithiothreitol at 60 °C for another 10 min. Next, samples were 
alkylated with 9 mM iodoacetamide at room temperature for 30 min in the dark. 
Proteomic grade trypsin was added a 50:1 protein:trypsin ratio, samples were 
incubated at 37°C overnight. 
In parallel, to maximise protein separation, protein samples were also 
solubilised and resolved on NuPAGE® Novex® 4-12 % Bis-Tris Gels following 
manufacturer’s instruction. Four gel slices were excised and each digested with 
trypsin. 
2.2.4.2/ Proteomic analysis 
 Mass Spectrometry 
 A nano-LC MS ESI (ElectronSpray Ionisation) MS/MS analysis was performed. 
Peptide mixtures from both in solution digestion and 1D-SDS PAGE were analysed 
by on-line nanoflow liquid chromatography (LC) using the nanoACQUITY- nLC 
system coupled to a linear ion trap quadrupole mass filter (LTQ)-Orbitrap Velomass 
spectrometer equipped with the manufacturer’s nanospray ion source. The 
analytical column (nanoACQUITY UPLCTM BEH130 C18 15 cm x 75 µm, 1.7 µm 
capillary column) was maintained at 35 °C and a flow-rate of 30 nl/min. The 
gradient consisted of 3-40 % acetonitrile in 0.1 % formic acid for 90 min then a 
ramp of 40-85% acetonitrile in 0.1 % formic acid for 3 min. Full scan MS spectra 
(mass to ion charge ratio, m/z, range 300-2000) were acquired by the Orbitrap at a 
resolution of 30,000. Analysis was performed in data dependant mode, the top 20 
most intense ions from MS1 scan (full MS) were selected for tandem MS by coll ision 
induced dissociation (CID) and all product spectra were acquired in the LTQ ion 
trap. Ion trap and Orbitrap maximal injection times were set to 50 milliseconds (ms) 
and 500 ms respectively. assay and SDS-PAGE were performed to assess protein 
level and protein degradation prior to proteomic assay. This protocol was modified 
from the procedure described by Jackson et al (Jackson et al., 2014).  
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 Data analysis 
 Thermo RAW files were imported into Progenesis LC-MS (version 4.1, 
Nonlinear Dynamics, UK); runs were aligned using default settings and an auto 
selected runs as reference. Peaks were picked by the software and filtered to 
include only peaks with a charge state of between +2 and +6. Peptides intensities 
were normalised against the reference run by Progenesis LC-MS; these intensities 
were used to highlight differences in protein expression between control and 
treated samples with supporting statistical analysis (ANOVA and q-values) 
calculated by Progenesis LC-MS software, Spectral data were transformed to mgf 
files with Progenesis LC-MS software and exported for peptide identification using 
Mascot (version 2.3.02, Matrix Science) search engine.  
 Tandem MS data were searched against the sequence database. Search 
parameters were as followed: precursor mass tolerance set to 10 parts -per-million 
(ppm) and fragment mass tolerance set to 0.5 dalton (Da). One missed tryptic 
cleavage was permitted; carbamidomethylation (cysteine) was set as a fixed 
modification and oxidation (methionine) was set as variable modification. Mascot 
search results were further processed using the machine learning algorithm 
Percolator. The false discovery rate (FDR) was inferior to 1% (< 1%) and individual 
ion scores were superior to 13 (>13) indicated identity or extensive homology (p < 
0.05). Results were imported to Progenesis LC-MS as .xml file. At least two unique 
peptides were required for reporting proteins that were differentially expressed. 
Results from in solution digestion and gel slices of 1D-SDS PAGE were grouped using 
“Combine analysed fractions” function in Progenesis LC -MS where statistical 
analyses were updated. Peptide sequences and their normalised abundances were 
associated with matching proteins using GiardiaDB online database 
(www.Giardiadb.org).  
Once all the proteins present in the pellet and supernatant samples were 
identified, pellet and supernatant data were merged to establish which proteins 
were found in both pellet and supernatant samples, and which proteins were only 
found in either pellet samples or supernatant samples. This was performed for all 
datasets obtained both Giardia GS and WB isolates. Then, for proteins found in 
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both pellet and supernatant samples, a supernatant : pellet ratio was calculated to 
determine which proteins were more likely to be more present within supernatant 
than pellet. The top 50 of “ratioed” proteins was combined with the proteins only 
identified in the supernatant samples. Proteins were ranked according to their 
abundance in the supernatant; this was performed for the four datasets (GS 
Orbitrap and QeXactive, and WB Orbitrap and QeXactive). For all datasets, proteins 
were matched to their Giardia assemblage A (WB or A2 isolate) or B (GS isolate) 
orthologs using GiardiaDB online database. The different localisations of the 
proteins identified and their gene ontology (GO) functions were established via the 
Uniprot online database (http://www.uniprot.org) and GiardiaDB online database 
(http://www.giardiadb.org). Secretion profiles from the four datasets were then 
compared to determine similarities. Proteins of interest were aligned and 
compared using ClustalW and phylogenetic trees were built via maximum likelihood 
approach using MEGA software (version 6.06). 
2.2.5/ Statistical analysis 
 Error bars on all graphs presented in this work represent the standard error 
mean (SEM). The normal distribution and homogeneity of variance of all data were 
assessed using the Kolmogarov-Smirnoff test and the Levene test respectively. For 
parametric data, an independent t test, a paired t test, or a one way ANOVA was 
performed. For non-parametric data, the Mann-Whitney U test, or the Kruskal-
Wallis test was carried out. P-values of less than 0.05 were considered significant. 
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Effect of Giardia supernatant on 
intestinal epithelial cells and 
their water transporters. 
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3.1/ Introduction 
The in vitro study of transport through the intestine is difficult to realise, 
due to the complex topology and the diverse cellular heterogeneity that this organ 
exhibits. Moreover, access to the serosal side of the epithelium is impaired by the 
presence of subjacent tissues which complicates study of interactions on the 
basolateral side. A solution to this problem is to use cultured human colon 
carcinoma cell lines as a model for human colonic tissue epithelia. In 1988, Chantret 
and collaborator compared 20 different human colonic carcinoma cell lines in order 
to determine which cell line can spontaneously develop the greatest degree of 
similarity to normal human intestinal cells. Characteristics such as cell polarity, 
expression of villin, and ability to undergo enterocytic differentiation under 
standard culture conditions were assessed (Chantret et al., 1988). The only human 
colonic carcinoma cell line that exhibited these features at the same time was the 
human colonic adenocarcinoma derived epithelial cell line-2 (CaCo-2). Indeed, 
CaCo-2 spontaneously acquired the following enterocytic differentiation 
characteristics: (i) organization of the cells into a polarized monolayer; (ii) presence 
of an apical brush border; and (iii) presence of brush border-associated hydrolases 
such as sucrase-isomaltase, lactase, or alkaline phosphatase (Chantret et al., 1988). 
Another study showed that CaCo-2 cells possessed similar electrochemical 
properties to enterocytes. A measurable TEER and a positive Isc which reflect ion 
transport across the cell membrane were evaluated (Grasset et al., 1984). In 2005, 
Roxstrom-Lindquist et al showed that the CaCo-2 cell line were a suitable model for 
the in vitro study of Giardia effects on intestinal cells (Roxstrom-Lindquist et al., 
2005). 
As stated in chapter I (section 1.3.2.1), giardiasis symptoms are watery 
diarrhoea, abdominal cramps, vomiting, malabsorption and weight loss (Cotton et 
al., 2011, Abel et al., 2001, Robertson et al., 2010, Flanagan, 1992, Wolfe, 1992, 
Beaumont and James, 1986). According to several studies, diarrhoea may be caused 
by disruption of the intestinal epithelial barrier (Yu et al., 2008, Troeger et al., 2007, 
Scott et al., 2002, Chin et al., 2002), increase of apoptosis (Cotton et al., 2011, 
Troeger et al., 2007, Roxstrom-Lindquist et al., 2005, Chin et al., 2002), and diffuse 
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shortening of the brush border microvilli leading to malabsorption and anion 
hypersecretion (Baldi et al., 2009, Troeger et al., 2007, Buret, 2007, Scott et al., 
2004, Faubert, 2000, Scott et al., 2000, Cevallos et al., 1995) (Chapter I, Fig 1.14). 
However, whether or not these effects are due to the trophozoites or any 
molecules secreted by Giardia remains unclear as these studies were performed 
either on patients biopsies (obtained at the site of infection), or in vitro, on 
intestinal cells incubated with Giardia trophozoites. A previous study undertaken in 
our laboratory showed that prolonged exposure to Giardia supernatant reduces 
chloride efflux of CaCo-2 cells and inhibits intestinal cell Isc (data unpublished) 
(Chapter I, Fig 1.17-19). This loss of efflux may create a loss in water within 
intestinal cells leading to a reduction of cell size; suggesting a dysregulation of 
intestinal water transporters. Indeed, during electrophysiological analysis, cells 
appeared to be shrunken which led us to look for a surrogate microscopic assay to 
investigate the effect of Giardia supernatant on intestinal cell morphology and 
water transporter expression. 
 The aims of the studies described in this chapter were: 
(i) to investigate the effects of Giardia supernatant on intestinal cell 
morphology.  
(ii) to investigate the effects of Giardia supernatant on the main 
intestinal water transporters: aquaporin 3 (AQP3) (Fig 3.1), sodium-
glucose co-transporter (SGLT-1) (Fig 3.2), and cystic fibrosis 
conductance regulator (CFTR) (Fig 3.3) . 
(iii) to determine the chronology of any effects observed.  
This was undertaken by incubating CaCo-2 cells with different dilution of 
Giardia WB (assemblage A) and GS (assemblage B) strains supernatants for 1, 8 and 
24 hours. After incubation, either immunofluorescence assay followed by 
microscopic analysis (IFA) or western blot assay were performed on the intestinal 
cells. 
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Fig 3. 1: Schematic representation of AQP3 structure. AQP3 is present on the apical side of 
colonic cells; it transports water and small molecules from the lumen of the intestine to the 
cell cytoplasm via osmosis. AQP3 is composed of a single chain of approximately 270 AAs 
and spans the membrane 6 times. 
 
Fig 3. 2: Schematic representation of SGLT-1. SGLT-1 is the main apical co-transporter for 
active glucose uptake; it is also involved in the water and small molecules (such as Na2+) 
uptake via osmosis and co transport. SGLT-1 is composed of 14 transmembrane α-helical 
domains (664 AAs). The glucose-binding and –translocation domain (C5) is located at the 
COOH-terminal end of the protein. 
 
 
Fig 3. 3: Schematic representation of CFTR. CFTR is a membrane channel that actively 
transports ions. It contains 1480 AAs. CFTR has several distinct regions, the majority of 
which span the cell membrane. On the inside of the cell, connected to the membrane 
spanning domains, are two tightly folded regions that bind nucleotides (NBF). A larger ‘R’ 
domain is located between the NBFs; it is a region with multiple sites for phosphorylation. 
The R domain and the NBFs regulate chloride conductance through the channel. 
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3.2/ Effect on intestinal cell morphology 
3.2.1/ Pilot study to determine potential CaCo-2 shrinkage 
after 24 hours incubation with Giardia supernatant 
 To investigate the effect of both Giardia WB and GS strains supernatants on 
intestinal cell morphology, CaCo-2 cells monolayers grown on coverslips were 
incubated for a further 24 hours in the presence or absence of Giardia culture 
medium diluted to 1:250 and 1:5,000 (as stated in chapter II, section 2.2.1.1, Fig 2.2 
A.), and compared with controls. After 24 hours, coverslips were fixed with 4 % PFA, 
and cells were visualized by differential interference contrast (DIC) microscopy 
using Axiovision (v 4.7.1). Cell length was defined as greatest length between each 
cell margins, and width as the distance between cell margins at 90° to the length 
(Fig 3.4 A.). A hundred cells were measured and statistically compared to the 
controls. 
 Results showed that significant differences were observed between controls 
and treated groups. In the case of cells treated with WB supernatant higher 
concentration, the reduction in size compared to DMEM only was superior to 40 %, 
for other groups the reductions was more modest but nevertheless significant (Fig 
3.4 B.). It was noted however that the TYI-S-33 media itself might have a minor 
effect on intestinal cells. 
 These results suggest that even at fairly high dilution, Giardia supernatants 
obtained directly from culture induce cell shrinkage. The inhibition of intestinal 
chloride secretion previously observed and these results strongly suggest that the 
intestinal water uptake may be disrupted by Giardia supernatant leading to a 
reduction in size of intestinal cells. However, due to the effect that Giardia growth 
medium may have on intestinal cells, the changes in intestinal cell morphology 
could not be accurately assessed. Further experiments aim to remove TYI-S-33 from 
supernatants and improve the visualization of cell margins through the use of 
markers of cell periphery such as tight junction (TJ) proteins. TJs seal the 
paracellular space between epithelial cells and maintain the distinct composition of 
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Fig 3. 4: Giardia supernatant induces shrinkage of Caco-2 cells after 24 hours incubation. 
CaCo-2 cells were incubated with either Giardia GS or WB supernatant at 1:250 and 1:5,000 
dilutions, incubation in both DMEM and TYI-S-33 (1:1,000 dilution) was used as control. 
After 24 hrs, cells were fixed with 4% PFA and analysed on microscope using DIC light. Cells 
length and width were measured blindly using the Axiovision software (v 4.7.1).  A. DIC 
microscopy showed a decrease of CaCo-2 cells length and width when cells were incubated 
with Giardia supernatant. Scale bar= 20 μm. B. Caco-2 cells length and width means 
showed a significant shrinkage of the intestinal cells when compared to the control: DMEM. 
Giardia milieu of culture, TYI-S-33, appeared to also have some effects on the cells 
morphology when compared to Giardia supernatant.  
Values were expressed compared to the control, DMEM (*) and to TYI-S-33 (    ). 
Results were assessed by paired t-test and expressed as mean values ± SEM. * p-value < 
0.05 and ** p-value < 0.01 (Appendix II). Data represents one independent experiment. 
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adjacent tissue compartments, they are composed of 8 different proteins forming a 
complex: occluding, claudin-1, e-cadherin, junctional adhesion molecule-1 (JAM-1), 
catenin, actin and zonula occludens-1 and 2 (ZO-1 and ZO-2) (Anderson and Van 
Itallie, 1995) (Fig 3.5). Immunostaining one of the proteins composing the TJs may 
allow a more accurate measurement of intestinal cell surface area and perimeter as 
these proteins are present on the whole cell circumference. ZO-1 was shown to be 
a good indicator of epithelial cells morphology and was used in this study (Umeda 
et al., 2004). 
3.2.2/ Giardia-derived supernatant compounds induce 
shrinkage of intestinal cells after 8 hours. 
To investigate the effect of soluble factors from healthy Giardia 
trophozoites on intestinal cells, an improved supernatant compound preparation 
was undertaken by harvesting trophozoites from confluent culture, washing and 
resuspending in non-supplemented DMEM for 45 minutes at 37°C (as stated in 
Chapter II, section 2.2.1.1, Fig 2.2 B.). At this incubation length, all Giardia remain 
viable as shown via cell viability flow cytometry assay (Chapter IV, section 4.2.2, Fig 
4.3). CaCo-2 monolayers were prepared as in the previous experiment and were 
incubated with the diluted supernatants diluted at 1:250 and 1:1,000 and with 
control media. Three time points for incubation were assessed: 1 hour, 8 hours and 
24 hours for each dilution and for each Giardia strain. Following incubation, cells on 
coverslips were fixed and stained for ZO-1 to establish the intestinal cell perimeter. 
Image J software (v 1.45s) was utilized for measurement and samples were blinded 
during measurements of surface area and perimeter (Fig 3.6 A., 3.7 A., 3.8 A.). 
Apoptotic and mitotic cells were excluded from the analysis to have only non-
dividing living cells. Between 400 and 800 cells were measured and statistically 
compared to the control. 
 Results showed no significant differences between control and treated 
group for both surface area and perimeter after one hour incubation (Fig 3.6). After 
8 hours incubation, results showed significant differences between control and 
treated groups (Fig 3.7). GS supernatant higher concentration appeared to have a
 Chapter I  
Chapter III 
136 | P a g e  
Fi
g 
3.
 5
: 
C
o
m
p
o
si
ti
o
n
 o
f 
e
pi
th
el
ia
l 
ti
gh
t 
ju
n
ct
io
n
s 
(T
Js
) 
an
d
 a
d
he
re
n
s 
ju
n
ct
io
n
s.
 B
o
th
 t
yp
e
 o
f 
ju
n
ct
io
ns
 a
re
 p
o
si
tio
n
ed
 a
s 
co
n
ti
n
u
ou
s 
co
n
ta
ct
s 
at
 t
h
e
 a
p
ic
al
-
la
te
ra
l m
em
b
ra
ne
 b
o
rd
e
rs
 b
e
tw
e
en
 e
n
te
ro
cy
te
s.
 T
Js
 a
re
 f
o
rm
e
d
 b
y 
h
o
m
o
ty
pi
c 
co
n
ta
ct
s 
o
f 
tr
an
sm
e
m
b
ra
ne
 p
ro
te
in
s:
 o
cc
lu
di
n
g 
an
d
 c
la
ud
in
 w
hi
ch
 a
re
 b
o
u
nd
 
o
n
 t
he
 c
yt
op
la
sm
ic
 s
u
rf
ac
e
 d
ir
e
ct
ly
 t
o
 Z
O
-1
. 
Th
e
 Z
O
-1
/Z
O
-2
 h
e
te
ro
d
im
e
r 
b
in
d
s 
th
e
 c
yt
o
sk
el
e
ta
l 
p
ro
te
in
 a
ct
in
. A
dh
e
re
n
s 
ju
n
ct
io
n
s 
ar
e
 f
o
rm
e
d
 b
y 
h
o
m
o
ty
pi
c 
p
ro
te
in
s:
 e
-c
ad
h
e
ri
n
s 
w
h
ic
h
 a
ss
e
m
b
la
ge
o
ci
at
e 
d
ir
e
ct
ly
 to
 c
yt
o
p
la
sm
ic
 p
ro
te
in
s 
α
-,
 β
-,
 a
n
d
 γ
-c
at
e
n
in
s.
 
 
 Chapter II  
Chapter III 
137 | P a g e  
more pronounced effect with a reduction in size superior to 15 % compared to the 
control. GS and WB supernatants lower concentration appeared to have a similar 
effect with a reduction in size of approximately 12 %. In the case of intestinal cells 
treated with WB supernatant higher concentration, the effect was less pronounced 
than for the other groups, a reduction in size inferior to 10 % was observed; yet this 
difference in size was statistically significant. After 24 hours incubation, results 
showed significant differences between control and treated group (Fig 3.8), but the 
effect appeared to be less pronounced than after 8 hours treatment with Giardia 
supernatant. As above, WB supernatant at higher concentration appeared to have a 
more pronounced effect than other groups, with a reduction in size of 10 %. Other 
groups had a lesser effect, but still statistically significant, on intestinal cell 
morphology, with a reduction in size ranging between 5 % and 7 %. 
 These results suggest that Giardia-derived supernatant compounds induce 
shrinkage of intestinal cells after 8 hours incubation. This reduction in size was still 
occurring after 24 hours, even if less pronounced than after 8 hours incubation, 
suggesting that this effect may be a long lasting event. As previously suggested, this 
change in intestinal cell morphology may be due to a disruption in the cellular 
water uptake; the loss of water may lead to a reduction in size. However, the effect 
observed in this study was lesser than the one observed during the pilot study, 
suggesting that Giardia growth medium was increasing the observed intestinal cell 
size reduction. 
3.2.3/ Giardia-derived supernatant compounds can induce 
ruffling of CaCo-2 cell margins. 
 Apart from the size reduction observed while investigating Giardia 
supernatant effect on intestinal cell morphology (as stated in section 3.2.1.2), cells 
also appeared to be more wrinkled compared to control. This wrinkling effect is 
similar to the effect observed in host cells during bacterial infection and ca lled 
ruffling effect. This ruffling effect was described as a disruption of host cell 
membrane and cytoskeleton due to the attachment of bacteria or bacterial 
secreted factors (Guichard et al., 2013). To obtain an index of this ruffling effect,  
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Fig 3. 6: Giardia supernatant does not induce any changes in CaCo-2 cells morphology 
after 1 hour incubation. Caco-2 cells were incubated with either GS or WB strain 
supernatant, at 1:250 and 1:1,000 dilutions. DMEM was used as a control. After 1 hr, cells 
were fixed with 4%PFA and stained with anti-ZO-1 antibody to detect changes in the cells 
morphology; the nuclei were stained with DAPI (blue). ZO-1 was visualised using secondary 
antibodies conjugated with Alexa fluor 488 (green). A. Surface area and perimeter of CaCo-
2 cells were measured blindly using Image J software (v. 1.45s) after obtaining images via 
Axiovision (v 4.8.2), x40 magnification, scale bar = 50 μm. B.  Variation in CaCo-2 cells 
surface area compared to the control: DMEM. C. Variation in CaCo-2 cells perimeter 
compared to the control: DMEM. For both surface area and perimeter, results were 
assessed by non-parametric paired t-tests and expressed as mean values ± SEM, * p-value < 
0.05 and ** p-value <0.001 (Appendix III A.). Data represents three independent 
experiments with biological replicates. 
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Fig 3. 7: Giardia supernatant induces a decrease in CaCo-2 cell size after 8 hours 
incubation. Caco-2 cells were incubated with either GS or WB strain supernatant, at 1:250 
and 1:1,000 dilutions. DMEM was used as a control. After 8 hrs, cells were fixed with 
4%PFA and stained with anti-ZO-1 antibody to detect changes in the cells morphology; the 
nuclei were stained with DAPI (blue). ZO-1 was visualised using secondary antibodies 
conjugated with Alexa fluor 488 (green). A. Surface area and perimeter of CaCo-2 cells were 
measured blindly using Image J software (v. 1.45s) after obtaining images via Axiovision (v 
4.8.2), x40 magnification, scale bar = 50 μm. B. Variation in CaCo-2 cells surface area 
compared to the control: DMEM. C. Variation in CaCo-2 cells perimeter compared to the 
control: DMEM. For both surface area and perimeter, results were assessed by non-
parametric paired t-tests and expressed as mean values ± SEM, * p-value < 0.05 and ** p-
value <0.001 (Appendix III B.). Data represents three independent experiments with 
biological replicates. 
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Fig 3. 8: Giardia supernatant induces a decrease in CaCo-2 size after 24 hours incubation. 
Caco-2 cells were incubated with either GS or WB strain supernatant, at 1:250 and 1:1,000 
dilutions. DMEM was used as a control. After 24 hrs, cell s were fixed with 4%PFA and 
stained with anti-ZO-1 antibody to detect changes in the cells morphology; the nuclei were 
stained with DAPI (blue). ZO-1 was visualised using secondary antibodies conjugated with 
Alexa fluor 488 (green). A. Surface area and perimeter of CaCo-2 cells were measured 
blindly using Image J software (v. 1.45s) after obtaining images via Axiovision (v 4.8.2), x40 
magnification, scale bar = 50 μm. B.  Variation in CaCo-2 cells surface area compared to the 
control: DMEM. C. Variation in CaCo-2 cells perimeter compared to the control: DMEM. For 
both surface area and perimeter, results were assessed by non-parametric paired t-tests 
and expressed as mean values ± SEM, * p-value < 0.05 and ** p-value <0.001 (Appendix III 
C.). Data represents three independent experiments with biological replicates. 
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the following formula:  
𝐏𝐞𝐫𝐢𝐦𝐞𝐭𝐞𝐫
√(𝐒𝐮𝐫𝐟𝐚𝐜𝐞 𝐚𝐫𝐞𝐚)
  was used to measure the intestinal cell ruffle 
(Fig 3.9). Perimeter and surface area are measured in μm and in μm2 respectively, 
an index is not define by a measurement unit; therefore, to obtain the ruffling index 
in this case perimeter was divided by the square root of the surface area, this was 
done for each treatment group and each time point (Fig 3.9). 
 Results showed no significant ruffling effect after one hour incubation, yet, 
there were some significant differences in ruffling between groups treated with WB 
higher concentration and lower concentration (Fig 3.9 A.). After 8 hours, significant 
differences in ruffling between control groups and groups only treated with WB 
supernatant higher concentration were observed. Even if WB supernatant lower 
concentration did not induce a significant ruffling of intestinal cells, some significant 
differences were observed between the two WB dilutions (Fig 3.9 B.). After 24 
hours, only cells treated with WB supernatant lower concentration showed 
significant differences in ruffling than the control group. In this case too, there were 
significant differences between groups treated with WB supernatant higher and 
lower dilutions (Fig 3.9 C.). 
 These results show that only WB-derived supernatant compounds induce a 
significant ruffling of Caco-2 cells after 8 hours and 24 hours. The previous study on 
the effect of Giardia-derived supernatant effect on intestinal cell morphology 
showed that GS-derived supernatant had a more pronounced effect than WB 
supernatant on intestinal cell size. These results and the fact that WB supernatant 
has a significant ruffling effect on intestinal cells suggest that WB supernatant may 
cause more mucosal damages than GS-derived supernatant. These results also 
showed significant differences between groups treated with WB higher and lower 
concentrations at both 8 hours and 24 hours; which suggests that there may be a 
dose-effect response in this case.  
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Fig 3. 9: Giardia WB supernatant induces some ruffling of Caco-2 cells after 8 and 24 
hours incubation. Caco-2 cells were incubated with either GS or WB strain supernatant, at 
1:250 and 1:1,000 dilutions for 1, 8 and 24 hours. DMEM was used as a control. After 
incubation, cells were fixed with 4%PFA and stained with anti-ZO-1 antibody to detect 
changes in the cells morphology; the nuclei were stained with DAPI obtained via Axiovision 
(v 4.8.2 and the ruffling index was calculated after measuring the surface area and 
perimeter of intestinal cells using image J. A. Ruffling effect after 1 hour incubation. B. 
Ruffling effect after 8 hours incubation. C. Ruffling effect after 24 hours. Indexes were 
compared to the control: DMEM (**), and between different concentration for each strain  
( ). Results were assessed via a panel data approach on Stata software (v 13.1) and 
expressed as mean values ± SEM, * p-value < 0.05 and ** p-value <0.001 (Appendix IV). 
Data represents three independent experiments with biological replicates.  
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3.3/ Effect on intestinal cells water and ion 
transporters 
As previously stated (Chapter I, section 1.5.1.2.), intestinal water uptake 
occurs by osmosis, co-transport and co-transport + osmosis (Zeuthen, 2010). AQP3 
and SGLT-1 are two of the main water transporters present in intestinal cells (Fig 
3.1, 3.2). The preceding study on intestinal morphology showed that intestinal 
water efflux was disrupted by Giardia supernatant after 8 hours. This suggests that 
one or several intestinal water transporters may interact with Giardia supernatant. 
Another study showed that after 24 hours exposure to Giardia supernatant, 
intestinal chloride secretion was inhibited suggesting that Giardia supernatant may 
have an effect on one of the intestinal chloride channels such as CFTR (Fig 3.3) (Al-
Naimi et al, unpublished, Chapter I, section 1.5.4.). In this study, the effect of 
Giardia supernatant on the expression and translocation of AQP3, SGLT-1 and CFTR 
was investigated throughout time course IF microscopy and western blot assays. 
3.3.1/ Pilot experiment to evaluate translocation of intestinal 
AQP3 after incubation with Giardia supernatant 
 To investigate the effect of Giardia assemblage A (WB strain) and B (GS 
strain) supernatants on AQP3. Caco-2 cell monolayers grown on coverslips were 
incubated for 1hour, 8 hours, and 24 hours in presence or absence of Giardia 
culture medium diluted to 1:250, 1:500, 1:1,000 and 1:5,000 in non-supplemented 
DMEM (as stated in Chapter II, section 2.2.1.1., Fig 2.2 A), and compared with 
controls. Following incubations, coverslips were fixed with 4 % PFA, stained for 
AQP3 and AQP3 distribution throughout cells was visualized via Axiovision software 
(v 4.8.2). AQP3 was shown to be the main AQP protei n present on the apical side of 
colonic cells such as CaCo-2 cell line (Matsuzaki et al., 2004) (Fig 3.1); CaCo-2 cells 
were used in this study, AQP3 was therefore chosen to realize the assay. 
Results showed that a diffuse staining was observed under all conditions, at 
the early time point (Fig 3.10 1hr). After 8 hours, AQP3 proteins appeared to 
localise towards the periphery of the intestinal cells, particularly at higher 
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concentrations (1:250 and 1:500) for both Giardia isolates (Fig 3.10 8 hrs). A similar 
peripheral protein distribution was observed after 24 hours (Fig 3.10 24 hrs). It was 
also noted that TYI-S-33 and non-supplemented DMEM media induce the 
translocation of AQP3 proteins after 8 hours (Fig 3.10 A and D).  
These results suggest that Giardia supernatants obtained directly from 
culture may induce the translocation of intestinal AQP3 protein after 8 hours 
incubation. The inhibition of chloride secretion and the changes in intestinal cell 
morphology previously observed suggested that the intestinal water uptake may be 
disrupted by Giardia supernatant. This study strongly supports this hypothesis and 
also suggests that AQP3 may be the intestinal water channel involved in this 
disruption. However, due to the effect that both growth media may have on AQP3, 
the changes in AQP3 translocation could not be accurately assessed. In addition, 
some CaCo-2 cells were clearly not in a confluent monolayer during the experiment 
which may have affected the reaction between Giardia supernatant and the 
intestinal cells (Fig 3.12 B and C). Further experiments aim to remove TYI-S-33 from 
Giardia supernatant. Moreover, to avoid any starvation of the CaCo-2 cells, 
supplemented DMEM was used instead of non-supplemented DMEM for the 
different incubation periods and intestinal cell monolayers were grown to reach 
confluence. 
3.3.2/ Giardia supernatant induces the translocation of AQP3 
protein 
To investigate the effect of soluble factors from healthy Giardia 
trophozoites on intestinal AQP3 protein, an improved supernatant compound 
preparation was undertaken by harvesting trophozoites from confluent culture,  
washing and resuspending in non-supplemented DMEM for 45 minutes at 37°C (as 
stated in Chapter II, section 2.2.1.1, Fig 2.2 B.). CaCo-2 monolayers were prepared 
as in the previous experiment and were incubated with the supernatants diluted to 
1:250 and 1:1,000 and with control media for 1 hour, 8 hours and 24 hours. 
Following incubation, cells on coverslips were fixed and stained for AQP3. 
Axiovision software (v 4.8.2) was utilized to observe AQP3 translocation (Fig 3.11 A., 
3.12 A., 3.13 A.). In addition, CaCo-2 monolayers grown on 12-well plates were  
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Fig 3. 10: Giardia supernatant induces the translocation of intestinal AQP3 after 8 hrs 
incubation. Caco-2 cells were incubated with different dilutions of Giardia GS and WB 
supernatants for 1, 8 and 24 hrs. Supernatants were collected form Giardia culture and 
diluted at 1:250, 1:500, 1:1,000 and 1:5,000 in non-supplemented DMEM. CaCo-2 cells 
were fixed with 4% PFA and stained with anti-AQP3 antibody to detect changes in the 
protein location in intestinal cells. AQP3 was visualised using secondary antibodies 
conjugated with Alexa fluor 488 (green). A. CaCo-2 cells were incubated with non-
supplemented DMEM as a control. B. Incubation with Giardia GS isolate supernatant. C. 
Incubation with Giardia WB isolate supernatant. D. Incubation with TYI-S-33 at 1:1,000 
dilution. Images were obtained using Axiovision software (v 4.7.1), x100 magnitude. Scale 
bar = 20 μm. Data represents one independent experiment.  
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incubated in presence or absence of supernatants diluted to 1:250, 1:500, 1:1,000 
and 1:5,000 for 1 hour, 8 hours and 24 hours. Following incubation, proteins were  
extracted and blotted for AQP3. Odyssey machine (Li-Cor, UK) with associated 
software was utilized to assess AQP3 protein expression (Fig 3.11 B., 3.12 B., 3.13.). 
Results showed a small but significant decrease in AQP3 expression in treated 
groups after one hour incubation (Fig 3.11 B.). No significant changes in AQP3 
expression were observed after 8 hours incubation (Fig 3.12 B.). Results also 
showed a slight but significant increase in AQP3 expression for groups treated with 
WB supernatant diluted to 1:500 and 1:5,000 after 24 hours incubation (Fig 3.13 B.). 
Microscopic analysis results showed differences in AQP3 distribution throughout 
intestinal cells between control and groups treated with GS supernatant, after one 
hour incubation; particularly for groups treated with supernatant higher 
concentration (Fig 3.11 A.). A similar peripheral distribution was observed after 8 
hours incubation with WB supernatant; AQP3 proteins appeared to be more 
peripheral in groups treated with GS supernatant (Fig 3.12 A.). Results showed a 
greater peripheral distribution of AQP3 for groups treated with WB supernatant 
than for the groups treated with GS supernatant, after 24 hours (Fig 3.13 A.). It was 
also noted that AQP3 distribution was slightly more peripheral in control groups  
after 24 hours (Fig 3.13 A.). 
These results suggest that Giardia–derived supernatant may have a weak 
marginal effect on AQP3 expression. However, a high level of variation in AQP3 
expression between biological replicates was observed which suggests that 
Giardia–derived supernatant may not have any effect on AQP3 expression. The 
microscopic analysis results suggest that Giardia–derived supernatant induces the 
translocation of AQP3 protein, even shortly after inoculation. The fact that AQP3  
are more translocated when intestinal cells are in contact with Giardia supernatant 
suggests that AQP3 may be involved in the water efflux disruption which may cause 
the changes in intestinal cell morphology and the inhibition of chloride secretion 
previously observed. Yet, the quantification of protein translocation observed in 
this study could not be assessed via simple immunofluorescence microscopy and 
has to be investigated. 
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Fig 3. 11: Giardia GS isolate (assemblage B) supernatant induces the translocation of 
intestinal AQP3 after 1 hr incubation. A. CaCo-2 cells were incubated with Giardia GS and 
WB strains supernatants at 1:250 and 1:1,000 for 1 hr. After incubation, CaCo-2 cells were 
fixed with 4%PFA and stained with anti-AQP3 antibody; the nuclei were stained with DAPI 
(blue). AQP3 was visualised using secondary antibodies conjugated with Alexa fluor 488 
(green). Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale bar= 20μm. 
B. CaCo-2 cells were incubated with Giardia GS and WB strains supernatant at 1:250, 1:500, 
1:100 and 1:5,000 for 1 hr. After incubation, proteins were extracted using M-PER, as 
stated in Chapter II (section 2.2.2.1). 1: Control incubated with DMEM. AQP3 expression 
was assessed by western blot analysis and normalised to β-actin using the ODYSSEY 
software. Results were assessed by non-parametric Mann-Whitney-U tests (compared to 
control) and expressed as mean values ± SEM, * p-value < 0.05 and ** p-value <0.001 
(Appendix V). Data represents three independent experiments with biological replicates. 
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Fig 3. 12: Giardia WB and GS isolates (assemblage A and B) supernatants induce the 
translocation of AQP3 after 8 hrs incubation. A. CaCo-2 cells were incubated with Giardia 
GS and WB strains supernatants at 1:250 and 1:1,000 for 8 hrs. After incubation, CaCo-2 
cells were fixed with 4%PFA and stained with anti-AQP3 antibody; the nuclei were stained 
with DAPI (blue). AQP3 was visualised using secondary antibodies conjugated with Alexa 
fluor 488 (green). Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale 
bar= 20μm. B. CaCo-2 cells were incubated with Giardia GS and WB strains supernatant at 
1:250, 1:500, 1:100 and 1:5,000 for 8 hrs. After incubation, proteins were extracted using 
M-PER, as stated in Chapter II (section 2.2.2.1). 1: Control incubated with DMEM. AQP3 
expression was assessed by western blot analysis and normalised to β-actin using the 
ODYSSEY software. Results were assessed by non-parametric Mann-Whitney-U tests 
(compared to control) and expressed as mean values ± SEM, * p-value < 0.05 and ** p-
value <0.001 (Appendix V). Data represents three independent experiments with biological 
replicates. The duplicate bands represent either the AQP3 below F-actin or F-actin above 
AQP3. Due to their similar MW, it was challenging to crop images to only see the targeted 
bands. 
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Fig 3. 13: Giardia WB and GS isolates (assemblage A and B) supernatants induce the 
translocation of AQP3 after 24 hrs incubation. A. CaCo-2 cells were incubated with Giardia 
GS and WB strains supernatants at 1:250 and 1:1,000 for 24 hrs. After incubation, CaCo-2 
cells were fixed with 4%PFA and stained with anti-AQP3 antibody; the nuclei were stained 
with DAPI (blue). AQP3 was visualised using secondary antibodies conjugated with Alexa 
fluor 488 (green). Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale 
bar= 20μm. B. CaCo-2 cells were incubated with Giardia GS and WB strains supernatant at 
1:250, 1:500, 1:100 and 1:5,000 for 24 hrs. After incubation, proteins were extracted using 
M-PER, as stated in Chapter II (section 2.2.2.1). 1: Control incubated with DMEM. AQP3 
expression was assessed by western blot analysis and normalised to β-actin using the 
ODYSSEY software. Results were assessed by non-parametric Mann-Whitney-U tests 
(compared to control) and expressed as mean values ± SEM, * p-value < 0.05 and ** p-
value <0.001 (Appendix V). Data represents three independent experiments with biological 
replicates. 
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3.3.3/ Giardia GS supernatant may decrease SGLT-1 
expression level  
To determine the effect of Giardia supernatant on intestinal SGLT-1, 
expression and translocation, CaCo-2 monolayers were grown either on coverslips 
or in 12-well plates and incubated with different dilutions of Giardia-derived 
supernatant for 1 hour, 8 hours and 24 hours, as previously described in the AQP3 
study (section 3.2.2). Intestinal cells were fixed with 4 % PFA and stained for SGLT-1 
or proteins were extracted and blotted for SGLT-1. 
 Results showed a significant decrease of SGLT1 expression only for groups 
treated with WB supernatant diluted to 1: 1,1000 and GS supernatant diluted to 
1:250 (Fig 3.14 B.). After 8 hours, results showed a significant increase of SGTL1 
expression for groups treated with WB supernatant diluted to 1:1,000; and a 
significant decrease of SGLT1 expression for groups treated with GS supernatant 
diluted to 1:250, 1:500 and 1:1,1000 (Fig 3.15 B.). After 24 hours, results showed a 
similar significant increase in SGLT1 expression for groups also treated with WB 
supernatant diluted to 1:1,000; and a significant decrease of SGLT1 expression for 
groups treated with GS supernatant diluted to 1:250 (Fig 3.16 B.). It was noted that, 
after 8 and 24 hours, groups treated with WB supernatant diluted to 1:5,000 
showed a SGLT1 expression profile similar to the control group however, the 
statistical analysis showed no significant differences between the control and these 
treated groups. Results of the microscopic analysis showed that SGLT1 proteins of 
treated groups had a distribution similar to control groups, under all conditions and 
at all time (Fig 3.14 A., 3.15 A., 3.16 A.). 
These results suggest that a high concentration of Giardia GS supernatant 
might induce a slight reduction of SGLT-1 expression. However, this reduction of  
expression appears to be less than 40 % which indicates that SGLT-1 expression 
may not be dramatically affected by Giardia supernatant. Moreover, like for the 
AQP3 data previously discussed, the important variation in SGLT-1 expression 
between biological replicates suggests that, the whole effect of GS supernatant on 
SGLT-1 expression might have not been fully observed and may be stronger than 
these data suggest. These results also suggest that WB supernatant lower  
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Fig 3. 14: Giardia WB and GS isolates (assemblage A and B) supernatants have no effect 
on the translocation and expression of SGLT-1 after 1 hr incubation.. A. CaCo-2 cells were 
incubated with Giardia GS and WB strains supernatants at 1:250 and 1:1,000 for 1 hr. After 
incubation, CaCo-2 cells were fixed with 4%PFA and stained with anti-SGLT-1 antibody; the 
nuclei were stained with DAPI (blue). SGLT-1 was visualised using secondary antibodies 
conjugated with Alexa fluor 488 (green). Images were obtained using Axiovision (v 4.8.2), 
x100 magnitude. Scale bar= 20μm. B. CaCo-2 cells were incubated with Giardia GS and WB 
strains supernatant at 1:250, 1:500, 1:100 and 1:5,000 for 1 hr. After incubation, protei ns 
were extracted using M-PER, as stated in Chapter II (section 2.2.2.1). 1: Control incubated 
with DMEM. SGLT-1 expression was assessed by western blot analysis and normalised to β-
actin using the ODYSSEY software. Results were assessed by non-parametric Mann-
Whitney-U tests (compared to control) and expressed as mean values ± SEM, * p-value < 
0.05 and ** p-value <0.001 (Appendix V). Data represents three independent experiments 
with biological replicates. 
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Fig 3. 15: Giardia WB and GS isolates (assemblage A and B) supernatants have no effect 
on the translocation and expression of SGLT-1 after 8 hrs incubation. A. CaCo-2 cells were 
incubated with Giardia GS and WB strains supernatants at 1:250 and 1:1,000 for 8 hrs. 
After incubation, CaCo-2 cells were fixed with 4%PFA and stained with anti -SGLT-1 
antibody; the nuclei were stained with DAPI (blue). SGLT-1 was visualised using secondary 
antibodies conjugated with Alexa fluor 488 (green). Images were obtained using Axiovision 
(v 4.8.2), x100 magnitude. Scale bar= 20μm. B. CaCo-2 cells were incubated with Giardia GS 
and WB strains supernatant at 1:250, 1:500, 1:100 and 1:5,000 for 8 hrs. After incubation, 
proteins were extracted using M-PER, as stated in Chapter II (section 2.2.2.1). 1: Control 
incubated with DMEM. SGLT-1 expression was assessed by western blot analysis and 
normalised to β-actin using the ODYSSEY software. For WB/β-actin, the extra represent the 
SGLT-1 bands which could not be removed on image due to the oblique migration of 
proteins. Results were assessed by non-parametric Mann-Whitney-U tests (compared to 
control) and expressed as mean values ± SEM, * p-value < 0.05 and ** p-value <0.001 
(Appendix V). Data represents three independent experiments with biological replicates. 
The duplicate bands represent either the SGLT-1 below F-actin or F-actin above SGLT-1. 
Due to their similar MW, it was challenging to crop images to only see the targeted bands. 
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Fig 3. 16: Giardia WB and GS isolates (assemblage A and B) supernatants have no effect 
on the translocation and expression of SGLT-1 after 24 hrs incubation. A. CaCo-2 cells 
were incubated with Giardia GS and WB strains supernatants at 1:250 and 1:1,000 for 24 
hrs. After incubation, CaCo-2 cells were fixed with 4%PFA and stained with anti -SGLT-1 
antibody; the nuclei were stained with DAPI (blue). SGLT-1 was visualised using secondary 
antibodies conjugated with Alexa fluor 488 (green). Images were obtained using Axiovision 
(v 4.8.2), x100 magnitude. Scale bar= 20μm. B. CaCo-2 cells were incubated with Giardia GS 
and WB strains supernatant at 1:250, 1:500, 1:100 and 1:5,000 for 24 hrs. After incubation, 
proteins were extracted using M-PER, as stated in Chapter II (section 2.2.2.1). 1: Control 
incubated with DMEM. SGLT-1 expression was assessed by western blot analysis and 
normalised to β-actin using the ODYSSEY software. Results were assessed by non-
parametric Mann-Whitney-U tests (compared to control) and expressed as mean values ± 
SEM, * p-value < 0.05 and ** p-value <0.001 (Appendix V). Data represents three 
independent experiments with biological replicates. 
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concentration may increase SGLT1 expression after 8 hours. However, due the 
great variation between biological replicates and the inconsistency of results 
between the different treated groups, this cannot be confirm nor deny. The 
microscopic analysis results suggest that Giardia supernatant does not induce 
SGLT1 translocation. 
3.3.4/ Giardia supernatant induces CFTR translocation in 
intestinal cells in early stages of infection. 
 To determine the effect of Giardia supernatant on intestinal CFTR 
expression and translocation, CaCo-2 monolayers were grown either on coverslips 
or in 12-well plates and incubated with different dilutions of Giardia-derived 
supernatant for 1 hour, 8 hours and 24 hours, as previously described in the AQP3 
and SGLT1 studies (section 3.2.2 and 3.2.3.). Intestinal cells were fixed with 4 % PFA 
and stained for CFTR or proteins were extracted and blotted for CFTR (Fig 3.17-
3.19). 
Western blots were performed on extracted proteins to quantify CFTR 
expression levels under different concentrations of Giardia supernatant at different 
times. Proteins were blotted with three different monoclonal mouse anti -CFTR 
antibodies from three different companies (AbCam, R&D systems, and Santa-Cruz 
Biotechnologies) as stated in chapter II (Table 2.3). All antibodies were tested at 
concentrations ranging from 1:500 to 1:250 and left overnight at 4°C, 0.2 % tween 
was added to improve the bond between proteins and antibodies; but no bands 
were observed for CFTR. Following these conditions, no bands were ever observed 
for CFTR apart from one western blot with AbCam antibody (Appendix VI). The gel 
showed either poor quality bands or no bands for CFTR. Due to this negative 
blotting on CFTR, the effect of Giardia supernatant on CFTR expression could not be 
assessed. Many different concentrations (up to 1:250) were tried but no 
reproducible data were obtained (Appendix VI). Even though the western blot assay 
was non-reproducible, this was considered not to affect the immunofluorescence 
assay; this was shown by the similarities in microscopic images observed after each 
experiment. 
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 Results showed that CFTR distribution was more peripheral in groups 
treated with GS supernatant than control group after one hour; particularly groups 
treated with higher concentration (Fig 3.17). After 8 hours, a greater peripheral 
distribution of CFTR was observed for groups treated with Giardia supernatant (Fig 
3.18). After 24 hours, groups treated with GS supernatant appeared to have  a 
similar CFTR distribution to the control group, and groups treated with WB  
supernatant appeared to have a CFTR distribution more peripheral (Fig 3.19). 
These results suggest that Giardia supernatant induces the translocation of 
CFTR towards the periphery of the intestinal cells. Giardia assemblage B (GS strain) 
appears to have an effect on CFTR distribution during the early stage of infection 
whereas assemblage A (WB strain) induces an effect sometimes between 1 hour 
and 8 hours (Fig 3.17-3.19). This suggests that Giardia assemblage A (WB strain) 
effect on intestinal CFTR may last longer than the effect of assemblage B (GS strain). 
These results also strongly suggest that CFTR may be the intestinal channel by 
which Giardia supernatant inhibits the intestinal chloride secretion. Even if CFTR 
translocation was observed in this study, its quantification could not be assessed via 
simple immunofluorescence microscopy and has to be investigated. 
3.4/ Discussion 
3.4.1/ Effect on intestinal cell morphology 
Giardia has been shown to disrupt several intestinal cell functions such as 
the intestinal barrier, the anion absorption or apoptosis (Cotton et al., 2011, 
Troeger et al., 2007, Buret, 2007, Scott et al., 2002). However, no studies have yet 
demonstrated the effect of Giardia supernatant on the intestinal cells morphology. 
In this study, Giardia supernatant was shown to provoke a change in intestinal cell 
morphology and size; cells appeared shrunk and ruffled after exposure to Giardia 
supernatant (Fig 3.4, 3.6-3.11). It was previously shown that an inhibition of 
chloride secretion lead to a decrease of cell volume (Walters et al., 1992). This 
suggests that the changes in intestinal cell morphology after exposure to Giardia 
supernatant correlate with the changes in electrophysiology observed in our 
laboratory (Chapter I, section 1.5.4., Fig 1.17-1.19). 
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Fig 3. 17: Giardia GS isolate (assemblage B) supernatant induces the translocation of 
intestinal CFTR after 1 hr incubation. CaCo-2 cells were incubated with Giardia GS and WB 
strains supernatants at 1:250 and 1:1,000 for 1 hr. After incubation, CaCo-2 cells were fixed 
with 4%PFA and stained with anti-CFTR antibody; the nuclei were stained with DAPI (blue). 
CFTR was visualised using secondary antibodies conjugated with Alexa fluor 594 (red). 
Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale bar= 20μm. Data 
represents three independent experiments with biological replicates. 
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Fig 3. 18: Giardia WB and GS isolates (assemblage A and B) supernatants induce the 
translocation of CFTR after 8 hrs incubation. CaCo-2 cells were incubated with Giardia GS 
and WB strains supernatants at 1:250 and 1:1,000 for 8 hrs. After incubation, CaCo-2 cells 
were fixed with 4%PFA and stained with anti-CFTR antibody; the nuclei were stained with 
DAPI (blue). CFTR was visualised using secondary antibodies conjugated with Alexa fluor 
594 (red). Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale bar= 
20μm. Data represents three independent experiments with biological replicates. 
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Fig 3. 19: Giardia WB and GS isolates (assemblage A and B) supernatants induce the 
translocation of CFTR after 24 hrs incubation. CaCo-2 cells were incubated with Giardia GS 
and WB strains supernatants at 1:250 and 1:1,000 for 24 hrs. After incubation, CaCo-2 cells 
were fixed with 4%PFA and stained with anti-CFTR antibody; the nuclei were stained with 
DAPI (blue). CFTR was visualised using secondary antibodies conjugated with Alexa fluor 
594 (red). Images were obtained using Axiovision (v 4.8.2), x100 magnitude. Scale bar= 
20μm. Data represents three independent experiments with biological replicates. 
 
 Chapter II  
Chapter III 
159 | P a g e  
In this study, intestinal cells were first incubated with Giardia supernatant 
from culture for 24 hours. The cells length and width were measured to preliminary 
assess the effect of Giardia supernatant on the intestinal cell morphology. This pilot 
study showed apparent cell shrinkage when intestinal cells were incubated with 
Giardia culture supernatants (Fig 3.4). However, some effects from Giardia growth 
media were also observed (Fig 3.4 B.). As a growth media, TYI-S-33 components are 
present in supernatant in higher quantity than Giardia secreted component within 
culture tubes. This suggests that within diluted Giardia supernatant, more TYI-S-33 
components were present than Giardia components. The fact that intestinal cells 
incubated with TYI-S-33 diluted at 1:1,000 were similar in size to intestinal cells 
under normal condition of growth showed that TYI-S-33 does not affect 
dramatically the intestinal cell size. However, intestinal cells under GS 1:5,000 
treatment had a significant reduction in size than cells incubated with TYI-S-33 
while intestinal cells incubated with GS 1:250 were not which indicates that TYI-S-
33 does have some marginal effects on the intestinal cells morphology (Fig 3.4 B.). 
The study was improved by removing the influence of Giardia growth media 
and by delineating cell margins (Fig 3.6-3.8). These results show a marginal effect of 
Giardia supernatant on cell morphology suggesting that TYI-S-33 contributed 
significantly to the initial observations. Nevertheless, small reduction in cell size and 
turgidity from 8 hours incubation with Giardia products is observed (Fig 3.6-3.9). 
Indeed, Giardia supernatant was shown to have a slight effect on the intestinal cells 
morphology and water flux, especially after 8 hours incubation with the parasite 
supernatant. Giardia assemblage B (GS strain) appears to have a more important 
effect on the intestinal cells surface area and perimeter than assemblage A (WB 
strain) which suggests that Giardia assemblage B may have a greater inhibition 
effect on the intestinal water uptake (Fig 3.7 and 3.8). However, intestinal cells 
appear to be more ruffled when incubated with Giardia assemblage A which 
indicates that assemblage A may cause more mucosal damage than assemblage B 
(Fig 3.9).  
Studies on gerbils and rats showed that the diffuse loss of epithelial brush 
border and decrease of water absorption during giardiasis were Giardia strain-
dependent (Benere et al., 2012, Cevallos et al., 1995). These studies also 
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demonstrated that assemblage B had a greater effect on brush-border enzymes 
deficiencies; and that these brush-border enzymes deficiencies were caused by a 
diffuse loss of epithelial brush-border microvillus surface area rather than alteration 
in villus structure (Benere et al., 2012). The fact that CaCo-2 cells surface area and 
perimeter were found to be more decreased when intestinal cells were incubated 
with Giardia GS supernatant correlates with these previous studies realised on 
gerbils and rats. Benere et al also suggested that assemblage A trophozoites can 
induce a high degree of mucosal and functional damages without causing obvious 
signs of diarrhoea (Benere et al., 2012). Here, assemblage A was shown to have a 
lesser effect on intestinal cell size suggesting that the intestinal water uptake may  
not be as affected by assemblage A supernatant as it is by assemblage B 
supernatant. Moreover, assemblage A supernatant causes a more important 
ruffling effect of intestinal cells than assemblage B which also correlates with the 
previous studies realised on gerbils and rats. 
The immunostaining of ZO-1 allowed calculating the surface area and 
perimeter changes occurring in intestinal cells during infection with Giardia 
supernatant, however, the water loss could not be accurately assessed via 
microscopy. The realisation of an electrophysiology assay using Ussing chamber 
may allow assessing the actual loss of water in real time. It is important to note that 
the measurement of surface area and perimeter were done via Image J software by 
redrawing the outline of non-mitotic and non-apoptotic cells in order for the 
software to calculate these two data. This is not the most accurate method and it 
might have led to a slight loss of information. Due to this lack of accuracy in the 
measurement of surface area and perimeter, the ruffling index may not be accurate 
either suggesting that this effect might be more pronounced too. This could explain 
the non-significant data for GS supernatant when some ruffling of Caco-2 was 
microscopically observed. However, even with a slight loss of information, this 
study shows that Giardia supernatant induces significant but not dramatic 
morphological changes in intestinal cells. 
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3.4.2/ Effect on intestinal cell water and ions transporters 
Some of the effects of Giardia on intestinal cells have long been well-
established (Cotton et al., 2011, Roxstrom-Lindquist et al., 2005, Scott et al., 2000). 
Yet, the possible involvement of both Giardia-secreted factors and host cell 
transport mechanisms remains unknown. In this study, the implications of two main 
water channels, AQP3 and SGLT-1, and of one chloride secretion channel, CFTR 
were investigated (Fig 3.1-3.3).  
Aquaporins are responsible for the water uptake by osmosis in many cells; 
but they can also transport small molecules through the lipid bilayer, AQP3 is also 
involved in the transport of glycerol, urea and other small solutes such as 
ammonia/ammonium (Krane and Goldstein, 2007, Holm et al., 2005). The pilot 
study shows apparent translocation of AQP3 protein under exposure to Giardia.  
However, Giardia growth media induces an even more pronounced effect (Fig 
3.10).  
Study was improved by removing the influence of Giardia growth media and 
by using supplemented DMEM for the incubation with intestinal cells  as non-
supplemented DMEM was initially used during incubation with Giardia 
supernatants (Fig 3.10-3.13). This study shows that Giardia supernatant may not 
have any effect on AQP3 expression due to the marginal effect observed. It also 
shows that Giardia supernatant induces the translocation of AQP3 protein. Giardia 
assemblage B induces the translocation of AQP3 shortly after inoculation as 
proteins appeared to be peripheral after one hour incubation (Fig 3.11 A., 3.12 A., 
3.13 A.). Giardia assemblage A supernatant induces both AQP3 translocation 
between 1 and 8 hours incubation; and its effect appeared to last longer as more 
proteins were peripheral after 24 hours incubation with WB supernatant. This 
translocation appeared to be a dose-response effect as more proteins were 
observed to be peripheral with a 1:250 dilution for the parasite supernatants. 
However, the quantification of this translocation was not possible using an Axioplan 
2 imaging microscope. The investigation of the density of vesicles in close proximity 
of the plasma membrane via the use of a confocal XZ-plane imaging microscope 
and a peripheral stain as a marker of cells shape, such as a tight junction protein, 
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should allow the quantification of the translocation observed (Domanova et al., 
2011, Yu et al., 2008). The quantitative measurement of AQP3 translocation could 
also be assessed by flow cytometry as suggested by Koshy and collaborators in their 
study of GLUT4 translocation to the plasma membrane (Koshy et al., 2010).  
SGLT-1 is responsible for the active transport of glucose across the brush 
border membrane of small intestine, via a coupled transport of two sodium ions for 
one glucose molecule (Wright et al., 2007); it can also be involved in the osmotic 
water uptake (Zeuthen, 2010). Like for the study on AQP3 proteins, CaCo-2 cells 
were incubated with both Giardia GS and WB supernatants at different dilutions, 
for 1, 8 and 24 hours; immunofluorescence microscopy assay and western blots 
were performed (Fig 3.14-3.16). This study shows that Giardia supernatant has a 
slight marginal effect on SGLT-1 expression suggesting that Giardia supernatant 
may not have any effect on this protein expression. This study also shows that 
Giardia supernatant has no effect on SGLT-1 translocation (Fig 3.14 A., 3.17 A., 3.18 
A.). However, some studies described biological process in which SGLT-1 activation 
by Giardia may rescue enterocytes from lipopolysaccharide (LPS)-induced epithelial 
cell apoptosis by enhancing glucose uptake (Buret, 2008, Yu et al., 2008, Yu et al., 
2006, Yu et al., 2005). Indeed, Yu et al showed that in a high glucose environment, 
Giardia induces the apical translocation of SGLT-1 transporters which leads to the 
inhibition of Giardia-induced apoptosis (Yu et al., 2008, Yu et al., 2006, Yu et al., 
2005). Yu et al also suggested that a soluble heat-labile protein fraction in Giardia 
trophozoites may trigger the SGLT-1-mediated host response observed in their 
study (Yu et al., 2008). In this study, the lack of translocation observed could be 
explained by an environment low in glucose. Moreover, in their study, Yu and 
collaborators incubated Giardia trophozoites either in a low glucose concentration 
environment or in a high glucose concentration environment to specifically 
investigate the effect on SGLT-1 transporter which was not the aim of this study. 
Yet, it may be interested to repeat the assay on SGLT-1 in a high glucose 
concentration environment to investigate further the findings of Yu et al. 
CFTR is a cAMP-activated channel responsible for the chloride secretion via 
an osmotic gradient (Murek et al., 2010). The effect of Giardia supernatant on CFTR 
expression and translocation was investigated following the same protocol as for 
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the study of AQP3 and SGLT-1. The influence of Giardia supernatant on CFTR 
expression could not be assessed due to the lack of reproducibility of the western 
blot assays for this protein (Appendix VI). CFTR is a heavy protein of approximately 
150 kDa, the use of pre-cast gels with a lower gradient than the ones used during 
this study may allow a better reproducibility of the assay. CFTR proteins show a 
similar translocation effect to AQP3 when incubated with Giardia supernatants with 
an early and more pronounced translocation effect induced by Giardia assemblage 
B (Fig 3.17-3.19). This translocation also appears to be dose-dependent as more 
CFTR proteins were observed at the periphery of intestinal cells with a 1:250 
dilution for Giardia supernatant. As for AQP3, the quantification of this 
translocation could not be evaluated and should be investigated either via confocal 
microscopy or flow cytometry as previously stated.  
These studies suggest that Giardia supernatant induces the translocation of 
both AQP3 and CFTR which are involved in intestinal water uptake and chloride 
secretion respectively (Zeuthen, 2010, Murek et al., 2010). This suggests that these 
two intestinal proteins may be involved in the changes in cell morphology and 
turgidity, and chloride secretion inhibition caused by Giardia supernatant.  
3.5/ Summary 
These studies show that Giardia trophozoites secrete factors affecting the 
host cells morphology and cell trafficking mechanisms. Giardia supernatant induces 
a disruption of the intestinal water uptake suggesting an implication of the 
intestinal water channels in this biological process. The translocation of AQP3 
observed indicates that AQP3 transporter may be involved in the decrease of cell 
turgidity observed, as AQP3 translocation occurs after one hour incubation and the 
first effects on morphology were observed after 8 hours incubation (Fig 3.4-3.9, 
3.11-3.13). The fact that GS supernatant appears to have a greater effect than WB 
supernatant on both intestinal cell size and AQP3 translocation suggests that AQP3 
may be involved in the loss of water occurring under treatment with assemblage B 
supernatant. Giardia assemblage A appeared to have a milder effect on both 
intestinal cell size and AQP3 translocation which suggests that assemblage A may 
have a lesser effect on intestinal water uptake. 
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A previous study on chloride secretion inhibition by Giardia supernatant 
realised in our laboratory suggests that CFTR might not be involved in the 
morphological changes as it was inhibited by Giardia supernatant (Chapter I, 
section 1.5.4, Fig 1.17-1.19). However, Giardia supernatant was shown to induce 
CFTR translocation after 1 hour which suggests that CFTR may be involved in some 
of the host cell disruptions caused by Giardia. In which of the different cellular 
disruptions caused by Giardia CFTR might be involved has yet to be investigated. 
These studies show that Giardia does secrete soluble factors inducing some 
disruptions in host cells via their interaction with intestinal transporters. Whether 
these soluble mediators are proteins or other solutes remains unanswered.  
Reproducing all the different assays performed in this study with Giardia 
supernatant boiled prior to incubation would be an easy way to determine if these 
effects are due to Giardia-released proteins or not. 
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4.1/ Introduction 
 As stated in Chapter I (section 1.5.2.3.), Giardia supernatant was shown to 
reduce intestinal chloride efflux and to inhibit CaCo-2 cells Isc suggesting that 
Giardia secretes mediators acting on intestinal cells functions (Al-Naimi et al, 
unpublished data). However, what kind of Giardia-secreted molecules are involved 
remains unknown and requires further investigation. Proteins are the most 
abundant cellular macromolecules and are involved in diverse cellular functions 
such as enzymatic reaction, transport of molecules across membranes or the 
conservation of the cellular cytoskeletal structure (Lodish et al., 2000). This suggests 
that the Giardia-secreted mediators involved in the cellular Isc inhibition may be 
proteins. Besides, only a few proteins were shown to be secreted or released by 
trophozoites upon interaction with intestinal cells; and a protein secretion profile 
for Giardia has yet to be determined (Cotton et al., 2014, Ringqvist et al., 2011, 
Ringqvist et al., 2008, Rodriguez-Fuentes et al., 2006).  
As stated in Chapter II and III, the in vitro growth of Giardia trophozoites 
requires the use of numerous components such as BSA, pancreatic and bile digests, 
B12 vitamin, and yeast extract (Chapter II, Table 2.1). Therefore, TYI-S-33 proteins 
may interfere in the investigation of Giardia-secreted proteins from trophozoites 
cultured in vitro. To verify this hypothesis, supernatants form Giardia culture were 
collected for both assemblage A and B and a SDS-PAGE assay was performed to 
compare protein profile for Giardia supernatant to TYI-S-33 (Fig 4.1). Both 
assemblage supernatant showed a similar secretion profile to TYI-S-33; a similar 
profile was also observed with a 1:10 dilution (Fig 4.1 B.). This indicates that TYI-S-
33 is too enriched in Giardia supernatant to use it directly from trophozoites in vitro 
culture. 
The aims of this study were: 
(i) To develop a method to obtain a supernatant as clear as possible from 
TYI-S-33 
(ii) To optimise this method prior to proteomics analysis of Giardia samples. 
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Fig 4. 1: Giardia supernatant from trophozoites culture is too enriched in TYI-S-33 
proteins. Parasites were chilled on ice for 15 min, and centrifuged 10 min at 3,000 rpm. 
Supernatants were collected and SDS-PAGE on 12% gels, using a SYPRO staining, were 
realised. A. Protein profile of undiluted supernatant B. Protein profile in 1:10 dilution. Data 
represents two independent experiments 
MW: Molecular weight.  
 
 Chapter IV 
References 
168 | P a g e  
4.2/ Pilot study to determine Giardia secretion profile 
4.2.1/ Giardia secretes proteins 
In order to obtain Giardia supernatants as clean as possible from TYI-S33 
proteins (Fig 4.1), Giardia trophozoites were collected from culture tube and 
washed three times with PBS. At first, trophozoites were incubated in PBS for 
approximately 2 hours after PBS washes. However, only a few protein bands were 
observed on SDS-PAGE gel, which were also present in the TYI-S-33 control (data 
not shown). This suggested that Giardia trophozoites were not releasing any 
proteins in the milieu when incubated in PBS. PBS is not a growth medium;  
therefore no nutrients were available for the trophozoites in this environment 
which may explain the lack of Giardia proteins in the supernatants. To counteract 
this effect, Giardia was incubated in a growth medium different from TYI-S-33 with 
no bovine or calf proteins. DMEM, a standard in vitro growth medium used to 
culture several cell lines, was used. DMEM was not supplemented with BSA no r FCS, 
only antibiotics were added to keep an axenic milieu. Parasites were incubated for 
up to 60 minutes with DMEM. Parasites were then collected and centrifuged to 
collect supernatant from DMEM incubation; BCA protein assay and SDS-PAGE were 
performed to verify the protein profile (Fig 4.2). A maximum of 45 minutes 
incubation was shown to give optimum protein concentration and profile on SDS-
PAGE gels as less debris were observed in the culture tubes (data not shown). 
Protein concentrations ranged between 0.655 and 1.339 μg/ml which confirmed 
that proteins were present in supernatants (Fig 4.2). Some TYI-S-33 proteins 
appeared to be still present in Giardia supernatant; however, Giardia-specific 
protein bands were also present on SDS-PAGE gel (Fig 4.2). Moreover, no bands 
were observed for non-supplemented DMEM which confirmed that trophozoites 
were incubated in a protein-free medium (Fig 4.2).  
 To obtain exploitable supernatant for the study of Giardia assemblage A and 
B secretion profiles, Giardia trophozoites had to be incubated in different 
conditions than their standard in vitro culture. Giardia-specific proteins were 
observed (Fig 4.2); however, these proteins may have been the products of death 
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Fig 4. 2: Giardia supernatant contains less TYI-S-33 proteins after 45 minutes incubation 
in non-supplemented DMEM. Parasites were chilled on ice for 15 min, washed 3 times in 
pre-warmed PBS, centrifuged 10 min at 3,000 rpm between each wash; and then were 
incubated in pre-warmed non-supplemented DMEM for 45 min. at 37°C. After 45 min 
incubation, parasites were chilled on ice for 5 min and centrifuged 10 min at 3,000 rpm. 
Supernatants were collected and SDS-PAGE on 12% gels, using a SYPRO staining, and BCA 
assay were performed. Protocol was repeated to confirm the results. A. First Giardia 
supernatant protein profile and protein concentration after incubation in DMEM. B. Repeat 
of incubation in DMEM, protein profile and concentration. Data represents two 
independent experiments. 
MW: Molecular weight; 2: TYI-S-33, 1:500 dilution; 3: GS supernatant; 4: WB supernatant; 
5: non-supplemented DMEM; 6: TYI-S-33, 1:100 dilution. 
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cell caused by the incubation in DMEM. A viability flow cytometry assay was 
performed on parasites to analyse the percentage of dead and living trophozoites 
during incubation in DMEM (Fig 4.3). Giardia trophozoites collected from standard 
growth condition were used as a control for living population. To compare Giardia 
trophozoites population incubated in DMEM with a dead population, trophozoites 
collected from Giardia culture were killed using 2 % Trigene, a disinfectant cleaner 
for laboratories applications, and used as a dead population control. Both controls 
of living and dead populations were represented by two gates: P2 and P3 
respectively (Fig 4.3). When incubated with DMEM, both Giardia assemblage A and 
B trophozoites population had a similar profile to trophozoites under standard 
conditions of growth; the percentage of living cells within the populations 
incubated in DMEM were of 97.44 % for assemblage B (GS isolate) and 97.62 % for 
assemblage A (WB isolate) (Fig 4.3). When 2 % trigene was added, the flow 
cytometry profile was completely different from the normal condition of growth 
with a diffused granularity compared to the living cells which had a low granularity 
(Fig 4.3). The percentage of parasites still alive in population resupsended in 2 % 
Trigene was less than 1 %. This confirmed that parasites were still alive after 45 
minutes incubation in DMEM. Moreover, it showed that proteins observed on SDS-
PAGE were more likely to be secreted by living parasites rather than by-products of 
dead cells (Fig 4.2). 
4.2.2/ Pilot mass spectrometry study on Giardia assemblage 
A and B secretion profile 
 SDS-PAGE and flow cytometry analyses asserted that Giardia secretes 
proteins (Fig 4.2 and 4.3). To determine the secretion profile for both assemblages, 
replicates for both assemblage A and B were prepared to run a mass spectrometry 
(MS) analysis. The MS analysis was performed by Prof Johnathan Wastling and Dr 
Dong Xia at the Institute of Infection and Global Health, from the University of 
Liverpool. Giardia trophozoites were incubated with DMEM for 45 minutes after 
three washes in PBS (as stated in Chapter II, section 2.1.1.2., Fig 2.2). At first, one 
replicate was prepared for each assemblage, BCA protein assay performed to 
estimate the amount of protein present in supernatant (Table 4.1). Only one  
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Table 4. 1: Giardia supernatant protein concentration before mass spectrometry analysis. 
Parasites were chilled on ice for 15 min, washed 3 times in pre-warmed PBS, centrifuged 10 
min at 3,000 rpm between each wash; and then were incubated in pre-warmed non-
supplemented DMEM for 45 min. at 37°C. After 45 min incubation, parasites were chilled 
on ice for 5 min and centrifuged 10 min at 3,000 rpm. BCA protein assays were performed 
before running MS analysis (either Orbitrap or QeXactive) on samples.  
 
 
 
 
 
 
Table 4. 2: Total amount of proteins obtained for Giardia replicates after Orbitrap and 
QeXactive MS analyses. After preparation of supernatants and pellets following protocol 
stated in chapter 2 (section 2.1.1.2.). Pellet samples were first resuspended in 25 mM Ambic. 
For all samples, proteins were denatured with 1% Rapigest™ in 25 mM Ambic, followed by 3 
x freeze-thaw cycles and 2 x 10 min sonication in water bath; then incubated at 80°C for 10 
min, reduced with 3 mM dithiothreitol at 60°C for 10 min. Proteins were alkylated with 9 mM 
iodoacetamide at room temperature for 30 min in the dark, then proteins were digested by 
adding a 50:1 protein:trypsin ratio at 37°C overnight. MS analysis was either performed via 
Orbitrap MS or QeXactive MS. Bioinformatics and statistical analyses were performed using 
Progenesis LC-MS software (v. 4.1), Mascot software and the online database: GiardiaDB. A. 
Total amount of proteins identified for both MS techniques.  B. Total amount of proteins in 
Giardia pellet and supernatant via the Orbitrap MS. C. Total amount of proteins identified in 
Giardia pellet and supernatant via QeXactive MS. 
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replicate per assemblage were sent to obtain a preliminary profile. Both pellet and 
supernatant were collected and run through an Orbitrap MS. Orbitrap is part of the 
linear ion trap (LTQ) MS family. A total amount of 442 proteins and 660 proteins 
were identified for assemblage B (GS) and assemblage A (WB) respectively (Table 
4.2 A.). For assemblage B (GS isolate), 357 proteins were identified in the pellet and 
222 were identified in the supernatant; as for assemblage A (WB isolate), 650 
proteins were identified in the pellet and 146 in the supernatant (Table 4.2 B.). For 
both assemblages, most of the proteins identified in the supernatant were also 
identified in the pellet; 137 and 136 proteins for GS and WB isolate respectively (Fig 
4.4). 85 proteins were isolated and identified in GS supernatant and only 10 were 
identified in WB supernatant.  
Although this dataset showed an interesting preliminary secretion profile for 
both assemblages (data not shown), only one set of replicates was used and the 
assay needed to be reproduced. Two more replicates per assemblages were 
prepared and sent for analysis (Table 4.1). MS techniques and apparatus are 
constantly improving and changing. By the time the two new replicates were sent 
for analysis, a new mass spectrometer was developed and used at the Institute of 
Infection and Global Health: the QeXactive MS. The QeXactive MS is a hybrid mass 
spectrometer combining a quadrupole mass filter and an Orbitrap analyser; it is a 
very sensitive LC-MS/MS technique which allows the identification of more proteins 
than the Orbitrap. By using QeXactive MS, the number of proteins identified was 
increased by approximately two fold compared to the Orbitrap dataset. Indeed, 910 
proteins and 1025 proteins were identified in GS and WB isolates respectively 
(Table 4.2 A.). In GS isolate, 878 proteins were identified in pellet and 677 in 
supernatant; in WB isolate, 942 and 804 proteins were identified in pellet and 
supernatant respectively (Table 4.2 C.). A lot more proteins were identified in both 
pellet and supernatant for both assemblages with QeXactive MS; 645 proteins for 
GS isolate and 721 proteins for WB isolate (Fig 4.5). Only 32 proteins were isolated 
only in GS supernatant; which is approximately two fold less than with the Orbitrap 
(Fig 4.4). Interestingly, 83 proteins were identified only in WB supernatant with  
QeXactive (Fig 4.5). All these results indicated that QeXactive MS was a very 
sensitive technique compared to the Orbitrap MS. For both dataset, proteins  
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Fig 4. 4: Common proteins between pellet and supernatant identified via Orbitrap MS.  
A. 137 proteins were identified in both supernatant and pellet for GS isolate, 85 and 220 
were identified only in supernatant and pellet respectively.  B. 136 proteins were identified 
in both supernatant and pellet for WB isolate, 10 and 514 were identified only in 
supernatant and pellet respectively.  
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Fig 4. 5: Common proteins between pellet and supernatant identified via QeXactive MS. 
A. 645 proteins were identified in both supernatant and pellet for GS isolate, 32 and 233 
were identified only in supernatant and pellet respectively. B. 721 proteins were identified 
in both supernatant and pellet for WB isolate, 83 and 221 were identified only in 
supernatant and pellet respectively.  
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 present in both pellet and supernatant were identified, and a supernatant : pellet 
ratio was calculated to determine which proteins were more likely to be secreted or 
released by the trophozoites. Proteins were then ranked from the highest ratio to 
the lowest which showed a high variability in ranking between the datasets for both 
assemblages (Data not shown). For both Orbitrap and QeXactive datasets, proteins 
only present in supernatant were also ranked from the most abundant to the less 
abundant. Surprisingly, in these datasets, not a single protein was found in common 
in the two dataset, and this for each Giardia assemblage (Data not shown). Some 
proteins that were only identified in Orbitrap supernatant dataset were found to be 
identified in both pellet and superntant via QeXactive MS. This was explained by 
the high sensitiity of the QeXactive MS. Due to this high variability between dataset 
and to verify the correlation between the two datasets and the two replicates 
within QeXactive dataset, a Spearman correlation test was also performed to 
compare the different protein expression profiles  (Fig 4.6). For both assemblages, 
Qexactive datasets appeared to be highly correlated indicating that data from both 
replicates were exploitable together (Fig 4.6). However, the Orbitrap dataset for the 
supernatant samples appeared to be highly variable and poorly correlated to the 
pellet replicate Orbitrap dataset. Therefore, for both assemblages, the two datasets 
were also poorly correlated which demonstrated that the datasets were not 
exploitable together and that the protocol had to be optimised.  
4.3/ Optimisation of protocol for the preparation of 
Giardia supernatant prior to mass spectrometry 
analysis 
Due to the low correlation between the previous datasets and the high 
variability in protein rankings, three new replicates per Giardia assemblage had to 
be prepared and sent to the Institute of Infection and Global Health. To ensure that 
the best would be obtained, each replicate was passed through both the Orbitrap 
MS and QeXactive MS. However, prior to run the new MS analysis, the preparation 
of supernatant had to be optimised, and a new step was added to concentrate the 
proteins present in supernatants. 
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Fig 4. 6: Protein expression profile for Giardia assemblage A and B. Both GS and WB pellet 
(P) and supernatant (S) replicates were analysed via Orbitrap and QeXactive MS. Orbitrap 
supernatant datasets show a variation in protein expression profile compared to the pellet 
Orbitrap datasets and also the QeXactive datasets for both assemblage. The correlation of 
these two datasets was tested via Spearman correlation tests (Appendix VII). A. Protein 
expression profile for GS isolate pellet and supernatant replicates. B. Protein expression 
profile for WB isolate pellet and supernatant replicates. Data represents one independent 
experiment for Orbitrap dataset and two independent experiments for QeXactive dataset. 
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Two different approaches (i) Trichloroacetic acid (TCA) precipitation and (ii) 
Vivaspin columns with a 3,000 molecular weight cutt off (MWCO) were chosen and 
compared. Old samples stored at - 20°C were used to test which techniques was the 
best option for this study, which explained the low protein concentrations prior to 
precipitate proteins (Table 4.3). BCA protein assays were also performed after the 
protein concentration or precipitation in order to verify the final protein 
concentration in Giardia supernatants (Table 4.3). TCA precipitation was shown to 
give very low protein concentrations which suggested that this was not the best 
method to use in this study. Vivaspin columns were then the approach taken to 
optimise the protein concentration within Giardia supernatants. An initial protocol 
of (i) an initial centrifugation at 12,000 rcf for 30 minutes to remove DMEM; (ii) two 
centrifugations with 25 mM Ammnonium bicarbonate (Ambic) at 12,000 rcf for 30 
min to remove DMEM; (iii) one hour incubation with 25 mM Ambic and 1 % 
Rapigest™ which is a reagent used to solubilise proteins making them more 
susceptible to enzymatic cleavage, at room temperature; (iv) and a final 
centrifugation at 3,000 rcf for 2 minutes to recover proteins (Fig 4.7). However, 
protein concentrations were lower than the initial concentrations, with a variation 
in concentration ranging from 1.5- to 5-fold (Table 4.3). Alternatively, a similar 
Vivaspin protocol was also performed but with an extra centrifugation at 12,000 rcf 
for 30 minutes, and incubation with 25 mM Ambic only. Final protein 
concentrations were also lower than the initial concentrations; but only by 1.65-
fold (Table 4.3).  
The fact that protein concentrations were lower after protein precipitation 
suggested that proteins may be degrading during incubation at room temperature. 
An SDS-PAGE electrophoresis was performed on samples concentrated with and 
without 1 % Rapigest™ to verify protein profiles within samples (Fig 4.8). BSA was 
used as a control of the technique as proteins with high molecular weights are 
present in high quantity. The SDS-PAGE showed that proteins were not degraded 
after one hour incubation at room temperature (Fig 4.8). It also showed that 
incubated with 25 mM Ambic only had a better protein profile as they appeared 
more concentrated on the gel (Fig 4.7). This indicated that the use of 25 mM Ambic 
without 1 % Rapigest™ allowed a better concentration of the proteins present in  
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Table 4. 3: Vivaspin columns give supernatant samples more concentrated in proteins 
than TCA precipitation. Parasites were chilled on ice for 15 min, washed 3 times in pre-
warmed PBS, centrifuged 10 min at 3,000 rpm between each wash; and then were 
incubated in pre-warmed non-supplemented DMEM for 45 min. at 37°C. After 45 min 
incubation, parasites were chilled on ice for 5 min and centrifuged 10 min at 3,000 rpm. 
BCA protein assays were performed before and after protein concentration. 
 
 
 
 
 
 
 
 
Fig 4. 7: Initial Vivaspin column protocol with 25mM Ambic / 1 % Rapigest™. Parasites 
were chilled on ice for 15 min, washed 3 times in pre-warmed PBS, centrifuged 10 min at 
3,000 rpm between each wash; and then were incubated in pre-warmed non-
supplemented DMEM for 45 min. at 37°C. After 45 min incubation, parasites were chilled 
on ice for 5 min and centrifuged 10 min at 3,000 rpm. Supernatants were collected and 
protein concentration within samples was assessed by BCA assay. Proteins were 
concentrated in Vivaspin columns. First, samples were spun at 12,000 rcf for 30 min. 25 
mM Ambic was added and samples were centrifuged for 30 min at 12,000 rcf twice. 
Samples were incubated at room temperature with 50 μl 25mM Ambic/1 % Rapigest™ 
solution for one hour. A final centrifugation was done for 2 min at 3,000 rcf. BCA and SDS-
PAGE were performed to determine protein concentration and profile. 
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the samples as suggested by the BCA protein assay performed previously (Table 
4.3). According to these results, a final protocol of (i) an initial centrifugation at 
12,000 rcf for 30 minutes to remove DMEM; (ii) 3 centrifugations at 12,000 rcf for  
30 minutes; (iii) one hour incubation with 25 mM Ambic at room temperature; and 
(iv) a protein recovery centrifugation at 3,000 rcf for 2 minutes was set (Fig 4.9).  
Once this protocol was established, Giardia trophozoites were incubated in 
non-supplemented DMEM as stated in Chapter II (section 2.1.1.2., Fig 2.2). Three 
replicates were prepared with at least two passages between supernatant 
preparations; pellet samples were stored at - 20°C until shipment to Liverpool for 
MS analysis. Protein concentrations in Giardia supernatant were assessed via BCA 
protein assay (Fig 4.10 B.). Proteins present in supernatants were concentrated via 
the final Vivaspin column protocol (Fig 4.9) and a final BCA protein assay was 
performed on concentrated samples (Fig 4.10 B.). An SDS-PAGE electrophoresis was 
performed on samples after protein concentration to verify their protein profiles 
(Fig 4.10 A.). According to the BCA protein assays and the SDS-PAGE gel, only two 
replicates were exploitable for MS analysis GS replicate 1 and WB repl icate 2; 
therefore two more replicates per assemblage had to be prepared (Fig 4.10).  
The fact that DMEM containing phenol-red was used for the incubation with 
Giardia trophozoites may have an effect on the supernatant concentrations. 
Indeed, phenol red may skew the BCA protein assay results. Moreover, some 
phenol red was still visible after protein concentration via Vivaspin columns which 
suggested that some DMEM was still present in samples and may interfere with the 
proteins recovery. To counteract that effect, phenol red-free DMEM was used to 
prepare the last replicates. Because no phenol red was present in these samples 
and to reduce the time at room temperature for the samples, two centrifugations in 
25 mM Ambic at 12,000 rcf for 30 min were done instead of three previously set 
prior to the protein incubation at room temperature (Fig 4.9). As stated before, a 
BCA protein assay was performed before and after the protein concentration in 
Vivaspin columns, and a SDS-PAGE electrophoresis was also performed to verify the 
protein profile (Fig 4.11). The SDS-PAGE gel showed a good profile for GS replicates 
with a lot of bands; However, WB isolate showed less bands which appeared 
weaker than the one observed for GS replicates, particularly for the replicate WB 2  
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Fig 4. 8: Incubation with 25 mM Ambic without 1 % Rapigest™ gives a better protein 
profile for Giardia supernatant. Parasites were chilled on ice for 15 min, washed 3 times in 
pre-warmed PBS, centrifuged 10 min at 3,000 rpm between each wash; and then were 
incubated in pre-warmed non-supplemented DMEM for 45 min. at 37°C. After 45 min 
incubation, parasites were chilled on ice for 5 min and centrifuged 10 min at 3,000 rpm. 
Supernatants were collected and protein concentration within samples was assessed by 
BCA assay. Proteins were concentrated using Vivaspin columns. Lane 5 and 8: 2 x 30 min 
centrifugation with 25 mM Ambic, protein concentration with 1 % Rapigest™/25 mM 
Ambic. Lane 6 and 9: 3 x 30 min centrifugation with 25 mM Ambic, protein concentration 
with 25 mM Ambic. Before = before protein concentration via Vivaspin columns, After = 
after protein concentration using Vivaspin columns. 
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Fig 4. 9: Final protocol for the protein recovery of Giardia supernatant samples on 
Vivaspin columns. Parasites were chilled on ice for 15 min, washed 3 times in pre-warmed 
PBS, centrifuged 10 min at 3,000 rpm between each wash; and then were incubated in pre -
warmed non-supplemented DMEM for 45 min. at 37°C. After 45 min incubation, parasites 
were chilled on ice for 5 min and centrifuged 10 min at 3,000 rpm. Supernatants were 
collected and protein concentration within samples was assessed by BCA assay. 
Supernatants were transferred in Vivaspin columns with a 3,000 MWCO and centrifuged at 
12,000 rcf for 30 min. Proteins were washed up to 3 times with 25 mM Ambic (depending 
on presence of phenol red within DMEM) and centrifuged at 12,000 rcf for 30 min. Then, 
50 μl of 25 mM Ambic were added and samples were left at room temperature for one 
hour; final spin at 3,000 rcf for 2 min to recover proteins. BCA assay and SDS-PAGE were 
performed to assess protein level and protein degradation prior to proteomic assay.  
 
Fig 4. 10: Only WB 2 and GS 1 replicates are exploitable for mass spectrometry. Parasites 
were chilled on ice for 15 min, washed 3 times in pre-warmed PBS, centrifuged 10 min at 
3,000 rpm between each wash; and then were incubated in pre-warmed non-
supplemented DMEM for 45 min. at 37°C. After 45 min incubation, parasites were chilled 
on ice for 5 min and centrifuged 10 min at 3,000 rpm. Supernatants were collected and 
protein concentration within samples was assessed by BCA assay. Proteins were 
concentrated via Vivaspin columns. Supernatants were spun at 12,000 rcf for 30 min. 25 
mM Ambic was added and samples were centrifuged for 30 min at 12,000 rcf , 3 times. 
Samples were incubated at room temperature with 50 μl 25mM Ambic solution for one 
hour. A final centrifugation was done for 2 min at 3,000 rcf.  A. SDS-PAGE on 4-12% gel was 
performed to see the protein profile after protein concentration for the  3 replicates for 
each Giardia isolate. Lane 1: MW, 2: WB 1, 3: WB2, 4: WB 3, 5: GS 1, 6: GS 2, 7: GS. 3 B. BCA 
assays were performed before and after protein concentration on Vivaspin columns.  
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(Fig 4.11 A.). The BCA protein assays showed a better protein recovery than 
previously (Fig 4.11 B.). Even if the protein concentrations were lower than before 
the protein recovery, according to the SDS-PAGE and BCA assay, enough proteins 
were present in the replicates for MS analysis. For each Giardia assemblages, three 
replicates were finally prepared and were sent to the Institute of Infection and  
Global Health to be analysed via Orbitrap and QeXactive analyses (Table 4.4).  
 The same MS protocol as for the first MS analysis was followed in this 
analysis (as stated in Chapter II, section 2.4.2). For both MS techniques, peptides 
isolated were matched to Giardia proteins via the online database GiardiaDB. A 
total of 1,151 and 1,542 proteins were identified for assemblage B (GS isolate) via 
Orbitrap MS and QeXactive MS analyses respectively; which represent an increase 
in protein identified of approximately 1.5- to 2.5-fold compared to the first datasets 
(Table 4.5 A.). For assemblage A (WB isolate), a total of 1,219 and 1,641 proteins 
were identified via Orbitrap and QeXactive MS analysis respectively; which 
represent an increase in proteins of approximately 2-fold compared to the previous 
datasets (Table 4.5 A.). For assemblage B, 1,100 proteins were identified in pellet 
samples and 689 in the supernatant samples via Orbitrap MS analysis which 
represents a 3-fold increase in proteins compared to the first Orbitrap dataset 
(Table 4.2 B., 4.5 B.). The new QeXactive analysis showed a lesser increase, 1.5-fold, 
with 1,515 proteins identified in pellet samples and 973 in supernatants (Table 4.5 
C.). For assemblage A, the new Obitrap MS dataset showed an increase of 
approximately 2- and 3-fold for pellet and supernatant samples respectively, with 
1,184 proteins identified in pellets and 461 in supernatants (Table 4.5 B.). The new 
QeXactive dataset showed a similar increase in protein identification to the new 
Orbitrap, 1,617 proteins were identified in pellet samples and 514 in supernatant 
samples (Table 4.5 C.). Interestingly, these new datasets showed that less proteins 
were present in assemblage A supernatant than in assemblage B supernatant; 
which was also the case within the previous MS analysis (Table 4.2 and 4.5). A lot 
more proteins were identified via both MS technique which suggested that the new  
replicates were of better quality than the first prepared. 
Even if these datasets appeared to be exploitable and prior to any secretion 
profile analysis, they were compared to the first MS datasets by Spearman  
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Fig 4. 11: Replicates, incubated in phenol red-free non-supplemented DMEM, are good 
for MS analysis. Parasites were chilled on ice for 15 min, washed 3 times in pre-warmed 
PBS, centrifuged 10 min at 3,000 rpm between each wash; and then were incubated in pre -
warmed non-supplemented, phenol red-free DMEM for 45 min. at 37°C. After 45 min 
incubation, parasites were chilled on ice for 5 min and centrifuged 10 min at 3,000 rpm. 
Supernatants were collected and protein concentration within samples was assessed by 
BCA assay. Proteins were concentrated in Vivaspin columns. First, samples were spun at 
12,000 rcf for 30 min. 25 mM Ambic was added and samples were centrifuged for 30 min at 
12,000 rcf, twice. Samples were incubated at room temperature with 50 μl 25mM Ambic 
solution for one hour. A final centrifugation was done for 2 min at 3,000 rcf. A. SDS-PAGE 
on 4-12% gel was performed to see the protein profile after protein concentration for the 2 
new replicates for each Giardia isolate. Lane 1: MW, 2: WB 1, 3: WB2, 4:  GS 1, 5: GS 2. B.  
BCA assays were performed before and after protein concentration on Vivaspin columns. 
 
 
 
 
Table 4. 4:  Giardia supernatant protein concentration before mass spectrometry 
analysis. GS 1 and WB 1 represent samples incubated in DMEM containing red phenol (GS 
1 and WB2 respectively on Fig 4.7). For both GS and WB, replicates 2 and 3 represent 
samples incubated in red phenol-free DMEM (Replicate 1 and 2 respectively on Fig 4.8).  
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Table 4. 5: Total number of proteins obtained for Giardia replicates after Orbitrap MS 
and QeXactive MS analyses. After preparation of supernatants and pellets following 
protocol stated in chapter 2 (section 2.1.1.2.). Pellet samples were first resuspended in 25 
mM Ambic. For all samples, proteins were denatured with 1% Rapigest™ in 25 mM Ambic, 
followed by 3 x freeze-thaw cycles and 2 x 10 min sonication in water bath; then incubated 
at 80°C for 10 min, reduced with 3 mM dithiothreitol at 60°C for 10 min. Proteins were 
alkylated with 9 mM iodoacetamide at room temperature for 30 min in the dark, then 
proteins were digested by adding a 50:1 protein:trypsin ratio at 37°C overnight. MS 
analysis was either performed via Orbitrap MS or QeXactive MS. Bioinformatics and 
statistical analyses were performed using Progenesis LC-MS software (v. 4.1), Mascot 
software and the online database GiardiaDB. A. Total amount of proteins identified for 
both MS techniques. B. Total amount of proteins in Giardia pellet and supernatant via the 
Orbitrap MS. C. Total amount of proteins identified in Giardia pellet and supernatant via 
QeXactive MS. Data represents three independent experiments. 
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correlation test. This test showed that the two datasets were poorly correlated and 
could not be exploited together to investigate Giardia trophozoites secretion 
profile. As for the previous dataset, the different datasets were compared via a 
Spearman correlation test (Fig 4.12). The previous and new datasets were shown to 
be poorly correlated. The new orbitrap datasets showed a high correlation within 
assemblages and between them. The QeXactive datasets were also highly 
correlated (Fig 4.12). This suggests that the protein datasets obtained from the new 
Giardia replicates were exploitable for the study of Giardia protein secretion profile 
but not the first sets of data which were excluded from the analysis. The new 
Orbitrap and QeXactive datasets were however analysed separately. The fact that  
they had a higher correlation between techniques than the first datasets but high 
enough may have skew the analysis if the datasets were merged. For both dataset, 
proteins most likely to be secreted were identified and then data were merged and 
compared to verify analysis (Chapter V). 
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Fig 4. 12: Protein expression profile for Giardia assemblage A and B. Both GS and WB 
pellet (P) and supernatant (S) replicates were analysed via Orbitrap and QeXactive MS. 
Supernatant protein expression profile are similar to each other within each assemblage, so 
are pellet protein expression profiles. The correlation of these four new datasets was tested 
via Spearman correlation tests (Appendix VIII). A. Protein expression profile for GS isolate 
pellet and supernatant replicates. B. Protein expression profile for WB isolate pellet and 
supernatant replicates. Data represents three biological replicates. 
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Quantitative identification of 
the most abundant Giardia 
trophozoite-secreted proteins. 
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Glossary 
Gene ontology: is the representation of a given gene and its product. The gene 
ontology covers three domains: 
  Cellular component which is the protein location in the cell 
or in the extracellular environment 
 Molecular function which is the elemental activities of the 
gene product a molecular level, e.g.: catalysis 
 Biological process which represents the sets of event with a 
beginning and an end that are pertinent to the functioning of 
integrated living units such as cell, tissues, organs and 
organisms. 
Lineage-specific protein: In this study, proteins were considered lineage-specific 
when no orthologs were identified in either assemblage A (WB and DH isolates) or B 
(GS isolate). 
Orbitrap MS: Ion trap analyser trapping ions in an orbital motion around the 
spindle. It is part of the LTQ MS family. 
QeXactive MS: Hybrid MS which combines a quadrupole mass filter and an Orbitrap 
analyser. 
Ratioed proteins: proteins identified in both pellet and supernatant for which a 
supernatant: pellet ratio was obtained. 
Signal peptide: Short peptide, 5 to 30 AAs long, present at the N-terminus of most 
of the newly synthetized proteins that are destined towards secretory pathways 
(Blobel and Dobberstein, 1975). 
Transmembrane domain: any three-dimensional protein structure that is 
thermodynamically stable in a membrane. Most TM are single α helixes of usually 
20 AAs (Sharpe et al., 2010). 
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5.1/ Introduction 
Proteins are the most abundant of the cellular macromolecules. They are 
involved in many cellular functions such as enzymatic reaction, transport of 
molecules across membranes and the conservation of cellular cytoskeletal 
structures (Lodish et al., 2000). The proteome, which represents the cell’s 
repertoire of proteins, is the final product of genome expression and comprises all 
the proteins present in the cell at a particular time. The copy numbers of individual 
proteins can highly vary within a cell; from less than 20,000 per cell to 100 million 
copies. Most of the abundant proteins are found in every eukaryotic cell type 
suggesting a specific housekeeping function for these abundant proteins in all 
eukaryotic cells (Brown, 2002). 
Proteomics attempts to study biological processes by the systematic analysis 
of the proteins expressed in cells, tissues, organisms or sub-cellular fractions under 
a given set of conditions at a specific time point (Steuart, 2010, Aebersold and 
Goodlett, 2001). Tools for proteomics have been available since 1970; however, its 
true potential has only been shown within the last decade. In particular, the 
advances made in genomics and computational biology have permitted to develop 
and explore in depth proteomes (Steuart, 2010, Aebersold and Mann, 2003). The 
different techniques used in proteomics concentrate on separating proteins and 
then on identifying them. Thanks to its ability to detect and identify individual 
proteins from whole cells, proteomics has allowed the investigation of pathogenic 
organisms such as protozoan pathogens (Wastling et al., 2009). Indeed, proteomics 
can be used to identify key proteins within organisms providing insight for 
taxonomy, cell biology, pathology, host-pathogen interactions, secretion profile and 
towards the identification of potential new drugs/targets.  
Most of the proteomic studies so far reported using Giardia were 
undertaken in trophozoites undergoing encystation (Wampfler et al., 2014, Faso et 
al., 2013, Lingdan et al., 2012). Only a few studies have focused on proteins 
secreted by Giardia and their role in the host-pathogen interaction (Table 5.1) 
(Cotton et al., 2014, Ringqvist et al., 2008, Roxstrom-Lindquist et al., 2006). These 
studies were focused on parasite interaction with intestinal cell lines. No studies 
 Chapt r V 
References 
191 | P a g e  
have yet attempted to quantify proteins which are the product of steady state 
secretion by healthy, growing Giardia trophozoites and which were hypothesized as 
the primary mediators of giardiasis pathology in this analysis. 
The aims of this study were: 
I. To identify, to the limit of existing technology, the proteins expressed 
by populations of healthy, growing human infective Giardia 
trophozoites  
II. To further identify which of these proteins are released by healthy 
growing populations of human infective Giardia trophozoites 
III. To provide quantitation or the relative abundance and strain specific 
expression of trophozoite proteins from two human infective 
assemblages. 
IV. To provide quantitation of the relative abundance of retained and 
released proteins for both assemblages. 
V. To evaluate the specific enrichment of released proteins in order to 
describe which are secreted by trophozoites of each assemblage. 
VI. To compare the secreted proteins of each assemblage to identify 
secreted proteins which are conserved in both assemblages and 
secreted proteins which are assemblage-specific. 
Briefly, the genome reference strain for each of the human infective Giardia 
assemblages was cultured, WB for assemblage A and GS for assemblage B. Giardia 
trophozoites were taken from cultures under standard conditions and harvested 
during the midlog phase of their growth curves. Trophozoites were washed 3x in 
PBS and then incubated in non-supplemented DMEM for 45 minutes at 37°C. After 
incubation, trophozoites and supernatant were separated by centrifugation; and 
both trophozoite pellet and supernatant were harvested. Supernatants and pellets 
were sent to the Institute of Infection and Global Health at the University of 
Liverpool for mass spectrometry analysis. Proteins contained in supernatant were 
concentrated in Vivaspin columns with 25 mM Ambic. Proteins were digested and 
passed through the Orbitrap MS and the QeXactive MS. Once samples had run 
through both Orbitrap MS and Qexactive MS, and peptides matched to their 
proteins on GiardiaDB.org, abundances were normalised against the reference run  
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by Progenesis LC-MS which highlights differences in protein expression between 
control and treated samples with support from statistical analysis calculated by 
Progenesis LC-MS software (Jackson et al., 2014). For a more reliable abundance 
not influenced by the size of proteins, an “intensity based absolute quantification” 
(iBAQ) number which represents the number of theoretically observable peptides 
in a protein based on an in silico digestion was determined (Schwanhausser et al., 
2011). The average normalised abundance was then divided by the iBAQ values 
giving the Expression-iBAQ and datasets were then further analysed 
bioinformatically.  
5.2/ Giardia trophozoite proteome 
5.2.1/ QeXactive MS is more sensitive than Orbitrap MS 
 The results obtained from GS pellet (P), GS supernatant (SP), WB P, WB SP 
datasets using two distinct proteomics systems were compared. For the Orbit rap 
MS system 1,100 pellet and 690 supernatant proteins were identified in GS and a 
total of 1,184 pellet and 461 supernatant proteins in WB. Furthermore, 639 GS 
proteins were identified in both pellet and supernatant, 51 only in supernatant and 
461 only in pellet giving a total of 1,151 GS proteins identified (Fig 5.1 A.). Similarly 
426 WB proteins were present in both pellet and supernatant, 35 only in 
supernatant and 758 proteins only in pellet for a total of 1,219 WB proteins 
identified via Orbitrap MS (Fig 5.1 B.). 
For QeXactive MS, 1,515 GS pellet proteins and 973 GS supernatant proteins 
were identified compared with 1,617 WB pellet and 514 WB supernatant proteins 
(Fig 5.2). Thus, both strains gave comparable and consistent results by both 
techniques with the sensitivity of detection being roughly 1.5 times greater for 
QeXactive MS and a range of detection which spanned 5 logs. Almost all of the 
proteins identified by use of the Orbitrap MS were also identified by the QeXactive 
MS, and in total the two techniques identified 1,587 GS proteins and 1,690 WB 
proteins (Fig 5.3). This represents over a quarter of the open reading frames  (ORFs) 
predicted by the respective genomes in this single life-cycle stage under this steady 
state set of conditions (Jerlstrom-Hultqvist et al., 2010). 
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Fig 5. 1: Pellet and supernatant common proteins identified via Orbitrap MS. A. 639 
proteins were identified in both supernatant and pellet for GS isolate, 51 and 461 were 
identified only in supernatant and pellet respectively. B. 426 proteins were identified in 
both pellet and supernatant for WB isolate, 35 and 758 proteins were present only in 
supernatant and pellet respectively. Data represents three biological replicates 
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Fig 5. 2: Pellet and supernatant common proteins identified via QeXactive MS. A. 946 
proteins were identified in both supernatant and pellet for GS isolate, 27 and 569 were 
identified only in supernatant and pellet respectively. B. 490 proteins were identified in 
both pellet and supernatant for WB isolate, 24 and 1,127 proteins were present only in 
supernatant and pellet respectively. Data represents three biological replicates.  
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Fig 5. 3: Orbitrap and QeXactive common proteins for each Giardia isolate. A. 1,587 
proteins were identified in total via both MS techniques for GS isolate. 1,106 proteins were 
present in both datasets, 42 and 439 were identified only via Orbitrap Ms and QeXactive 
respectively. B. A total of 1,690 proteins were identified for WB isolate via both MS 
techniques. 1,170 proteins were present in both dataset, 44 and 471 proteins were 
identified only in Orbitrap MS dataset and QeXactive Ms datasets respectively. 
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In total 1,542 GS proteins and 1,641 WB proteins were identified by 
QeXactive MS (Fig 5.3). Of these, 946 GS proteins were present in both pellet and 
supernatant, 45 GS proteins in supernatant only and 436 GS proteins in pellet only. 
By comparison 490 WB proteins identified in supernatant and pellet, 24 WB 
proteins in supernatant only and1, 127 WB proteins in pellet only. So, although both 
assemblages showed similar numbers of proteins identified overall, a greater 
proportion of proteins were identified in the supernatant of GS than of WB. 
All these results suggest that QeXactive MS is a technique more sensitive 
than Orbitrap MS. Therefore, for the rest of the study, the data were presented 
according to their QeXactive supernatant abundance for a simplified and clear 
organisation of the results.  
5.2.2/ Assemblage-specific expression of trophozoite proteins 
Results showed that roughly 61 % of GS and WB proteins identified were 
functionally or structurally annotated in the genomic databases. Between 36 and 
37% of proteins were annotated as hypothetical and only 2-3 % of annotated 
proteins were found to be specific to each strain (Fig 5.4 A., 5.5 A.). Most proteins 
identified were annotated proteins with syntenic orthologs in both assemblages 
which represent the single best hits in reciprocal blasts of the two genomic 
databases and occupy equivalent genomic locations. For the four datasets, proteins 
were matched to their orthologs in Giardia assemblage A (WB and DH isolates) and 
B (GS isolate) using the online database GiardiaDB (as stated in Chapter II, section 
2.4, Fig 2.4 A and 2.5). Their signal peptide (SignalP) and transmembrane domain 
(TM) and MW were also obtained from GiardiaDB. The orthologs of roughly three 
quarters of the proteins were found in the proteomes of both strains. 
For annotated proteins, over 85% of orthologs were identified in both 
assemblages. For hypothetical proteins this fell significantly to approximately 75%. 1 
% of GS and 3% of WB hypothetical proteins were identified only for their own 
assemblage. Less than 1% of proteins identified in GS datasets recognised orthologs 
in sub-assemblage A2 (DH isolate) genome but not in the WB isolate (Fig 5.4 B., 5. 5 
B.).  
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Fig 5. 4: Proportion of GS isolate hypothetical, lineage-specific and annotated proteins 
shared with assemblage A (WB and DH isolates). Protein orthologs were defined using 
gene synteny information on GiardiaDB.org. A. 1,587 proteins have been identified in total 
in assemblage B dataset via both MS techniques, 585 proteins (37 %) are uncharacterised 
hypothetical proteins (including some lineage-specific proteins), 974 (61 %) are annotated 
proteins that are orthologous to assemblage A, and 29 (2 %) are annotated assemblage B-
specific proteins. B. 1,323 proteins are also identified in WB isolate dataset as orthologs, 
218 proteins have known orthologs which were either not included in the proteomics 
dataset cut-off or were not identified, 11 proteins have assemblage A2 orthologs known, 
and 35 are assemblage B-specific proteins. Data represent three biological replicates.  
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Fig 5. 5: Proportion of WB isolate hypothetical, lineage-specific and annotated proteins 
shared with assemblage B (GS isolate). Protein orthologs were defined using gene synteny 
information on GiardiaDB.org. A. 1,690 proteins have been identified in total in assemblage 
A dataset via both MS techniques, 602 proteins (36 %) are uncharacteri sed hypothetical 
proteins (including some lineage-specific proteins,) 1,033 (61 %) are annotated proteins 
that are orthologous to assemblage A, and 55 (2 %) are annotated assemblage A-specific 
proteins. B. 1,326 proteins have also been identified in GS isolate dataset as orthologs, 290 
proteins have known orthologs which were not included in the proteomics dataset cut-off 
or were not identified, and 74 proteins are assemblage A-specific proteins. Data represents 
three biological replicates. 
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Comparison between the WB and GS proteomes identified VSPs, high cysteine 
membrane proteins (HCMPs), NEK kinases, and hypothetical proteins as the major 
classes of lineage-specific proteins (Tables 5.2 and 5.3). A few of the GS isolate 
proteins were also shown to have an ortholog in DH isolate (sub-assemblage A2) 
but not in WB isolate (Table 5.2). 
5.3/ Proteins secreted by healthy trophozoites during 
logarithmic growth.  
Others have observed high levels of abundant cytoplasmic house-keeping 
proteins released into media by cultured trophozoites (Skarin et al., 2011, Ringqvist 
et al., 2008), whether this represents an inherent leakiness, or subpatent levels of 
cell death in cultures is not clear but for this study it was reasoned that although 
the levels of such proteins could be high, the levels could never be enriched in the 
supernatants compared with the levels present in the cells. Thus, by comparing 
normalised concentrations for each protein found in the supernatant with that 
found in the cell, it was reasoned that the highest level of enrichment would be of 
those that were truly secreted and those expressed on the external face of the 
parasite surface and then clipped or shed. It was realised, though, that very soluble 
highly abundant cytosolic proteins would be present at higher levels than insoluble 
cytoskeletal proteins or proteins associated with internal membrane systems, that 
quantitation was likely to be less robust for proteins expressed at low 
concentrations which might limit the identification of proteins secreted at very low 
levels and that some biases might exist to make some proteins more readily 
detectable than others. 
To evaluate supernatant enrichment, proteins identified in the SP datasets 
were gathered and compared to their concentration in the pellet to provide a ratio 
using the following formula:
𝑆𝑃 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛
𝑃 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛
 . These proteins were then ranked from 
highest to lowest ratio and an arbitrary cut-off invoked such that the top 50 were 
considered as the most likely to be secreted. Proteins identified only in SP were also 
included in the analysis as most likely to be secreted. All the proteins selected as “of 
interest” were ranked according to their SP expression from most to least abundant 
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to obtain a quantitative secretion profile for each isolate and this was performed 
for each MS technique. Orbitrap and QeXactive secretion profile datasets were 
compared within isolate. Proteins were considered as most likely secreted when 
identified as such by QeXactive MS and confirmed by Orbitrap MS. The different 
secretion profiles were also compared between isolates to look for commonalities 
and determine which proteins may be “conserved” rather than “strain-specific” 
secreted factors.  
The results showed a set of 15 proteins that were identified in both isolates 
by both techniques (Table 5.4). One protein was identified as annotated in GS 
isolate and hypothetical in WB isolate (GL50581_4180 Tenascin, GL50803_113038 
Hypothetical protein). Apart from this protein, 11 proteins were annotated and 
identified with the same ortholog. These annotated proteins were mostly 
represented by Tenascins and Cathepsin B precursors. One VSP was also identified 
as secreted by both isolates, and an extracellular nuclease. Three proteins were 
hypothetical proteins. The five most abundant, secreted proteins appeared to be 
the same in both isolates: a hypothetical protein, followed by two Tenascins, a 
Cathepsin B precursor and another Tenascin (Table 5.4). Below the fifth most 
abundant conserved proteins, proteins appeared to have a greater variation in their 
SP abundances. 
Within GS dataset, 31 proteins appeared to be most likely secreted; 
including the 15 conserved secreted proteins (Table 5.5). 23 proteins had an 
ortholog in WB isolate, 2 were ortholog to sub-assemblage A2 DH isolate, and 6 
proteins were lineage-specific. 23 of these proteins were annotated and 8 hitherto 
hypothetical proteins. Most of the proteins secreted by GS isolate appeared to be 
VSPs and Tenascin precursors. Within WB dataset, 44 proteins appeared to be most 
likely secreted by trophozoites, including the 15 conserved secreted proteins (Table 
5.6). 34 were orthologous to GS isolate proteins and 10 were lineage-specific. 36 
proteins were annotated and 7 were hitherto hypothetical proteins. More Giardia 
protein families were represented in WB isolate secretion profile than in GS isolate. 
 Interestingly, the five most abundant conserved secreted proteins were also 
present in the top 10 secreted proteins amongst other VSPs, Tenascins, and 
Cathepsin B; and this regardless of the MS technique or the isolate. All these 
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results suggest that Giardia GS and WB isolates secrete mostly Tenascins, VSPs, 
Cathepsin B, HCMPs and hypothetical proteins . This also suggests the potential key 
role of these proteins in the early host-pathogen interactions; and particularly for 
the Cathepsin B, three Tenascins and the hypothetical proteins that are closely 
related. 
5.4/ Discussion 
Giardia trophozoites have been shown to release a Cathepsin B-like 
protease, Enolase, ADI and OCT upon interaction with host intestinal epithelia 
(Cotton et al., 2014, Ringqvist et al., 2008, Roxstrom-Lindquist et al., 2006). 
However, which proteins were actively secreted by the parasite has not previously 
been explored. In this study, Giardia trophozoites were shown to secrete primarily 
Cathepsin B proteins, High cysteine membrane proteins (including Tenascins and 
VSPs) and Hypothetical proteins. In each case the encoding loci are genetically 
polymorphic between isolates and a number of lineage specific features are present 
which could be exploited for strain specific identification and which could be 
directly associated with virulence. 
5.4.1/ Giardia Cathepsins B family 
 In this study, the Giardia Cathepsin B (GCATB) family was shown to contain 
secreted and non-secreted trophozoite expressed proteins. Fourteen GCATBs were 
identified within GS and WB proteomes and secretomes, their coding genes were 
retrieved from GiardiaDB and aligned on ClustalW to assess their sequence 
similarity scores. A phylogenetic tree was also built by maximum likelihood 
approach using MEGA software (v 6.06) to determine their relationship (Table 5.7, 
Fig 5.6). Ten of the proteins were shown to be orthologs; four pairs of orthologs 
were part of the conserved secreted proteins. The last pair of orthologs and two 
GS-specific GCATBs were identified in the proteomes as non-secreted (Fig 5.6). 
 The two non-secreted GS lineage-specific GCATBs appeared to be near 
identical duplicates of the same gene; however, whether they are tandem repeat as 
might be expected is not clear as they do not seem to be located on the same 
contig of the genome assembly and their chromosome locations are unassigned. So, 
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this may bear further consideration; particularly as it represents a substantial and 
recent cladistic feature which could be used to discriminate the assemblage B 
lineage. Four pairs of GCATB orthologs were conserved secreted factors and 
comprised closely related orthologs (Fig 5.6). Two GCATBs were secreted by WB 
isolate only; one of these was closely related to one of the conserved GCATBs 
orthologous pairs and may represent another example of gene duplication and 
divergence. The other WB secreted GCATB appeared to be most orthologous to the 
two near identical non-secreted GS GCATBs previously mentionned.  
Cathepsins B are Cysteine proteases that are involved in several Giardia 
pathogenicity processes such as encystation, excystation, attachment to the host 
intestinal epithelia and the degradation of mucin, intestinal IL-8 and degradation of 
intracellular junction (Table 5.1) (Cotton et al., 2014, DuBois et al., 2008, DuBois et 
al., 2006, Rodriguez-Fuentes et al., 2006, Ward et al., 1997, Paget and James, 1994). 
Cysteine proteases tend to differ not in substrate specificity but may in terms of 
activity, compartmentalisation, stability, environmental resistance, conditional 
optima, partner proteins and so forth. That several GCATBs appear to be secreted 
by growing trophozoites from both Giardia isolates suggests that different GCATBs 
may be responsible for different functions and perhaps even different pathogenic 
effects. Moreover, that ortholog proteins remain closely related suggests 
preservation of function between isolates. Interestingly, two GCATBs shared 
between the two isolates were only identified in WB secretome. The fact that these 
two proteins appear not to be secreted by GS isolate trophozoites suggests a 
potential mechanism by which the two isolates might vary in terms of 
pathogenicity, and also that some environmental changes may be needed to trigger 
the secretion of the non-secreted GCATB orthologs in GS isolate. Finally, the genetic 
heterogeneity of these proteins between assemblages is generally high compares 
with other proteins (50 to 80 % similarities, Table 5.7). As GCATBs are likely to be 
the primary mediators of pathology, it is to be expected that intra-assemblage 
variation in sequence will be evident and that this may vary with the virulence 
characteristics of the strains. Further testing of more and less virulent clinical 
isolates is warranted to validate these GCATBs as markers for upstream use in the 
characterisation and discrimination of Giardia strains. 
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Table 5.7: Sequence similarities of the genes coding for the Cathepsin B proteins 
identified in GS and WB isolate proteomes via Orbitrap and QeXactive MS. Proteins 
identified as secreted in both isolate are represented in blue, proteins identified as 
secreted in WB isolate only are represented in orange, and proteins present in proteomes 
but not as secreted factors are shown in black. Orthologs are shown in bold. All  the 
GL50581_ accession numbers represent GS isolate proteins and all the GL50803_ represent 
WB isolate proteins. Similarity scores were assessed via ClustalW (Appendix X).  
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Fig 5. 6: Phylogenetic tree of the Cathepsins B identified in GS and WB isolate proteomes. 
Gene sequences were obtained from GiardiaDB, aligned using ClustalW. The tree was realised 
by a Maximum likelihood approach using MEGA software (v 6.06) (Appendix X). All the 
Cathepsin B proteins identified in the four datasets were included in the analysis. Proteins 
identified as secreted in both isolate are highlighted in blue, proteins identified as secreted 
only in WB isolate dataset are highlighted in orange, and proteins identified in proteomes but 
not as secreted factors are highlighted in black. Ortholog proteins are shown by *. 
All the GL50581_ accession numbers represent GS isolate proteins and all the GL50803_ 
represent WB isolate proteins. 
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5.4.2/ High cysteine membrane protein superfamily 
Tenascins, VSPs and HCMPs together form the largest group of proteins 
enriched in the Giardia SPs. These three protein families have been shown to be 
rich in cysteine residues and to be either present at the surface of the parasite or as  
extracellular matrix (Bedore et al., 2014, Ankarklev et al., 2010); genes coding for 
these proteins were compared for similarities (Table 5.8). Interestingly, when 
aligned and analysed phylogenetically, a clear pattern emerges with VSPs 
segregated form Tenascins and HCMPS spanning the two groups (Fig 5.7). 
VSPs are well characterised surface glycoproteins with transmembrane 
domains TM, which are expressed one at a time by Giardia trophozoites through 
RNAi regulated mechanism. They are quintessential virulence factors responsible 
for antigenic variations as well as cell signalling, immune evasion, and potentially in 
the protection against luminal proteases, oxygen and free-radicals (Table 5.1) 
(Adam et al., 2010, Touz et al., 2005, Nash, 2002, Singer et al., 2001). VSPs are 
hypervariable by nature and thus, it is to be expected that they do not form 
orthologous pairs. This was the case for most of the VSPs observed in this study; 
intriguingly though, a few proteins annotated VSPs were conserved between 
isolates. This suggests that they are not actually VSPs and would not be subject to 
“one at a time” control expression but are actually misannotated HCMPs which may 
have a conserved function in both GS and WB isolates. 
HCMPs are an enigmatic group of proteins with few associated functional 
studies. They may protect trophozoites against proteolysis (Table 5.1) (Davids et al., 
2006, Nash, 2002). In other eukaryotes, and in keeping with the reductive potential 
of cysteine itself, HCMPs have also been shown to protect against oxidative damage 
which suggests that may have the same function in Giardia trophozoites (Requejo 
et al., 2010). In Giardia, it appears that one lineage of HCMPs has given rise to the 
VSPs whilst another has given rise to a group with high homology to mammalian 
Tenascins. 
Tenascins are characterised by the presence of epidermal growth factor 
(EGF-) repeats and are able to act as weak ligands for EGF receptors. Mammalian 
Tenascins are extracellular matrix proteins which modulate cell adhesion and 
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migration (Chiquet-Ehrismann and Chiquet, 2003). They appear to have evolved 
from a group of proteins specific to vertebrates, presumably co-evolving with the 
EGF receptor (Chiquet-Ehrismann and Chiquet, 2003). Thus, the presence of 
homologous proteins in Giardia evolving independently from HCMPs is a clear 
example of the kind of convergent evolution best described as molecular MIMICRY 
(Oldstone, 1998). The role of Giardia-secreted Tenascins has yet to be established, 
but they are defined by the presence of EGF repeats and it is to be anticipated that 
they will act similarly as weak ligands of the EGF receptor. The fact that several 
types of Tenascins are secreted by Giardia trophozoites suggests that Tenascins 
may have one or more functions in the host-pathogen interactions during Giardia 
infection. While VSPs are hypervariable and do not have orthologs, Tenascins and 
HCMPs showed low similarities between the orthologs that could be identified 
suggesting that all these proteins were highly variable (Table 5.8). The phylogenetic 
tree indicated that the conserved secreted proteins were more closely related to 
their orthologs than the other proteins though they remain more variable than 
most other orthologs (Fig 5.7). Interestingly, at least one syntenic set of Tenascin 
orthologs showed more divergence from its ortholog than to other Tenas cins. 
It is likely that rather like the extended VSG family of Trypanosoma brucei, 
the HCMP superfamily of Giardia contains multifunctional proteins with a range of 
related contingency functions from immune evasion to resisting environmental 
pressure to virulence and pathogenicity. The degree of variation between orthologs 
in this group is the highest of any family and it is to be anticipated that they may be 
good markers for strain discrimination and even source tracking. As with the 
Cathepsin B family, the genes identified in this study warrant systematic 
investigation as markers against a diverse range of clinically virulent and avirulent 
Giardia strains. 
5.4.3/ Secreted formerly hypothetical proteins (SFHPs) 
 One other annotation of proteins formed a substantial group of secreted 
proteins, those encoded by reading frames annotated as hypothetical. Although 
this study provides evidence that they are indeed expressed and indeed secreted, 
there is no functional data associated with them and their roles are not clear.  
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Table 5.8: Sequence similarities of the genes coding for the Tenascins, High cysteine 
membrane proteins and VSPs identified as secreted in GS and WB isolate proteomes. 
Proteins identified in both isolate are represented in blue, proteins identified in WB isolate 
only are represented in orange, and proteins identified in GS isolate only are shown in 
green. Orthologs are shown in bold. All the GL50581_ accession numbers represent GS 
isolate proteins and all the GL50803_ represent WB isolate proteins. Similarity scores were 
assessed via ClustalW (Appendix XI). a: Tenascin, b: High cysteine membrane protein, c: 
VSP. 
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Fig 5. 7: Phylogenetic tree of the Tenascins, VSPs and High cysteine membrane proteins 
identified as secreted factors in GS and WB isolate proteomes. Gene sequences were 
obtained from GiardiaDB, aligned using ClustalW. The tree was realised by a Maximum 
likelihood approach using MEGA software (v 6.06) (Appendix XI). Only the proteins present 
in the different secretion profiles were included in the analysis. Proteins identified in both 
isolate are highlighted in blue, proteins identified in WB isolate dataset only are 
highlighted in orange, and proteins identified in GS isolate dataset are highlighted in green. 
Ortholog proteins are shown by *. a: Tenascin, b: HCMP, c: VSP. 
All the GL50581_ accession numbers represent GS isolate proteins and all the GL50803_ 
represent WB isolate proteins. 
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Interestingly, alignment and clustering of sequences suggest that all eight of these 
proteins show some degree of inter-relatedness. They fall into three sets of 
orthologous pairs with similarity from 77.86 % to 88.64 % (Table 5.9). One 
orthologous pair could be linked to the HCMP/Tenascin family and this may suggest 
that all the hypothetical secreted proteins are actually extended members of this 
group. Two lineage-specific proteins cluster with two of the three orthologous pairs 
implying that they may have arisen by duplication and divergence of this group (Fig 
5.8). As with the GCATB and HCMP families, the SFHPs of Giardia show substantial 
heterogeneity between assemblages and are good candidate for intra-assemblage 
strain discrimination which may warrant further testing against a range of clinical 
isolates 
A comparative genomic analysis between assemblage A, WB isolate, 
assemblage B, GS isolate, and assemblage E, P15 isolate, identified 5,012 protein 
coding genes of which approximately 90 % were shared between the three Giardia 
isolates (Jerlstrom-Hultqvist et al., 2010). This correlates with the fact that over 90 
% of the proteins expressed were shared between GS and WB lineages. This 
suggests that a set of core genes may be common to all Giardia isolates and at the 
origin of most of the protein expression occurring in Giardia trophozoites. In their 
genome analysis, Jerlstrom-Hultqvist et al also identified 5, 31 and 38 protein 
coding genes as WB-, GS-, and P15- specific respectively. The proteins identified as 
lineage-specific in this study were compared to the WB- and GS-specific protein 
coding genes from Jerlstrom-Hulqvist and collaborator study to look for correlation. 
Only two GS hypothetical proteins, GL50581_3192 and GL50581_2613, were 
present in both studies as lineage-specific (Table 5.2). As previously stated, in this 
Giardia proteome analysis, proteins with no defined orthologs in either assemblage 
A (DH and WB isolates) or assemblage B (GS isolate) were considered lineage-
specific; therefore, these proteins were also compared to the protein coding 
sequences shared between P15 and GS or P15 and WB (Table 5.2 and 5.3). None of 
the lineage-specific proteins identified in this study were in Jerlstrom-Hultqvist et al 
study. This suggests that these two GS lineage-specific may allow further testing as 
assemblage-specific markers and for discrimination of lineages within assemblage 
B. 
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Table 5.9: Sequence similarities of the genes coding for the hypothetical proteins 
identified as secreted in GS and WB isolate proteomes. Orthologs are highlighted in bold. 
Similarity scores were assessed via ClustalW (Appendix XII). 
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Fig 5. 8: Phylogenetic tree of the hypothetical proteins identified as secreted by GS and 
WB isolate trophozoites. Gene sequences were obtained from GiardiaDB, aligned using 
ClustalW. The tree was realised by a Maximum likelihood approach using MEGA software (v 
6.06) (Appendix XII). Only the proteins identified in both GS and WB isolates via both MS 
techniques were included in this analysis. Ortholog proteins are shown by *. 
All the GL50581_ accession numbers represent GS isolate proteins and all the GL50803_ 
represent WB isolate proteins. 
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5.4.4/ Other Giardia-secreted proteins 
5.4.4.1/ Other conserved Giardia-secreted proteins 
When WB and GS secretomes were compared, 15 proteins were shown to be 
conserved between the two secretomes, (Table 5.4). The five most abundant 
conserved secreted proteins were the same hypothetical protein, Cathepsin B 
precursor and three Tenascins in both isolates; which suggests that these proteins 
may play an important role in Giardia secretory pathway. An extracellular nuclease 
was also shown to be secreted by both Giardia isolates; this protein is also an 
ortholog to assemblage E P15 isolate suggesting a function conserved between all 
Giardia assemblages. In bacterial pathogens such as V. cholera and S. aureus, 
extracellular nucleases have been shown to be involved in nutrient acquisition, 
detachment from biofilms but also inhibition of biofilm initiation and evasion of 
neutrophil extracellular traps (Kiedrowski et al., 2014, Seper et al., 2011). In 
Trypanosomitidae, such as Leishmania, nucleases have been shown to be present at 
the surface of the plasma membrane and involved in the salvage of preformed 
purines from host sources (Gottlieb, 1989). Some studies have shown that the 
importance of extracellular nuclease such as DNase in cystic fibrosis. Extracellular 
DNases have been shown to reduce mucus thickness by cleaving nucleic acids 
present in it (Harms et al., 1998, Brandt et al., 1995) which suggests that Giardia 
extracellular nuclease may play a role in the degradation of mucin during infection. 
Interestingly, bacterial extracellular nucleases have also been shown to have a 
mucolytic activity during host-pathogen interactions (Sanders et al., 2007) which 
suggests that giardial extracellular nuclease may also have a mucolytic activity. Yet, 
its role in Giardia-host interactions requires further investigations.  
Interestingly, a cyclin-dependent kinases regulatory subunit was shown to 
be released by both Giardia isolates. Cyclin-dependent kinases (CDKs) have been 
shown to be involved in the cell cycle progression and regulation; and, in 
eukaryotes, CDKs are also implicated in the control of gene transcription. 
Moreover, in complex cell cycles, they are acting as information processors 
integrating extracellular and intracellular signals to ensure the smooth coordination 
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of cell cycle events in the case of environmental change or mechanical failure 
(Morgan, 1997); which suggests that CDKs may communicate with some surface 
proteins. CDKs are regulated by CDKs regulatory subunits. Giardia CDKs regulatory 
subunit has a high signalP suggesting this protein may be released in the 
environment or present at the surface of the parasite. This protein may be acting as 
transmitter of any environmental changes within the host intestinal lumen to CDKs 
which will regulate the parasite cell cycle accordingly to this signal. This may allow 
trophozoites to adapt to any environmental changes or may even be at the origin of 
trophozoite encystation, as CDKs can regulate the gene transcription function. 
However, the involvement of CDKs regulatory subunit in these different Giardia 
processes has to be further investigated to confirm or refute these hypotheses. 
Surprisingly, two proteins belonging to the phosphoglycolate phosphatase 
family have been shown to be secreted by GS and WB isolate trophozoites. These 
two proteins are both orthologs to a different phosphoglycolate phosphatase 
within each isolate (Table 5.5 and 5.6). In plants and blood red cells, this enzyme is 
responsible for the assimilation of oxygen and the affinity of Haemoglobin for 
oxygen respectively (Rose et al., 1986). In chemoautotrophic organisms, this 
enzyme participates in CO2 assimilation (Shively et al., 1998). In E. coli, 
phosphoglycolate phosphatase has been shown to be involved in DNA repair after 
exposure to oxidative stress and also in the bacteria carbon metabolic process 
(Teresa Pellicer et al., 2003). Being part of the carbon metabolic process, this 
protein should be located within the cell cytoplasm; yet, in Giardia, proteomic 
analysis suggests that it may be secreted. However, the proteomic analysis matched 
only three and four peptides to these proteins indicating that the identification may 
not be robust and the ratio obtained was not reliable. This along with the possibility 
of a misannotation of these proteins suggests that the results should be interpreted 
with care. 
5.4.4.2/ GS lineage-specific secreted proteins 
During this study, differences in GS and WB secretion profiles were noticed. 
Indeed, some proteins appeared to be secreted in one isolate but only present as 
non-secreted factor in the other isolate. Three proteins were secreted by GS isolate 
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trophozoites: (i) A-type flavoprotein lateral transfer candidate, (ii) FixW protein, (iii) 
Sentrin.  
(i) A-type flavoprotein lateral transfer candidate has been shown to 
have a high oxygen reductase activity during Giardia infection (Di Matteo et al., 
2008); this protein may be released in the host intestinal environment to scavenge 
O2 thus allowing Giardia trophozoites to survive in the small intestinal environment 
and promoting its pathogenicity. This protein was also expressed in both pellet and 
supernatant in WB isolate but to a very low abundance suggesting that GS isolate 
trophozoites may be more sensitive to oxidative stress early in the infection. 
Whether GS isolate trophozoites require A-type flavoprotein lateral transfer 
candidate throughout the infection or just at the beginning remains unclear and 
should be investigated. Moreover, whether WB isolate trophozoites only require 
this protein when some drastic changes occur within the host intestinal lumen 
occur also requires further investigation.  
(ii) FixW protein has been shown to be a redox sensor in non-
pathogenic bacteria such as  Rhizobium leguminosarum (Martinez et al., 2004). 
Redox sensors can detect hypoxia, nictric oxide or carbaon monoxide changes in 
the bacteria environment; however, not a lot is known about FixW protein yet. 
Another Fix protein, FixL, in M. tuberculosis has been shown to be involved in 
environmental redox changes sensing and thus involved in M. tuberculosis 
pathogenicity (Bhat et al., 2012). However, the role of this bacterial protein in 
Giardia remains unclear. Moreover, FixW protein has a very low signalP suggesting 
that this protein is unlikely to be secreted (Table 5.5). The fact that this protein has 
been identified as secreted in GS isolate suggests a possible misannotation of this 
protein in the database. Protein annotations are based on sequence homology with 
other proteins that may be not closely related, thus leading to some wrong 
annotation of proteins.  
(iii) The last protein identified as most likely secreted by GS isolate 
trophozoites is a Sentrin protein. Sentrin is a protein involved in the ubiquitination 
of proteins to render them resistant to degradation (Kamitani et al., 1998). This 
protein appears to be an evolutionary conserved protein as it has been identified in 
prokaryotic and eukaryotic organisms such as S. cerevisiae, A. thaliana and Homo 
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sapiens, which suggests that Sentrin may have a specialised function in cell 
metabolism. Most of the proteins ubiquitinated by Sentrin appear to be located in 
the cell nucleus, and the overexpression of this protein protects organisms against 
tumour necrosis factor-induced cell death (Kamitani et al., 1998). Due to its role in 
the ubiquitination of proteins, Sentrin was expected to be present in Giardia 
trophozoite cytosol and not in its secretome. Why this protein would be secreted in 
GS isolate remains unclear. What would be the advantages for Giardia GS isolate 
trophozoites to secrete such a protein are also undetermined. Similarly to 
phosphoglycolate phosphatase, the identification of this protein during the 
proteomic analysis was not as robust as for the other proteins as only two peptides 
were matched to Sentrin protein. 
5.4.4.3/ WB lineage-specific secreted proteins 
Six proteins were secreted by WB isolate trophozoites but not GS isolate 
trophozoites: (i) Peptidyl-prolyl cis-trans isomerase B (PPIB) precursor, (ii) 
Neurogenic locus notch protein precursor, (iii) Translation initiation inhibitor, (iv)  
ATP-binding cassette (ABC) protein 5, (v) Peptide methionine sulfoxide reductase 
(MsrB), (vi) CXC rich protein and (vii) Elongation factor 1-α (EF-1 α) (Table 5.6).  
(i) PPIBs are conserved proteins that bind the immunosuppressive drug 
Cyclosporin A with high affinity (Price et al., 1991). They are mainly located in the 
ER but can be associated with secretory pathway and released in biological fluids. 
PPIBs have been shown to be secreted by parasites such as T. gondii and N. 
caninum to control the acute phase of both toxoplamosis and neosporosis (Bell et 
al., 2006). It has been suggested that these proteins may play a crucial role in the 
stimulation of interferon (IFN)-γ. In this study, PPIB was shown to be present in 
both P and SP with a SP : P ratio of approximately 0.3; which suggests that this 
protein may not be released by the parasite. Or if released, perhaps to a very low 
level when there are no host stimulus to enforce the parasite survival. Whether this 
protein is released and has the same function as T. gondii and N. caninum PPIB 
requires further investigation. 
(ii) Neurogenic locus notch proteins are transmembrane proteins with 
repeated extracellular EGF- domains and intracellular notch domains. In mammals, 
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these proteins are part of an evolutionary conserved intercellular pathway that 
regulates interactions between physically adjacent cells (Vardar et al., 2003). In 
Schistosoma mansoni, Notch proteins may play major roles in pairing process, 
proliferation, differentiation of vitelline cell, expression of female-specific genes, 
embryogenesis and sexual reproduction (Morais et al., 2013, Loverde et al., 2007). 
In this study, Neurogenic locus notch protein precursor was identified in both P and 
SP with a SP : P ratio of approximately 0.6 suggesting that this protein is more 
abundant within the trophozoites. In Giardia, this transmembrane protein was 
shown to have a high signalP suggesting that if not secreted, this protein may be 
present at the cell surface of trophozoites. This protein may be labile and easily 
detach from the surface membrane which could explain why it has been identified 
in high abundance in the supernatant too. What its role in Giardia is remains 
unknown and should be further investigated. 
(iii) Translation initiation inhibitors are proteins inhibiting the initiation 
of the mRNA translation into proteins; therefore they should be located into the 
cell cytosol (Malys and McCarthy, 2011). However, in this study, one translation 
initiation inhibitor was identified as most likely secreted by Giardia WB isolate 
trophozoites. This protein was abundantly present in both P and SP and with a low 
SP : P ratio of approximately 0.5 which suggests that this protein may not be 
secreted or released by the trophozoites. Why this protein is present in such 
abundance in the SP is not known, over 15 peptides were present and matched to 
this protein during the analysis. A misannotation in the Giardia database may be 
plausible. However, another explanation would be the over-representation of this 
protein in the supernatant due to its high solubility and stability suggesting the 
adoption of a new role in Giardia as previously shown for ADI, OCT and enolase 
(Ringqvist et al., 2008). 
(iv) ABC proteins play a role in transducing the energy of ATP binding 
and hydrolysis to a wide variety of physiological processes in all eukaryotic and 
bacterial organisms. Most of them are associated with transport of substrates 
across biological membranes. In many bacteria, ABC transporters play roles in 
virulence and survival to various environments (Linton and Higgins, 1998). ABC 
proteins possess two TM domains and a hydrophobic tail where it hydrolyses ATP 
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which suggests that these proteins are more likely not being secreted (Dean et al., 
2001). However, some of the ABC transporters have been shown to be vacuolar in 
plants (Jasinski et al., 2001). The fact that ABC protein 5 is more abundant in WB 
isolate supernatant than pellet suggests that this protein may be released in the 
external environment which is unexpected due to its two TM domains. Perhaps, 
this protein is abundantly present in vacuoles in Giardia WB isolate and is involved 
in some of the parasite resistance mechanisms as vacuolar ABC proteins  observed 
in plants (Jasinski et al., 2001). As with VSPs and HCMPs, this protein may be shed 
into the supernatant and have an undetermined role in the host-parasite 
interactions. Not all the functions of the ABC transporter family have been 
understood yet, and require further investigations.  
(v) MsrB catalyses the reduction of free and protein-bound methionine 
sulfoxides to corresponding methionines (Kim and Gladyshev, 2004). The reduction 
of protein methionine residues constitutes a mechanism for the scavenging of 
reactive oxygen species (ROS) which are responsible for a fundamental innate 
defence against pathogens in various host organisms (Kim and Gladyshev, 2004). 
MrsB is an antioxidant protein that protect organisms from the cytotoxic effect of 
ROS and therefore from cell death. MsrB has been shown to be crucial for the 
virulence of Salmonella typhimurium and for the immune evasion of Schistosoma 
mansoni (Denkel et al., 2011, Oke et al., 2009). This is a cytosolic protein which is 
unlikely to be secreted. Similarly to Sentrin, only three peptides were matched to 
this protein during the proteomic analysis indicating an unreliable ratio. This 
suggests that this data should also be interpreted with care. 
(vi) CXC rich proteins are proteins rich in cysteine residues. Giardia has 
been shown to express various types of cysteine-rich proteins such as VSPs, 
Tenascins and HCMPs. Another CXC rich protein family was identified in Giardia cyst 
but also involved in the antigenic variation process in trophozoites (Davids et al., 
2006, Adam et al., 1992). Similarly to Tenascins, VSPs and HCMPs, these proteins 
have a very high SignalP and only one TM domain suggesting that they may be 
labile surface protein. CXC rich protein may be involved in the parasite escape from 
the host immune system; however to what degree this protein is involved in this 
immune evasion has yet to be determined. Moreover, CXC rich protein exists in GS 
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isolate but was not identified as secreted in this study, what trigger the expression 
and secretion of this protein at the surface of the trophozoite remains unclear and 
should be investigated. Also, how different from VSPs are these proteins is 
unknown and should be studied. 
(vii) EF-1α is responsible for the enzymatic delivery of the aminoacyl 
transfer RNAs (tRNAs) to the ribosome. This protein is normally located in the 
nucleus. However, a study suggested that Giardia WB trophozoites may release EF-
1α into the culture medium during in vitro growth (Skarin et al., 2011), which 
correlates with the WB lineage-specific EF-1α identified as secreted in this study. 
Many organisms have been shown to express EF-1α in excess, suggesting that this 
protein may have some other functions (Condeelis, 1995). EF-1α was studied in the 
context of pathogenicity and virulence for various micro-organisms. In H. pylori, 
virulence factor CagA is translocated into the host cell and disrupts the epithelial 
cell polarity (Tan et al., 2009). The secreted Leishmania EF-1α appears to down-
regulate host inflammatory cell signalling (Nandan and Reiner, 2005). In this 
analysis, EF-1α was shown to be of high abundance, high stability and high solubility 
suggesting that it might be over-represented into supernatants and be involved in 
Giardia pathogenicity. However, it remains to be seen what role has EF-1α as 
secreted factor in giardial infection. Whether this protein is also released by Giardia 
GS isolate later during infection or is only released by WB isolate trophozoites 
throughout the infection requires further investigation.  
5.4.4.4/ Discrepancy in Orbitrap and QeXactive datasets 
Although various proteins have been identified by both MS techniques, a 
few differences and inconsistencies were also observed within the isolate secretion 
profiles obtained by Orbitrap and QeXactive MS (Data shown in Appendix IX). For 
example, in GS secretion profiles, two different PDI5 were identified as the most 
abundant secreted proteins. PDIs are enzymes located in the ER which catalyses the 
formation and breakage of disulfide bonds between cysteine residues within 
proteins as they fold (Wilkinson and Gilbert, 2004). PDI5 were excluded from the 
analysis as two different PDI5 were identified in the two datasets, but whether or 
not these proteins can be secreted or released by the parasite should be verified, 
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especially considering their high signalP which suggests that PDIs may have the 
potential to be secreted. Apart from PDI, in both isolate datasets, some proteins 
present in the proteasome and some cytoskeletal proteins such as spindle pole 
protein, β-tubulin, and Axonemal p66.0 were suggested to be secreted by either 
the Orbitrap MS dataset or the QeXactive Ms dataset. This indicates that these two 
datasets are best analysed together to increase robustness, as it has been in this 
study. 
5.5/ Summary 
 This study shows that both Giardia GS and WB isolate trophozoites have an 
enriched proteome and that most proteins expressed are shared between isolates. 
When the secretome analysis was performed, several proteins known to be 
cytosolic and with low signalP were identified as secreted which suggests that more 
proteins than expected may be misannotated within the databases used in this 
study, GiardiaDB and Uniprot, and that a correction of these databases should be 
done. 
Although several proteins have been shown to potentially be secreted by 
trophozoites, only seven candidates appear to be more likely secreted: (i) Cathepsin 
B (ii) Tenascin, (iii) Hypotethical proteins, (iv) Extracellular nuclease; which were all 
conserved between isolates or lineage-specific. (v) A-type flavoprotein lateral 
transfer candidate identified in GS isolate, (vi) PPIB and (vii) EF-1α (lineage-specific), 
which were both identified in WB isolate (Table 5.10). Four other families were 
abundantly present in secretome but are known cell-surface proteins: VSPs, 
HCMPs, CXC-rich protein and Neurogenic locus notch protein precursor.  
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6.1/ General discussion 
 In this thesis, data has been provided to determine the secretion profile of 
both Giardia assemblage A (WB isolate) and B (GS isolate) trophozoites from in vitro 
culture (Table 6.1), and to illustrate the effects of Giardia-secreted factors on 
intestinal cell morphology and on their main water and ion transporters. Giardiasis 
and associated symptoms have been thought to be mainly caused by trophozoites, 
at the site of infection. Therefore, most studies have focused on the effect of 
trophozoites on intestinal epithelia. The data presented demonstrates that Giardia 
trophozoites secrete proteins factors causing disruption of intestinal epithelia and 
suggests that these secreted proteins may act as possible mediators of symptoms 
even at distal points from the infection site.  
Limitations in protein detection technology and the presence of exogenous  
bovine and yeast proteins contained in the Giardia growth medium has meant that 
the study of its secretion profile has hitherto been proved challenging. The data 
presented in this thesis gives for the first time a secretion profile for both Giardia 
GS and WB isolates and demonstrates that most Giardia-secreted protein families 
are conserved between these two isolates suggesting a conserved mechanism of 
pathogenesis. Future research should focus on the functions of these proteins in 
the mediation of host-parasite interactions and on using these markers to elucidate 
the Giardia secretory pathways. 
6.1.1/ A Giardia supernatant free from exogenous proteins. 
 During in vitro growth, serum proteins such as BSA bind to the trophozoite 
surface which interferes with the characterisation of the parasite secretome (Skarin 
et al., 2011). Moreover, it indicates that serum proteins can affect detection. To 
address these problems, I removed indicators and most of the exogenous proteins 
from the Giardia culture media (Chapter IV). Nevertheless, I found that a high 
number of giardial proteins were present in the in vitro growth supernatant and 
that proteomic analysis was possible.  
 Chapter III showed that Giardia growth media can affect cultured intestinal 
cells, potentially biasing the results of the analysis. The use of an exogenous 
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protein-free Giardia supernatant showed a lesser but still significant effect on 
intestinal cells and their water and ion transporters. This data demonstrates how 
factors released during Giardia growth can affect cultured intestinal epithelia, 
suggesting that effects from Giardia-secreted factors on intestinal epithelia are best 
investigated only in exogenous protein-free milieu. 
6.1.2/ Disruption of intestinal cell morphology and 
AQP3/CFTR translocation caused by Giardia supernatant 
 To understand the causes of giardiasis and giardial diarrhoea, various 
studies have focused their investigations on the effects of trophozoite infection 
(Cotton et al., 2011, Baldi et al., 2009, Yu et al., 2008, Buret, 2007, Troeger et al., 
2007, Roxstrom-Lindquist et al., 2005, Chin et al., 2002, Scott et al., 2002). Data 
presented in this thesis shows shrinkage and ruffling of intestinal cells in presence 
of Giardia supernatant for more than 8 hours suggesting a loss of turgidity in 
intestinal cells; it also showed translocation of intestinal AQP3 and CFTR following 
one hour incubation with the parasite supernatant suggesting that these two 
intestinal transporters may be involved in the decrease of cell turgidity. 
The loss in cell size and ruffling effect were assessed by measurement of 
intestinal cell surface area and perimeter via Image J software and calculation of a 
ruffling index using the formula: 
𝐏𝐞𝐫𝐢𝐦𝐞𝐭𝐞𝐫
√(𝐒𝐮𝐫𝐟𝐚𝐜𝐞 𝐚𝐫𝐞𝐚)
. Assemblage B (GS isolate) may have 
a greater inhibiting effect on the cell turgidity whereas assemblage A (WB isolate) 
may cause more mucosal damage to the intestinal cells suggesting that these two 
isolates may have different pathophysiologic effects on the host intestinal epithelia 
(Chapter III). It is worth considering that the morphology assay was done manually 
using Image J software which is susceptible to observer bias. The measurement of 
the cell volume changes using fluorescence self-quenching or scanning conductance 
ion microscopy (SCIM), which uses the increase of access resistance in a micro-
pipette in an electrolyte containing environment when it approaches a poorly 
conducting surface to measure the ion efflux, would afford greater subjectivity and 
potentially increase the intestinal water efflux disruption and therefore cell volume 
changes occurring during incubation with parasite supernatant (Korchev et al., 
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2000). Attribution of the intestinal cell morphological changes observed to a 
specific protein secreted by the parasite or to another parasite-derived factor was 
not assessed in this thesis and should be further investigated. The nature and 
identity of the soluble mediators involved could be investigated through the use of 
size selection of filtration/fractionation of Giardia supernatant and by selective 
deactivation/inhibition of possible identified proteins in the supernatants. 
Intestinal AQP3 and CFTR were translocated after one hour incubation with 
Giardia GS isolate supernatant and after eight hours incubation with Giardia WB 
supernatant suggesting that assemblage B (GS isolate) may be more bioactive than 
assemblage A (WB isolate) early in the infection. The translocation of AQP3 and 
CFTR suggests that Giardia may secrete factors activating the translocation of these 
transporters. Whether these transporters may be involved in the decrease of cell 
turgidity and inhibition of Isc previously observed is not known and should be 
investigated. The inhibition of these two transporters while repeating the intestinal 
cell morphology study under the same conditions would either confirm or deny this 
theory. Interestingly, the inhibition of intestinal cell electrophysiology using 
chloride secretion inhibitors (DIDS and Gly101, Chapter I, section 1.5.4) implicates 
CFTR directly in the disruption of intestinal epithelium homeostasis observed when 
Giardia supernatants are applied. However, whether CFTR is involved in the 
intestinal cell shrinkage or the decrease of cell turgidity was not directly tested and 
should be further investigated. The quantification of this translocation was not 
possible while using the fluorescent microscope. The use of a confocal XZ plane 
imaging microscope and a peripheral stain as a cell shape marker to investigate the 
density of vesicles close to the plasma membrane or flow cytometry would better 
enable evaluation of the translocation effect. AQP3 and CFTR are two of the main 
water and ion transporters in the intestine, along with SGLT-1. Yet, many more are 
present on the apical side of intestinal cells and may interact with Giardia-secreted 
factors. The use of probes for different ions such as potassium (K+), sodium (Na+), or 
chloride (Cl-) to observe the intestinal ion transport during infection with Giardia 
supernatant will give a better understanding of which intestinal transporter may be 
involved in the host-Giardia-secreted factors interactions. As with morphology 
assay, the possible Giardia-secreted factors involved in the translocation of 
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intestinal transporters were not investigated in this thesis and should be performed 
by deactivating proteins contained in Giardia supernatant and repeating the protein 
translocation assays. 
6.1.3/ Giardia secretion profile 
 Only four proteins have been proposed to be released and involved in 
Giardia trophozoites pathogenicity so far; Arginine deiminase (ADI), Ornithine 
carbamoyltransferase (OCT), enolase and more recently Cathepsin B-like protease 
(Cotton et al., 2014, Ringqvist et al., 2008). Elongation factor 1-α (EF-1α) has also 
been proposed to be released by trophozoites during in vitro growth (Skarin et al., 
2011). However, which proteins are secreted by Giardia trophozoites has not been 
previously explored. This thesis demonstrates that various proteins are secreted by 
Giardia trophozoites; 55 % of Giardia secretome is composed of proteins secreted 
either by one or both isolates and the 45 % remaining are cell-surface proteins such 
as VSPs and HCMPs (Chapter V) (Table 6.1). Interestingly, ADI, enolase and OCT are 
present in both isolate pellet and supernatant as some of the most abundant 
proteins but not as proteins most likely to be secreted by trophozoites. Their 
presence in Giardia supernatant represents either a generalised “leakiness” of 
some Giardia cells or arising from cell damage and patent levels of cell death. This 
suggests that these proteins may not be secreted into the intestinal lumen by the 
parasite but may still have a role in Giardia pathogenesis nonetheless, as previously 
shown by Ringqvist and collaborator. 
6.1.4/ Conserved and lineage-specific protein secretion 
6.1.4.1/ Identification of proteins secreted only by Giardia WB 
or GS isolates 
 During the identification of putatively secreted Giardia trophozoites 
proteins, five were shown to be secreted in a strain-specific manner. WB isolate 
trophozoites secrete CXC-rich protein and Neurogenic locus notch protein 
precursor, PPIB and one EF-1α; and GS isolate trophozoite secrete A-type 
flavoprotein lateral transfer candidate (Chapter V). These differences may go some  
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way towards explaining differences in pathogenicity between GS and WB isolates  
The coding genes of all the proteins have orthologs in multiple Giardia 
genome strains (Fig 6.1) suggesting that these proteins may have evolutionary 
conserved functions. Interestingly, EF-1α does not form an ortholog with GS isolate 
but is shared by WB, DH and P15 isolates which suggests that assemblages A and E 
share virulence factors that have not been acquired by assemblage B trophozoites. 
This correlates with a previous genomic comparative study which showed that 
assemblage A and B share 77 % genome sequence identity whereas assemblage A 
and E share 87 % sequence identity (Franzen et al., 2013).  
 The fact that GS and WB strains release different proteins provide potential 
explanation for differences in pathogenicity between the two assemblages; arising 
from differences in host-pathogen interactions. This could explain the dissimilarities 
of effect on intestinal cells observed in this thesis (Chapter III). Questions regarding 
relative levels of activities as well as the trigger for the secretion of these proteins 
by the different isolates during Giardia infection should be further investigated. 
6.1.4.2/ Secretion of formerly Hypothetical proteins and a 
conserved extracellular nuclease 
 The work presented shows that a substantial group of hypothetical proteins 
and an extracellular nuclease are secreted by both GS and WB isolates. 
Interestingly, conserved hypothetical proteins show some degree of inter-
relatedness (chapter V); their coding genes also show high sequence similarities 
with their DH (assemblage A) and P15 (assemblage E) orthologs. This suggests 
potentially conserved but yet unknown functions between the three Giardia 
assemblages for these proteins. Interestingly, one hypothetical protein secreted by 
WB isolate is a lineage-specific assemblage (Fig 6.1 B.). Although no syntenic 
orthologs have been associated to it, this protein appears to have some degree of 
relatedness with the HCMP super family and is therefore more likely to be a cell -
surface protein. This demonstrates the importance of a correct annotation of 
proteins and genes when working on proteomics or genomics; further 
investigations are required to verify this. 
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Fig 6. 1: Comparison of lineage-specific and orthologous proteins between assemblage B 
(GS isolate), A (WB and DH isolate) and E (P15 isolate). Orthologs were matched using 
GiardiaDB for the proteins identified as part of Giardia trophozoite secretome. Venn 
diagrams show the proteins having an orthologs in either one, or more assemblages, or the 
lineage-specific proteins. A. Orthologs and lineage-specific proteins located in the 
trophozoite surface: CXC-rich protein, VSPs, HCMPs, Neurogenic locus notch protein 
precursor. B. Orthologs and lineage-specific secreted proteins: Cathepsins B, Tenascins, A-
type flavoprotein lateral transfer candidate, PPIB, EF-1α and hypothetical proteins. 
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The locus encoding for the extracellular nuclease is shared between GS 
(assemblage B), WB and DH (assemblage A) and P15 (assemblage E) isolates and 
highly conserved between these isolates strongly suggesting an evolutionary 
conserved function. Although DH and P15 isolates possess the coding gene for this 
protein, whether these two isolates also secrete this protein during in vitro growth 
or require environmental modifications to trigger its secretion should be 
investigated. 
6.1.5/ HCMP super family 
 The HCMP superfamily is composed of Tenascins, VSPs and HCMPs. This 
thesis shows that this group of proteins is the most enriched in Giardia 
supernatant. VSPs being hypervariable, it is to be expected that they do not form 
syntenic orthologous pairs. Some VSPs identified showed true lineage-specificity for 
both GS and WB isolates as is to be expected from VSPs (Fig 6.1). This suggests that 
most VSPs conserved between isolates are not actual VSPs but misannotated 
HCMPs. The analysis of their function and encoding loci should determine what 
these proteins really are. The true lineage-specific VSPs may be considered as 
markers for specific Giardia strains and should be further investigated for a better 
understanding of Giardia isolate-specific pathogenicity.  
 I have shown that the Tenascin group is one of the most secreted groups of 
proteins by both Giardia GS and WB isolates. Transcript profiles during host-
parasite interactions for these proteins were retrieved from the GiardiaDB 
database; and indicate that Tenascins conserved between GS and WB isolates have 
a decreasing transcript profile during host-parasite interactions suggesting a 
function in the early stage of the infection. These proteins also form orthologous  
groups with Tenascins in DH isolate (assemblage A) and P15 isolate (assemblage E) 
suggesting a conserved function in the early stage of giardial infection. Intriguingly, 
the Tenascins secreted only by WB isolate trophozoites show the opposite profile, 
their expression appears to increase throughout the infection. Similarly to the 
conserved Tenascins, these proteins form orthologous pairs with DH and P15 
isolates also suggesting a certain conservation of function. The question of the 
secretion of these proteins by DH and P15 isolates trophozoites remains unknown 
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and should be investigated. Furthermore, the mechanisms triggering the expression 
and secretion of these Tenascins should be determined. Moreover, I observed a 
high degree of variation between Tenascin orthologs making then potential good 
markers for virulent and avirulent Giardia strains discrimination. 
6.1.6/ Giardia Cathepsin B family 
 Along with the HCMP superfamily, the GCATB family contains some of the 
proteins the most secreted by both GS and WB isolates. Similarly to the Tenascins, 
their transcript profiles during host-parasite interactions were retrieved from 
GiardiaDB. The expression of most of the GCATBs conserved between GS and DH 
isolates increases during infection. This suggests that these proteins are required 
throughout the infection. However, the expression of one conserved GCATB 
decreases during infection suggesting that this GCATB may facilitate the attachment 
to the host intestinal epithelia for both isolates. All but one conserved GCATBs are 
also orthologous to Cathepsins B in DH and P15 isolates showing potential 
conserved functions for these proteins in Giardia pathogenicity.  
 Interestingly, the GCATBs only secreted by WB isolate trophozoites show 
either a constant transcript expression profile during host-pathogen interactions or 
a very high transcript expression profile early in the infection which greatly 
decreases later on during host-pathogen interactions. Here too, all GCATBs but one 
form orthologous pairs with Cathepsins B in DH and P15 isolates showing a 
potential mechanism by which these isolates may vary in term of pathogenicity. 
Whether environmental changes may trigger the expression and secretion of these 
proteins by the other isolates is not known yet and should be further investigated. 
 The genetic heterogeneity of these proteins between isolates is generally 
low compared with their orthologs (75 – 99 % similarities, data not shown). This 
suggests that GCATBs may have conserved functions between isolates. Yet, the fact 
that some are secreted during in vitro growth in one isolate and not the others may 
explain the variations in human pathogenicity between isolates. The question of 
their secretion in the early stage of infection in DH and P15 isolates should be 
investigated to verify if the secretion of several GCATBs is a pathogenic 
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characteristic of WB isolates or is shared with sub-assemblage AII and assemblage 
E. 
6.2/ Summary and future work 
 Despite the recent advances in Giardia genomic, proteomics and 
pathogenesis, important questions still remain unanswered; including whether 
these newly identified secreted proteins play a role in Giardia pathogenicity. 
Further, the variation in protein secreted between isolates, and thus in 
pathogenicity is far from being understood. Similarly, the effects of these secreted 
virulence factors on host intestinal epithelia are still under debate and 
investigation. 
 In this thesis, I have presented microscopic and proteomic data to identify 
Giardia-secreted virulence factors and their effects on human intestinal epithelia. 
Morphological changes were shown to occur after only 8 hours. Variations in 
pathogenic effects on intestinal cells were also observed between the two Giardia 
isolates which could be explained by the difference in GS and WB secretion profiles. 
Yet, the question of these effects being caused by Giardia-secreted proteins could 
not be answered during my studies and should be further investigated. In the 
future, the use of inhibitors of targeted Giardia-secreted proteins will determine 
which of these proteins are responsible for the morphological changes occurring in 
intestinal cells during host-parasite interactions. Moreover, the use of “flat” 
organoids as a model of small intestinal tissue (Jabaji et al., 2013) allowing the 
inoculation on the apical side will give a better understanding of how Giardia –
secreted virulence factors cause the disruption of the intestinal epithelia. 
 This thesis has exploited proteomic data from Giardia and compared their 
coding sequences to identify orthologs and sequence similarities. Several proteins 
identified were either shown to be secreted or paired with orthologs, such as FixW 
protein and VSPs respectively, when it should have not been the case. This 
illustrates the pitfalls of genomic comparative analysis and gene predictions in 
complete eukaryote genomes as it can lead to misannotation of proteins. 
Unfortunately, this was the case for a few proteins in this analysis and shows the 
importance of deeper analyses on these predicted features for annotated genes. 
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Nevertheless, proteomic analysis of Giardia-secreted proteins showed interesting 
results and potential new markers and mechanisms for Giardia pathogenicity. 
In this analysis, proteins that are released and enriched to a substantial 
concentration outside of human infective Giardia trophozoites have been 
identified. It is most likely that these proteins are ones that have been classically 
secreted or shed. Just three groups form the majority of these proteins: GCATBs 
and the HCMP superfamily which encode known virulence factors and the SFHPs 
which are an intriguing new group awaiting functional studies. The elucidation of 
the SFHP group is likely to dramatically increase our understanding of the 
pathogenic mechanisms underlying giardiasis at molecular level. The genes 
encoding these proteins are among the most heterogeneous of all genes between 
assemblages and their probable role in interaction with the host and luminal 
environment ensure that their variation is likely to be associated with their survival 
ability in the host and thus to virulence. Demonstration of the positive selection 
pressure through examination of parameters such as dN/dS ratios should confirm 
this. Correlation of variation within assemblages at these loci with strain virulence is 
the essential next step for their use in diagnosis of virulent strains, risk assessment, 
informing therapeutic options and disease prognosis. 
In this thesis, I showed that an extracellular nuclease, GCATBs and Tenascins 
were potentially involved in various pathogenic mechanisms (Table 6.1). The fact 
that both extracellular nuclease and GCATBs can be involved in the degradation of 
the intestinal mucus layers and that both GCATBs and Tenascins can be associated 
with intestinal intracellular junction disruption suggests concerted action between 
these proteins. Based on my analysis of the proteomic data, I propose a model of 
pathogenic mechanism for Giardia-induced damage to the enteric epithelium and 
by extension for giardiasis (Fig 6.2). The extracellular nuclease may contribute to 
reducing the viscosity of mucus while GCATBs may degrade mucins and disrupt the 
intestinal intracellular junctions. Lastly, Tenascins may be involved in maintaining 
the intestinal cell separation by attaching to the EGF receptors present at the 
surface of intestinal cells. Taken together overtime, this would lead to the apoptosis 
of these disrupted cells which have become isolated in the epithelium. Further 
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experimental investigations will be required to verify this as the mechanism of 
pathogenesis by Giardia. 
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Appendix I: 
 Part of this work has been presented at conferences: 
 
Abstract:  
1. British Society of Immunology. June 2011. Norwich, UK. Enterocyte function 
is compromised by a soluble mediator from Giardia. Audrey Dubourg, Suha 
Al-Naimi. John Winpenny, Paul Hunter, Kevin Tyler. Poster presentation. 
2. Third Seminar of European PhD students on Water and Health. June 2011. 
Cannes, France. Enterocyte function is compromised by a soluble mediator 
from Giardia. Suha Al-Naimi, Audrey Dubourg, John Winpenny, Paul Hunter, 
Kevin Tyler. Oral presentation.  
3. British Society for Parasitology meeting. April 2012. Glasgow, UK. Enterocyte 
function is compromised by a Giardia-secreted mediator. Audrey Dubourg, 
Suha Al-Naimi. John Winpenny, Dong Xia, Jonathan Wastling, Paul Hunter, 
Kevin Tyler. Oral presentation. 
4. Cell, Development and Biomedicine seminar. May 2012. Norwich, UK. 
Giardia-released factors and their effect on enterocyte function. Audrey 
Dubourg. Oral presentation. 
5. Fifth International Conference on Anaerobic Protists. September 2012. Los 
Angeles, USA. Enterocyte function is compromised by a Giardia-secreted 
mediator. Audrey Dubourg, Suha Al-Naimi. John Winpenny, Dong Xia, 
Jonathan Wastling, Paul Hunter, Kevin Tyler. Poster presentation.
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Appendix II: 
 Paired t-test compared to controls for difference in length and width of 
Caco-2 cells after incubation with different concentrations of Giardia 
supernatant for 24 hours. A. Compared to incubation in DMEM. B. 
Compared to incubation in TYI-S-33. 
A. 
  
 
 
 
 
 
 
B. 
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Appendix III:  
Non-parametric Mann-Whitney U-test compared to control (DMEM) for 
difference in surface area and perimeter of Caco-2 cells after incubation 
with different concentrations of Giardia supernatant for A. 1 hr. B. 8 
hrs. C. 24 hrs. 
 
A. 
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B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. 
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Appendix IV:  
Panel data approach performed on Stata software (v 13.1) to compare the ruffling 
index of CaCo-2 cells under different Giardia supernatant treatment to the control 
(DMEM) at different times. A. 1 hour. B. 8 hours. C. 24 hours. 
 
A. 
 
 
 
 
 
 
 B. 
 
 
 
 
 
 
 
 
 C. 
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Appendix V:  
Non-parametric Mann-Whitney U-test compared to control (DMEM) for difference 
in AQP3 and SGLT-1 expression after incubation with different concentrations of 
Giardia supernatant for A. 1 hr. B. 8 hrs. C. 24 hrs. 
A.
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Appendix VI:  
CFTR bands obtained using the AbCam monoclonal Mouse anti-CFTR antibody. 
Membranes were incubated overnight with the antibody diluted at 1:750. Bands 
were obtained for the three time points 1, 8 and 24 hours. However, 24hours, not 
all the bands were visible for CFTR. 
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Appendix VII:  
Correlation between data obtained with Orbitrap and QeXactive MS via 
spearman correlation test using SPSS. A. GS Pellet replicates; B. GS 
Supernatant replicates; C. WB Pellet replicates; D. WB Supernatant 
replicates. 
   . 
. 
A. 
B. 
C. 
D. 
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Appendix VIII:  
Correlation between the first and second datasets obtained with 
Orbitrap and QeXactive MS via spearman correlation test using SPSS. A. 
GS Pellet replicates; B. GS Supernatant replicates; C. WB Pellet 
replicates; D. WB Supernatant replicates. 
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Appendix X:  
ClustalW sequence alignment of the Cathepsin B precursor genes 
coding for the Cathepsin B proteins identified in Giardia proteome. All 
the GL50581_ accession numbers represent GS isolate proteins and all the 
GL50803_ represent WB isolate proteins. 
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 Appendix XI:  
CLustalW sequence alignments of the conserved secreted tenascin, high 
cysteine proteins and VSPs. All the GL50581_ accession numbers represent GS 
isolate proteins and all the GL50803_ represent WB isolate proteins. Orthologs are 
shown by *. a: Tenascin, b: High cysteine membrane protein, c: VSP. 
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Appendix XII:  
CLustalW sequence alignments of the conserved secreted hypothetical protein 
coding genes. All the GL50581_ accession numbers represent GS isolate proteins 
and all the GL50803_ represent WB isolate proteins. 
 App ndice  
References 
 
340 | P a g e  
 
 App ndices 
References 
 
341 | P a g e  
  
 App ndice  
References 
 
342 | P a g e  
 
 App ndices 
References 
 
343 | P a g e  
 
 App ndices 
 344 | P a g e  
 
 
 
 
 
 
 
 
 
References 
References 
345 | P a g e  
ABEL, E. S., DAVIDS, B. J., ROBLES, L. D., LOFLIN, C. E., GILLIN, F. D. & CHAKRABARTI, R. 
2001. Possible roles of protein kinase A in cell motility and excystation of the early 
diverging eukaryote Giardia lamblia. J Biol Chem, 276, 10320-9. 
ADAM, R. D. 1991. The biology of Giardia spp. Microbiol Rev, 55, 706-32. 
ADAM, R. D. 2001. Biology of Giardia lamblia. Clin Microbiol Rev, 14, 447-75. 
ADAM, R. D., DAHLSTROM, E. W., MARTENS, C. A., BRUNO, D. P., BARBIAN, K. D., RICKLEFS, 
S. M., HERNANDEZ, M. M., NARLA, N. P., PATEL, R. B., PORCELLA, S. F. & NASH, T. E. 
2013. Genome sequencing of Giardia lamblia genotypes A2 and B isolates (DH and 
GS) and comparative analysis with the genomes of genotypes A1 and E (WB and 
Pig). Genome Biol Evol, 5, 2498-511. 
ADAM, R. D., NIGAM, A., SESHADRI, V., MARTENS, C. A., FARNETH, G. A., MORRISON, H. G., 
NASH, T. E., PORCELLA, S. F. & PATEL, R. 2010. The Giardia lamblia vsp gene 
repertoire: characteristics, genomic organization, and evolution. BMC Genomics, 
11, 424. 
ADAM, R. D., YANG, Y. M. & NASH, T. E. 1992. The cysteine-rich protein gene family of 
Giardia lamblia: loss of the CRP170 gene in an antigenic variant. Mol Cell Biol, 12,  
1194-201. 
AEBERSOLD, R. & GOODLETT, D. R. 2001. Mass spectrometry in proteomics. Chemical 
reviews, 101, 269-95. 
AEBERSOLD, R. & MANN, M. 2003. Mass spectrometry-based proteomics. Nature, 422, 198-
207. 
AGARWAL, S. & MAYER, L. 2009. Pathogenesis and treatment of gastrointestinal disease in 
antibody deficiency syndromes. J Allergy Clin Immunol, 124, 658-64. 
AGRE, P., KING, L. S., YASUI, M., GUGGINO, W. B., OTTERSEN, O. P., FUJIYOSHI, Y., ENGEL, A. 
& NIELSEN, S. 2002. Aquaporin water channels--from atomic structure to clinical 
medicine. J Physiol, 542, 3-16. 
AGUAYO-ORTIZ, R., MENDEZ-LUCIO, O., ROMO-MANCILLAS, A., CASTILLO, R., YEPEZ-MULIA, 
L., MEDINA-FRANCO, J. L. & HERNANDEZ-CAMPOS, A. 2013. Molecular basis for 
benzimidazole resistance from a novel beta-tubulin binding site model. J Mol Graph 
Model, 45, 26-37. 
AL-NAIMI, S., WINPENNY, J., HUNTER, P. R. & TYLER, K. M. Unpublished data. A soluble 
mediator from Giardia Lamblia disrupts human gastrointestinal epithelial cell 
function. 
ALDEEN, W. E., CARROLL, K., ROBISON, A., MORRISON, M. & HALE, D. 1998. Comparison of 
nine commercially available enzyme-linked immunosorbent assays for detection of 
Giardia lamblia in fecal specimens. J Clin Microbiol, 36, 1338-40. 
ALMEIDA, A., POZIO, E. & CACCIO, S. M. 2010. Genotyping of Giardia duodenalis cysts by 
new real-time PCR assays for detection of mixed infections in human samples. Appl 
Environ Microbiol, 76, 1895-901. 
ALUM, A., SBAI, B., ASAAD, H., RUBINO, J. R. & KHALID IJAZ, M. 2012. ECC-RT-PCR: a new 
method to determine the viability and infectivity of Giardia cysts. Int J Infect Dis, 
16, e350-3. 
ALVARADO, M. E. & WASSERMAN, M. 2010. Analysis of phosphorylated proteins and 
inhibition of kinase activity during Giardia intestinalis excystation. Parasitol Int, 59, 
54-61. 
ANDERSON, J. M. & VAN ITALLIE, C. M. 1995. Tight junctions and the molecular basis for 
regulation of paracellular permeability. Am J Physiol, 269, G467-75. 
ANDREWS, B. J. & BJORVATN, B. 1994. Chemotherapy of Entamoeba histolytica: studies in 
vitro with bacitracin and its zinc salt. Trans R Soc Trop Med Hyg, 88, 98-100. 
References 
346 | P a g e  
ANDREWS, B. J., MYLVAGANAM, H. & YULE, A. 1994. Sensitivity of Trichomonas vaginalis, 
Tritrichomonas foetus and Giardia intestinalis to bacitracin and its zinc salt in vitro. 
Trans R Soc Trop Med Hyg, 88, 704-6. 
ANDREWS, B. J., PANITESCU, D., JIPA, G. H., VASILE-BUGARIN, A. C., VASILIU, R. P. & 
RONNEVIG, J. R. 1995. Chemotherapy for giardiasis: randomized clinical trial of 
bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin. Am 
J Trop Med Hyg, 52, 318-21. 
ANKARKLEV, J., JERLSTROM-HULTQVIST, J., RINGQVIST, E., TROELL, K. & SVARD, S. G. 2010. 
Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev 
Microbiol, 8, 413-22. 
ARBO, A., PAVIA-RUZ, N. & SANTOS, J. I. 2006. Opsonic requirements for the respiratory 
burst of neutrophils against Giardia lamblia trophozoites. Arch Med Res, 37, 465-
73. 
BACKHED, F., LEY, R. E., SONNENBURG, J. L., PETERSON, D. A. & GORDON, J. I. 2005. Host-
bacterial mutualism in the human intestine. Science, 307, 1915-20. 
BALCIOGLU, I. C., KURT, O., LIMONCU, M. E., DINC, G., GUMUS, M., KILIMCIOGLU, A. A., 
KAYRAN, E. & OZBILGIN, A. 2007. Rural life, lower socioeconomic status and 
parasitic infections. Parasitol Int, 56, 129-33. 
BALDI, F., BIANCO, M. A., NARDONE, G., PILOTTO, A. & ZAMPARO, E. 2009. Focus on acute 
diarrhoeal disease. World J Gastroenterol, 15, 3341-8. 
BALLWEBER, L. R., XIAO, L., BOWMAN, D. D., KAHN, G. & CAMA, V. A. 2010. Giardiasis in 
dogs and cats: update on epidemiology and public health significance. Trends 
Parasitol, 26, 180-9. 
BARAKAT, A. & HALAWA, E. F. 2013. Household costs of seeking outpatient care in Egyptian 
children with diarrhea: a cross-sectional study. Pan Afr Med J, 14, 42. 
BARTLETT, A. V., ENGLENDER, S. J., JARVIS, B. A., LUDWIG, L., CARLSON, J. F. & TOPPING, J. 
P. 1991. Controlled trial of Giardia lamblia: control strategies in day care centers. 
Am J Public Health, 81, 1001-6. 
BAYLESS, T. M. & CHRISTOPHER, N. L. 1969. Disaccharidase deficiency. Am J Clin Nutr, 22, 
181-90. 
BAZAN-TEJEDA, M. L., ARGUELLO-GARCIA, R., BERMUDEZ-CRUZ, R. M., ROBLES-FLORES, M. 
& ORTEGA-PIERRES, G. 2007. Protein kinase C isoforms from Giardia duodenalis: 
identification and functional characterization of a beta-like molecule during 
encystment. Arch Microbiol, 187, 55-66. 
BEAUMONT, D. M. & JAMES, O. F. 1986. Unsuspected giardiasis as a cause of malnutrition 
and diarrhoea in the elderly. Br Med J (Clin Res Ed), 293, 554-5. 
BEDNARSKA, M., BAJER, A., SINSKI, E., GIROUARD, A. S., TAMANG, L. & GRACZYK, T. K. 
2007. Fluorescent in situ hybridization as a tool to retrospectively identify 
Cryptosporidium parvum and Giardia lamblia in samples from terrestrial 
mammalian wildlife. Parasitol Res, 100, 455-60. 
BEDORE, J., LEASK, A. & SEGUIN, C. A. 2014. Targeting the extracellular matrix: Matricellular 
proteins regulate cell-extracellular matrix communication within distinct niches of 
the intervertebral disc. Matrix Biol. 
BEHR, M. A., KOKOSKIN, E., GYORKOS, T. W., CEDILOTTE, L., FAUBERT, G. M. & MACLEAN, J. 
D. 1997. Laboratory diagnosis for Giardia lamblia infection: A comparison of 
microscopy, coprodiagnosis and serology. Can J Infect Dis, 8, 33-8. 
BELL, A., MONAGHAN, P. & PAGE, A. P. 2006. Peptidyl-prolyl cis-trans isomerases 
(immunophilins) and their roles in parasite biochemistry, host-parasite interaction 
and antiparasitic drug action. Int J Parasitol, 36, 261-76. 
BENCHIMOL, M. 2002. A new set of vesicles in Giardia lamblia. Exp Parasitol, 102, 30-7. 
References 
347 | P a g e  
BENERE, E., T, V. A. N. A., COS, P. & MAES, L. 2011. Variation in growth and drug 
susceptibility among Giardia duodenalis assemblages A, B and E in axenic in vitro 
culture and in the gerbil model. Parasitology, 138, 1354-61. 
BENERE, E., VAN ASSCHE, T., VAN GINNEKEN, C., PEULEN, O., COS, P. & MAES, L. 2012. 
Intestinal growth and pathology of Giardia duodenalis assemblage subtype A(I), 
A(II), B and E in the gerbil model. Parasitology, 139, 424-33. 
BERKMAN, D. S., LESCANO, A. G., GILMAN, R. H., LOPEZ, S. L. & BLACK, M. M. 2002. Effects 
of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition 
in late childhood: a follow-up study. Lancet, 359, 564-71. 
BERNAL, R. M., TOVAR, R., SANTOS, J. I. & MUNOZ, M. L. 1998. Possible role of calmodulin 
in excystation of Giardia lamblia. Parasitol Res, 84, 687-93. 
BERNANDER, R., PALM, J. E. & SVARD, S. G. 2001. Genome ploidy in different stages of the 
Giardia lamblia life cycle. Cell Microbiol, 3, 55-62. 
BERTRAND, I., GANTZER, C., CHESNOT, T. & SCHWARTZBROD, J. 2004. Improved specificity 
for Giardia lamblia cyst quantification in wastewater by development of a real-time 
PCR method. J Microbiol Methods, 57, 41-53. 
BETANCOURT, W. Q. & ROSE, J. B. 2004. Drinking water treatment processes for removal of 
Cryptosporidium and Giardia. Vet Parasitol, 126, 219-34. 
BHAT, S. A., SINGH, N., TRIVEDI, A., KANSAL, P., GUPTA, P. & KUMAR, A. 2012. The 
mechanism of redox sensing in Mycobacterium tuberculosis. Free Radic Biol Med, 
53, 1625-41. 
BINGLE, L. E., EASTLAKE, J. L., MBAILEY, M. & GIBSON, W. C. 2001. A novel GFP approach for 
the analysis of genetic exchange in trypanosomes allowing the in situ detection of 
mating events. Microbiology, 147, 3231-40. 
BIRKY, C. W., JR. 1996. Heterozygosity, heteromorphy, and phylogenetic trees in asexual 
eukaryotes. Genetics, 144, 427-37. 
BIRKY, C. W., JR. 2005. Sex: is giardia doing it in the dark? Curr Biol, 15, R56-8. 
BLOBEL, G. & DOBBERSTEIN, B. 1975. Transfer of proteins across membranes. I. Presence of 
proteolytically processed and unprocessed nascent immunoglobulin light chains on 
membrane-bound ribosomes of murine myeloma. J Cell Biol, 67, 835-51. 
BOREHAM, P. F., PHILLIPS, R. E. & SHEPHERD, R. W. 1985. A comparison of the in-vitro 
activity of some 5-nitroimidazoles and other compounds against Giardia 
intestinalis. J Antimicrob Chemother, 16, 589-95. 
BORGSTROM, B. 1988. Mode of action of tetrahydrolipstatin: a derivative of the naturally 
occurring lipase inhibitor lipstatin. Biochim Biophys Acta, 962, 308-16. 
BOTERO-GARCES, J. H., GARCIA-MONTOYA, G. M., GRISALES-PATINO, D., AGUIRRE-
ACEVEDO, D. C. & ALVAREZ-URIBE, M. C. 2009. Giardia intestinalis and nutritional 
status in children participating in the complementary nutrition program, Antioquia, 
Colombia, May to October 2006. Rev Inst Med Trop Sao Paulo, 51, 155-62. 
BRANDT, T., BREITENSTEIN, S., VON DER HARDT, H. & TUMMLER, B. 1995. DNA 
concentration and length in sputum of patients with cystic fibrosis during 
inhalation with recombinant human DNase. Thorax, 50, 880-2. 
BRASSEUR, P. & FAVENNEC, L. 1995. Two cases of giardiasis unsuccessfully treated by 
albendazole. Parasite, 2, 422. 
BREATHNACH, A. S., MCHUGH, T. D. & BUTCHER, P. D. 2010. Prevalence and clinical 
correlations of genetic subtypes of Giardia lamblia in an urban setting. Epidemiol 
Infect, 138, 1459-67. 
BROWN, D. M., UPCROFT, J. A., EDWARDS, M. R. & UPCROFT, P. 1998. Anaerobic bacterial 
metabolism in the ancient eukaryote Giardia duodenalis. Int J Parasitol, 28, 149-64. 
BROWN, T. 2002. Chapter 3: Transcriptomes and Proteomes. Genomes, Second Edition. 
Oxford: Wiley-Liss. 
References 
348 | P a g e  
BURET, A. G. 2007. Mechanisms of epithelial dysfunction in giardiasis. Gut, 56, 316-7. 
BURET, A. G. 2008. Pathophysiology of enteric infections with Giardia duodenalius. 
Parasite, 15, 261-5. 
CACCIO, S. M., BECK, R., LALLE, M., MARINCULIC, A. & POZIO, E. 2008. Multilocus 
genotyping of Giardia duodenalis reveals striking differences between assemblages 
A and B. Int J Parasitol, 38, 1523-31. 
CACCIO, S. M. & RYAN, U. 2008. Molecular epidemiology of giardiasis. Mol Biochem 
Parasitol, 160, 75-80. 
CACCIO, S. M. & SPRONG, H. 2010. Giardia duodenalis: genetic recombination and its 
implications for taxonomy and molecular epidemiology. Exp Parasitol, 124, 107-12. 
CACCIO, S. M., THOMPSON, R. C., MCLAUCHLIN, J. & SMITH, H. V. 2005. Unravelling 
Cryptosporidium and Giardia epidemiology. Trends Parasitol, 21, 430-7. 
CARNABY, S., BUTCHER, P. D., SUMMERBELL, C. D., NAEEM, A. & FARTHING, M. J. 1995. 
Minisatellites corresponding to the human polycore probes 33.6 and 33.15 in the 
genome of the most 'primitive' known eukaryote Giardia lamblia. Gene, 166, 167-
72. 
CARNABY, S., KATELARIS, P. H., NAEEM, A. & FARTHING, M. J. 1994. Genotypic 
heterogeneity within Giardia lamblia isolates demonstrated by M13 DNA 
fingerprinting. Infect Immun, 62, 1875-80. 
CARRANZA, P. G. & LUJAN, H. D. 2010. New insights regarding the biology of Giardia 
lamblia. Microbes Infect, 12, 71-80. 
CAVALIER-SMITH, T. 2002. Origins of the machinery of recombination and sex. Heredity 
(Edinb), 88, 125-41. 
CAVALIER-SMITH, T. 2003. Protist phylogeny and the high-level classification of Protozoa. 
European Journal of Protistology, 39, 338-348. 
CDC. Prevention and Control- Giardiasis [Online]. 
http://www.cdc.gov/parasites/giardia/prevent.html. Available: 
http://www.cdc.gov/parasites/giardia/prevent.html. 
CDC 2013. Notifiable Diseases and Mortality Tables for 2004-2013. 
CEVALLOS, A., CARNABY, S., JAMES, M. & FARTHING, J. G. 1995. Small intestinal injury in a 
neonatal rat model of giardiasis is strain dependent. Gastroenterology, 109, 766-
73. 
CHANTRET, I., BARBAT, A., DUSSAULX, E., BRATTAIN, M. G. & ZWEIBAUM, A. 1988. 
Epithelial polarity, villin expression, and enterocytic differentiation of cultured 
human colon carcinoma cells: a survey of twenty cell lines. Cancer Res, 48, 1936-42. 
CHIN, A. C., TEOH, D. A., SCOTT, K. G., MEDDINGS, J. B., MACNAUGHTON, W. K. & BURET, A. 
G. 2002. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia 
disrupts epithelial barrier function in a caspase-3-dependent manner. Infect 
Immun, 70, 3673-80. 
CHIQUET-EHRISMANN, R. & CHIQUET, M. 2003. Tenascins: regulation and putative 
functions during pathological stress. J Pathol, 200, 488-99. 
CIFUENTES, E., GOMEZ, M., BLUMENTHAL, U., TELLEZ-ROJO, M. M., ROMIEU, I., RUIZ-
PALACIOS, G. & RUIZ-VELAZCO, S. 2000. Risk factors for Giardia intestinalis 
infection in agricultural villages practicing wastewater irrigation in Mexico. Am J 
Trop Med Hyg, 62, 388-92. 
CLARK, J. T. & HOLBERTON, D. V. 1988. Triton-labile antigens in flagella isolated from 
Giardia lamblia. Parasitol Res, 74, 415-23. 
COBRIN, G. M. & ABREU, M. T. 2005. Defects in mucosal immunity leading to Crohn's 
disease. Immunol Rev, 206, 277-95. 
CONDEELIS, J. 1995. Elongation factor 1 alpha, translation and the cytoskeleton. Trends 
Biochem Sci, 20, 169-70. 
References 
349 | P a g e  
CONNER, S. D. & SCHMID, S. L. 2003. Regulated portals of entry into the cell. Nature, 422,  
37-44. 
CONNOLLY, P. F., JAGER, R. & FEARNHEAD, H. O. 2014. New roles for old enzymes: killer 
caspases as the engine of cell behavior changes. Front Physiol, 5, 149. 
COOPER, M. A., ADAM, R. D., WOROBEY, M. & STERLING, C. R. 2007. Population genetics 
provides evidence for recombination in Giardia. Curr Biol, 17, 1984-8. 
COSTACHE, C. A., COLOSI, I. A. & COLOSI, H. A. 2009. Immunochromatography versus 
microscopy for the identification of Giardia lamblia and Cryptosporidium parvum in 
human feces Sci Parasitol, 10, 26-31. 
COTTON, J. A., BEATTY, J. K. & BURET, A. G. 2011. Host parasite interactions and 
pathophysiology in Giardia infections. Int J Parasitol, 41, 925-33. 
COTTON, J. A., BHARGAVA, A., FERRAZ, J. G., YATES, R. M., BECK, P. L. & BURET, A. G. 2014. 
Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 
and attenuate interleukin-8-induced neutrophil chemotaxis. Infect Immun. 
COVACIN, C., AUCOIN, D. P., ELLIOT, A. & THOMPSON, R. C. 2011. Genotypic 
characterisation of Giardia from domestic dogs in the USA. Vet Parasitol, 177, 28-
32. 
CRAIG, E. A., GAMBILL, B. D. & NELSON, R. J. 1993. Heat shock proteins: molecular 
chaperones of protein biogenesis. Microbiol Rev, 57, 402-14. 
CROSSLEY, R. & HOLBERTON, D. 1985. Assembly of 2.5 nm filaments from giardin, a protein 
associated with cytoskeletal microtubules in Giardia. J Cell Sci, 78, 205-31. 
D'ANCHINO, M., ORLANDO, D. & DE FEUDIS, L. 2002. Giardia lamblia infections become 
clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect, 45, 
169-72. 
DACKS, J. B. & DOOLITTLE, W. F. 2002. Novel syntaxin gene sequences from Giardia, 
Trypanosoma and algae: implications for the ancient evolution of the eukaryotic 
endomembrane system. J Cell Sci, 115, 1635-42. 
DARBON, A., PORTAL, A., GIRIER, L., PANTIN, J. & LECLAIRE, C. 1962. [Treatment of 
giardiasis (lambliasis) with metronidazole. Apropos of 100 cases]. La Presse 
medicale, 70, 15-6. 
DAS, S., STEVENS, T., CASTILLO, C., VILLASENOR, A., ARREDONDO, H. & REDDY, K. 2002. 
Lipid metabolism in mucous-dwelling amitochondriate protozoa. Int J Parasitol, 32, 
655-75. 
DAVIDS, B. J., REINER, D. S., BIRKELAND, S. R., PREHEIM, S. P., CIPRIANO, M. J., MCARTHUR, 
A. G. & GILLIN, F. D. 2006. A new family of giardial cysteine-rich non-VSP protein 
genes and a novel cyst protein. PLoS One, 1, e44. 
DAWSON, D. 2005. Foodborne protozoan parasites. Int J Food Microbiol, 103, 207-27. 
DEAN, M., HAMON, Y. & CHIMINI, G. 2001. The human ATP-binding cassette (ABC) 
transporter superfamily. J Lipid Res, 42, 1007-17. 
DENG, M. Q. & CLIVER, D. O. 1999. Rapid DNA extraction methods and new primers for 
randomly amplified polymorphic DNA analysis of Giardia duodenalis. J Microbiol 
Methods, 37, 193-200. 
DENKEL, L. A., HORST, S. A., ROUF, S. F., KITOWSKI, V., BOHM, O. M., RHEN, M., JAGER, T. & 
BANGE, F. C. 2011. Methionine sulfoxide reductases are essential for virulence of 
Salmonella typhimurium. PLoS One, 6, e26974. 
DI MATTEO, A., SCANDURRA, F. M., TESTA, F., FORTE, E., SARTI, P., BRUNORI, M. & 
GIUFFRE, A. 2008. The O2-scavenging flavodiiron protein in the human parasite 
Giardia intestinalis. J Biol Chem, 283, 4061-8. 
DOBELL, C. 1920. The Discovery of the Intestinal Protozoa of Man. Proc R Soc Med, 13, 1-
15. 
References 
350 | P a g e  
DOMANOVA, O., BORBE, S., MUHLFELD, S., BECKER, M., KUBITZ, R., HAUSSINGER, D. & 
BERLAGE, T. 2011. Toponomics method for the automated quantification of 
membrane protein translocation. BMC Bioinformatics, 12, 370. 
DORSCH, M. R. & VEAL, D. A. 2001. Oligonucleotide probes for specific detection of Giardia 
lamblia cysts by fluorescent in situ hybridization. J Appl Microbiol, 90, 836-42. 
DRUBIN, D. G. & NELSON, W. J. 1996. Origins of cell polarity. Cell, 84, 335-44. 
DUBOIS, K. N., ABODEELY, M., SAJID, M., ENGEL, J. C. & MCKERROW, J. H. 2006. Giardia 
lamblia cysteine proteases. Parasitol Res, 99, 313-6. 
DUBOIS, K. N., ABODEELY, M., SAKANARI, J., CRAIK, C. S., LEE, M., MCKERROW, J. H. & 
SAJID, M. 2008. Identification of the major cysteine protease of Giardia and its role 
in encystation. J Biol Chem, 283, 18024-31. 
DUREL, P., ROIRON, V., SIBOULET, A. & BOREL, L. J. 1960. Systemic treatment of human 
trichomoniasis with a derivative of nitro-imidazole, 8823 RP. The British journal of 
venereal diseases, 36, 21-6. 
ECDC 2010a. - Annual Epidemiological Report on Communicable Diseases in Europe 2010. 
ECDC. 2010b. Factsheet for the general public - Giardia [Online]. 
http://www.ecdc.europa.eu/en/healthtopics/giardiasis/factsheet-general-
public/Pages/Factsheet_general_public.aspx. Available: 
http://www.ecdc.europa.eu/en/healthtopics/giardiasis/factsheet-general-
public/Pages/Factsheet_general_public.aspx. 
ECDC 2012. Annual epidemiological report reporting on 2010 surveillance ata and 2011 
epidemic data. 
ECDC 2013. Annual epidemiological report reporting on 2011 surveillance data and 2012 
epidemic intelligence data. 
ECKMANN, L., LAURENT, F., LANGFORD, T. D., HETSKO, M. L., SMITH, J. R., KAGNOFF, M. F. 
& GILLIN, F. D. 2000. Nitric oxide production by human intestinal epithelial cells and 
competition for arginine as potential determinants of host defense against the 
lumen-dwelling pathogen Giardia lamblia. J Immunol, 164, 1478-87. 
EDLIND, T. D. 1989. Susceptibility of Giardia lamblia to aminoglycoside protein synthesis 
inhibitors: correlation with rRNA structure. Antimicrob Agents Chemother, 33, 484-
8. 
ELIGIO-GARCIA, L., CORTES-CAMPOS, A., COTA-GUAJARDO, S., GAXIOLA, S. & JIMENEZ-
CARDOSO, E. 2008. Frequency of Giardia intestinalis assemblages isolated from 
dogs and humans in a community from Culiacan, Sinaloa, Mexico using beta-giardin 
restriction gene. Vet Parasitol, 156, 205-9. 
ELLIS, J. G. T., DAVILA, M. & CHAKRABARTI, R. 2003. Potential involvement of extracellular 
signal-regulated kinase 1 and 2 in encystation of a primitive eukaryote, Giardia 
lamblia. Stage-specific activation and intracellular localization. J Biol Chem, 278, 
1936-45. 
ELMENDORF, H. G., DAWSON, S. C. & MCCAFFERY, J. M. 2003. The cytoskeleton of Giardia 
lamblia. Int J Parasitol, 33, 3-28. 
ELNIFRO, E. M., ASHSHI, A. M., COOPER, R. J. & KLAPPER, P. E. 2000. Multiplex PCR: 
optimization and application in diagnostic virology. Clin Microbiol Rev, 13, 559-70. 
ELSAFI, S. H., AL-MAQATI, T. N., HUSSEIN, M. I., ADAM, A. A., HASSAN, M. M. & AL 
ZAHRANI, E. M. 2013. Comparison of microscopy, rapid immunoassay, and 
molecular techniques for the detection of Giardia lamblia and Cryptosporidium 
parvum. Parasitol Res, 112, 1641-6. 
ERLANDSEN, S. L., BEMRICK, W. J., SCHUPP, D. E., SHIELDS, J. M., JARROLL, E. L., SAUCH, J. F. 
& PAWLEY, J. B. 1990. High-resolution immunogold localization of Giardia cyst wall 
antigens using field emission SEM with secondary and backscatter electron 
imaging. J Histochem Cytochem, 38, 625-32. 
References 
351 | P a g e  
ERLANDSEN, S. L., JARROLL, E., WALLIS, P. & VAN KEULEN, H. 2005. Development of 
species-specific rDNA probes for Giardia by multiple fluorescent in situ 
hybridization combined with immunocytochemical identification of cyst wall 
antigens. J Histochem Cytochem, 53, 917-27. 
ESCOBEDO, A. A. & NUNEZ, F. A. 1999. Prevalence of intestinal parasites in Cuban acquired 
immunodeficiency syndrome (AIDS) patients. Acta Trop, 72, 125-30. 
FARTHING, M. J. 1992. Giardia comes of age: progress in epidemiology, immunology and 
chemotherapy. J Antimicrob Chemother, 30, 563-6. 
FARTHING, M. J., PEREIRA, M. E. & KEUSCH, G. T. 1986. Description and characterization of 
a surface lectin from Giardia lamblia. Infect Immun, 51, 661-7. 
FASO, C., BISCHOF, S. & HEHL, A. B. 2013. The proteome landscape of Giardia lamblia 
encystation. PLoS One, 8, e83207. 
FAUBERT, G. 2000. Immune response to Giardia duodenalis. Clin Microbiol Rev, 13, 35-54, 
table of contents. 
FELIZIANI, C., MERINO, M. C., RIVERO, M. R., HELLMAN, U., PISTORESI-PALENCIA, M. C. & 
ROPOLO, A. S. 2011. Immunodominant proteins alpha-1 giardin and beta-giardin 
are expressed in both assemblages A and B of Giardia lamblia. BMC Microbiol, 11, 
233. 
FENG, Y. & XIAO, L. 2011. Zoonotic potential and molecular epidemiology of Giardia species 
and giardiasis. Clin Microbiol Rev, 24, 110-40. 
FILICE, F. P. 1952. Studies on the cytology and life history of a Giardia from the laboratory 
rat. In: ZOOLOGY, U. O. C. P. I. (ed.) Studies on the cytology and life history of a 
Giardia from the laboratory rat. University of California Press: Berkeley. 
FLANAGAN, P. A. 1992. Giardia--diagnosis, clinical course and epidemiology. A review. 
Epidemiol Infect, 109, 1-22. 
FLUEGGE, K., SCHWEIER, O., SCHILTZ, E., BATSFORD, S. & BERNER, R. 2004. Identification 
and immunoreactivity of proteins released from Streptococcus agalactiae. Eur J Clin 
Microbiol Infect Dis, 23, 818-24. 
FORD, B. J. 2005. The discovery of Giardia. Microscope, 53, 147-53. 
FRANZEN, O., JERLSTROM-HULTQVIST, J., CASTRO, E., SHERWOOD, E., ANKARKLEV, J., 
REINER, D. S., PALM, D., ANDERSSON, J. O., ANDERSSON, B. & SVARD, S. G. 2009. 
Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human 
giardiasis caused by two different species? PLoS Pathog, 5, e1000560. 
FRANZEN, O., JERLSTROM-HULTQVIST, J., EINARSSON, E., ANKARKLEV, J., FERELLA, M., 
ANDERSSON, B. & SVARD, S. G. 2013. Transcriptome profiling of Giardia intestinalis 
using strand-specific RNA-seq. PLoS Comput Biol, 9, e1003000. 
GARCIA, L. S. & GARCIA, J. P. 2006. Detection of Giardia lamblia antigens in human fecal 
specimens by a solid-phase qualitative immunochromatographic assay. J Clin 
Microbiol, 44, 4587-8. 
GARDNER, T. B. & HILL, D. R. 2001. Treatment of giardiasis. Clinical microbiology reviews, 
14, 114-28. 
GAUNT, M. W., YEO, M., FRAME, I. A., SLOTHARD, J. R., CARRASCO, H. J., TAYLOR, M. C., 
MENA, S. S., VEAZEY, P., MILES, G. A., ASCOTA, N., DE ARIAS, A. R. & MILES, M. A. 
2003. Mechanism of genetic exchange in American trypanosomes. Nature, 421, 
936-9. 
GELANEW, T., LALLE, M., HAILU, A., POZIO, E. & CACCIO, S. M. 2007. Molecular 
characterization of human isolates of Giardia duodenalis from Ethiopia. Acta Trop, 
102, 92-9. 
GILBERT, H. F. 1997. Protein disulfide isomerase and assisted protein folding. J Biol Chem, 
272, 29399-402. 
References 
352 | P a g e  
GILLIN, F. D. & DIAMOND, L. S. 1981. Inhibition of clonal growth of Giardia lamblia and 
Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial 
agents. J Antimicrob Chemother, 8, 305-16. 
GONI, P., MARTIN, B., VILLACAMPA, M., GARCIA, A., SERAL, C., CASTILLO, F. J. & CLAVEL, A. 
2012. Evaluation of an immunochromatographic dip strip test for simultaneous 
detection of Cryptosporidium spp, Giardia duodenalis, and Entamoeba histolytica 
antigens in human faecal samples. Eur J Clin Microbiol Infect Dis, 31, 2077-82. 
GORDTS, B., HEMELHOF, W., ASSELMAN, C. & BUTZLER, J. P. 1985. In vitro susceptibilities 
of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal 
agents. Antimicrob Agents Chemother, 28, 378-80. 
GOTTIG, N., ELIAS, E. V., QUIROGA, R., NORES, M. J., SOLARI, A. J., TOUZ, M. C. & LUJAN, H. 
D. 2006. Active and passive mechanisms drive secretory granule biogenesis during 
differentiation of the intestinal parasite Giardia lamblia. J Biol Chem, 281, 18156-
66. 
GOTTLIEB, M. 1989. The surface membrane 3'-nucleotidase/nuclease of trypanosomatid 
protozoa. Parasitol Today, 5, 257-60. 
GRASSET, E., PINTO, M., DUSSAULX, E., ZWEIBAUM, A. & DESJEUX, J. F. 1984. Epithelial 
properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am J 
Physiol, 247, C260-7. 
GRAZIOLI, B., MATERA, G., LARATTA, C., SCHIPANI, G., GUARNIERI, G., SPINIELLO, E., 
IMENEO, M., AMOROSI, A., FOCA, A. & LUZZA, F. 2006. Giardia lamblia infection in 
patients with irritable bowel syndrome and dyspepsia: a prospective study. World J 
Gastroenterol, 12, 1941-4. 
GUICHARD, A., CRUZ-MORENO, B., AGUILAR, B., VAN SORGE, N. M., KUANG, J., KURKCIYAN, 
A. A., WANG, Z., HANG, S., PINETON DE CHAMBRUN, G. P., MCCOLE, D. F., 
WATNICK, P., NIZET, V. & BIER, E. 2013. Cholera toxin disrupts barrier function by 
inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. 
Cell Host Microbe, 14, 294-305. 
HADRYS, H., BALICK, M. & SCHIERWATER, B. 1992. Applications of random amplified 
polymorphic DNA (RAPD) in molecular ecology. Mol Ecol, 1, 55-63. 
HAHN, J., SEEBER, F., KOLODZIEJ, H., IGNATIUS, R., LAUE, M., AEBISCHER, T. & KLOTZ, C. 
2013. High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro. 
PloS one, 8, e71597. 
HALL, P. A., COATES, P. J., ANSARI, B. & HOPWOOD, D. 1994. Regulation of cell number in 
the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci, 107 (  
Pt 12), 3569-77. 
HAMPL, V., HUG, L., LEIGH, J. W., DACKS, J. B., LANG, B. F., SIMPSON, A. G. & ROGER, A. J. 
2009. Phylogenomic analyses support the monophyly of Excavata and resolve 
relationships among eukaryotic "supergroups". Proc Natl Acad Sci U S A, 106,  3859-
64. 
HAQUE, R., ROY, S., SIDDIQUE, A., MONDAL, U., RAHMAN, S. M., MONDAL, D., HOUPT, E. & 
PETRI, W. A., JR. 2007. Multiplex real-time PCR assay for detection of Entamoeba 
histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg, 76,  
713-7. 
HARMS, H. K., MATOUK, E., TOURNIER, G., VON DER HARDT, H., WELLER, P. H., ROMANO, 
L., HEIJERMAN, H. G., FITZGERALD, M. X., RICHARD, D., STRANDVIK, B., KOLBE, J., 
KRAEMER, R. & MICHALSEN, H. 1998. Multicenter, open-label study of recombinant 
human DNase in cystic fibrosis patients with moderate lung disease. DNase 
International Study Group. Pediatr Pulmonol, 26, 155-61. 
HARRIS, J. C., PLUMMER, S. & LLOYD, D. 2001. Antigiardial drugs. Appl Microbiol Biotechnol, 
57, 614-9. 
References 
353 | P a g e  
HEHL, A. B. & MARTI, M. 2004. Secretory protein trafficking in Giardia intestinalis. Mol 
Microbiol, 53, 19-28. 
HEHL, A. B., MARTI, M. & KOHLER, P. 2000. Stage-specific expression and targeting of cyst 
wall protein-green fluorescent protein chimeras in Giardia. Mol Biol Cell, 11, 1789-
800. 
HEITMAN, J. 2006. Sexual reproduction and the evolution of microbial pathogens. Curr Biol, 
16, R711-25. 
HELED, J. & DRUMMOND, A. J. 2010. Bayesian inference of species trees from multilocus 
data. Mol Biol Evol, 27, 570-80. 
HERBST, E. W., ARMBRUSTER, M., RUMP, J. A., BUSCHER, H. P. & PETER, H. H. 1994. 
Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol, 
95, 215-21. 
HERMASZEWSKI, R. A. & WEBSTER, A. D. 1993. Primary hypogammaglobulinaemia: a survey 
of clinical manifestations and complications. Q J Med, 86, 31-42. 
HEYWOOD, P. & MAGEE, P. T. 1976. Meiosis in protists. Some structural and physiol ogical 
aspects of meiosis in algae, fungi, and protozoa. Bacteriol Rev, 40, 190-240. 
HILTPOLD, A., FREY, M., HULSMEIER, A. & KOHLER, P. 2000. Glycosylation and 
palmitoylation are common modifications of giardia variant surface proteins. Mol 
Biochem Parasitol, 109, 61-5. 
HODGES, K. & GILL, R. 2010. Infectious diarrhea: Cellular and molecular mechanisms. Gut 
Microbes, 1, 4-21. 
HOLBERTON, D. V. 1981. Arrangement of subunits in microribbons from Giardia. J Cell Sci, 
47, 167-85. 
HOLM, L. M., JAHN, T. P., MOLLER,  A. L., SCHJOERRING, J. K., FERRI, D., KLAERKE, D. A. & 
ZEUTHEN, T. 2005. NH3 and NH4+ permeability in aquaporin-expressing Xenopus 
oocytes. Pflugers Arch, 450, 415-28. 
HOMAN, W. L. & MANK, T. G. 2001. Human giardiasis: genotype linked differences in 
clinical symptomatology. Int J Parasitol, 31, 822-6. 
HOYNE, G. F., BOREHAM, P. F., PARSONS, P. G., WARD, C. & BIGGS, B. 1989. The effect of 
drugs on the cell cycle of Giardia intestinalis. Parasitology, 99 Pt 3, 333-9. 
HUEY, C. S., MAHDY, M. A., AL-MEKHLAFI, H. M., NASR, N. A., LIM, Y. A., MAHMUD, R. & 
SURIN, J. 2013. Multilocus genotyping of Giardia duodenalis in Malaysia. Infect 
Genet Evol, 17, 269-76. 
HUNTER, P. R. & THOMPSON, R. C. 2005. The zoonotic transmission of Giardia and 
Cryptosporidium. Int J Parasitol, 35, 1181-90. 
IANELLI, C. J., DELELLIS, R. & THORLEY-LAWSON, D. A. 1998. CD48 binds to heparan sulfate 
on the surface of epithelial cells. J Biol Chem, 273, 23367-75. 
INVS 2012. Institut de Veille Sanitaire -Bulletin epidemiologique hebdomadaire: 
Recommendations sanitaires pour les voyageurs, 2012. 
JABAJI, Z., SEARS, C. M., BRINKLEY, G. J., LEI, N. Y., JOSHI, V. S., WANG, J., LEWIS, M., 
STELZNER, M., MARTIN, M. G. & DUNN, J. C. 2013. Use of collagen gel as an 
alternative extracellular matrix for the in vitro and in vivo growth of murine small 
intestinal epithelium. Tissue Eng Part C Methods, 19, 961-9. 
JACKSON, A. P., OTTO, T. D., DARBY, A., RAMAPRASAD, A., XIA, D., ECHAIDE, I. E., FARBER, 
M., GAHLOT, S., GAMBLE, J., GUPTA, D., GUPTA, Y., JACKSON, L., MALANDRIN, L., 
MALAS, T. B., MOUSSA, E., NAIR, M., REID, A. J., SANDERS, M., SHARMA, J., TRACEY, 
A., QUAIL, M. A., WEIR, W., WASTLING, J. M., HALL, N., WILLADSEN, P., 
LINGELBACH, K., SHIELS, B., TAIT, A., BERRIMAN, M., ALLRED, D. R. & PAIN, A. 2014. 
The evolutionary dynamics of variant antigen genes in Babesia reveal a history of 
genomic innovation underlying host-parasite interaction. Nucleic Acids Res. 
References 
354 | P a g e  
JASINSKI, M., STUKKENS, Y., DEGAND, H., PURNELLE, B., MARCHAND-BRYNAERT, J. & 
BOUTRY, M. 2001. A plant plasma membrane ATP binding cassette-type 
transporter is involved in antifungal terpenoid secretion. Plant Cell, 13, 1095-107. 
JEFFREYS, A. J., WILSON, V. & THEIN, S. L. 1985. Hypervariable 'minisatellite' regions in 
human DNA. Nature, 314, 67-73. 
JENKINS, M. C., O'BRIEN, C. N., MURPHY, C., SCHWARZ, R., MISKA, K., ROSENTHAL, B. & 
TROUT, J. M. 2009. Antibodies to the ventral disc protein delta-giardin prevent in 
vitro binding of Giardia lamblia trophozoites. J Parasitol, 95, 895-9. 
JERLSTROM-HULTQVIST, J., FRANZEN, O., ANKARKLEV, J., XU, F., NOHYNKOVA, E., 
ANDERSSON, J. O., SVARD, S. G. & ANDERSSON, B. 2010. Genome analysis and 
comparative genomics of a Giardia intestinalis assemblage E isolate. BMC 
Genomics, 11, 543. 
JEX, A. R., STANLEY, K. K., LO, W., LITTMAN, R., VERWEIJ, J. J., CAMPBELL, B. E., NOLAN, M. 
J., PANGASA, A., STEVENS, M. A., HAYDON, S. & GASSER, R. B. 2012. Detection of 
diarrhoeal pathogens in human faeces using an automated, robotic platform. Mol 
Cell Probes, 26, 11-5. 
JOHNSTON, B. C., DONEN, R., POONI, A., POND, J., XIE, F., GIGLIA, L., KAM, A., BHAMBER, 
A., BAMI, K., PATEL, Y. & GUYATT, G. H. 2013. Conceptual framework for health-
related quality of life assessment in acute gastroenteritis. J Pediatr Gastroenterol 
Nutr, 56, 280-9. 
JOHNSTON, S. P., BALLARD, M. M., BEACH, M. J., CAUSER, L. & WILKINS, P. P. 2003. 
Evaluation of three commercial assays for detection of Giardia and 
Cryptosporidium organisms in fecal specimens. J Clin Microbiol, 41, 623-6. 
JUNG, H. C., ECKMANN, L., YANG, S. K., PANJA, A., FIERER, J., MORZYCKA-WROBLEWSKA, E. 
& KAGNOFF, M. F. 1995. A distinct array of proinflammatory cytokines is expressed 
in human colon epithelial cells in response to bacterial invasion. J Clin Invest, 95, 
55-65. 
KAMITANI, T., KITO, K., NGUYEN, H. P., FUKUDA-KAMITANI, T. & YEH, E. T. 1998. 
Characterization of a second member of the sentrin family of ubiquitin-like 
proteins. J Biol Chem, 273, 11349-53. 
KARANIS, P., KOURENTI, C. & SMITH, H. 2007. Waterborne transmission of protozoan 
parasites: a worldwide review of outbreaks and lessons learnt. J Water Health, 5, 1-
38. 
KATELARIS, P. H. & FARTHING, M. J. 1992. Diarrhoea and malabsorption in giardiasis: a 
multifactorial process? Gut, 33, 295-7. 
KATIYAR, S. K., GORDON, V. R., MCLAUGHLIN, G. L. & EDLIND, T. D. 1994. Antiprotozoal 
activities of benzimidazoles and correlations with beta-tubulin sequence. 
Antimicrob Agents Chemother, 38, 2086-90. 
KAVOUSI, S. 1979. Giardiasis in infancy and childhood: a prospective study of 160 cases 
with comparison of quinacrine (Atabrine) and metronidazole (Flagyl). Am J Trop 
Med Hyg, 28, 19-23. 
KEELING, P. J., BURGER, G., DURNFORD, D. G., LANG, B. F., LEE, R. W., PEARLMAN, R. E., 
ROGER, A. J. & GRAY, M. W. 2005. The tree of eukaryotes. Trends Ecol Evol, 20, 
670-6. 
KEISTER, D. B. 1983. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented 
with bile. Trans R Soc Trop Med Hyg, 77, 487-8. 
KELLOGG, J. A. & ELDER, C. J. 1999. Justification for use of a single trichrome stain as the 
sole means for routine detection of intestinal parasites in concentrated stool 
specimens. J Clin Microbiol, 37, 835-7. 
References 
355 | P a g e  
KIEDROWSKI, M. R., CROSBY, H. A., HERNANDEZ, F. J., MALONE, C. L., MCNAMARA, J . O., 
2ND & HORSWILL, A. R. 2014. Staphylococcus aureus Nuc2 Is a Functional, Surface-
Attached Extracellular Nuclease. PLoS One, 9, e95574. 
KIM, H. Y. & GLADYSHEV, V. N. 2004. Methionine sulfoxide reduction in mammals: 
characterization of methionine-R-sulfoxide reductases. Mol Biol Cell, 15, 1055-64. 
KIM, K. T., MOK, M. T. & EDWARDS, M. R. 2005. Protein kinase B from Giardia intestinalis. 
Biochem Biophys Res Commun, 334, 333-41. 
KNODLER, L. A., NOIVA, R., MEHTA, K., MCCAFFERY, J. M., ALEY, S. B., SVARD, S. G., NYSTUL, 
T. G., REINER, D. S., SILBERMAN, J. D. & GILLIN, F. D. 1999. Novel protein-disulfide 
isomerases from the early-diverging protist Giardia lamblia. J Biol Chem, 274,  
29805-11. 
KOEHLER, A. V., JEX, A. R., HAYDON, S. R., STEVENS, M. A. & GASSER, R. B. 2013. 
Giardia/giardiasis - A perspective on diagnostic and analytical tools. Biotechnol Adv. 
KOFOID, C. A. & CHRISTIANSEN, E. B. 1915. On the Life-History of Giardia. Proc Natl Acad Sci 
U S A, 1, 547-52. 
KORCHEV, Y. E., GORELIK, J., LAB, M. J., SVIDERSKAYA, E. V., JOHNSTON, C. L., COOMBES, C. 
R., VODYANOY, I. & EDWARDS, C. R. 2000. Cell volume measurement using 
scanning ion conductance microscopy. Biophys J, 78, 451-7. 
KOSHY, S., ALIZADEH, P., TIMCHENKO, L. T. & BEETON, C. 2010. Quantitative measurement 
of GLUT4 translocation to the plasma membrane by flow cytometry. J Vis Exp. 
KOTLER, B. M., KERSTETTER, J. E. & INSOGNA, K. L. 2013. Claudins, dietary milk proteins, 
and intestinal barrier regulation. Nutr Rev, 71, 60-5. 
KOTLOFF, K. L., NATARO, J. P., BLACKWELDER, W. C., NASRIN, D., FARAG, T. H., 
PANCHALINGAM, S., WU, Y., SOW, S. O., SUR, D., BREIMAN, R. F., FARUQUE, A. S., 
ZAIDI, A. K., SAHA, D., ALONSO, P. L., TAMBOURA, B., SANOGO, D., ONWUCHEKWA, 
U., MANNA, B., RAMAMURTHY, T., KANUNGO, S., OCHIENG, J. B., OMORE, R., 
OUNDO, J. O., HOSSAIN, A., DAS, S. K., AHMED, S., QURESHI, S., QUADRI, F., 
ADEGBOLA, R. A., ANTONIO, M., HOSSAIN, M. J., AKINSOLA, A., MANDOMANDO, I., 
NHAMPOSSA, T., ACACIO, S., BISWAS, K., O'REILLY, C. E., MINTZ, E. D., BERKELEY, L.  
Y., MUHSEN, K., SOMMERFELT, H., ROBINS-BROWNE, R. M. & LEVINE, M. M. 2013. 
Burden and aetiology of diarrhoeal disease in infants and young children in 
developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, 
case-control study. Lancet, 382, 209-22. 
KRANE, C. M. & GOLDSTEIN, D. L. 2007. Comparative functional analysis of 
aquaporins/glyceroporins in mammals and anurans. Mamm Genome, 18, 452-62. 
KREUTNER, A. K., DEL BENE, V. E. & AMSTEY, M. S. 1981. Giardiasis in pregnancy. Am J 
Obstet Gynecol, 140, 895-901. 
KUCERS, A., CROWE, S. M., GRAYSON, L. M. & HOY, J. F. 1997. Bacitracin and gramicidin. In: 
HOY, J. F. (ed.) The use of antibiotics. A clinical review of antibacterial, antifungal, 
and antiviral drugs, 5th edition. Oxford, United Kingdom: Butterworth-Heinemann. 
KULAKOVA, L., SINGER, S. M., CONRAD, J. & NASH, T. E. 2006. Epigenetic mechanisms are 
involved in the control of Giardia lamblia antigenic variation. Mol Microbiol, 61,  
1533-42. 
LACEY, E. 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and 
mechanism of drug resistance to benzimidazoles. Int J Parasitol, 18, 885-936. 
LAEMMLI, U. K., BEGUIN, F. & GUJER-KELLENBERGER, G. 1970. A factor preventing the 
major head protein of bacteriophage T4 from random aggregation. J Mol Biol, 47,  
69-85. 
LANFREDI-RANGEL, A., ATTIAS, M., DE CARVALHO, T. M., KATTENBACH, W. M. & DE SOUZA, 
W. 1998. The peripheral vesicles of trophozoites of the primitive protozoan Giardia 
References 
356 | P a g e  
lamblia may correspond to early and late endosomes and to lysosomes. J Struct 
Biol, 123, 225-35. 
LANGFORD, T. D., SILBERMAN, J. D., WEILAND, M. E., SVARD, S. G., MCCAFFERY, J. M., 
SOGIN, M. L. & GILLIN, F. D. 2002. Giardia lamblia: identification and 
characterization of Rab and GDI proteins in a genome survey of the ER to Golgi 
endomembrane system. Exp Parasitol, 101, 13-24. 
LASEK-NESSELQUIST, E., WELCH, D. M. & SOGIN, M. L. 2010. The identification of a new 
Giardia duodenalis assemblage in marine vertebrates and a preliminary analysis of 
G. duodenalis population biology in marine systems. Int J Parasitol, 40, 1063-74. 
LASEK-NESSELQUIST, E., WELCH, D. M., THOMPSON, R. C., STEUART, R. F. & SOGIN, M. L. 
2009. Genetic exchange within and between assemblages of Giardia duodenalis. J 
Eukaryot Microbiol, 56, 504-18. 
LAU, A. H., LAM, N. P., PISCITELLI, S. C., WILKES, L. & DANZIGER, L. H. 1992. Clinical 
pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin 
Pharmacokinet, 23, 328-64. 
LAUWAET, T., DAVIDS, B. J., TORRES-ESCOBAR, A., BIRKELAND, S. R., CIPRIANO, M. J., 
PREHEIM, S. P., PALM, D., SVARD, S. G., MCARTHUR, A. G. & GILLIN, F. D. 2007. 
Protein phosphatase 2A plays a crucial role in Giardia lamblia differentiation. Mol 
Biochem Parasitol, 152, 80-9. 
LE BORGNE, R. & HOFLACK, B. 1998. Protein transport from the secretory to the endocytic 
pathway in mammalian cells. Biochim Biophys Acta, 1404, 195-209. 
LEBBAD, M., MATTSSON, J. G., CHRISTENSSON, B., LJUNGSTROM, B., BACKHANS, A., 
ANDERSSON, J. O. & SVARD, S. G. 2010. From mouse to moose: multilocus 
genotyping of Giardia isolates from various animal species. Veterinary parasitology, 
168, 231-9. 
LEBWOHL, B., DECKELBAUM, R. J. & GREEN, P. H. 2003. Giardiasis. Gastrointest Endosc, 57, 
906-13. 
LECHEVALLIER, M. W., NORTON, W. D. & LEE, R. G. 1991. Giardia and Cryptosporidium spp. 
in filtered drinking water supplies. Appl Environ Microbiol, 57, 2617-21. 
LEITSCH, D., BURGESS, A. G., DUNN, L. A., KRAUER, K. G., TAN, K., DUCHENE, M., UPCROFT, 
P., ECKMANN, L. & UPCROFT, J. A. 2011. Pyruvate:ferredoxin oxidoreductase and 
thioredoxin reductase are involved in 5-nitroimidazole activation while flavin 
metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J Antimicrob 
Chemother, 66, 1756-65. 
LEMOS, V., GRACZYK, T. K., ALVES, M., LOBO, M. L., SOUSA, M. C., ANTUNES, F. & MATOS, 
O. 2005. Identification and determination of the viability of Giardia lamblia cysts 
and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal 
and water supply samples by fluorescent in situ hybridization (FISH) and 
monoclonal antibodies. Parasitol Res, 98, 48-53. 
LEV, B., WARD, H., KEUSCH, G. T. & PEREIRA, M. E. 1986. Lectin activation in Giardia lamblia 
by host protease: a novel host-parasite interaction. Science, 232, 71-3. 
LI, Z., KULAKOVA, L., LI, L., GALKIN, A., ZHAO, Z., NASH, T. E., MARIANO, P. S., HERZBERG, O. 
& DUNAWAY-MARIANO, D. 2009. Mechanisms of catalysis and inhibition operative 
in the arginine deiminase from the human pathogen Giardia lamblia. Bioorg Chem, 
37, 149-61. 
LINGDAN, L., PENGTAO, G., WENCHAO, L., JIANHUA, L., JU, Y., CHENGWU, L., HE, L., 
GUOCAI, Z., WENZHI, R., YUJIANG, C. & XICHEN, Z. 2012. Differential dissolved 
protein expression throughout the life cycle of Giardia lamblia. Exp Parasitol, 132,  
465-9. 
LINTON, K. J. & HIGGINS, C. F. 1998. The Escherichia coli ATP-binding cassette (ABC) 
proteins. Mol Microbiol, 28, 5-13. 
References 
357 | P a g e  
LIU, J., GRATZ, J., AMOUR, C., KIBIKI, G., BECKER, S., JANAKI, L., VERWEIJ, J. J., TANIUCHI, 
M., SOBUZ, S. U., HAQUE, R., HAVERSTICK, D. M. & HOUPT, E. R. 2013. A 
laboratory-developed TaqMan Array Card for simultaneous detection of 19 
enteropathogens. J Clin Microbiol, 51, 472-80. 
LIU, L. X. & WELLER, P. F. 1996. Antiparasitic drugs. N Engl J Med, 334, 1178-84. 
LODISH, H., BERK, A., ZIPURSKY, J., MATSUDAIRA, P., BALTIMORE, D. & DARNELL, J. (eds.) 
2000. Molecular Cell biology, Fourth Edition, New York: W. H. Freeman. 
LOGDSON, J. M. J. 2008. Evolutionary genetics: sex happens in Giardia. Curr Biol, 18, R66-8. 
LOPEZ-RUBIO, J. J., RIVIERE, L. & SCHERF, A. 2007. Shared epigenetic mechanisms control 
virulence factors in protozoan parasites. Curr Opin Microbiol, 10, 560-8. 
LOPEZ, M. F., BERGGREN, K., CHERNOKALSKAYA, E., LAZAREV, A., ROBINSON, M. & 
PATTON, W. F. 2000. A comparison of silver stain and SYPRO Ruby Protein Gel Stain 
with respect to protein detection in two-dimensional gels and identification by 
peptide mass profiling. Electrophoresis, 21, 3673-83. 
LOVERDE, P. T., OSMAN, A. & HINCK, A. 2007. Schistosoma mansoni: TGF-beta signaling 
pathways. Exp Parasitol, 117, 304-17. 
LUCAS, M. L. 2010. Diarrhoeal disease through enterocyte secretion: a doctrine untroubled 
by proof. Exp Physiol, 95, 479-84. 
LUJAN, H. D., MAROTTA, A., MOWATT, M. R., SCIAKY, N., LIPPINCOTT-SCHWARTZ, J. & 
NASH, T. E. 1995a. Developmental induction of Golgi structure and function in the 
primitive eukaryote Giardia lamblia. J Biol Chem, 270, 4612-8. 
LUJAN, H. D., MOWATT, M. R., BYRD, L. G. & NASH, T. E. 1996. Cholesterol starvation 
induces differentiation of the intestinal parasite Giardia lamblia. Proc Natl Acad Sci 
U S A, 93, 7628-33. 
LUJAN, H. D., MOWATT, M. R., CONRAD, J. T., BOWERS, B. & NASH, T. E. 1995b. 
Identification of a novel Giardia lamblia cyst wall protein with leucine-rich repeats. 
Implications for secretory granule formation and protein assembly into the cyst 
wall. J Biol Chem, 270, 29307-13. 
LUJAN, H. D., MOWATT, M. R. & NASH, T. E. 1997. Mechanisms of Giardia lamblia 
differentiation into cysts. Microbiol Mol Biol Rev, 61, 294-304. 
LUJAN, H. D., MOWATT, M. R. & NASH, T. E. 1998. The molecular mechanisms of giardia 
encystation. Parasitol Today, 14, 446-50. 
LUJAN, H. D. & TOUZ, M. C. 2003. Protein trafficking in Giardia lamblia. Cell Microbiol, 5, 
427-34. 
LUO, J., TENG, M., ZHANG, G. P., LUN, Z. R., ZHOU, H. & QU, L. H. 2009. Evaluating the 
evolution of G. lamblia based on the small nucleolar RNAs identified from Archaea 
and unicellular eukaryotes. Parasitol Res, 104, 1543-6. 
MALYS, N. & MCCARTHY, J. E. 2011. Translation initiation: variations in the mechanism can 
be anticipated. Cell Mol Life Sci, 68, 991-1003. 
MARTI, M. & HEHL, A. B. 2003. Encystation-specific vesicles in Giardia: a primordial Golgi or 
just another secretory compartment? Trends Parasitol, 19, 440-6. 
MARTI, M., LI, Y., SCHRANER, E. M., WILD, P., KOHLER, P. & HEHL, A. B. 2003. The secretory 
apparatus of an ancient eukaryote: protein sorting to separate export pathways 
occurs before formation of transient Golgi-like compartments. Mol Biol Cell, 14,  
1433-47. 
MARTINEZ, M., PALACIOS, J. M., IMPERIAL, J. & RUIZ-ARGUESO, T. 2004. Symbiotic 
autoregulation of nifA expression in Rhizobium leguminosarum bv. viciae. J 
Bacteriol, 186, 6586-94. 
MATSUZAKI, T., TAJIKA, Y., ABLIMIT, A., AOKI, T., HAGIWARA, H. & TAKATA, K. 2004. 
Aquaporins in the digestive system. Med Electron Microsc, 37, 71-80. 
References 
358 | P a g e  
MAYRHOFER, G., ANDREWS, R. H., EY, P. L. & CHILTON, N. B. 1995. Division of Giardia 
isolates from humans into two genetically distinct assemblages by electrophoretic 
analysis of enzymes encoded at 27 loci and comparison with Giardia muris. 
Parasitology, 111 ( Pt 1), 11-7. 
MCCAFFERY, J. M., FAUBERT, G. M. & GILLIN, F. D. 1994. Giardia lamblia: traffic of a 
trophozoite variant surface protein and a major cyst wall epitope during growth, 
encystation, and antigenic switching. Exp Parasitol, 79, 236-49. 
MEDZHITOV, R. & JANEWAY, C., JR. 2000. Innate immune recognition: mechanisms and 
pathways. Immunol Rev, 173, 89-97. 
MELLMAN, I. & SIMONS, K. 1992. The Golgi complex: in vitro veritas? Cell, 68, 829-40. 
MEYER, E. A. 1970. Isolation and axenic cultivation of Giardia trophozoites from the rabbit, 
chinchilla, and cat. Exp Parasitol, 27, 179-83. 
MING, L. J. & EPPERSON, J. D. 2002. Metal binding and structure-activity relationship of the 
metalloantibiotic peptide bacitracin. J Inorg Biochem, 91, 46-58. 
MONIS, P. T., ANDREWS, R. H., MAYRHOFER, G. & EY, P. L. 1999. Molecular systematics of 
the parasitic protozoan Giardia intestinalis. Mol Biol Evol, 16, 1135-44. 
MONIS, P. T., ANDREWS, R. H., MAYRHOFER, G. & EY, P. L.  2003. Genetic diversity within 
the morphological species Giardia intestinalis and its relationship to host origin. 
Infect Genet Evol, 3, 29-38. 
MONIS, P. T., CACCIO, S. M. & THOMPSON, R. C. 2009. Variation in Giardia: towards a 
taxonomic revision of the genus. Trends Parasitol, 25, 93-100. 
MONIS, P. T. & THOMPSON, R. C. 2003. Cryptosporidium and Giardia-zoonoses: fact or 
fiction? Infect Genet Evol, 3, 233-44. 
MORAIS, E. R., OLIVEIRA, K. C., MAGALHAES, L. G., MOREIRA, E. B., VERJOVSKI-ALMEIDA, S. 
& RODRIGUES, V. 2013. Effects of curcumin on the parasite Schistosoma mansoni: a 
transcriptomic approach. Mol Biochem Parasitol, 187, 91-7. 
MOREIRA, E. D., JR., NASSRI, V. B., SANTOS, R. S., MATOS, J. F., DE CARVALHO, W. A., 
SILVANI, C. S. & SANTANA E SANT'ANA, C. 2005. Association of Helicobacter pylori 
infection and giardiasis: results from a study of surrogate markers for fecal 
exposure among children. World J Gastroenterol, 11, 2759-63. 
MORGAN, D. O. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessors. 
Annu Rev Cell Dev Biol, 13, 261-91. 
MORKEN, M. H., VALEUR, J., NORIN, E., MIDTVEDT, T., NYSAETER, G. & BERSTAD, A. 2009. 
Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J 
Gastroenterol, 44, 1296-303. 
MORRISON, H. G., MCARTHUR, A. G., GILLIN, F. D., ALEY, S. B., ADAM, R. D., OLSEN, G. J., 
BEST, A. A., CANDE, W. Z., CHEN, F., CIPRIANO, M. J., DAVIDS, B. J., DAWSON, S. C., 
ELMENDORF, H. G., HEHL, A. B., HOLDER, M. E., HUSE, S. M., KIM, U. U., LASEK-
NESSELQUIST, E., MANNING, G., NIGAM, A., NIXON, J. E., PALM, D., PASSAMANECK, 
N. E., PRABHU, A., REICH, C. I., REINER, D. S., SAMUELSON, J., SVARD, S. G. & 
SOGIN, M. L. 2007. Genomic minimalism in the early diverging intestinal parasite 
Giardia lamblia. Science, 317, 1921-6. 
MOWATT, M. R.,  LUJAN, H. D., COTTEN, D. B., BOWERS, B., YEE, J., NASH, T. E. & STIBBS, H. 
H. 1995. Developmentally regulated expression of a Giardia lamblia cyst wall 
protein gene. Mol Microbiol, 15, 955-63. 
MPHB 2013. Manitoba Public Health Branch - Communicable disease management 
protocol: Giardiasis. 
MULLER, J., WASTLING, J., SANDERSON, S., MULLER, N. & HEMPHILL, A. 2007. A novel 
Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other 
thiazolides. Antimicrob Agents Chemother, 51, 1979-86. 
References 
359 | P a g e  
MUREK, M., KOPIC, S. & GEIBEL, J. 2010. Evidence for intestinal chloride secretion. Exp 
Physiol, 95, 471-8. 
NAGESHAN, R. K., ROY, N., RANADE, S. & TATU, U. 2014. Trans-spliced Heat Shock Protein 
90 Modulates Encystation in Giardia lamblia. PLoS Negl Trop Dis, 8, e2829. 
NANDAN, D. & REINER, N. E. 2005. Leishmania donovani engages in regulatory interference 
by targeting macrophage protein tyrosine phosphatase SHP-1. Clin Immunol, 114, 
266-77. 
NARAI, A., ARAI, S. & SHIMIZU, M. 1997. Rapid decrease in transepithelial electrical 
resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane 
perturbents. Toxicol In Vitro, 11, 347-54. 
NASH, T. E. 2002. Surface antigenic variation in Giardia lamblia. Mol Microbiol, 45, 585-90. 
NASH, T. E. 2013. Unraveling how Giardia infections cause disease. J Clin Invest, 123, 2346-
7. 
NATHNAC 2013. National Travel Health Network and Centre - Giardiasis. 
NHS. Giardiasis - Prevention [Online]. 
http://www.nhs.uk/Conditions/Giardiasis/Pages/Prevention.aspx. Available: 
http://www.nhs.uk/Conditions/Giardiasis/Pages/Prevention.aspx. 
NICHOLS, G., LANE, C., ASGARI, N., VERLANDER, N. Q. & CHARLETT, A. 2009. Rainfall and 
outbreaks of drinking water related disease and in England and Wales. J Water 
Health, 7, 1-8. 
NILLIUS, D., MULLER, J. & MULLER, N. 2011. Nitroreductase (GlNR1) increases susceptibility 
of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother, 66, 
1029-35. 
NKENFOU, C. N., NANA, C. T. & PAYNE, V. K. 2013. Intestinal parasitic infections in HIV 
infected and non-infected patients in a low HIV prevalence region, West-
Cameroon. PLoS One, 8, e57914. 
NOOR AZIAN, M. Y., SAN, Y. M., GAN, C. C., YUSRI, M. Y., NURULSYAMZAWATY, Y., 
ZUHAIZAM, A. H., MASLAWATY, M. N., NORPARINA, I. & VYTHILINGAM, I. 2007. 
Prevalence of intestinal protozoa in an aborigine community in Pahang, Malaysia. 
Trop Biomed, 24, 55-62. 
NZMH. 2013. New Zealand Ministry of Health - Giardia [Online]. 
https://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-
illnesses/food-and-water-borne-diseases/giardia. Available: 
https://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-
illnesses/food-and-water-borne-diseases/giardia. 
OKE, T. T., MOSKOVITZ, J. & WILLIAMS, D. L. 2009. Characterization of the methionine 
sulfoxide reductases of Schistosoma mansoni. J Parasitol, 95, 1421-8. 
OKSENHENDLER, E., GERARD, L., FIESCHI, C., MALPHETTES, M., MOUILLOT, G., JAUSSAUD, 
R., VIALLARD, J. F., GARDEMBAS, M., GALICIER, L., SCHLEINITZ, N., SUAREZ, F., 
SOULAS-SPRAUEL, P., HACHULLA, E., JACCARD, A., GARDEUR, A., THEODOROU, I., 
RABIAN, C. & DEBRE, P. 2008. Infections in 252 patients with common variable 
immunodeficiency. Clin Infect Dis, 46, 1547-54. 
OLDSTONE, M. B. 1998. Molecular mimicry and immune-mediated diseases. FASEB J, 12, 
1255-65. 
ORTEGA, Y. R. & ADAM, R. D. 1997. Giardia: overview and update. Clin Infect Dis, 25, 545-9; 
quiz 550. 
OSTERHOLM, M. T., FORFANG, J. C., RISTINEN, T. L., DEAN, A. G., WASHBURN, J. W., GODES, 
J. R., RUDE, R. A. & MCCULLOUGH, J. G. 1981. An outbreak of foodborne giardiasis. 
New England Journal of Medicine  
304, 24–28. 
References 
360 | P a g e  
PAGET, T. A. & JAMES, S. L. 1994. The mucolytic activity of polyamines and mucosal 
invasion. Biochem Soc Trans, 22, 394S. 
PAGET, T. A., JARROLL, E. L., MANNING, P., LINDMARK, D. G. & LLOYD, D. 1989. Respiration 
in the cysts and trophozoites of Giardia muris. J Gen Microbiol, 135, 145-54. 
PALM, D., WEILAND, M., MCARTHUR, A. G., WINIECKA-KRUSNELL, J., CIPRIANO, M. J., 
BIRKELAND, S. R., PACOCHA, S. E., DAVIDS, B., GILLIN, F., LINDER, E. & SVARD, S. 
2005. Developmental changes in the adhesive disk during Giardia differentiation. 
Mol Biochem Parasitol, 141, 199-207. 
PALM, J. E., WEILAND, M. E., GRIFFITHS, W. J., LJUNGSTROM, I. & SVARD, S. G. 2003. 
Identification of immunoreactive proteins during acute human giardiasis. J Infect 
Dis, 187, 1849-59. 
PARLATI, F., VARLAMOV, O., PAZ, K., MCNEW, J. A., HURTADO, D., SOLLNER, T. H. & 
ROTHMAN, J. E. 2002. Distinct SNARE complexes mediating membrane fusion in 
Golgi transport based on combinatorial specificity. Proc Natl Acad Sci U S A, 99,  
5424-9. 
PEATTIE, D. A. 1990. The giardins of Giardia lamblia: genes and proteins with promise. 
Parasitol Today, 6, 52-6. 
PEATTIE, D. A., ALONSO, R. A., HEIN, A. & CAULFIELD, J. P. 1989. Ultrastructural localization 
of giardins to the edges of disk microribbons of Giardia lamblia and the nucleotide 
and deduced protein sequence of alpha giardin. J Cell Biol, 109, 2323-35. 
PELAYO, L., FRAGA, J., NUNEZ, F. A., MENDOZA, D., TORRES, D. R. & FINLAY, C. M. 2003. 
Genetic characterization by random amplified polymorphic DNA analysis (RAPD) of 
18 isolates of Giardia lamblia obtained from day care children. Exp Parasitol, 104,  
162-6. 
PEREZ, T., ALBORNOZ, J. & DOMINGUEZ, A. 1998. An evaluation of RAPD fragment 
reproducibility and nature. Mol Ecol, 7, 1347-57. 
PERRY, D. A., MORRISON, H. G. & ADAM, R. D. 2011. Optical map of the genotype A1 WB C6 
Giardia lamblia genome isolate. Mol Biochem Parasitol, 180, 112-4. 
PFEFFER, S. R. 2001. Rab GTPases: specifying and deciphering organelle identity and 
function. Trends Cell Biol, 11, 487-91. 
PHAC. Public Health Agency Canada - GIARDIASIS [Online]. http://dsol-smed.phac-
aspc.gc.ca/dsol-smed/ndis/diseases/giar-eng.php. 
PHE 2013. Epidemiological data: Gastrointestinal diseases from 2000 to 2012.  
. 
PHILIP, R., CAMPBELL, E. & WHEATLEY, D. N. 2003. Arginine deprivation, growth inhibition 
and tumour cell death: 2. Enzymatic degradation of arginine in normal and 
malignant cell cultures. Br J Cancer, 88, 613-23. 
PILLAI, D. R. & KAIN, K. C. 1999. Immunochromatographic strip-based detection of 
Entamoeba histolytica-E. dispar and Giardia lamblia coproantigen. J Clin Microbiol, 
37, 3017-9. 
PINTO, M., ROBINE-LEON, S., APPAY, M., KEDINGER, M., TRIADOU, N., DUSSAULX, E., 
LACROIX, B., SIMON-ASSMANN, P., HAFFEN, K., FOGH, J. & ZWEIBAUM, A. 1983. 
Enterocyte-like Differenciation and Polarization of the Human Colon Carcinoma Cell 
Line Caco-2 in culture. Biol Cell, 47, 323-330. 
PLUTZER, J., ONGERTH, J. & KARANIS, P. 2010. Giardia taxonomy, phylogeny and 
epidemiology: Facts and open questions. Int J Hyg Environ Health, 213, 321-33. 
PORTER, J. D., GAFFNEY, C., HEYMANN, D. & PARKIN, W. 1990. Food-borne outbreak of 
Giardia lamblia. Am J Public Health, 80, 1259-60. 
POXLEITNER, M. K., CARPENTER, M. L., MANCUSO, J. J., WANG, C. J., DAWSON, S. C. & 
CANDE, W. Z. 2008. Evidence for karyogamy and exchange of genetic material in 
the binucleate intestinal parasite Giardia intestinalis. Science, 319, 1530-3. 
References 
361 | P a g e  
PRADO, M. S., STRINA, A., BARRETO, M. L., OLIVEIRA-ASSIS, A. M., PAZ, L. M. & 
CAIRNCROSS, S. 2003. Risk factors for infection with Giardia duodenalis in pre-
school children in the city of Salvador, Brazil. Epidemiol Infect, 131, 899-906. 
PRICE, E. R., ZYDOWSKY, L. D., JIN, M. J., BAKER, C. H., MCKEON, F. D. & WALSH, C. T. 1991. 
Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase 
with a signal sequence. Proc Natl Acad Sci U S A, 88, 1903-7. 
PRUCCA, C. G., RIVERO, F. D. & LUJAN, H. D. 2011. Regulation of antigenic variation in 
Giardia lamblia. Annu Rev Microbiol, 65, 611-30. 
PRUCCA, C. G., SLAVIN, I., QUIROGA, R., ELIAS, E. V., RIVERO, F. D., SAURA, A., CARRANZA, 
P. G. & LUJAN, H. D. 2008. Antigenic variation in Giardia lamblia is regulated by RNA 
interference. Nature, 456, 750-4. 
RAMESH, M. A., MALIK, S. B. & LOGSDON, J. M., JR. 2005. A phylogenomic inventory of 
meiotic genes; evidence for sex in Giardia and an early eukaryotic origin of meiosis. 
Curr Biol, 15, 185-91. 
READ, C., WALTERS, J., ROBERTSON, I. D. & THOMPSON, R. C. 2002. Correlation between 
genotype of Giardia duodenalis and diarrhoea. Int J Parasitol, 32, 229-31. 
REINER, D. S., DOUGLAS, H. & GILLIN, F. D. 1989. Identification and localization of cyst-
specific antigens of Giardia lamblia. Infect Immun, 57, 963-8. 
REINER, D. S., HETSKO, M. L., MESZAROS, J. G., SUN, C. H., MORRISON, H. G., BRUNTON, L. 
L. & GILLIN, F. D. 2003. Calcium signaling in excystation of the early diverging 
eukaryote, Giardia lamblia. J Biol Chem, 278, 2533-40. 
REINER, D. S., MCCAFFERY, J. M. & GILLIN, F. D. 2001. Reversible interruption of Giardia 
lamblia cyst wall protein transport in a novel regulated secretory pathway. Cell 
Microbiol, 3, 459-72. 
RENDTORFF, R. C. 1954. The experimental transmission of human intestinal protozoan 
parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg, 59, 209-20. 
REQUEJO, R., HURD, T. R., COSTA, N. J. & MURPHY, M. P. 2010. Cysteine residues exposed 
on protein surfaces are the dominant intramitochondrial thiol and may protect 
against oxidative damage. FEBS J, 277, 1465-80. 
RICHARD, S. A., BLACK, R. E., GILMAN, R. H., GUERRANT, R. L., KANG, G., LANATA, C. F., 
MOLBAK, K., RASMUSSEN, Z. A., SACK, R. B., VALENTINER-BRANTH, P., CHECKLEY, 
W., CHILDHOOD, M. & INFECTION, N. 2013. Diarrhea in early childhood: short-term 
association with weight and long-term association with length. Am J Epidemiol, 
178, 1129-38. 
RIMHANEN-FINNE, R., ENEMARK, H. L., KOLEHMAINEN, J., TOROPAINEN, P. & HANNINEN, 
M. L. 2007. Evaluation of immunofluorescence microscopy and enzyme-linked 
immunosorbent assay in detection of Cryptosporidium and Giardia infections in 
asymptomatic dogs. Vet Parasitol, 145, 345-8. 
RINGQVIST, E., AVESSON, L., SODERBOM, F. & SVARD, S. G. 2011. Transcriptional changes in 
Giardia during host-parasite interactions. Int J Parasitol, 41, 277-85. 
RINGQVIST, E., PALM, J. E., SKARIN, H., HEHL, A. B., WEILAND, M., DAVIDS, B. J., REINER, D. 
S., GRIFFITHS, W. J., ECKMANN, L., GILLIN, F. D. & SVARD, S. G. 2008. Release of 
metabolic enzymes by Giardia in response to interaction with intestinal epithelial 
cells. Mol Biochem Parasitol, 159, 85-91. 
ROBERTSON, L. J., FORBERG, T., HERMANSEN, L., HAMNES, I. S. & GJERDE, B. 2007. Giardia 
duodenalis cysts isolated from wild moose and reindeer in Norway: genetic 
characterization by PCR-rflp and sequence analysis at two genes. J Wildl Dis, 43,  
576-85. 
ROBERTSON, L. J. & GJERDE, B. K. 2006. Fate of Cryptosporidium oocysts and Giardia cysts 
in the Norwegian aquatic environment over winter. Microb Ecol, 52, 597-602. 
References 
362 | P a g e  
ROBERTSON, L. J., HANEVIK, K., ESCOBEDO, A. A., MORCH, K. & LANGELAND, N. 2010. 
Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol, 26, 75-
82. 
RODRIGUEZ-FUENTES, G. B., CEDILLO-RIVERA, R., FONSECA-LINAN, R., ARGUELLO-GARCIA, 
R., MUNOZ, O., ORTEGA-PIERRES, G. & YEPEZ-MULIA, L. 2006. Giardia duodenalis: 
analysis of secreted proteases upon trophozoite-epitheial cell interaction in vitro. 
Mem Inst Oswaldo Cruz, 101, 693-6. 
ROSE, Z. B., GROVE, D. S. & SEAL, S. N. 1986. Mechanism of activation by anions of 
phosphoglycolate phosphatases from spinach and human red blood cells. J Biol 
Chem, 261, 10996-1002. 
ROSSIGNOL, J. F. 2010. Cryptosporidium and Giardia: treatment options and prospects for 
new drugs. Exp Parasitol, 124, 45-53. 
ROXSTROM-LINDQUIST, K., PALM, D., REINER, D., RINGQVIST, E. & SVARD, S. G. 2006. 
Giardia immunity--an update. Trends Parasitol, 22, 26-31. 
ROXSTROM-LINDQUIST, K., RINGQVIST, E., PALM, D. & SVARD, S. 2005. Giardia lamblia-
induced changes in gene expression in differentiated Caco-2 human intestinal 
epithelial cells. Infect Immun, 73, 8204-8. 
ROY, N., NAGESHAN, R. K., RANADE, S. & TATU, U. 2012. Heat shock protein 90 from 
neglected protozoan parasites. Biochim Biophys Acta, 1823, 707-11. 
SAJID, M. & MCKERROW, J. H. 2002. Cysteine proteases of parasitic organisms. Mol 
Biochem Parasitol, 120, 1-21. 
SANDERS, N. N., EIJSINK, V. G., VAN DEN PANGAART, P. S., JOOST VAN NEERVEN, R. J., 
SIMONS, P. J., DE SMEDT, S. C. & DEMEESTER, J. 2007. Mucolytic activity of 
bacterial and human chitinases. Biochim Biophys Acta, 1770, 839-46. 
SARAIYA, A. A. & WANG, C. C. 2008. snoRNA, a novel precursor of microRNA in Giardia 
lamblia. PLoS Pathog, 4, e1000224. 
SAUCH, J. F. 1985. Use of immunofluorescence and phase-contrast microscopy for 
detection and identification of Giardia cysts in water samples. Appl Environ 
Microbiol, 50, 1434-8. 
SAVAGE, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol, 31, 
107-33. 
SCHARF, R. J., DEBOER, M. D. & GUERRANT, R. L. 2014. Recent advances in understanding 
the long-term sequelae of childhood infectious diarrhea. Curr Infect Dis Rep, 16,  
408. 
SCHUURMAN, T., LANKAMP, P., VAN BELKUM, A., KOOISTRA-SMID, M. & VAN ZWET, A. 
2007. Comparison of microscopy, real-time PCR and a rapid immunoassay for the 
detection of Giardia lamblia in human stool specimens. Clin Microbiol Infect, 13, 
1186-91. 
SCHWANHAUSSER, B., BUSSE, D., LI, N., DITTMAR, G., SCHUCHHARDT, J., WOLF, J., CHEN, 
W. & SELBACH, M. 2011. Global quantification of mammalian gene expression 
control. Nature, 473, 337-42. 
SCORZA, A. V., BALLWEBER, L. R., TANGTRONGSUP, S., PANUSKA, C. & LAPPIN, M. R. 2012. 
Comparisons of mammalian Giardia duodenalis assemblages based on the beta-
giardin, glutamate dehydrogenase and triose phosphate isomerase genes. Vet 
Parasitol, 189, 182-8. 
SCOTT, C. C., VACCA, F. & GRUENBERG, J. 2014. Endosome maturation, transport and 
functions. Semin Cell Dev Biol. 
SCOTT, K. G., LOGAN, M. R., KLAMMER, G. M., TEOH, D. A. & BURET, A. G. 2000. Jejunal 
brush border microvillous alterations in Giardia muris-infected mice: role of T 
lymphocytes and interleukin-6. Infect Immun, 68, 3412-8. 
References 
363 | P a g e  
SCOTT, K. G., MEDDINGS, J. B., KIRK, D. R., LEES-MILLER, S. P. & BURET, A. G. 2002. 
Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin 
light chain kinase-dependent fashion. Gastroenterology, 123, 1179-90. 
SCOTT, K. G., YU, L. C. & BURET, A. G. 2004. Role of CD8+ and CD4+ T lymphocytes in jejunal 
mucosal injury during murine giardiasis. Infect Immun, 72, 3536-42. 
SEPER, A., FENGLER, V. H., ROIER, S., WOLINSKI, H., KOHLWEIN, S. D., BISHOP, A. L., 
CAMILLI, A., REIDL, J. & SCHILD, S. 2011. Extracellular nucleases and extracellular 
DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol, 82,  
1015-37. 
SHARPE, H. J., STEVENS, T. J. & MUNRO, S. 2010. A comprehensive comparison of 
transmembrane domains reveals organelle-specific properties. Cell, 142, 158-69. 
SHETTY, N. & PRABHU, T. 1988. Evaluation of faecal preservation and staining methods in 
the diagnosis of acute amoebiasis and giardiasis. J Clin Pathol, 41, 694-9. 
SHIELDS, J. M., GLEIM, E. R. & BEACH, M. J. 2008. Prevalence of Cryptosporidium spp. and 
Giardia intestinalis in swimming pools, Atlanta, Georgia. Emerg Infect Dis, 14, 948-
50. 
SHIVELY, J. M., VAN KEULEN, G. & MEIJER, W. G. 1998. Something from almost nothing: 
carbon dioxide fixation in chemoautotrophs. Annu Rev Microbiol, 52, 191-230. 
SIMON, C. E. 1922. A critique of the supposed rodent origin of human giardiasis. 
SIMPSON, A. G., INAGAKI, Y. & ROGER, A. J. 2006. Comprehensive multigene phylogenies of 
excavate protists reveal the evolutionary positions of "primitive" eukaryotes. Mol 
Biol Evol, 23, 615-25. 
SINGER, S. M., ELMENDORF, H. G., CONRAD, J. T. & NASH, T. E. 2001. Biological selection of 
variant-specific surface proteins in Giardia lamblia. J Infect Dis, 183, 119-24. 
SKARIN, H., RINGQVIST, E., HELLMAN, U. & SVARD, S. G. 2011. Elongation factor 1-alpha is 
released into the culture medium during growth of Giardia intestinalis 
trophozoites. Exp Parasitol, 127, 804-10. 
SLAVIN, I., SAURA, A., CARRANZA, P. G., TOUZ, M. C., NORES, M. J. & LUJAN, H. D. 2002. 
Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase 
is essential for excystation of Giardia lamblia. Mol Biochem Parasitol, 122, 95-8. 
SLEE, E. A., HARTE, M. T., KLUCK, R. M., WOLF, B. B., CASIANO, C. A., NEWMEYER, D. D., 
WANG, H. G., REED, J. C., NICHOLSON, D. W., ALNEMRI, E. S., GREEN, D. R. & 
MARTIN, S. J. 1999. Ordering the cytochrome c-initiated caspase cascade: 
hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-
dependent manner. J Cell Biol, 144, 281-92. 
SMITH, H. V., CACCIO, S. M., COOK, N., NICHOLS, R. A. & TAIT, A. 2007. Cryptosporidium 
and Giardia as foodborne zoonoses. Vet Parasitol, 149, 29-40. 
SMITH, P. D., GILLIN, F. D., SPIRA, W. M. & NASH, T. E. 1982. Chronic giardiasis: studies on 
drug sensitivity, toxin production, and host immune response. Gastroenterology, 
83, 797-803. 
SNOECK, V., GODDEERIS, B. & COX, E. 2005. The role of enterocytes in the intestinal barrier 
function and antigen uptake. Microbes Infect, 7, 997-1004. 
SOGAARD, M., TANI, K., YE, R. R., GEROMANOS, S., TEMPST, P., KIRCHHAUSEN, T., 
ROTHMAN, J. E. & SOLLNER, T. 1994. A rab protein is required for the assembly of 
SNARE complexes in the docking of transport vesicles. Cell, 78, 937-48. 
SOLAYMANI-MOHAMMADI, S. & SINGER, S. M. 2011. Host immunity and pathogen strain 
contribute to intestinal disaccharidase impairment following gut infection. Journal 
of immunology, 187, 3769-75. 
SOLTYS, B. J., FALAH, M. & GUPTA, R. S. 1996. Identification of endoplasmic reticulum in the 
primitive eukaryote Giardia lamblia using cryoelectron microscopy and antibody to 
Bip. J Cell Sci, 109 ( Pt 7), 1909-17. 
References 
364 | P a g e  
SPRONG, H., CACCIO, S. M. & VAN DER GIESSEN, J. W. 2009. Identification of zoonotic 
genotypes of Giardia duodenalis. PLoS Negl Trop Dis, 3, e558. 
STARK, D., AL-QASSAB, S. E., BARRATT, J. L., STANLEY, K., ROBERTS, T., MARRIOTT, D., 
HARKNESS, J. & ELLIS, J. T. 2011. Evaluation of multiplex tandem real-time PCR for 
detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, 
and Giardia intestinalis in clinical stool samples. J Clin Microbiol, 49, 257-62. 
STEUART, R. F. 2010. Proteomic analysis of Giardia: studies from the pre- and post-genomic 
era. Experimental parasitology, 124, 26-30. 
STEUART, R. F., O'HANDLEY, R., LIPSCOMBE, R. J., LOCK, R. A. & THOMPSON, R. C. 2008. 
Alpha 2 giardin is an assemblage A-specific protein of human infective Giardia 
duodenalis. Parasitology, 135, 1621-7. 
STRAND, E. A., ROBERTSON, L. J., HANEVIK, K., ALVSVAG, J. O., MORCH, K. & LANGELAND, 
N. 2008. Sensitivity of a Giardia antigen test in persistent giardiasis following an 
extensive outbreak. Clin Microbiol Infect, 14, 1069-71. 
SULEMANA, A., PAGET, T. A. & JARROLL, E. L. 2014. Commitment to cyst formation in 
Giardia. Microbiology, 160, 330-9. 
SULLIVAN, P. B., MARSH, M. N., PHILLIPS, M. B., DEWIT, O., NEALE, G., CEVALLOS, A. M., 
YAMSON, P. & FARTHING, M. J. 1991. Prevalence and treatment of giardiasis in 
chronic diarrhoea and malnutrition. Arch Dis Child, 66, 304-6. 
SUN, C. H., MCCAFFERY, J. M., REINER, D. S. & GILLIN, F. D. 2003. Mining the Giardia lamblia 
genome for new cyst wall proteins. J Biol Chem, 278, 21701-8. 
SUNDSTROM, P. & ALIAGA, G. R. 1994. A subset of proteins found in culture supernatants 
of Candida albicans includes the abundant, immunodominant, glycolytic enzyme 
enolase. J Infect Dis, 169, 452-6. 
TAIPALE, M., JAROSZ, D. F. & LINDQUIST, S. 2010. HSP90 at the hub of protein homeostasis: 
emerging mechanistic insights. Nat Rev Mol Cell Biol, 11, 515-28. 
TAIT, S. W. & GREEN, D. R. 2010. Mitochondria and cell death: outer membrane 
permeabilization and beyond. Nat Rev Mol Cell Biol, 11, 621-32. 
TAKATA, K., MATSUZAKI, T. & TAJIKA, Y. 2004. Aquaporins: water channel proteins of the 
cell membrane. Prog Histochem Cytochem, 39, 1-83. 
TAN, S., TOMPKINS, L. S. & AMIEVA, M. R. 2009. Helicobacter pylori usurps cell polarity to 
turn the cell surface into a replicative niche. PLoS Pathog, 5, e1000407. 
TANIUCHI, M., VERWEIJ, J. J., NOOR, Z., SOBUZ, S. U., LIESHOUT, L., PETRI, W. A., JR., 
HAQUE, R. & HOUPT, E. R. 2011. High throughput multiplex PCR and probe-based 
detection with Luminex beads for seven intestinal parasites. Am J Trop Med Hyg, 
84, 332-7. 
TERESA PELLICER, M., FELISA NUNEZ, M., AGUILAR, J., BADIA, J. & BALDOMA, L. 2003. Role 
of 2-phosphoglycolate phosphatase of Escherichia coli in metabolism of the 2-
phosphoglycolate formed in DNA repair. J Bacteriol, 185, 5815-21. 
THOMPSON, R. C. 2002. Presidential address: rediscovering parasites using molecular tools-
-towards revising the taxonomy of Echinococcus, Giardia and Cryptosporidium. Int J 
Parasitol, 32, 493-6. 
THOMPSON, R. C., REYNOLDSON, J. A. & MENDIS, A. H. 1993. Giardia and giardiasis. Adv 
Parasitol, 32, 71-160. 
TIBAYRENC, M., KJELLBERG, F., ARNAUD, J., OURY, B., BRENIERE, S. F., DARDE, M. L. & 
AYALA, F. J. 1991. Are eukaryotic microorganisms clonal or sexual? A population 
genetics vantage. Proc Natl Acad Sci U S A, 88, 5129-33. 
TOUZ, M. C., CONRAD, J. T. & NASH, T. E. 2005. A novel palmitoyl acyl transferase controls 
surface protein palmitoylation and cytotoxicity in Giardia lamblia. Mol Microbiol, 
58, 999-1011. 
References 
365 | P a g e  
TOUZ, M. C., LUJAN, H. D., HAYES, S. F. & NASH, T. E. 2003. Sorting of encystation-specific 
cysteine protease to lysosome-like peripheral vacuoles in Giardia lamblia requires a 
conserved tyrosine-based motif. J Biol Chem, 278, 6420-6. 
TOUZ, M. C., NORES, M. J., SLAVIN, I., CARMONA, C., CONRAD, J. T., MOWATT, M. R., NASH, 
T. E., CORONEL, C. E. & LUJAN, H. D. 2002. The activity of a developmentally 
regulated cysteine proteinase is required for cyst wall formation in the primitive 
eukaryote Giardia lamblia. J Biol Chem, 277, 8474-81. 
TOUZ, M. C., ROPOLO, A. S., RIVERO, M. R., VRANYCH, C. V., CONRAD, J. T., SVARD, S. G. & 
NASH, T. E. 2008. Arginine deiminase has multiple regulatory roles in the biology of 
Giardia lamblia. J Cell Sci, 121, 2930-8. 
TOVAR, J., LEON-AVILA, G., SANCHEZ, L. B., SUTAK, R., TACHEZY, J., VAN DER GIEZEN, M., 
HERNANDEZ, M., MULLER, M. & LUCOCQ, J. M. 2003. Mitochondrial remnant 
organelles of Giardia function in iron-sulphur protein maturation. Nature, 426, 172-
6. 
TRAUB, R. J., INPANKAEW, T., REID, S. A., SUTTHIKORNCHAI, C., SUKTHANA, Y., 
ROBERTSON, I. D. & THOMPSON, R. C. 2009. Transmission cycles of Giardia 
duodenalis in dogs and humans in Temple communities in Bangkok--a critical 
evaluation of its prevalence using three diagnostic tests in the field in the absence 
of a gold standard. Acta Trop, 111, 125-32. 
TRAUB, R. J., MONIS, P. T., ROBERTSON, I., IRWIN, P., MENCKE, N. & THOMPSON, R. C. 
2004. Epidemiological and molecular evidence supports the zoonotic transmission 
of Giardia among humans and dogs living in the same community. Parasitology, 
128, 253-62. 
TROEGER, H., EPPLE, H. J., SCHNEIDER, T., WAHNSCHAFFE, U., ULLRICH, R., BURCHARD, G. 
D., JELINEK, T., ZEITZ, M., FROMM, M. & SCHULZKE, J. D. 2007. Effect of chronic 
Giardia lamblia infection on epithelial transport and barrier function in human 
duodenum. Gut, 56, 328-35. 
TURK, V., TURK, B., GUNCAR, G., TURK, D. & KOS, J. 2002. Lysosomal cathepsins: structure, 
role in antigen processing and presentation, and cancer. Adv Enzyme Regul, 42,  
285-303. 
UMEDA, K., MATSUI, T., NAKAYAMA, M., FURUSE, K., SASAKI, H., FURUSE, M. & TSUKITA, S. 
2004. Establishment and characterization of cultured epithelial cells lacking 
expression of ZO-1. J Biol Chem, 279, 44785-94. 
UPCROFT, J. & UPCROFT, P. 1998. My favorite cell: Giardia. Bioessays, 20, 256-63. 
UPCROFT, J. A., CAMPBELL, R. W., BENAKLI, K., UPCROFT, P. & VANELLE, P. 1999. Efficacy of 
new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, 
Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother, 43, 73-6. 
UPCROFT, P., MITCHELL, R. & BOREHAM, P. F. 1990. DNA fingerprinting of the intestinal 
parasite Giardia duodenalis with the M13 phage genome. Int J Parasitol, 20, 319-
23. 
UPCROFT, P. & UPCROFT, J. A. 2001. Drug targets and mechanisms of resistance in the 
anaerobic protozoa. Clin Microbiol Rev, 14, 150-64. 
VAN DER GIESSEN, J. W., DE VRIES, A., ROOS, M., WIELINGA, P., KORTBEEK, L. M. & MANK, 
T. G. 2006. Genotyping of Giardia in Dutch patients and animals: a phylogenetic 
analysis of human and animal isolates. Int J Parasitol, 36, 849-58. 
VARDAR, D., NORTH, C. L., SANCHEZ-IRIZARRY, C., ASTER, J. C. & BLACKLOW, S. C. 2003. 
Nuclear magnetic resonance structure of a prototype Lin12-Notch repeat module 
from human Notch1. Biochemistry, 42, 7061-7. 
VENKATESAN, P. 1998. Albendazole. J Antimicrob Chemother, 41, 145-7. 
VILLENEUVE, A. M. & HILLERS, K. J. 2001. Whence meiosis? Cell, 106, 647-50. 
References 
366 | P a g e  
WALLIS, P. M., ERLANDSEN, S. L., ISAAC-RENTON, J. L., OLSON, M. E., ROBERTSON, W. J. & 
VAN KEULEN, H. 1996. Prevalence of Giardia cysts and Cryptosporidium oocysts 
and characterization of Giardia spp. isolated from drinking water in Canada. Appl 
Environ Microbiol, 62, 2789-97. 
WALTERS, R. J., O'BRIEN, J. A., VALVERDE, M. A. & SEPULVEDA, F. V. 1992. Membrane 
conductance and cell volume changes evoked by vasoactive intestinal polypeptide 
and carbachol in small intestinal crypts. Pflugers Arch, 421, 598-605. 
WAMPFLER, P. B., TOSEVSKI, V., NANNI, P., SPYCHER, C. & HEHL, A. B. 2014. Proteomics of 
Secretory and Endocytic Organelles in Giardia lamblia. PLoS One, 9, e94089. 
WARD, W., ALVARADO, L., RAWLINGS, N. D., ENGEL, J. C., FRANKLIN, C. & MCKERROW, J. H. 
1997. A primitive enzyme for a primitive cell: the protease required for excystation 
of Giardia. Cell, 89, 437-44. 
WASTLING, J. M., XIA, D., SOHAL, A., CHAUSSEPIED, M., PAIN, A. & LANGSLEY, G. 2009. 
Proteomes and transcriptomes of the Apicomplexa--where's the message? 
International journal for parasitology, 39, 135-43. 
WEBSTER, B. H. 1960. Furazolidone in the treatment of giardiasis. Am J Dig Dis, 5, 618-22. 
WEGAYEHU, T., ADAMU, H. & PETROS, B. 2013. Prevalence of Giardia duodenalis and 
Cryptosporidium species infections among children and cattle in North Shewa 
Zone, Ethiopia. BMC Infect Dis, 13, 419. 
WEI, C. J., TIAN, X. F., ADAM, R. D. & LU, S. Q. 2010. Giardia lamblia: intracellular 
localization of alpha8-giardin. Exp Parasitol, 126, 489-96. 
WEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E. & LENGSFELD, H. 1987. Lipstatin, an 
inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing 
organism, fermentation, isolation and biological activity. J Antibiot (Tokyo), 40,  
1081-5. 
WEILAND, M. E., PALM, J. E., GRIFFITHS, W. J., MCCAFFERY, J. M. & SVARD, S. G. 2003. 
Characterisation of alpha-1 giardin: an immunodominant Giardia lamblia annexin 
with glycosaminoglycan-binding activity. Int J Parasitol, 33, 1341-51. 
WELCH, T. P. 2000. Risk of giardiasis from consumption of wilderness water in North 
America: a systematic review of epidemiologic data. Int J Infect Dis, 4, 100-3. 
WELSH, J. & MCCLELLAND, M. 1990. Fingerprinting genomes using PCR with arbitrary 
primers. Nucleic Acids Res, 18, 7213-8. 
WHO 1996. -The world health report. . 
WHO 2008. – Guidelines for drinking-water quality (Third edition incorporating first and 
second addenda). 
WHO. 2013. International travel and health - Giardiasis [Online]. 
http://www.who.int/ith/diseases/giardiasis/en/. Available: 
http://www.who.int/ith/diseases/giardiasis/en/. 
WILKINSON, B. & GILBERT, H. F. 2004. Protein disulfide isomerase. Biochim Biophys Acta, 
1699, 35-44. 
WILLIAMS, J. G., KUBELIK, A. R., LIVAK, K. J., RAFALSKI, J. A. & TINGEY, S. V. 1990. DNA 
polymorphisms amplified by arbitrary primers are useful as genetic markers. 
Nucleic Acids Res, 18, 6531-5. 
WOLFE, M. S. 1992. Giardiasis. Clin Microbiol Rev, 5, 93-100. 
WRIGHT, E. M., HIRAYAMA, B. A. & LOO, D. F. 2007. Active sugar transport in health and 
disease. J Intern Med, 261, 32-43. 
YU, L. C., FLYNN, A. N., TURNER, J. R. & BURET, A. G. 2005. SGLT-1-mediated glucose uptake 
protects intestinal epithelial cells against LPS-induced apoptosis and barrier 
defects: a novel cellular rescue mechanism? FASEB J, 19, 1822-35. 
References 
367 | P a g e  
YU, L. C., HUANG, C. Y., KUO, W. T., SAYER, H., TURNER, J. R. & BURET, A. G. 2008. SGLT-1-
mediated glucose uptake protects human intestinal epithelial cells against Giardia 
duodenalis-induced apoptosis. Int J Parasitol, 38, 923-34. 
YU, L. C., TURNER, J. R. & BURET, A. G. 2006. LPS/CD14 activation triggers SGLT-1-mediated 
glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic 
signals upstream of caspase-3. Exp Cell Res, 312, 3276-86. 
ZEUTHEN, T. 2010. Water-transporting proteins. J Membr Biol, 234, 57-73. 
ZHANG, W., ZHANG, X., WANG, R., LIU, A., SHEN, Y., LING, H., CAO, J., YANG, F., ZHANG, X. 
& ZHANG, L. 2012. Genetic characterizations of Giardia duodenalis in sheep and 
goats in Heilongjiang Province, China and possibility of zoonotic transmission. PLoS 
Negl Trop Dis, 6, e1826. 
  
 
